{"BGC0000692.1|Apramycin_1 # 3 # 1199 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744": {"gnl|BL_ORD_ID|2386|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3, "orf_end": 1199, "orf_from": "BGC0000692.1|Apramycin_1 ", "model_name": "LpeA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "680", "model_id": "2758", "ARO_accession": "3004099", "ARO_name": "LpeA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.56944, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "41208", "query": "EGDPAIVQGMRYSQFHLFGSIDRGRTVHNVPA", "match": "EG P  V G RYS  HL   +D     H  PA", "sequence_from_db": "EGQPVYVLGKRYSLSHLQKMLDED--THMCPA", "sequence_from_broadstreet": "MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS", "dna_sequence_from_broadstreet": "GTGTTAGGAATTCAATTCAATAGAGGTCAATGGCGGTCAAACTATTATTGGCAAATACCTGTGCTGATAATAGCTGTTATTAGCATTCTGTTTTTCATCAGTAAAAAATTATTCTACTCAAAAGTTACGCCAGAAAGCATACCTAATAAACTGGTGGAAGTTGAGCCCATTAAAAGCCACAACTTACAACAAACAATCCATTTATTAGGTACCATTCATCCAAAACACGCAACGACATTAATTGCTAAAGAATCAGGTATGTTGGACACCCTTATCCCAACTGGTCAAAAAGTCACAAAAGGGACACTTATTGCAAAAATCAACAACCCTGATCTTGAAAAAAATCTACAGCTTTCATTAAGTGCGGTAGAATTGGCAAAAGCACAATATGAACGTATCACCCCTTTAATTAAATCAGGATATGTCAGTACAAAGGAAGTCGAAGAAAAAAAACAAGCCTGGATTGATGCCCAAAAAGAATTATCAAAAACAAGGATTGAATTAGATAACCTCCGCTTTTACGCTCCTTTCGACGGAATAATTGGAGCATACAAAAAGAGAGAAGGAGCACAAGTCAATGCAGGTGAATCTGTTGTAAGTATTTACGACCCTTCTGCTTTAGTTGTCGATTTTGATATTCCTTGCAGTAATTTGGCAACTCTTAATGAAGGTCAGCCGGTTTATGTGCTGGGTAAACGGTATTCATTAAGTCATTTACAAAAAATGCTCGACGAAGACACCCACATGTGCCCTGCTGATGTTGATATTCAATGTGATGATTGTCTTATTGGTGCGACCACAAGTGTTGAGCTCCTTGTTGCGGAAAAAAATAACACTATTGTCATCCCCTTCCAGGCAATATTTTTGAGAAATAGTAAACCTTTTGTATATCTTGTAAAAAAGGGAAAGATTGTGCTTGCTTCAGTGAAAACTGGGTTGCAACAAGAGGATAAAATTGAAATTGTCGAGGGATTAAAAGCTGGGCAACAACTGGTTACAAAAGGCCAGGAACGCTTATATCCTGAAATGACCGTTGATATTTATCATCCAGCGACAAGTAGCAGCTAA", "partial": "0", "query_start": 915, "query_end": 1010, "hit_start": 666, "hit_end": 756, "orf_dna_sequence": "ATGACGAGCACGGCGAGCGACCCGAACCGGGGCCCCGGCGGCCAGGCCGATCCCGGCTGGGTGATCGAGCGCACCGCCTACCGGCGGACCGAGGACAGCTTCTACGAGAGCCTGTTCGCCCTGTCCAACGGCCGGATCGGCGTCCGCGCGACCGCGGACTTCGACGCCGGAGGCGGTTGGCCCGGCTTCTACCACGCGCGGATGTACGCCAGGGCGGTGACCGTGCGGCGGCACCTGGTCAACGCGCCCACCCCGGCCTTCCGCGCCGTCCTGGTCGACGGCGTCCCGCTGGCGGTGACCGCGGACCGGGTGACGGAGTTCCGGCAGCGCCTCGACCTGCGCCGGGCCCGCCAGGAGCTGGTCGTCACCGTGCGCGACGGTCAGGGCCGGCACACCCGGATCGAGACGACCACCCTGCTGCCGGCGCAGTTCACCACCACCCTGGTCCAGCGCGTCGCGGTGACCCCGCTGGACCACGACGCCCCGGTCACGGTCCTGACCGGGGTGGACTGGTCGACCGGGAACGGCGACCTGGGCGGGCAGCTGCCCCGGGTCCGGGTGCACCACGCCGAACCGCTGGACCTGGGGTACCGCCCCGGCCGGCTGGACGCGCGGGTCCGCAGCTTCGGCCACGAGGAGGAGATCACCGAGCGGTTGGCGGTGCTGGCGGCGTCGGCCGAGCCGGAGGCACGGGACGTCTGCTTCGGCCGGGTCCGGCACGCCGAGGCGCTGCGCTTCGCCGGCGGGGCCGGGCGCGAGATCCGCGTGGACACCGTCGCCGTGATCAGCACGAACTTCGACGACGACGCTGTGTCCGTCGACCCCGACGTGGACGCGGTGCCCGACATCGACCTGGTGGTGGCCGAGCACGAGCGGATCTGGGCCGAGCGCTGGCGGCGGCACGCCGAGGTCGAGGGCGACCCGGCGATCGTGCAGGGCATGCGGTACTCGCAGTTCCACCTGTTCGGGTCGATCGACCGCGGCCGGACCGTCCACAACGTCCCGGCCAGGGGGCTGAGCAGCGAGTACCACTCGGGGCACTTCTTCTACAACACGGAGTTCTTCGCGCTGCCGCACGCCGCGTGGACCGATCCGGCGGCGGCCAAGGCCATGCTGCGGTTCCGCGTCGCCACGCTGGACGCGGCGCGCGAGCACGCGCGGCGCACCGGCTACGAGGGCGCCCGCTTCCCGGAGGAG", "orf_prot_sequence": "MTSTASDPNRGPGGQADPGWVIERTAYRRTEDSFYESLFALSNGRIGVRATADFDAGGGWPGFYHARMYARAVTVRRHLVNAPTPAFRAVLVDGVPLAVTADRVTEFRQRLDLRRARQELVVTVRDGQGRHTRIETTTLLPAQFTTTLVQRVAVTPLDHDAPVTVLTGVDWSTGNGDLGGQLPRVRVHHAEPLDLGYRPGRLDARVRSFGHEEEITERLAVLAASAEPEARDVCFGRVRHAEALRFAGGAGREIRVDTVAVISTNFDDDAVSVDPDVDAVPDIDLVVAEHERIWAERWRRHAEVEGDPAIVQGMRYSQFHLFGSIDRGRTVHNVPARGLSSEYHSGHFFYNTEFFALPHAAWTDPAAAKAMLRFRVATLDAAREHARRTGYEGARFPEE", "perc_identity": 43.75}}, "BGC0000692.1|Apramycin_2 # 1196 # 2134 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.774": {"gnl|BL_ORD_ID|1513|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1196, "orf_end": 2134, "orf_from": "BGC0000692.1|Apramycin_2 ", "model_name": "arnA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "1643", "ARO_accession": "3002985", "ARO_name": "arnA", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0816488, "max_identities": 44, "bit_score": 31.5722, "cvterm_id": "36804", "query": "RLVFLSSGAVYGRTGDAPVREDHPTL---PTSA----YGATKLAAEQAVGWYAGTGALSAVSLRLFTAAG-------SVRPGCRPDDSTLVARALSVAAGENAVLPVNGDGSTVRDFVHVADVADAVARAVEA-PARRPAEVVNLGA--VAASVREV", "match": "R+VF S+  VYG   D    ED   L   P +     Y  +K   ++ + W  G   L     R F   G       S R G     + L+   L +  G    L V+G G+  R F  V D  +A+AR ++    R   ++VN+G     AS+R++", "sequence_from_db": "RVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVI-WAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLI---LHLVEGTPIRL-VDG-GAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQL", "sequence_from_broadstreet": "MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA", "dna_sequence_from_broadstreet": "ATGACCTCGAAAGCCGTCGTCTTCGCCTACCACGACATCGGTTGCACCGGTATCGAAGCCCTGCTCAATGCCGGCTACGAGATCGCCGCCGTCTTCACCCATGCCGACGACCCACGGGAAAACACCTTCTACGCCTCGGTCGCACGCCTCTGCGCCGAGCGCGGCATTCCGCTGCACGCGCCCGAGGACGTGAACCATCCGCTGTGGCTGGAGCGTATCCGCCAACTGCGCCCGGACTTCCTGTTCTCCTTCTACTACCGCCGCCTGCTCGGCGCCGAGCTGCTCGCCTGCGCCGCACGCGGCGCCTACAACCTGCACGGTTCGCTGCTGCCGCGCTACCGCGGACGCGCCCCGGCGAACTGGGTGCTGGTCAACGGCGAAACGCAGACCGGGGTGACCCTGCATCGCATGATCGAGCGCGCCGACGCCGGGCCGATCCTCGCCCAGCAGGCCGTCGCCATCGACCCCGAGGACACCGCCCTGAGCCTGCACGGCAAGCTGCGCAAGGCCGCCGGCGCCCTGCTGCGCGACAGCCTGCCGCTGCTCGCCCTCGGCGTGCTGCCGGAAGTCGAGCAGGACGAGAGCCAGGCCAGCCACTTCGGCCGGCGCACCCCGGCGGACGGCCTGCTCGACTGGCACAGGCCGGCACGGCAGTTGTACGACCTGGTGCGCGCGGTGACCCAGCCCTACCCTGGCGCCTTCTGCCAGGTCGGCGAACAGAAGCTGATCGTCTGGAGCGCCGAGGTGGTCGCCGGCAACCACGGCCGCGAGCCGGGCAGCGTACTGTCCTGCGACCCGCTGCGGATCGCCTGCGGCGAGGACTCGCTGGTGCTGCGCTTCGGCCAGCGCGGCGAGCGCGGCCTGTACCTGGCCGGCACGCAACTGGCCACCGAGCTGGGCCTGGTCGAGGGCGCGCGCCTGCGTGGCGCGGCATGCAGTCCGCAGCGCCGCACGCGGGTGCTGATCCTCGGGGTCAACGGCTTCATCGGCAACCACCTGTCCGAACGCCTGCTGCGCGACGGTCGCTACGAGGTCCACGGCATGGACATCGGCTCCGACGCCATCGAACGGCTCAAGGCCGACCCGCATTTCCACTTCGTCGAAGGCGACATCGGCATCCATTCGGAGTGGCTCGAATACCATGTGAAGAAATGCGACGTGATCCTGCCGCTGGTGGCCATCGCCACGCCCATCGAGTACACGCGCAACCCGCTGCGGGTGTTCGAACTGGACTTCGAGGAAAACCTGCGGATCGTCCGCTACTGCGTGAAATACGGCAAACGCGTGGTGTTCCCTTCCACCTCCGAGGTCTACGGCATGTGCCAGGACCCGGACTTCGACGAAGACCGCTCGAACCTGGTGGTCGGGCCGATCAACAAGCAGCGCTGGATCTACTCGGTGTCCAAGCAGTTGCTCGACCGGGTGATCTGGGCCTACGGCCAGCAGGGCCTGCGCTTCACCCTGTTCCGTCCGTTCAACTGGATGGGCCCGCGCCTGGACCGCCTGGATTCGGCGCGGATCGGCAGCTCGCGGGCGATCACCCAGCTCATCCTGCACCTGGTCGAAGGCACGCCGATCCGCCTGGTCGACGGCGGCGCGCAGAAGCGCTGCTTCACCGACGTCGACGACGGCATCGAGGCCCTCGCGCGGATCATCGACAACCGCGACGGCCGCTGCGACGGGCAGATCGTCAACATCGGCAACCCGGACAACGAGGCGAGCATCCGCCAGCTCGGCGAGGAACTGCTGCGCCAGTTCGAGGCCCACCCGCTGCGCGCGCAGTTCCCGCCCTTCGCCGGCTTCCGCGAGGTGGAGAGCCGCAGCTTCTACGGCGACGGCTACCAGGACGTGGCCCACCGCAAGCCGAGCATCGACAACGCCCGGCGCCTGCTCGACTGGCAGCCCACCATCGAACTGCGCGAGACCATCGGCAAGACCCTCGACTTCTTCCTCCACGAAGCGCTCCGCGAGCGCGAGGCACAGGCGTGA", "partial": "0", "query_start": 1526, "query_end": 1945, "hit_start": 1281, "hit_end": 1734, "orf_dna_sequence": "ATGCGCATCTTCGTGACCGGGGCCGCCGGTTACGTCGGCCAGGCGGTCCTCGCGCGGCTGCTCGCCGCCGGGCACGACGTCACGGCCGTCGGCCACCGGACTCCGGTCGGGTGGCCGGCGGGCACGCCGAGCCGCCAGGCCGACCTGACCGACGCCCCGGCGGTGCTCCGGGCGCTCGACGGCGCCGAGGCGGTCTGCCACCTCGCCGGGCTGACCAGGGTGCGGGGAAGCGGCGTGGACGTGGACCGGTACTACCGGGTCAACGTGGTGGGCACCCTCAACGTGCTGGACGCCCTGGTCGCCCGGCACCGGGCCGGGGACGGCCCGGCCCGGCTGGTGTTCCTGTCCAGCGGGGCGGTCTACGGGCGGACCGGCGACGCGCCGGTCCGCGAGGACCACCCGACGCTGCCGACCAGCGCGTACGGGGCCACGAAGCTCGCGGCGGAGCAGGCCGTCGGCTGGTACGCGGGGACCGGCGCGCTGTCGGCGGTCTCGCTGCGCCTGTTCACCGCGGCGGGCAGCGTCCGCCCCGGTTGTCGGCCGGACGACAGCACCCTCGTCGCGCGGGCGCTGTCCGTCGCGGCGGGAGAGAACGCTGTTCTCCCGGTCAACGGCGACGGCTCGACGGTGCGGGACTTCGTGCACGTCGCCGACGTCGCCGACGCGGTCGCCCGCGCGGTCGAAGCGCCGGCGCGCCGGCCGGCCGAGGTGGTCAACCTGGGCGCCGTCGCGGCGAGCGTGCGCGAGGTGGTCGCGGCGGTCGAACGCGTCACCGGCCGCCGCGTCCCGGTGGCGCACGGCCCGGCGAACAGCGCGGACCAGCCGTGGCTGGCGGCCGACACCGGCGCGGCCAGGGAGCTGCTCGGCTGGGCGCCGACCCGGTCGAGCCTGGAACGGATGATCGAGGACCAGTGGCGAGTCGGGGGAGCGGGACGATGA", "orf_prot_sequence": "MRIFVTGAAGYVGQAVLARLLAAGHDVTAVGHRTPVGWPAGTPSRQADLTDAPAVLRALDGAEAVCHLAGLTRVRGSGVDVDRYYRVNVVGTLNVLDALVARHRAGDGPARLVFLSSGAVYGRTGDAPVREDHPTLPTSAYGATKLAAEQAVGWYAGTGALSAVSLRLFTAAGSVRPGCRPDDSTLVARALSVAAGENAVLPVNGDGSTVRDFVHVADVADAVARAVEAPARRPAEVVNLGAVAASVREVVAAVERVTGRRVPVAHGPANSADQPWLAADTGAARELLGWAPTRSSLERMIEDQWRVGGAGR", "perc_identity": 28.03}}, "BGC0000692.1|Apramycin_3 # 2150 # 3448 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761": {"gnl|BL_ORD_ID|1239|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000336472, "max_identities": 29, "bit_score": 38.891, "cvterm_id": "36789", "query": "LRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQA", "match": "L+   +   + +    +  +L  T       +E   L G D +  D     + D    N  ++ S     H K A+  G +LRD DL+ A+F Q               A +TG +L+ A+  + L+++ ", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYAD-----LRDASFKNCQLSMS-----HFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKC", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3038, "query_end": 3382, "hit_start": 51, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.31}, "gnl|BL_ORD_ID|1239|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.034729, "max_identities": 28, "bit_score": 32.7278, "cvterm_id": "36789", "query": "RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQ", "match": "R++  +T     T +    L G + SYA     S ++C L+ +     + + + + D  L  A  ++  F      +     A +   +L YA+F+Q               A+L GA    +DL R +  +", "sequence_from_db": "RSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSE", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3041, "query_end": 3379, "hit_start": 102, "hit_end": 498, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.21}, "gnl|BL_ORD_ID|1239|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.239392, "max_identities": 25, "bit_score": 30.4166, "cvterm_id": "36789", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYR---------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASF-----QQADLTGADLAGADLH", "match": "  G N  +   L  CDL GA+ ++V                    N+S    +  L+ +          A+LRGA  +++DL    F     +Q  + G DL+ ++L+", "sequence_from_db": "FKGAN-CFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELY", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3361, "hit_start": 234, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.15}, "gnl|BL_ORD_ID|1239|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35602, "max_identities": 31, "bit_score": 28.1054, "cvterm_id": "36789", "query": "CALRADTYETLSAVTTV-----LRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVP", "match": "C L+   +  +S V  V          + G NLSYA + E   +   DL E      N+       + ++R  F+    ++  ++G DL  ++L     ++ DLTG  +        LL+Q   + VP", "sequence_from_db": "CDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYA-NFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ-QEQLLEQLGVIIVP", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3032, "query_end": 3400, "hit_start": 273, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.22}, "gnl|BL_ORD_ID|1663|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000511539, "max_identities": 29, "bit_score": 38.5058, "cvterm_id": "36920", "query": "LRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQA", "match": "L+   +   + +    +  +L  T       +E   L G D +  D     + D    N  ++ S     H K A+  G +LRD DL+ A+F Q               A +TG +L+ A+  + L+++ ", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYAD-----LRDASFKNCQLSMS-----HFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKC", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3038, "query_end": 3382, "hit_start": 51, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.31}, "gnl|BL_ORD_ID|1663|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.128967, "max_identities": 23, "bit_score": 31.187, "cvterm_id": "36920", "query": "RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADL", "match": "R++  +T     T +    L G + SYA     S ++C L+ +     + + + + D  L  A   +  F      +     A +   +L YA+F+Q  +   DL", "sequence_from_db": "RSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDL", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3041, "query_end": 3343, "hit_start": 102, "hit_end": 417, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.9}, "gnl|BL_ORD_ID|1663|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.42072, "max_identities": 31, "bit_score": 27.335, "cvterm_id": "36920", "query": "CALRADTYETLSAVTTV-----LRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVP", "match": "C L+   +  +S V  V          + G NLSYA + E   +   DL E      N+       + ++R  F+    ++  ++G DL  ++L     ++ DLTG  +        LL+Q   + VP", "sequence_from_db": "CDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYA-NFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ-QEQLLEQLGVIIVP", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3032, "query_end": 3400, "hit_start": 273, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.22}, "gnl|BL_ORD_ID|1449|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00255303, "max_identities": 28, "bit_score": 36.1946, "cvterm_id": "39615", "query": "LRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQA", "match": "L+   +   + +    +  +L  T       +E   L G D +  D     + D    +  ++ S     H K A+  G +LRD DL+ A+F Q               A +TG +L+ A+  + L+++ ", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYAD-----LRDASFKDCQLSMS-----HFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKC", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3038, "query_end": 3382, "hit_start": 51, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.54}, "gnl|BL_ORD_ID|1449|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0985268, "max_identities": 28, "bit_score": 31.5722, "cvterm_id": "39615", "query": "RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQ", "match": "R++  +T     T +    L G + SYA     S + C L+ +     + + + + D  L  A  ++  F      +     A +   +L YA+F+Q               A+L GA    +DL R +  +", "sequence_from_db": "RSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSE", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3041, "query_end": 3379, "hit_start": 102, "hit_end": 498, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.21}, "gnl|BL_ORD_ID|1449|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.266555, "max_identities": 25, "bit_score": 30.0314, "cvterm_id": "39615", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYR---------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASF-----QQADLTGADLAGADLH", "match": "  G N  +   L  CDL GA+ ++V                    N+S    +  L+ +          A+LRGA  +++DL    F     +Q  + G DL+ ++L+", "sequence_from_db": "FKGAN-CFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELY", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3361, "hit_start": 234, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.15}, "gnl|BL_ORD_ID|1449|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.41787, "max_identities": 31, "bit_score": 27.7202, "cvterm_id": "39615", "query": "CALRADTYETLSAVTTV-----LRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVP", "match": "C L+   +  +S V  V          + G NLSYA + E   +   DL E      N+       + ++R  F+    ++  ++G DL  ++L     ++ DLTG  +        LL+Q   + VP", "sequence_from_db": "CDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYA-NFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ-QEQLLEQLGVIIVP", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 3032, "query_end": 3400, "hit_start": 273, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.22}, "gnl|BL_ORD_ID|1389|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00314459, "max_identities": 27, "bit_score": 36.1946, "cvterm_id": "36891", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHR", "match": "+ +G N  +      CDL GA+ +    Y   VS  +   A     C    +L  A+L G  L   +L   ++  A+L+GA L G+DL R", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYN-QVSHKMYFCAAYISGC----NLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3364, "hit_start": 231, "hit_end": 483, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1389|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0423324, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "36891", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEP", "match": "++G NL+YA      +L+G  L + + +  N S+  L  A +  S  +RG   R   +  +LR            DLT ADL G D  R  L+      V + A      +EP", "sequence_from_db": "ISGCNLAYA------NLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGC----------DLTFADLDGLDPRRVNLE-----GVKICAWQQEQLLEP", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3436, "hit_start": 354, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.32}, "gnl|BL_ORD_ID|1389|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.00112, "max_identities": 27, "bit_score": 28.4906, "cvterm_id": "36891", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRALLDQAVGLSVPVPA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA     V   +   A", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3409, "hit_start": 0, "hit_end": 348, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.43}, "gnl|BL_ORD_ID|1541|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00485609, "max_identities": 27, "bit_score": 35.4242, "cvterm_id": "36771", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYR--------------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "+ +G N  +      CDL GA+ +    Y                      N+S   L+   +  + ++  +L  ASL G+DL         +QQ +L G DL  ADL", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3358, "hit_start": 231, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|1541|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0311727, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36771", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLE", "match": "++G NL+YA     C L   +L E +    N+S   L  + ++   F+R   ++ +LRG DL  ADL+", "sequence_from_db": "ISGCNLAYANLSGQC-LEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3301, "hit_start": 354, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 32.35}, "gnl|BL_ORD_ID|1541|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.83634, "max_identities": 25, "bit_score": 27.7202, "cvterm_id": "36771", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3367, "hit_start": 0, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.32}, "gnl|BL_ORD_ID|952|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00494476, "max_identities": 27, "bit_score": 35.4242, "cvterm_id": "36891", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYR--------------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "+ +G N  +      CDL GA+ +    Y                      N+S   L+   +  + ++  +L  ASL G+DL         +QQ +L G DL  ADL", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3358, "hit_start": 231, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|952|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0311727, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLE", "match": "++G NL+YA     C L   +L E +    N+S   L  + ++   F+R   ++ +LRG DL  ADL+", "sequence_from_db": "ISGCNLAYANLSGQC-LEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3301, "hit_start": 354, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 32.35}, "gnl|BL_ORD_ID|952|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.71795, "max_identities": 25, "bit_score": 26.9498, "cvterm_id": "36891", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3367, "hit_start": 0, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.32}, "gnl|BL_ORD_ID|1470|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00529919, "max_identities": 30, "bit_score": 35.4242, "cvterm_id": "36771", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDAD-----LEYASFQQADLTGADLAGADLHRALLDQA", "match": "D +G +LS +    HC   G +       RVN+ D       M  +       +  +   ADLRDA      L  A+FQ A+  G +L   DL  A   QA", "sequence_from_db": "DFSGQDLS-SHHFSHCKFFGCNFN-----RVNLRDA----KFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQA", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 3095, "query_end": 3382, "hit_start": 33, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.7}, "gnl|BL_ORD_ID|1470|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00720363, "max_identities": 29, "bit_score": 35.039, "cvterm_id": "36771", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYR--VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASF-----QQADLTGADLAGADLH", "match": "C L    ++  +     LR  DL G N S A  + H       +     Y    N+S    D   + +          ASL+GA  +++DL   SF     +Q  + G DL  ++L+", "sequence_from_db": "CMLSMANFQGANCFGLELRECDLKGANFSQANFVNH---VSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELN", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 3032, "query_end": 3361, "hit_start": 213, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.79}, "gnl|BL_ORD_ID|1470|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.526388, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "36771", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVP", "match": "+ G NLSYA   + C L   DL E      ++       + ++R  F+    ++  ++G DL  ++L     ++ DLTG  +        LL+Q   + +P", "sequence_from_db": "ITGCNLSYANFDKQC-LEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQ-QEQLLEQLGVIVIP", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 3098, "query_end": 3400, "hit_start": 354, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.75}, "gnl|BL_ORD_ID|1062|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0053159, "max_identities": 31, "bit_score": 35.4242, "cvterm_id": "39525", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVP", "match": "+ G NLSYA     C +   DL E      N+S      + ++R  F+ G   +  L+G DL  ++L     ++ DLTG  +        LL+Q +GL + VP", "sequence_from_db": "ITGCNLSYANFERQC-IEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ-QEQLLEQ-LGL-IVVP", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3406, "hit_start": 354, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 30.1}, "gnl|BL_ORD_ID|1062|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0454912, "max_identities": 29, "bit_score": 32.3426, "cvterm_id": "39525", "query": "WLCAL-RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFA-----RGHLKRASLRGADLRDADLEYASFQQADL-----TGADLAGADLHRALLDQAV", "match": "+ C+  RA+  +T     + +   +L G + SY+     S ++C L+ +     + + +   +  L  A  +++ F      R +   A + G +L  A+ E    ++ DL      GA+L+GA    + L + V", "sequence_from_db": "FCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGV", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3026, "query_end": 3385, "hit_start": 84, "hit_end": 489, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.48}, "gnl|BL_ORD_ID|1835|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0053642, "max_identities": 27, "bit_score": 35.4242, "cvterm_id": "35915", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYR--------------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "+ +G N  +      CDL GA+ +    Y                      N+S   L+   +  + ++  +L  ASL G+DL         +QQ +L G DL  ADL", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3358, "hit_start": 231, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|1835|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0173544, "max_identities": 22, "bit_score": 33.8834, "cvterm_id": "35915", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLE", "match": "++G NL+Y      C L   +L E +    N+S   L  + ++R  F+R   ++ +LRG DL  ADL+", "sequence_from_db": "ISGCNLAYTNLSGQC-LEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3301, "hit_start": 354, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 32.35}, "gnl|BL_ORD_ID|1835|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29686, "max_identities": 26, "bit_score": 28.1054, "cvterm_id": "35915", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRALLDQAV", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA     V", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLQDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQV", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3385, "hit_start": 0, "hit_end": 324, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.03}, "gnl|BL_ORD_ID|408|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00546213, "max_identities": 31, "bit_score": 35.4242, "cvterm_id": "36936", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVP", "match": "+ G NLSYA     C +   DL E      N+S      + ++R  F+ G   +  L+G DL  ++L     ++ DLTG  +        LL+Q +GL + VP", "sequence_from_db": "ITGCNLSYANFERQC-IEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ-QEQLLEQ-LGL-IVVP", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3406, "hit_start": 354, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 30.1}, "gnl|BL_ORD_ID|408|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.020229, "max_identities": 30, "bit_score": 33.4982, "cvterm_id": "36936", "query": "WLCAL-RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFA-----RGHLKRASLRGADLRDADLEYASFQQADL-----TGADLAGADLHRALLDQAV", "match": "+ C+  RA+  +T     + +   +L G + SY+     S ++C L+ +     + + +   +  L  A  A++ F      R +   A + G +L  A+ E    ++ DL      GA+L+GA    + L + V", "sequence_from_db": "FCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGV", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3026, "query_end": 3385, "hit_start": 84, "hit_end": 489, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.22}, "gnl|BL_ORD_ID|688|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00636984, "max_identities": 23, "bit_score": 35.039, "cvterm_id": "36891", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLE", "match": "++G NL+YA     C L   +L E +    N+S   L  + ++R  F+R   ++ +LRG DL  ADL+", "sequence_from_db": "ISGCNLAYANLNGQC-LEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3301, "hit_start": 354, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 33.82}, "gnl|BL_ORD_ID|688|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00654498, "max_identities": 25, "bit_score": 35.039, "cvterm_id": "36891", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHR", "match": "+ +G N  +      CDL GA+ +    Y   +S  +   +     C    +L  A+L G  L   +L   ++  A+L+GA L G+DL R", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYN-QISHKMYFCSAYISGC----NLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3364, "hit_start": 231, "hit_end": 483, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.78}, "gnl|BL_ORD_ID|688|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.1947, "max_identities": 25, "bit_score": 27.335, "cvterm_id": "36891", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3367, "hit_start": 0, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.32}, "gnl|BL_ORD_ID|735|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00654498, "max_identities": 27, "bit_score": 35.039, "cvterm_id": "36891", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYR--------------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "+ +G N  +      CDL GA+ +    Y                      N+S   L+   +  + ++  +L  ASL G+DL         +QQ +L G DL  ADL", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3358, "hit_start": 231, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|735|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0427149, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "36891", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEP", "match": "++G NL+YA      +L+G  L + + +  N S+  L  A +  S  +RG   R   +  +LR            DLT ADL G D  R  L+      V + A      +EP", "sequence_from_db": "ISGCNLAYA------NLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGC----------DLTFADLDGLDPRRVNLE-----GVKICAWQQEQLLEP", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3436, "hit_start": 354, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.32}, "gnl|BL_ORD_ID|735|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.04367, "max_identities": 25, "bit_score": 27.335, "cvterm_id": "36891", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3367, "hit_start": 0, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.32}, "gnl|BL_ORD_ID|1717|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00722924, "max_identities": 31, "bit_score": 35.039, "cvterm_id": "36789", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVP", "match": "+ G NLSYA     C +   DL E      N+S      + ++R  F+ G   +  L+G DL  ++L     ++ DLTG  +        LL+Q +GL + VP", "sequence_from_db": "ITGCNLSYANFERQC-IEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ-QEQLLEQ-LGL-IVVP", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3406, "hit_start": 354, "hit_end": 651, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 30.1}, "gnl|BL_ORD_ID|1717|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162836, "max_identities": 27, "bit_score": 30.8018, "cvterm_id": "36789", "query": "WLCAL-RADTYETLSAVTTVLRHEDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHRALLDQAV", "match": "+ C+  RA+  +T     + +   +L G + SY+     S ++C L+ +     + + +   +  L  A  A++ F      R     A +   +L YA+F++               A+L+G     +DL R +  +  ", "sequence_from_db": "FCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGC", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 3026, "query_end": 3385, "hit_start": 84, "hit_end": 504, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 19.29}, "gnl|BL_ORD_ID|162|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00770136, "max_identities": 27, "bit_score": 35.039, "cvterm_id": "36891", "query": "DLAGTNLSYAPSLEHCDLTGADLTEVDGYR--------------------VNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "+ +G N  +      CDL GA+ +    Y                      N+S   L+   +  + ++  +L  ASL G+DL         +QQ +L G DL  ADL", "sequence_from_db": "NFSGAN-CFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3095, "query_end": 3358, "hit_start": 231, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|162|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0511334, "max_identities": 26, "bit_score": 32.3426, "cvterm_id": "36891", "query": "LAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNA-LMAR--SC--FARGHLKRASLRGADLRDADLE", "match": "++G NL+YA      +L+G  L + + +  N S+  L  A LM    SC  F+R   ++ +LRG DL  ADL+", "sequence_from_db": "ISGCNLAYA------NLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3098, "query_end": 3301, "hit_start": 354, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 35.62}, "gnl|BL_ORD_ID|162|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.17523, "max_identities": 25, "bit_score": 27.335, "cvterm_id": "36891", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGA----------DLAGADLHRA", "match": "+  +  V + ED +  +LS       C     D +        + D   ++     S    G ++      ADLRDA  +      A+ +GA          DL GA+  RA", "sequence_from_db": "MDIIDKVFQQEDFSRQDLS-DSRFRRCRFYQCDFSHC-----QLRDASFEDCSFIES----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 3062, "query_end": 3367, "hit_start": 0, "hit_end": 306, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.32}, "gnl|BL_ORD_ID|1684|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "oleI", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1824", "ARO_accession": "3000866", "ARO_name": "oleI", "ARO_category": {"36604": {"category_aro_accession": "3000465", "category_aro_cvterm_id": "36604", "category_aro_name": "ole glycosyltransferase", "category_aro_description": "OleI and OleD are glycosyltransferases found in Streptomyces antibioticus which is a natural producer of antibiotic oleandomycin. OleI glycosylates antibiotic oleandomycin whereas OleD can glycosylate a wide variety of macrolides.", "category_aro_class_name": "AMR Gene Family"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0141867, "max_identities": 22, "bit_score": 34.6538, "cvterm_id": "36823", "query": "DEDDPATG-PLADRAEEVAAALGTGDARAVVEACDALAR", "match": "+ED PA   P ADR EE AA  GTGDA    EA D L R", "sequence_from_db": "EEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVR", "sequence_from_broadstreet": "MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG", "dna_sequence_from_broadstreet": "ATGACGAGCGAGCACCGCTCTGCCTCCGTGACACCCCGTCACATCTCCTTCTTCAACATCCCCGGCCACGGCCACGTGAACCCGTCACTCGGCATCGTCCAGGAACTGGTCGCGCGCGGCCACCGGGTCAGCTACGCCATCACCGACGAGTTCGCCGCACAGGTCAAGGCGGCCGGCGCGACGCCCGTGGTGTACGACTCCATCCTGCCGAAGGAGTCCAACCCCGAGGAGTCGTGGCCGGAGGACCAGGAGTCCGCGATGGGCCTGTTCCTCGACGAAGCCGTCCGGGTCCTGCCGCAGCTGGAGGACGCCTACGCCGACGACCGGCCGGACCTGATCGTCTACGACATCGCCTCCTGGCCCGCCCCGGTGCTCGGCCGGAAGTGGGACATCCCCTTCGTCCAGCTCTCCCCGACCTTCGTCGCCTACGAGGGCTTCGAGGAGGACGTACCCGCGGTGCAGGACCCCACGGCCGACCGCGGCGAGGAGGCCGCCGCCCCCGCGGGGACCGGGGACGCCGAGGAGGGTGCCGAGGCCGAGGACGGCCTGGTGCGCTTCTTCACCCGGCTCTCGGCCTTCCTGGAGGAGCACGGGGTGGACACCCCGGCCACCGAGTTCCTCATCGCGCCCAACCGCTGCATCGTCGCGCTGCCGCGCACCTTCCAGATCAAGGGCGACACGGTCGGCGACAACTACACCTTCGTCGGTCCCACCTACGGCGACCGGTCCCACCAGGGCACCTGGGAAGGCCCCGGGGACGGGCGTCCGGTGCTGCTGATCGCCCTGGGCTCGGCGTTCACCGACCACCTCGACTTCTACCGCACCTGCCTGTCCGCCGTCGACGGCCTGGACTGGCACGTGGTGCTCTCCGTGGGCCGCTTCGTCGACCCCGCGGACCTCGGCGAGGTCCCGCCGAACGTCGAGGTGCACCAGTGGGTGCCGCAGCTCGACATCCTGACCAAAGCCTCCGCGTTCATCACGCACGCGGGCATGGGCAGCACCATGGAGGCCCTGTCGAACGCGGTGCCCATGGTCGCGGTGCCGCAGATCGCGGAGCAGACGATGAACGCCGAGCGGATCGTCGAGCTGGGCCTCGGCCGGCACATCCCGCGGGACCAGGTCACGGCCGAGAAGCTGCGCGAGGCCGTGCTCGCCGTCGCCTCCGACCCCGGTGTCGCCGAACGGCTCGCGGCCGTCCGGCAGGAGATCCGTGAGGCGGGCGGCGCCCGGGCGGCCGCCGACATCCTGGAGGGCATCCTCGCCGAAGCAGGCTGA", "partial": "0", "query_start": 2669, "query_end": 2782, "hit_start": 438, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 56.41}, "gnl|BL_ORD_ID|1692|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0207835, "max_identities": 29, "bit_score": 33.4982, "cvterm_id": "35715", "query": "LRHEDLAGTNLSYAPSLEHCDLTGADLTE-------------VDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQAD---------------LTGADLAGADLHRALLDQA", "match": "  H+DL+    + A +   CD   A+L +             ++G   +V+D  L +A   +   A  +   A+  G +LR+ DL+ A+F +A+               +TG +L+ A++ R  L++ ", "sequence_from_db": "FSHQDLSDITFT-ACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVAD--LRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKC", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3083, "query_end": 3382, "hit_start": 36, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.66}, "gnl|BL_ORD_ID|1692|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.189642, "max_identities": 22, "bit_score": 30.4166, "cvterm_id": "35715", "query": "RHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "RH   +  +LS          T       D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "RHHSFSHQDLSDIT------FTACTFIRCDFRRANLRDATFINCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3086, "query_end": 3361, "hit_start": 24, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.91}, "gnl|BL_ORD_ID|1692|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.214992, "max_identities": 34, "bit_score": 30.4166, "cvterm_id": "35715", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVDGYRVNVSDGV---------------LDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y   L  CDL GA+ +     R N ++ V               L  A M R C  +  L         L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIELRECDLKGANFS-----RANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.31}, "gnl|BL_ORD_ID|50|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0211615, "max_identities": 29, "bit_score": 33.4982, "cvterm_id": "36810", "query": "LRHEDLAGTNLSYAPSLEHCDLTGADLTE-------------VDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQAD---------------LTGADLAGADLHRALLDQA", "match": "  H+DL+    + A +   CD   A+L +             ++G   +V+D  L +A   +   A  +   A+  G +LR+ DL+ A+F +A+               +TG +L+ A++ R  L++ ", "sequence_from_db": "FSHQDLSDITFT-ACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVAD--LRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKC", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3083, "query_end": 3382, "hit_start": 36, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.66}, "gnl|BL_ORD_ID|50|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162836, "max_identities": 34, "bit_score": 30.8018, "cvterm_id": "36810", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVDGYRVNVSDGV---------------LDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y   L  CDL GA+ +     R N ++ V               L  A M R C  +  L         L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIELRECDLKGANFS-----RANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.31}, "gnl|BL_ORD_ID|50|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.209289, "max_identities": 22, "bit_score": 30.4166, "cvterm_id": "36810", "query": "RHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "RH   +  +LS          T       D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "RHHSFSHQDLSDIT------FTACTFIRCDFRRANLRDATFINCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3086, "query_end": 3361, "hit_start": 24, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.91}, "gnl|BL_ORD_ID|475|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0476404, "max_identities": 19, "bit_score": 32.3426, "cvterm_id": "35743", "query": "LEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADL", "match": "  +CD +G DLT+ +    +  D                   R SL G D   A L+ ASF+  DL+ ++ ", "sequence_from_db": "FSNCDFSGVDLTDTEFVDCSFYD-------------------RNSLEGCDFNRAKLKNASFKSCDLSMSNF", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 3131, "query_end": 3343, "hit_start": 72, "hit_end": 228, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.76}, "gnl|BL_ORD_ID|475|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.3011, "max_identities": 26, "bit_score": 26.5646, "cvterm_id": "35743", "query": "LTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLA-GTNLSYAPSLEH---CDLTGADLTEVDGYRVNVSDGV", "match": "+T+ +   +   RV + +  C L  + +        V R  DL+ G   S+  SL     CDLTG  L E+D  R N+ DGV", "sequence_from_db": "ITKTNLSYANFSRVILEK--CELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNL-DGV", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2972, "query_end": 3205, "hit_start": 345, "hit_end": 582, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 31.71}, "gnl|BL_ORD_ID|475|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.15887, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "35743", "query": "ASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "A  RG+DL   +     +  AD TG DL G  L", "sequence_from_db": "AVFRGSDLSCGEFSSFDWSLADFTGCDLTGGAL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 3260, "query_end": 3358, "hit_start": 444, "hit_end": 543, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 39.39}, "gnl|BL_ORD_ID|758|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0480715, "max_identities": 19, "bit_score": 32.3426, "cvterm_id": "35711", "query": "LEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADL", "match": "  +CD +G DLT+ +    +  D                   R SL G D   A L+ ASF+  DL+ ++ ", "sequence_from_db": "FSNCDFSGVDLTDTEFVDCSFYD-------------------RNSLEGCDFNRAKLKNASFKSCDLSMSNF", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 3131, "query_end": 3343, "hit_start": 72, "hit_end": 228, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.76}, "gnl|BL_ORD_ID|758|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.05298, "max_identities": 26, "bit_score": 28.1054, "cvterm_id": "35711", "query": "LTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLA-GTNLSYAPSLEH---CDLTGADLTEVDGYRVNVSDGV", "match": "+T+ +   +   RV + +  C L  + +        V R  DL+ G   S+  SL     CDLTG  L E+D  R+N+ DGV", "sequence_from_db": "ITKTNLSYANFSRVILEK--CELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINL-DGV", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2972, "query_end": 3205, "hit_start": 345, "hit_end": 582, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 31.71}, "gnl|BL_ORD_ID|758|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.99654, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "35711", "query": "ASLRGADLRDADLEYASFQQADLTGADLAGADL", "match": "A  RG+DL   +     +  AD TG DL G  L", "sequence_from_db": "AVFRGSDLSCGEFSSFDWSLADFTGCDLTGGAL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 3260, "query_end": 3358, "hit_start": 444, "hit_end": 543, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 39.39}, "gnl|BL_ORD_ID|629|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0959086, "max_identities": 27, "bit_score": 31.5722, "cvterm_id": "35767", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS        DLT    T +  D  R N+ D    N         +G ++      ADLRDA     SFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKFIE----QGDIEGCHFDAADLRDA-----SFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.47}, "gnl|BL_ORD_ID|629|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.336418, "max_identities": 32, "bit_score": 29.6462, "cvterm_id": "35767", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.83}, "gnl|BL_ORD_ID|1627|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.132485, "max_identities": 25, "bit_score": 31.187, "cvterm_id": "35914", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS        DLT    T +  D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.51}, "gnl|BL_ORD_ID|1627|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.259489, "max_identities": 16, "bit_score": 30.0314, "cvterm_id": "35914", "query": "RASLRGADLRDADLEYASF-QQADLTGADLAGADLHRALLDQA", "match": "R+  R A+LRD       F +Q D+ G     ADLH A   Q ", "sequence_from_db": "RSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQC", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3257, "query_end": 3382, "hit_start": 87, "hit_end": 216, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 37.21}, "gnl|BL_ORD_ID|1627|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.345573, "max_identities": 32, "bit_score": 29.6462, "cvterm_id": "35914", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.83}, "gnl|BL_ORD_ID|356|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.138563, "max_identities": 23, "bit_score": 31.187, "cvterm_id": "36957", "query": "RHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "RH + +  +LS A +   C    +D       R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "RHHNFSHKDLS-ALTFTACTFIRSDFR-----RANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3086, "query_end": 3361, "hit_start": 24, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|356|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.179713, "max_identities": 32, "bit_score": 30.8018, "cvterm_id": "36957", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y      CDL GA+ +  +  ++V+         ++   L  A M R C  R  L         L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.83}, "gnl|BL_ORD_ID|2054|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162836, "max_identities": 25, "bit_score": 30.8018, "cvterm_id": "35915", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+   +   RH + +  +LS        DLT    T +  D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "MEIYSHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.51}, "gnl|BL_ORD_ID|2054|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.283798, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35915", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3083, "query_end": 3358, "hit_start": 204, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.59}, "gnl|BL_ORD_ID|316|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.164411, "max_identities": 26, "bit_score": 30.8018, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFYCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|316|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.1355, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|645|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.174944, "max_identities": 25, "bit_score": 30.8018, "cvterm_id": "35915", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS        DLT    T +  D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.51}, "gnl|BL_ORD_ID|645|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.530897, "max_identities": 33, "bit_score": 29.261, "cvterm_id": "35915", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVDGYRVNVSDGV---------------LDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+      +R N +  V               L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANF-----FRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3083, "query_end": 3358, "hit_start": 204, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.27}, "gnl|BL_ORD_ID|348|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.178109, "max_identities": 25, "bit_score": 30.8018, "cvterm_id": "35711", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS        DLT    T +  D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.51}, "gnl|BL_ORD_ID|348|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.324586, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35711", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.83}, "gnl|BL_ORD_ID|212|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.198334, "max_identities": 23, "bit_score": 30.4166, "cvterm_id": "35915", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS          T   L   D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLSDLT------FTACTLIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.0}, "gnl|BL_ORD_ID|212|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.288926, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35915", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3083, "query_end": 3358, "hit_start": 204, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.213057, "max_identities": 26, "bit_score": 30.4166, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  + +DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1788|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.75063, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1714|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.243608, "max_identities": 26, "bit_score": 30.4166, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1714|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.357623, "max_identities": 19, "bit_score": 29.6462, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.243608, "max_identities": 26, "bit_score": 30.4166, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1435|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.37144, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|2180|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.24372, "max_identities": 27, "bit_score": 30.4166, "cvterm_id": "35914", "query": "LSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+       RH + +  +LS        DLT    T +  D  R N+ D    N         +G ++      ADLRDA     SFQQ  L  A+ + A+ +", "sequence_from_db": "METYNHTYRHHNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKFIE----QGDIEGCRFDVADLRDA-----SFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3062, "query_end": 3361, "hit_start": 0, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.47}, "gnl|BL_ORD_ID|2180|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.283798, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35914", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3083, "query_end": 3358, "hit_start": 204, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.59}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.247999, "max_identities": 26, "bit_score": 30.4166, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|436|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.296493, "max_identities": 19, "bit_score": 30.0314, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.250224, "max_identities": 26, "bit_score": 30.4166, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1506|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.25561, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L  +D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|2107|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.254883, "max_identities": 22, "bit_score": 30.0314, "cvterm_id": "35914", "query": "SLEHCDLTGADLTEV-----DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "+  H DL+G   T       D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "NFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3128, "query_end": 3361, "hit_start": 33, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.51}, "gnl|BL_ORD_ID|2107|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.264179, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35914", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3083, "query_end": 3358, "hit_start": 204, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.59}, "gnl|BL_ORD_ID|779|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.257019, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|779|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.32323, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.266366, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36950", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|377|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.92093, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36950", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.271167, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|238|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.354445, "max_identities": 19, "bit_score": 29.6462, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.276053, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "43754", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|4925|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.02679, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "43754", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.276053, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "35915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|571|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.321299, "max_identities": 19, "bit_score": 30.0314, "cvterm_id": "35915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|571|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.49465, "max_identities": 31, "bit_score": 25.7942, "cvterm_id": "35915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDA-----DLEYASFQQADLTGADLAGADLHRALLDQAVGL", "match": "C L    +   SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+  G+DL        D   A+F   DLT ++L   D+ R  L Q V L", "sequence_from_db": "CDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDL-QGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 3032, "query_end": 3391, "hit_start": 240, "hit_end": 624, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.03}, "gnl|BL_ORD_ID|1166|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.280308, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35914", "query": "LRHEDLAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": " +   LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "FQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 3083, "query_end": 3358, "hit_start": 201, "hit_end": 549, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1166|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.287942, "max_identities": 25, "bit_score": 30.0314, "cvterm_id": "35914", "query": "RHEDLAGTNLSYAPSLEHCDLTGADLTEV--DGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLH", "match": "RH + +  +LS        DLT    T +  D  R N+ D    N            +++  + G     ADL  ASFQQ  L  A+ + A+ +", "sequence_from_db": "RHRNFSHKDLS--------DLTFTACTFIRSDFRRANLRDTTFVNCKF---------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 3086, "query_end": 3361, "hit_start": 21, "hit_end": 252, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.6}, "gnl|BL_ORD_ID|99|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.288657, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|99|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.20959, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|32|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.291246, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|32|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.09894, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1839|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.292707, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRALLDQAVGLSVPVP", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     ++ +    S  + ", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYIT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3406, "hit_start": 66, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.74}, "gnl|BL_ORD_ID|1839|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.5581, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "35914", "query": "APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "AANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3122, "query_end": 3214, "hit_start": 501, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 38.71}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.295343, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.295343, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36884", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|703|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.22915, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "36884", "query": "APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "AANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3122, "query_end": 3214, "hit_start": 501, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 38.71}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.298003, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1643|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.22915, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "35914", "query": "APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "AANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 3122, "query_end": 3214, "hit_start": 501, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 38.71}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.315613, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36943", "query": "SLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": "+  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "TFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3128, "query_end": 3370, "hit_start": 105, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.55}, "gnl|BL_ORD_ID|1346|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.78409, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36943", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.317305, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1445|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.12506, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.323045, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|4920|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.52621, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|2142|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.324586, "max_identities": 32, "bit_score": 30.0314, "cvterm_id": "35914", "query": "LAGTNLS----YAPSLEHCDLTGADLTEVD-GYRVN---------VSDGVLDNALMARSCFARGHLKR-----ASLRGADLRDADLEYASFQ-----QADLTGADLAGADL", "match": "LA  N S    Y      CDL GA+ +  +  ++V+         +S   L  A M R C  +  L        +L GA L+++DL    F      Q  L GA+L  A+L", "sequence_from_db": "LAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAEL", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3358, "hit_start": 219, "hit_end": 552, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.83}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.325954, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|4921|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.73987, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.325954, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1392|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.337854, "max_identities": 19, "bit_score": 29.6462, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.325954, "max_identities": 26, "bit_score": 30.0314, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|291|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.8756, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.328889, "max_identities": 26, "bit_score": 29.6462, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1868|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.8987, "max_identities": 19, "bit_score": 27.335, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DLAG   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.348174, "max_identities": 19, "bit_score": 29.6462, "cvterm_id": "35915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1882|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.783807, "max_identities": 26, "bit_score": 28.8758, "cvterm_id": "35915", "query": "CDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": "CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS            GAD  GA     +", "sequence_from_db": "CDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 3140, "query_end": 3370, "hit_start": 117, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 30.95}, "gnl|BL_ORD_ID|1882|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.0039, "max_identities": 24, "bit_score": 25.7942, "cvterm_id": "35915", "query": "EDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQA", "match": "E   G N S A       + CDL+ AD        + +S            C A+G    A  RGA   +       F  A +T  +L+ A+  + +L++ ", "sequence_from_db": "ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIS-----------HCRAQG----ADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKC", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 3092, "query_end": 3382, "hit_start": 180, "hit_end": 438, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.76}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.35652, "max_identities": 26, "bit_score": 29.6462, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|661|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.98061, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|322|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.369532, "max_identities": 19, "bit_score": 29.6462, "cvterm_id": "36771", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D  RV++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|322|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.389944, "max_identities": 26, "bit_score": 29.6462, "cvterm_id": "36771", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS            GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|322|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.62566, "max_identities": 24, "bit_score": 25.409, "cvterm_id": "36771", "query": "EDLAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQA", "match": "E   G N S A       + CDL+ AD        + +S            C A+G    A  RGA   +       F  A +T  +L+ A+  + +L++ ", "sequence_from_db": "ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIS-----------HCRAQG----ADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKC", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3092, "query_end": 3382, "hit_start": 144, "hit_end": 402, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.76}, "gnl|BL_ORD_ID|1296|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.463226, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "36915", "query": "APSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": "+ +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   A+      +     GAD  GA     +", "sequence_from_db": "SSTFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3122, "query_end": 3370, "hit_start": 99, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.78}, "gnl|BL_ORD_ID|1296|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.02679, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.474888, "max_identities": 26, "bit_score": 29.261, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.21}, "gnl|BL_ORD_ID|1111|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50947, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|961|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.514746, "max_identities": 23, "bit_score": 29.261, "cvterm_id": "39584", "query": "PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSC-FARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL+  +       D         + C F+R  LK A  +  DL  AD   AS      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSSTEFIGCQFYD-----RESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.14}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.545445, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|542|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.41058, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.548756, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|459|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.36178, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.557941, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|61|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.557941, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|61|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.12506, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.573772, "max_identities": 25, "bit_score": 29.261, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|499|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.9559, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.599362, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "35915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|901|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.97373, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "35915", "query": "DLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3095, "query_end": 3214, "hit_start": 462, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 36.36}, "gnl|BL_ORD_ID|327|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.626793, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "35915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|327|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.48567, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "35915", "query": "DLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 3095, "query_end": 3214, "hit_start": 462, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 36.36}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.685744, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "35665", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.723407, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|354|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.742949, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|354|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.54512, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.749656, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL   D   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1009|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.43993, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.756362, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|863|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.08847, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.756365, "max_identities": 25, "bit_score": 28.8758, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|787|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.99119, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.770015, "max_identities": 19, "bit_score": 28.8758, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     + T     DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1163|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.20977, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  L+ A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.805236, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1453|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.54512, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.805236, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.819769, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1153|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.54512, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.827134, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "39586", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1886|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.46948, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "39586", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.842063, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1549|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.97373, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.856837, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|120|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.60043, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.87273, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|4918|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.18545, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.87273, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "39584", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|349|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.42983, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "39584", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.911962, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|490|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.16314, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|717|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.954362, "max_identities": 27, "bit_score": 28.4906, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPA", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +  +    S  + +   + A", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 3125, "query_end": 3427, "hit_start": 66, "hit_end": 372, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.0}, "gnl|BL_ORD_ID|717|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.43921, "max_identities": 31, "bit_score": 25.7942, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLD", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLD", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3376, "hit_start": 204, "hit_end": 591, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.03}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.10932, "max_identities": 24, "bit_score": 28.1054, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GAD+  TE  G +        D        F+R  LK A  +  DL   D   AS      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADMSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 102, "hit_end": 351, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|323|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.28501, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 435, "hit_end": 630, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.13103, "max_identities": 24, "bit_score": 28.1054, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R +LK A  +  DL  AD    +      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|2119|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.17219, "max_identities": 19, "bit_score": 28.1054, "cvterm_id": "35914", "query": "LEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADL", "match": "  +CD +G DLT  +       D                   RAS +G +   A L+ A F+  DL+ AD ", "sequence_from_db": "FRNCDFSGTDLTSSEFIGCQFYD-------------------RASQQGGNFNRAQLKDAIFKSCDLSMADF", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 3131, "query_end": 3343, "hit_start": 72, "hit_end": 228, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.76}, "gnl|BL_ORD_ID|2119|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.16509, "max_identities": 14, "bit_score": 25.7942, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVD", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D", "sequence_from_db": "CELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLD", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3175, "hit_start": 399, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.92}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.17561, "max_identities": 21, "bit_score": 28.1054, "cvterm_id": "46173", "query": "VDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQAD---------------LTGADLAGADLHRALLDQA", "match": "++G   + SD  L +A   R      + K A+  G + R+ DL+ A+F QA                +TG +L+ A+  R  +++ ", "sequence_from_db": "IEGCHFDYSD--LRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKC", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 3170, "query_end": 3382, "hit_start": 159, "hit_end": 411, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.42}, "gnl|BL_ORD_ID|4916|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.69385, "max_identities": 23, "bit_score": 26.9498, "cvterm_id": "46173", "query": "LAGTNLSYA----PSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQ---------------ADLTGADLAGADLHR", "match": "+ G +  Y+     S + C LT ++    + + V   +  L  A   ++ F      +     A +   +L YA+F++               A+L GA   G+DL R", "sequence_from_db": "IEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSR", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 3098, "query_end": 3364, "hit_start": 159, "hit_end": 483, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 21.3}, "gnl|BL_ORD_ID|1853|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.24785, "max_identities": 25, "bit_score": 28.1054, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1853|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.60888, "max_identities": 34, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLD--QAV", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD  QAV", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAV", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3385, "hit_start": 204, "hit_end": 606, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 25.37}, "gnl|BL_ORD_ID|1229|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25905, "max_identities": 25, "bit_score": 28.1054, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1229|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.24676, "max_identities": 31, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLDQ", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD ", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3379, "hit_start": 204, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 23.85}, "gnl|BL_ORD_ID|682|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.30486, "max_identities": 25, "bit_score": 28.1054, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|682|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.05017, "max_identities": 31, "bit_score": 25.7942, "cvterm_id": "35914", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLD", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLD", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3376, "hit_start": 204, "hit_end": 591, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.03}, "gnl|BL_ORD_ID|85|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35234, "max_identities": 25, "bit_score": 28.1054, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|85|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.94339, "max_identities": 31, "bit_score": 25.7942, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLD", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLD", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3376, "hit_start": 204, "hit_end": 591, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.03}, "gnl|BL_ORD_ID|1613|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.45251, "max_identities": 25, "bit_score": 27.7202, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 28.09}, "gnl|BL_ORD_ID|1613|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.05219, "max_identities": 31, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCD----LTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLR-----DADLEYASFQQADLTGA-----DLAGADLHRALLD", "match": "C L    +  +SA+   +RH    G +   A  +           A +T  +    N S  VL+   +  + +    +  A+L G+DL        D   A+F   DLT +     D+ G DL    LD", "sequence_from_db": "CDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLD", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3376, "hit_start": 204, "hit_end": 591, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 24.03}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.5882, "max_identities": 24, "bit_score": 27.7202, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.63133, "max_identities": 24, "bit_score": 27.7202, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.70581, "max_identities": 19, "bit_score": 27.7202, "cvterm_id": "39585", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADL", "match": " +  +CD +GADL  TE  G ++       D        F+R +LK A  +  DL  AD ", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQL------YDRESQKGCNFSRANLKDAIFKSCDLSMADF", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3298, "hit_start": 66, "hit_end": 228, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 31.67}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.81581, "max_identities": 19, "bit_score": 27.7202, "cvterm_id": "35914", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADL", "match": " +  +CD +GADL  TE  G +        D        F+R +LK A  +  DL  AD ", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRANLKDAIFKSCDLSMADF", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3298, "hit_start": 66, "hit_end": 228, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 31.67}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.84853, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD   +S      +     G D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|4919|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50947, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.9733, "max_identities": 19, "bit_score": 27.335, "cvterm_id": "39583", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADL", "match": " +  +CD +GADL  TE  G +        D        F+R +LK A  +  DL  AD ", "sequence_from_db": "STFFNCDFSGADLCGTEFIGCQF------YDRESQKGCNFSRANLKDAIFKSCDLSMADF", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3298, "hit_start": 69, "hit_end": 231, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 31.67}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.1514, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.3313, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  L+ A  +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|48|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.77335, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.35219, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "39643", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +G DL  TE  G +        D        F+R  LK A  +  DL  AD   AS      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGTDLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.39454, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK    +  DL  AD    S      +     GAD  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|244|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.12506, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVDGYRVNVSDGVLDN", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D   V++    LDN", "sequence_from_db": "CELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 3032, "query_end": 3214, "hit_start": 399, "hit_end": 594, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 27.69}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.44439, "max_identities": 24, "bit_score": 26.9498, "cvterm_id": "39583", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 69, "hit_end": 318, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.4595, "max_identities": 24, "bit_score": 26.9498, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 66, "hit_end": 315, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.53316, "max_identities": 24, "bit_score": 26.9498, "cvterm_id": "36915", "query": "PSLEHCDLTGADL--TEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYAS-----FQQADLTGADLAGADLHRAL", "match": " +  +CD +GADL  TE  G +        D        F+R  LK A  +  DL  AD    S      +     G+D  GA     +", "sequence_from_db": "STFFNCDFSGADLSGTEFIGCQF------YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 3125, "query_end": 3370, "hit_start": 69, "hit_end": 318, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.97}, "gnl|BL_ORD_ID|2118|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.91449, "max_identities": 14, "bit_score": 25.7942, "cvterm_id": "35915", "query": "CALRADTYETLSAVTTVLRHEDLAGTNLSY----APSLEHCDLTGADLTEVD", "match": "C L  + +     +       DL+G   S     A +  HCDLT ++L ++D", "sequence_from_db": "CELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLD", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 3032, "query_end": 3175, "hit_start": 399, "hit_end": 555, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 26.92}, "gnl|BL_ORD_ID|734|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 2150, "orf_end": 3448, "orf_from": "BGC0000692.1|Apramycin_3 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.36826, "max_identities": 19, "bit_score": 25.0238, "cvterm_id": "39507", "query": "CDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLE-----YASFQQADLTGADLAGADLHRALLD", "match": "C+ TG D  + D  R++      + A+ +   F+  +L  +  RG+  R+   E     +++F Q  + G+      L    LD", "sequence_from_db": "CEFTGRDFRDEDLSRLHT-----ERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLD", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 3140, "query_end": 3376, "hit_start": 18, "hit_end": 255, "orf_dna_sequence": "GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG", "orf_prot_sequence": "MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA", "perc_identity": 22.62}}, "BGC0000692.1|Apramycin_4 # 3424 # 4449 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.700": {"gnl|BL_ORD_ID|3912|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-662", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4982", "ARO_accession": "3005877", "ARO_name": "OXA-662", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.42089, "max_identities": 21, "bit_score": 29.261, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIRYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQFGFIALITTFSSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIRYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHAVQDLLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAATTTGGATTCATCGCCCTCATTACAACCTTCAGTTCCGCATGTACCACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCACGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACTGAGGTGTTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCTTGGGAAAAAGATATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTAGCACGGCGCATTGGTCTAGACCTAATGCAAAAAGAAGTACAGCGCATTCGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGCCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACCCAACTCGCTTTTAAGCCCGACGTGCAACATGCAGTACAAGACCTGCTGCTGATTGAACAAAAACCGAATTATAAACTTTATGCAAAATCAGGCTGGGGCATGGACCTAGAACCGCAAGTCGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|562|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-211", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "615", "ARO_accession": "3001710", "ARO_name": "OXA-211", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.59993, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMKKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQLALIALITTFGSACTTIPPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATSEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTTGGCTCTCATCGCCCTCATTACAACCTTCGGTTCCGCATGTACCACAATACCCCCCTCCGTAGAAACAGCTAAAAATCACCAGCAACAAAGTGCTCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACGGGGGTGATTGTCATTAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTATTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTAGCACGGCGCATTGGCCTAGACCTGATGAAAAAAGAAGTGCAACGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAAGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACGGGAATTTCAGCCAGCGTACGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3899|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-644", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4969", "ARO_accession": "3005864", "ARO_name": "OXA-644", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.610653, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMKKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKNLQLGLIVLITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATSEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGACTCATCGTCCTCATTACAACCTTCGGTTCCGCATGTACAACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCTCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACGGGGGTGATTGTCATTAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTATTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTAGCACGGCGCATTGGCCTAGACCTGATGAAAAAAGAAGTGCAACGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAAGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACGGGAATTTCAGCCAGCGTACGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|13|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-212", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "18", "ARO_accession": "3001711", "ARO_name": "OXA-212", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.610653, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMKKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQSGLIALITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVVKDKHSLHSYGNDLSRAQTPYIPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPTWEKDMTLGQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTCGGGCCTCATCGCCCTCATTACAACCTTCGGTTCCGCATGTACCACAATAAGCCCCTCGGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCGTTAAAGATAAGCATAGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATATACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTATTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTACTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTAGCACGGCGCATTGGCCTAGACCTGATGAAAAAAGAAGTGCAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTAAACCCGATGTACAACATGCAGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTATGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGGCAGGCTGGGTCGAAACTTCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGGATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2216|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-373", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3483", "ARO_accession": "3001559", "ARO_name": "OXA-373", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.632679, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQLALIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLRSYGNDLSRAQTAYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTTGGCTCTCATCGCCCTCATTACAACCTTCGGTTCTGCATGTACCACAATAAGCCCCTCAGTAGAAACAGCTAAAAATCACCAGCAACAAAGCGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCATGGCTTACGCAGCTACGGCAATGACTTGAGCCGTGCTCAGACAGCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACTGAGGTGTTTAAATGGGATGGTCAAAAGCGTAGTTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCTGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTCTAGACCTGATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTGCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACGCAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2615|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-280", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3445", "ARO_accession": "3001735", "ARO_name": "OXA-280", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.633716, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "42807", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQLGLIVLITTFGSACTIIRSPSIETAKNHEQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKNSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTTGGGCCTCATCGTCCTCATTACTACCTTCGGTTCTGCATGTACCATAATAAGAAGCCCCTCCATAGAAACAGCTAAAAACCATGAGCAACAAAGTGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACGGGGGTGATTGTCATAAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTGTTTAAATGGGATGGTCAAAAGAACAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCTGTTTATCAGGAGCTAGCACGGCGCATTGGCCTAGATCTAATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACGCAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGAATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 351, "hit_end": 567, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1834|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-309", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1986", "ARO_accession": "3001504", "ARO_name": "OXA-309", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.638308, "max_identities": 21, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQLALIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTGEKAYFALNMQMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTTGGCTCTCATCGCCCTCATTACAACCTTCGGTTCTGCATGTACCACAATAAGCCCCTCAGTAGAAACAGCTAAAAATCACCAGCAACAAAGCGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGAACCGAGGTGTTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTTGCACGGCGTATTGGTGTAGATCTAATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACGCAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTACTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCAGGCTGGGGTATGGACCTAGAACCACAAGTGGGCTGGTGGGCAGGCTGGGTCGAAACTTCAACAGGTGAAAAAGCGTATTTTGCTTTGAATATGCAGATGAAAACGGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|3902|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-651", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4972", "ARO_accession": "3005867", "ARO_name": "OXA-651", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.649716, "max_identities": 24, "bit_score": 28.8758, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQFGLIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLRSYGNDLSRAQTAYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAATTTGGACTCATCGCCCTCATTACAACCTTCGGTTCTGCATGTACCACAATAAGCCCCTCAGTAGAAACAGCTAAAAATCACCAGCAACAAAGCGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCATGGCTTACGCAGCTACGGCAATGACTTGAGCCGTGCTCAGACAGCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACTGAGGTGTTTAAATGGGATGGTCAAAAGCGTAGTTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCTGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTCTAGACCTGATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTGCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACGCAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGAATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1638|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-334", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1784", "ARO_accession": "3001522", "ARO_name": "OXA-334", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.673148, "max_identities": 21, "bit_score": 28.4906, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTVQLCLIVLITTFGSACTTISPSVETAKNQHQQSTQQQIQQAFNQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTGEKAYFALNMQMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTGTACAGTTGTGCCTCATCGTCCTCATTACTACCTTCGGTTCCGCATGTACCACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACATCAGCAAAGCACGCAGCAGCAGATCCAACAAGCCTTCAATCAACTCCAAACCACGGGGGTGATTGTCATTAAGGATAAACATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCGGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGAACCGAGGTGTTTAAATGGGATGGTCAAAAGCGCAGCTTCACTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTGTAGATCTAATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACGCAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTACTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCAGGCTGGGGTATGGACCTAGAACCACAAGTGGGCTGGTGGGCAGGCTGGGTCGAAACTTCAACAGGTGAAAAAGCGTATTTTGCTTTGAATATGCAGATGAAAACGGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|2637|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-281", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3446", "ARO_accession": "3001736", "ARO_name": "OXA-281", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.703628, "max_identities": 24, "bit_score": 28.4906, "cvterm_id": "42808", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKTLQFGLIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFEPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMQMKTGISASVREQLVKQSLITLGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAATTTGGACTCATCGCCCTCATTACAACCTTCGGTTCTGCATGTACCACAATAAGCCCCTCAGTAGAAACAGCTAAAAATCACCAGCAACAAAGCGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGAACCGAGGTGTTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTTGCACGGCGTATTGGTCTAGACCTGATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTGAGCCAGATGTGCAACATACCGTACAAGACATGTTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCAGATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTGATAACACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3901|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-650", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4971", "ARO_accession": "3005866", "ARO_name": "OXA-650", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.768784, "max_identities": 24, "bit_score": 28.4906, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPIQEVLFVEKLAN", "sequence_from_broadstreet": "MKNLQLGLIALITTFGSACTTINPSVETAKNHQQQSAQQQIQQAFNQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPIQEVLFVEKLANTKLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGAKVYFALNMQMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGCCTCATCGCCCTCATTACAACCTTCGGTTCCGCATGTACCACAATAAACCCCTCCGTAGAAACAGCTAAAAATCACCAACAACAAAGCGCGCAGCAGCAGATCCAACAAGCCTTCAATCAACTCCAAACCACGGGGGTGATTGTCATTAAGGATAAACATGGCTTGCACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCGGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTGTTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGCCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGCCTAGACCTGATGCAAAAAGAAGTGCAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTATTCAAGAAGTCCTTTTTGTGGAGAAACTAGCCAATACAAAACTCGCTTTTAAGCCCGACGTGCAACATGCAGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTATGCAAAATCAGGCTGGGGCATGGACCTAGAACCGCAAGTAGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGCAAAAGTGTATTTTGCTTTGAATATGCAGATGAAAACGGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGCCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 348, "hit_end": 561, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.38}, "gnl|BL_ORD_ID|3764|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-498", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4834", "ARO_accession": "3005729", "ARO_name": "OXA-498", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.782521, "max_identities": 24, "bit_score": 28.4906, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQKIGTVVDNFWLVGPLQITPVQEVLFVEKLAN", "sequence_from_broadstreet": "MKTLQLGLIALITTFGSACTTINPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKNSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQKIGTVVDNFWLVGPLQITPVQEVLFVEKLANTKLAFKPDVQHAVQDMLLIEQKSNYKLYAKSGWGMDLEPQVGWWTGWVETSTGEKVYFALNMHMKTGISASAREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAACTTTACAGTTGGGCCTCATCGCCCTCATTACAACCTTCGGTTCCGCATGTACTACTATAAACCCCTCAGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCGCAGCAGCAGATCCAACAAGCCTTCGATCAACTCCAAACCACGGGGGTGATTGTCATAAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTGTTTAAATGGGATGGTCAAAAGAACAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCTGTTTATCAGGAGCTTGCACGGCGCATTGGCCTAGACCTAATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAAAAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTGGAGAAACTGGCCAATACAAAACTCGCTTTTAAGCCCGACGTGCAACATGCAGTACAAGATATGCTGCTGATTGAACAAAAATCGAATTATAAACTCTACGCCAAATCAGGCTGGGGTATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACTTCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGGATTTCAGCCAGCGCGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCGTTGGGAATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 348, "hit_end": 561, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.38}, "gnl|BL_ORD_ID|3903|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-652", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4973", "ARO_accession": "3005868", "ARO_name": "OXA-652", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.810735, "max_identities": 24, "bit_score": 28.4906, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKNLQLGLIVLITTFGSACTTISPSVETAKNQHQQSAQQQIQQAFDQLQTTGVIVIKDKYGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFEPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMQMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGACTCATCGTCCTCATTACAACCTTCGGTTCCGCATGTACAACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACATCAGCAAAGCGCGCAGCAGCAGATCCAACAAGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGACAAGTATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCGGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACCGAGGTGTTTAAATGGGATGGTCAAAAGCGTAGTTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCTGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTCTAGACCTGATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACACCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTGAGCCAGATGTGCAACATACCGTACAAGACATGTTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCAGATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTAACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|885|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-333", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "965", "ARO_accession": "3001521", "ARO_name": "OXA-333", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.83256, "max_identities": 24, "bit_score": 28.4906, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T  + V++++ +A ", "sequence_from_db": "DMTLGQAIQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLAN", "sequence_from_broadstreet": "MKNLQLGLIVLITTFGSACTTISPSVETAKNQHQQSAQQQIQQAFNQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKILNALIGLEHGKATSTEVFKWDGQKRSFPTWEKDMTLGQAIQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANIQLAFKPDVQHTVQDMLLIEQKANYELYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGACTCATCGTCCTCATTACAACCTTCGGTTCCGCGTGTACCACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACATCAGCAAAGCGCGCAGCAGCAGATCCAACAGGCCTTCAATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCACGGTTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATATTAAATGCCTTAATCGGACTAGAACATGGTAAGGCAACCAGCACCGAGGTATTTAAATGGGATGGTCAAAAGCGTAGTTTCCCTACTTGGGAAAAAGACATGACTTTAGGGCAAGCCATACAAGCATCTGCCGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTCTAGACCTAATGCAAAAAGAAGTGCAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATATACAACTCGCTTTTAAGCCAGATGTGCAACATACCGTACAAGACATGCTGCTGATTGAACAAAAAGCGAATTATGAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACGGGAATTTCAGCCAGCGTACGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 348, "hit_end": 561, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.38}, "gnl|BL_ORD_ID|3042|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-496", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4067", "ARO_accession": "3005335", "ARO_name": "OXA-496", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.884849, "max_identities": 21, "bit_score": 28.1054, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++ ++AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSVLAR", "sequence_from_broadstreet": "MKILIFLPLLSCLSLTACSLPVSSSPSQITSTQSTQTIAQLFDQAQSSGVLGIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSVLAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALGELGLYPKVGQQSK", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTTCTGCCTTTACTGAGTTGCTTGAGCCTGACAGCGTGTAGCCTGCCCGTTTCATCTTCCCCATCTCAGATCACTTCAACTCAATCTACCCAAACCATTGCCCAATTATTTGATCAGGCGCAAAGCTCTGGCGTTTTAGGGATTCAGCGTGGTCAACAGATACAGGTCTATGGTAATGATTTAAGTCGTGCAAATACCGAATATGTTCCTGCTTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCTACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTTCAGCTTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCGTCTGCTGTACCCGTTTATCAGGAACTGGCACGTCGTATTGGCCTTGAACTGATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGTGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGGCGAATTAGGGCTTTACCCAAAAGTGGGGCAGCAAAGCAAATAG", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|3898|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-643", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4968", "ARO_accession": "3005863", "ARO_name": "OXA-643", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.901618, "max_identities": 22, "bit_score": 28.1054, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   ++   V D FW  G L +T", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMKKEVQRIGY-GNQQIGTVVDNFWLVGPLQIT", "sequence_from_broadstreet": "MKNLQLGLIVLITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEYGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEILFVEKLANTQLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASEREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGACTCATCGTCCTCATTACAACCTTCGGTTCCGCATGTACAACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCGCAGCAGCAGATCCAACAAGCCTTCGATCAACTCCAAACCACAGGGGTGATTGTCATAAAGGATAAGCATGGCTTACACAGCTACGGCAATGACTTGAGCCGTGCTCAGACACCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAATATGGTAAAGCAACCAGCACCGAGGTATTTAAATGGGATGGTCAAAAGCGCAGCTTCCCTGCTTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCCGTTCCCGTTTATCAGGAGCTAGCACGGCGCATTGGCCTAGACCTGATGAAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACAGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAATCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTAAACCCGATGTACAACATGCAGTACAAGACATGCTGCTGATTGAACAAAAACCGAATTATAAACTCTACGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCATATGAAAACAGGGATTTCAGCCAGCGAGCGTGAGCAACTGGTCAAACAAAGTCTGACAGCACTGGGAATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4365, "hit_start": 348, "hit_end": 522, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2562|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-308", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3470", "ARO_accession": "3001763", "ARO_name": "OXA-308", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.24932, "max_identities": 12, "bit_score": 27.7202, "cvterm_id": "41193", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGD", "match": "+++  P Y+E+A++IG  L +++     +   +   V D FW D", "sequence_from_db": "KVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLD", "sequence_from_broadstreet": "MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDGQHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMTLSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEAQFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQADGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL", "dna_sequence_from_broadstreet": "ATGAATAAAAAATTGAATTTGGCACTTTTGTGTTTTTTGAGTATTTTGTGTGCAGCTTGTCAGTCTAATCAACAACTGTCGGCTAATTCACATACTGAAAACCACAATACCCGTGCAGCAGAAATCTCGCTTCTTTTCGATGAGATGCATACTCAAGCAGTATTTGTGACCTATGACGGTCAGCATTTTCAGAGCTACGGTAATGCTTTACAAAGAGCAGATACTGCCTACGTTCCTGCTTCGACATTTAAAATGTTAAATGCATTGATTGGACTGCAAAATCATAAAGCAACCAACACCGAAGTCTTTAAATGGGATGGTCAAAAAAGGGCAATGTCGATCTGGGAAAAAGACATGACCTTATCCGATGCCATGAAAGTTTCAGCTGTACCGGTTTATCAAGAATTGGCGCGTCGTATTGGCTTGGATTTGATGCAAAAGGAAGTAACGCGGGTTAGATATGGCAATACGGATATCGGCACTGTTGTTGATCGTTTTTGGCTAGATGGACCACTGAAGATCACACCTAAACAAGAAGCCCAATTTGCATATCAATTGGCAACACAACAATTGCCATTTGATCAAAATGTGCAAAGCCAAGTTAAAGATATGTTGTATGTGGAAAGTCGAGGGCAATCCAAGCTTTTTGCCAAGTCTGGTTTGAGCATGAAAAATGGGCAACCTGACATCGGTTGGTATACGGGTTGGGTTGAACAAGCCGATGGCAAAATTGTGGCTTTTTCCATCAATATGCAAATGGTACAGGGGCTAGATGTCAATAGCCGTCAGCAGGCAACACTGGATATCTTAGATAAATTGGGCATATTTTTTTATTTATAA", "partial": "0", "query_start": 4222, "query_end": 4353, "hit_start": 375, "hit_end": 507, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 27.27}, "gnl|BL_ORD_ID|3900|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-645", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4970", "ARO_accession": "3005865", "ARO_name": "OXA-645", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35469, "max_identities": 24, "bit_score": 27.7202, "cvterm_id": "39092", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG DL+ +     GY   +    V D FW  G L +T  + V++++ +A  ", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLDLMQKEVQRIGY-GNQRIGTVVDNFWLVGPLQITPVQEVLFVEKLANT", "sequence_from_broadstreet": "MKNLQLGLIALITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLRSYGNDLSRAQTAYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQRIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFEPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMQMKTGISASVREQLVKQSLTALGII", "dna_sequence_from_broadstreet": "ATGAAAAATTTACAGTTGGGCCTCATCGCCCTCATTACAACCTTCGGTTCCGCATGTACCACAATAAGCCCCTCCGTAGAAACAGCTAAAAACCAACAGCAACAAAGTGCGCAGCAGCAGATCCAACAGGCCTTCGATCAACTCCAAACCACTGGGGTGATTGTCATTAAGGATAAGCATGGCTTACGCAGCTACGGCAATGACTTGAGCCGTGCTCAGACAGCCTATGTACCCGCCTCTACCTTTAAAATGCTGAATGCCTTAATCGGACTAGAACATGGTAAAGCAACCAGCACTGAGGTGTTTAAATGGGATGGTCAAAAGCGTAGTTTCCCTGCCTGGGAAAAAGACATGACTTTAGGGCAAGCCATGCAAGCATCTGCTGTTCCCGTTTATCAGGAGCTTGCACGGCGCATTGGTCTAGACCTGATGCAAAAAGAAGTACAGCGCATTGGATATGGCAATCAACGGATTGGCACCGTTGTCGATAATTTTTGGTTAGTCGGTCCACTGCAAATTACGCCTGTTCAAGAAGTCCTTTTTGTAGAGAAGCTGGCCAATACACAACTCGCTTTTGAGCCAGATGTGCAACATACCGTACAAGACATGTTGCTGATTGAACAAAAACCGAATTATAAACTCTATGCCAAATCTGGTTGGGGCATGGACCTAGAACCGCAAGTGGGCTGGTGGACAGGCTGGGTCGAAACAGCAACAGGTGAAAAAGTGTATTTTGCTTTGAATATGCAGATGAAAACAGGAATTTCAGCCAGCGTGCGTGAGCAACTGGTCAAACAAAGTCTAACAGCACTGGGGATAATTTAA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 348, "hit_end": 564, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|676|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-237", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "732", "ARO_accession": "3001678", "ARO_name": "OXA-237", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.78075, "max_identities": 19, "bit_score": 26.5646, "cvterm_id": "35507", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T E", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPE", "sequence_from_broadstreet": "MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFASALAQEQLAFDPQVQQQVKAMLLLQERQGYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATACTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAATCACCCCGGAACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGGTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGCGCTTTATCCGAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.36}, "gnl|BL_ORD_ID|1849|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-335", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2007", "ARO_accession": "3001523", "ARO_name": "OXA-335", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.79364, "max_identities": 21, "bit_score": 26.5646, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAR", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACSLPVSSLPSQSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYGNDLNRANTEYVPASTFKMPNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTTTGATTTTGCTGCCTTTACTTAGTTGCTTGGGCCTGACAGCATGTAGCCTACCCGTTTCATCTCTCCCATCTCAAAGCACTTCGACTCAAGCGATTGCCAGCTTATTTGATCAGGCGCAAAGCTCTGGTGTTTTAGTGATTCAGCGTGATCAACAAGTACAGGTCTATGGCAATGATTTAAATCGTGCAAATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCCCAATGCTCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGCTTTACCGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCGGTACCGGTCTATCAAGAACTGGCGCGTCGTATTGGTCTGGAATTAATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 330, "hit_end": 543, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|1585|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-235", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1730", "ARO_accession": "3001676", "ARO_name": "OXA-235", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.98443, "max_identities": 19, "bit_score": 26.5646, "cvterm_id": "35507", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T E", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPE", "sequence_from_broadstreet": "MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFASALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATACTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAATCACCCCGGAACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGATTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGCGCTTTATCCGAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.36}, "gnl|BL_ORD_ID|906|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-134", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "978", "ARO_accession": "3001695", "ARO_name": "OXA-134", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.02499, "max_identities": 21, "bit_score": 26.5646, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAR", "sequence_from_broadstreet": "MKILIFLPLLSCLGLTACSLPVSSLPSQSISTQAIASLFDQAQSSGVLVIQRDQQVQVYGNDLNRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTTTGATTTTTCTGCCTTTACTGAGTTGCTTGGGCCTGACAGCATGTAGCCTACCCGTTTCATCTCTCCCATCTCAAAGCATTTCGACTCAAGCGATTGCCAGCTTATTTGATCAGGCGCAAAGCTCTGGTGTTTTAGTGATTCAGCGTGATCAACAAGTACAGGTCTATGGCAATGATTTAAATCGTGCAAATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCTCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGCTTTACCGCCTGGGAAAAAGACATGACGCTCGGCCAAGCCATGCAAGCTTCTGCGGTACCGGTCTATCAAGAGCTGGCGCGTCGTATTGGTCTGGAATTAATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 330, "hit_end": 543, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|1357|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1472", "ARO_accession": "3002149", "ARO_name": "DHA-18", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.32141, "max_identities": 12, "bit_score": 26.5646, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E++Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCTGCCCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCAGCGGTGGTGGACAGCACTATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTATCCGTAAAGGGCAAGCCCTATTATTTTAACTATGGTTTTGCCGATGTTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGACGGCGCTGAATGATCCGGCGGCAAAATATCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACGCTGCTGGATCTGGCCACCTATACCGCAGGCGGGCTGCCGTTACAGGTACCGGATGCGGTGAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCATCATGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAATGCGGCGGGGATGCCGTATGAGCAGTTGCTGACCGCGCGGATCCTGGCACCGCTGGGATTATCTCACACCTTTATTACCGTGCCGGAAAGTGTGCAAAGCCGGTATGCGTACGGCTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|555|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-361", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "608", "ARO_accession": "3001548", "ARO_name": "OXA-361", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.43759, "max_identities": 21, "bit_score": 26.5646, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAR", "sequence_from_broadstreet": "MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKVMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVKTPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTGCCTTTATTTAGTTGCTTGGGACTGACGGCGTGTAGTCTGCCCGTTTCATCCTCCCCCTCTCAGATCACTTCAATTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCTGGCGTTTTAGTGATTCAGCGTGGTCAACAGATACAGGTTTATGGTAATGATTTAAGTCGTGCAAATACCGAATATGTTCCAGCCTCTACTTTCAAAATGCTCAATGCCCTGATTGGTCTACAACATGGTAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTTCAGCTTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCGTCTGCTGTACCCGTTTATCAGGAACTGGCACGTCGTATTGGCCTTGAACTGATGCAACAGGAAGTACAATGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGCTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAGCAAGTCAAAGTCATGTTACTGCTACAGGAGCAGCAAGCTTATCGACTATATGCCAAATCTGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTAAAACACCGCAAGCCGAGATCGTGGCATTTTCACTGAATATGCAGATGCGAAATGGTATGGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCAGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|4766|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-647", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4069", "ARO_accession": "3005337", "ARO_name": "OXA-647", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.64194, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAR", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACSLPVSSLPSPSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYGNDLNRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKDEG", "dna_sequence_from_broadstreet": "ATGAAAATTTTGATTTTGCTGCCTTTACTTAGTTGCTTGGGCCTGACAGCATGTAGCCTACCCGTTTCATCTCTCCCATCTCCAAGCACTTCGACTCAAGCGATTGCCAGCTTATTTGATCAGGCGCAAAGCTCTGGTGTTTTAGTGATTCAGCGTGATCAACAAGTACAGGTCTATGGCAATGATTTAAATCGTGCAAATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCTCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGCTTTACCGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCGGTACCGGTCTATCAAGAACTGGCGCGTCGTATTGGTCTGGAATTAATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGATGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 330, "hit_end": 543, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|330|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-278", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "361", "ARO_accession": "3001681", "ARO_name": "OXA-278", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.65687, "max_identities": 19, "bit_score": 26.1794, "cvterm_id": "39096", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L E++     +  +      D FW  G L +T +", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMEQEVRRIQFGNQHIGQQVDNFWLVGPLKITPK", "sequence_from_broadstreet": "MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMEQEVRRIQFGNQHIGQQVDNFWLVGPLKITPKQEVEFVSALAQEQLAFDPQVQQQVKAMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTTATTTTGTGGCCTTTACTCAGTTACTTGAGCCTGACAGCCTGTAGCTTCCCTGTTTCAAATTCGCCCTCTCAAATCACTTCAACTCAATCTATTCAAGCTATTGCAAAGTTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGTCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATGTTCCTGCTTCAACCTTTAAAATATTTAATGCTCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTAGCACGTCGCATTGGCCTTGAATTGATGGAACAGGAAGTGAGACGTATTCAATTCGGCAATCAACATATTGGGCAGCAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTTTTACAGGAACAGCAAGCTTATCGCCTATATGCCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCGAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.36}, "gnl|BL_ORD_ID|1390|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-423", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1511", "ARO_accession": "3003161", "ARO_name": "OXA-423", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.84025, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAAPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAAPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCGTTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGCCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1060|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-363", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1148", "ARO_accession": "3001550", "ARO_name": "OXA-363", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.95944, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAR", "sequence_from_broadstreet": "MKTLIFLPLLNCLSLTACTLPVSSSPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAREQLAFDPQVQQQVKAMLLLQERKAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTGATTTTTCTGCCTTTACTTAATTGCTTGAGCCTGACGGCGTGTACCTTACCCGTTTCATCTTCCCCATCTCATATCACTTCGACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCTCTGGCGTTTTAGTGATTCAGCGTGGTCAACAGATACAGGTCTATGGCAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGTAAGAAACGTAGTTTTTCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCGCGTCGTATTGGCCTTGAACTGATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAGCAAGTCGATAATTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAGGTCGAATTTGTCTCGGCTCTAGCCCGAGAGCAGCTTGCCTTTGATCCACAAGTCCAGCAGCAAGTCAAAGCCATGTTACTTTTACAGGAGCGGAAAGCTTATCGACTATATGCCAAATCTGGTTGGGGCATGGATGTGGAACCACAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATGGATCCGGCAATCCGCCTTGAAATTTTACAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|3803|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-542", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4873", "ARO_accession": "3005768", "ARO_name": "OXA-542", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.02462, "max_identities": 18, "bit_score": 26.1794, "cvterm_id": "36787", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "+L+  P Y+E+A++IG  L +++     +         D FW  G L +T  + V + D +A N", "sequence_from_db": "KLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHN", "sequence_from_broadstreet": "MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDNNHLAIYGNNLTRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMNLDEAMKLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHNKLPFKIETQETVKNMLLIKEINGSKIYAKSGWGMDVTPQVGWLTGWVEQPTGKIISFSLNLEMKNNMTGSIRNEITYKALENLGII", "dna_sequence_from_broadstreet": "ATGAAAAAAGTTGTATTTCCTATATTGAGTATCTTTACTTTATTTTCTCTGAATGCGTGTTCATCGGTTCAGACAGCATCCGAAAGTACTATTTCAGCTTACAATCAACAGAGTAAAGAAACTATAAAAAAATATTTTGATGATGCTCAAACACAAGGTGTAATTGTTATTAAAGATAATAATCATCTTGCGATATATGGTAATAATTTAACACGAGCACATACACAATATGTTCCAGCATCAACTTTTAAAATGTTGAACGCTTTAATTGGATTAGAAAATAATAAAGTAACCACGGATGAACTGTTTAAGTGGGATGGTAATAAAAAAGCTTTCCCAATTTGGGAAAAAGATATGAACTTAGATGAGGCGATGAAATTATCAGCAGTTCCTGTATATCAAGAACTTGCAAAACGTATTGGTATAGATTTAATGCAGAAAGAAGTAAAACGGGTTAATTTTGGTAATGCTAATATTGGAACTAAAGTTGATAATTTTTGGTTAGTTGGCCCTTTGAAGATTACACCTATTCAAGAAGTTAAATTTGCTGATGATCTTGCACATAACAAATTACCTTTCAAAATTGAAACTCAAGAAACAGTTAAAAATATGCTTCTAATTAAAGAAATTAATGGAAGTAAAATTTATGCAAAAAGTGGTTGGGGAATGGATGTTACACCTCAAGTGGGTTGGTTAACTGGTTGGGTAGAACAGCCTACAGGGAAGATAATTTCATTTTCATTAAATTTAGAAATGAAAAATAATATGACAGGTTCTATTCGCAATGAAATTACATATAAAGCATTAGAGAATCTTGGTATCATTTAA", "partial": "0", "query_start": 4222, "query_end": 4404, "hit_start": 375, "hit_end": 567, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.12}, "gnl|BL_ORD_ID|4041|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-806", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5111", "ARO_accession": "3006006", "ARO_name": "OXA-806", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.04935, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSGMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCACTAAATATGGAAATGCGGTCAGGAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3907|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-657", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4977", "ARO_accession": "3005872", "ARO_name": "OXA-657", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.19503, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMGIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGGTATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2649|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-282", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3447", "ARO_accession": "3001737", "ARO_name": "OXA-282", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.28701, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36791", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR ", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALARE", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTGCCTTTACTTAGTTGCTTGGGCCTGACAGCGTGTAGCCTGCCCGTTTCATCTCTCCTATCTCAAAGCACTTCGACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCGGGTGTTCTAGTGATTCAGCGTGGTCAACAGATACAGGTTTATGGTAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTGTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 339, "hit_end": 555, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|4120|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-893", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5190", "ARO_accession": "3006085", "ARO_name": "OXA-893", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.30771, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNVLLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGTATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4046|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-811", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5116", "ARO_accession": "3006011", "ARO_name": "OXA-811", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.30771, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVFASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSGMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGTTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGACTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCACTAAATATGGAAATGCGGTCAGGAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|632|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-239", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "685", "ARO_accession": "3001498", "ARO_name": "OXA-239", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.34594, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39095", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRLFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTTATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGAATATAAAATCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2656|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-283", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "510", "model_id": "3448", "ARO_accession": "3001738", "ARO_name": "OXA-283", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.36341, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "42809", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR ", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALARE", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTAATTTTGCTGCCTTTACTGAGTTGCTTGGGCCTGACAGCGTGTAGCCTGCCCGTTTCATCTCTCCTATCTCAAAGCACTTCGACTCAATCCACCCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCGGGTGTTCTAGTGATTCAGCGTGGTCAACAGATACAGGTTTATGGTAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTGTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAAGCCGAGATCGTGGCATTTTCACTGAATATGCAGATGCGAAATGGTATGGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 339, "hit_end": 555, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|4123|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-900", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5193", "ARO_accession": "3006088", "ARO_name": "OXA-900", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.44439, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "36915", "query": "GVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGD", "match": " + +AM Y +   P Y+E A+QIGD    +      +  E+     D FW D", "sequence_from_db": "NLISAMKYSVV--PIYQEFARQIGDARMGKMIAVFDYGNEDISGNLDSFWLD", "sequence_from_broadstreet": "MRLFVISAVLVMSSISAFPVFAASSPQKEWQETRSWDASFTQHQAKGVVVLWNENKQQGFTNNLKRANQGFLPASTFKIPNSLIALDLGMVKDEHQVFKWDGKNRDIAAWNRDHNLISAMKYSVVPIYQEFARQIGDARMGKMIAVFDYGNEDISGNLDSFWLDGGIRISAKEQIDFLRRLYHNKLHVSERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWVELDDNVWFFAMNMDMPSADGLALRQAITKEVLRQEKIIP", "dna_sequence_from_broadstreet": "ATGCGTTTGTTCGTCATCTCGGCGGTATTGGTGATGTCCTCCATCTCAGCTTTCCCTGTTTTTGCTGCTAGCTCGCCCCAAAAAGAGTGGCAAGAAACCCGCAGTTGGGATGCCAGTTTTACTCAGCACCAAGCTAAAGGCGTGGTGGTGTTATGGAATGAAAATAAACAACAGGGATTCACTAATAATCTTAAACGCGCCAATCAAGGTTTTTTACCTGCATCGACGTTTAAAATTCCCAACAGTTTGATTGCTCTCGATTTAGGGATGGTGAAAGATGAGCACCAAGTTTTTAAGTGGGATGGTAAAAATCGTGATATTGCCGCCTGGAATCGTGACCATAATTTGATTAGCGCCATGAAGTATTCGGTTGTGCCCATCTACCAAGAGTTTGCTCGCCAAATAGGTGATGCTCGCATGGGGAAGATGATCGCTGTTTTTGATTATGGCAATGAGGATATCTCAGGCAATTTAGACAGTTTTTGGTTAGATGGAGGCATTCGGATCTCAGCCAAAGAGCAAATCGATTTCCTACGTCGGCTTTATCATAACAAGTTGCATGTTTCCGAGAGAAGTCAGCGTATTGTTAAGCAAGCCATGCTGACTGAAGCCAATAGTGACTATATTATCCGCGCAAAAACGGGTTATGCCGTAAGGGCCGAACCGAGCATTGGTTGGTGGGTCGGTTGGGTAGAACTCGATGATAATGTATGGTTTTTTGCAATGAATATGGATATGCCATCAGCGGATGGTTTGGCACTGCGCCAAGCCATTACAAAAGAAGTACTCAGGCAGGAAAAGATTATCCCCTAA", "partial": "0", "query_start": 4198, "query_end": 4353, "hit_start": 342, "hit_end": 492, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.77}, "gnl|BL_ORD_ID|2866|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-818", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "560", "model_id": "3884", "ARO_accession": "3005159", "ARO_name": "OXA-818", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50227, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1662|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-168", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1802", "ARO_accession": "3001468", "ARO_name": "OXA-168", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50227, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLAGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGGCCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1222|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-170", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1326", "ARO_accession": "3001470", "ARO_name": "OXA-170", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50227, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEKSNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAAAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1020|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-435", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1115", "ARO_accession": "3003162", "ARO_name": "OXA-435", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.50227, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLSGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGTCCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|281|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-167", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "312", "ARO_accession": "3001467", "ARO_name": "OXA-167", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.54222, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELMMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTAATGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2091|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-440", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3510", "ARO_accession": "3003596", "ARO_name": "OXA-440", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58253, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDKKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATAAAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1049|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-169", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1141", "ARO_accession": "3001469", "ARO_name": "OXA-169", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58253, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDERNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAGAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|126|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "147", "ARO_accession": "3001422", "ARO_name": "OXA-27", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58253, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKADINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALKMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTCATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAGCGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAAAATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1632|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-146", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1780", "ARO_accession": "3001779", "ARO_name": "OXA-146", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58868, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4043|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-808", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5113", "ARO_accession": "3006008", "ARO_name": "OXA-808", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.62319, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASILNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACTTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4042|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-807", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5112", "ARO_accession": "3006007", "ARO_name": "OXA-807", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.62319, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1234|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-166", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1343", "ARO_accession": "3001466", "ARO_name": "OXA-166", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.62319, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGALVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGCGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|288|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-366", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "319", "ARO_accession": "3001553", "ARO_name": "OXA-366", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.62319, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTAQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGCTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3824|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-565", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4894", "ARO_accession": "3005789", "ARO_name": "OXA-565", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.66422, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2279|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-483", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "545", "model_id": "3544", "ARO_accession": "3003640", "ARO_name": "OXA-483", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.66422, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAVALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTGTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4133|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-911", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5203", "ARO_accession": "3006098", "ARO_name": "OXA-911", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.67046, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1718|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-165", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1860", "ARO_accession": "3001465", "ARO_name": "OXA-165", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.70561, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDVKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATGTAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|208|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-422", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "230", "ARO_accession": "3003160", "ARO_name": "OXA-422", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.70561, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASPFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCCTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2210|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-296", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "460", "model_id": "3356", "ARO_accession": "3001751", "ARO_name": "OXA-296", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.7305, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "42695", "query": "GVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": " +A AM  +L+  P Y+++A++IG  L +++     +  ++     D FW  G L +T E", "sequence_from_db": "NLAQAM--QLSAVPVYQQLARRIGLELMQKEISRLGFGNQKIGQQVDNFWLVGPLKITPE", "sequence_from_broadstreet": "MQQRLFYFGCLLLLTQLSACHMNRAQTSNQSVQKAVLQAPSERPEEIKQLFNSAHTSAVFITYDGRQFNRYGNALARAQNAYIPASTFKILNALIGLQHHKVSTSEVFKWKGEKRSFPAWEKDMNLAQAMQLSAVPVYQQLARRIGLELMQKEISRLGFGNQKIGQQVDNFWLVGPLKITPEQEAQFVYQLATEQLPFDVKVQKQVKEMLYIERRGDTKLYAKSGWGMDVKPQVGWYTGWVEQANGQITAFVLNLEMHDGDDVGERKQLTLDALDKLGLFFYLH", "dna_sequence_from_broadstreet": "ATGCAACAGCGGTTATTTTACTTTGGCTGTTTATTGCTCTTAACGCAATTAAGTGCTTGCCACATGAACAGGGCGCAGACGTCTAATCAATCCGTGCAAAAAGCTGTTTTGCAGGCACCCTCTGAACGCCCAGAAGAGATTAAGCAATTGTTTAATTCTGCACACACATCAGCCGTTTTTATCACCTATGACGGTCGGCAGTTTAATCGTTATGGTAATGCTTTGGCTCGTGCCCAAAATGCCTATATTCCAGCTTCAACGTTTAAAATATTAAATGCATTGATTGGTCTTCAGCATCATAAAGTCAGTACGTCTGAAGTGTTTAAATGGAAGGGTGAAAAGCGTTCATTTCCTGCGTGGGAAAAAGATATGAACTTGGCGCAAGCCATGCAGCTTTCAGCCGTTCCAGTGTATCAGCAGCTTGCTCGACGTATAGGCTTAGAACTCATGCAGAAAGAAATTTCTCGGCTTGGTTTTGGCAATCAAAAGATTGGTCAACAGGTGGATAATTTTTGGTTGGTTGGCCCTTTAAAAATAACCCCAGAACAAGAAGCACAATTTGTCTATCAACTGGCAACAGAGCAATTACCTTTTGATGTAAAAGTACAAAAACAGGTCAAAGAGATGCTTTATATTGAGCGTCGTGGTGATACAAAATTATATGCAAAAAGTGGTTGGGGAATGGATGTTAAGCCTCAAGTGGGGTGGTATACAGGGTGGGTTGAACAAGCAAATGGACAGATCACCGCTTTTGTTTTAAATTTGGAAATGCATGATGGCGATGATGTGGGCGAACGTAAGCAGCTCACTTTGGATGCATTGGATAAGCTGGGATTATTCTTTTATTTACACTAA", "partial": "0", "query_start": 4198, "query_end": 4371, "hit_start": 372, "hit_end": 546, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.33}, "gnl|BL_ORD_ID|4047|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-813", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5117", "ARO_accession": "3006012", "ARO_name": "OXA-813", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.74736, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "37046", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVFASLFLSGCTVQHNLINETPSQIAQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGTTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGCTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4045|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-810", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5115", "ARO_accession": "3006010", "ARO_name": "OXA-810", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.74736, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAATAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTAAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1573|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1715", "ARO_accession": "3001785", "ARO_name": "OXA-73", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.74736, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35915", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALKMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAAAATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|624|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-171", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "677", "ARO_accession": "3001471", "ARO_name": "OXA-171", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.74736, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASTRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTACACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|295|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-225", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "326", "ARO_accession": "3001493", "ARO_name": "OXA-225", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.74736, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAATCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|980|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1071", "ARO_accession": "3002153", "ARO_name": "DHA-22", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.75369, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35914", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSAIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDLAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCGCCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCAGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCTGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3045|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-646", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4071", "ARO_accession": "3005339", "ARO_name": "OXA-646", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78475, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A+ IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAR", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACTSPVSSFPSQITSTQSTQAIAQLFDQAQSSGVLVIQRGQKVQVYGNDLSRAGTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAREQLAFDPQVQQQVKAMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQTNMNPAIRLEILQQALGELGLYPKVGQQSK", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTACCTTTACTGAGTTGCTTGGGCCTGACAGCGTGTACCTCACCTGTTTCATCTTTCCCTTCTCAGATCACTTCAACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGTTCTGGCGTTTTAGTGATTCAGCGTGGTCAAAAAGTACAGGTCTATGGCAATGATTTAAGCCGTGCAGGTACCGAATATGTTCCAGCCTCTACTTTCAAAATGCTCAATGCCCTGATTGGTCTACAACATGGTAAAGCCACAACCAATGAGATTTTTAAATGGGATGGCAAGAAACGCAGTTTTGCAGCCTGGGAAAAAGACATGACGCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCATATTGGTTTGGAATTAATGCAGCAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAGCAGGTCGATAACTTCTGGTTGGTAGGTCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCTCTAGCCCGAGAGCAACTAGCCTTTGATCCTCAAGTCCAGCAGCAAGTCAAAGCCATGTTACTTCTACAGGAACGGCAAGCTTATCGCCTGTATGCCAAATCCGGTTGGGGCATGGATGTAGAACCGCAAGTCGGCTGGCTCACCGGGTGGGTCGAAACACCGCAGGCTGAAATCGTGGCATTTTCTCTAAATATGCAAATGCAAACCAATATGAATCCAGCCATTCGCCTTGAAATTTTACAGCAGGCTCTGGGCGAATTAGGGCTTTACCCAAAAGTGGGGCAGCAAAGCAAATAG", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|4048|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-814", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5118", "ARO_accession": "3006013", "ARO_name": "OXA-814", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78949, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2260|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-482", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "545", "model_id": "3543", "ARO_accession": "3003639", "ARO_name": "OXA-482", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78949, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVINQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTAATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1574|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-398", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1716", "ARO_accession": "3001584", "ARO_name": "OXA-398", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78949, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKQQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACAACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|1032|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1128", "ARO_accession": "3001418", "ARO_name": "OXA-23", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78949, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3514|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4583", "ARO_accession": "3002137", "ARO_name": "DHA-4", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.79543, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCCCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCTGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGACATTCCCGGGATGGCGGTTGCCGTCTCTGTAAAGGGCAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAACCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACCGCGCGGATCCTGGCACCGCTGGGATTATCTCACACCTTTATTACCGTGCCGGAAAGCGCGCAAAGTCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCACCGGGACAGCTTGATGCGGAATCTTACGGTGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGTTACTATAAAACCGCCGCGATTAATCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACGGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTAGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3043|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-915", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4068", "ARO_accession": "3005336", "ARO_name": "OXA-915", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.81479, "max_identities": 21, "bit_score": 25.7942, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIARN", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR ", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVRRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALARE", "sequence_from_broadstreet": "MKILILLPLFSCLGLTACSLPVSSSPSQITSTQSTQEAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLGRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTTWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVRRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVTFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTGCCTTTATTTAGTTGCTTGGGACTGACGGCGTGTAGTCTGCCCGTTTCATCCTCCCCCTCTCAGATCACTTCAACTCAATCGACTCAAGAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCTGGCGTTTTAGTGATTCAGCGTGGTCAGCAGATACAGGTCTATGGTAATGATTTAGGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGCTTTACCACCTGGGAAAAAGACATGACTCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTGTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGCAACAGGAAGTGAGACGTATTCAATTCGGCAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAGTTACTCCAAAACAGGAAGTCCAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGACATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4404, "hit_start": 342, "hit_end": 558, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.58}, "gnl|BL_ORD_ID|3508|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4577", "ARO_accession": "3006465", "ARO_name": "DHA-24", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.88002, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36788", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGAATGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAGCAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCGCTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|802|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "868", "ARO_accession": "3002132", "ARO_name": "DHA-1", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.88002, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35750", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3511|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4580", "ARO_accession": "3006468", "ARO_name": "DHA-27", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92287, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35506", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCTGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1109|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1207", "ARO_accession": "3002144", "ARO_name": "DHA-13", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92287, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCTGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCCGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATATCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACGCTGCTGGATCTGGCCACCTATACCGCAGGCGGGCTGCCGTTACAGGTACCGGATGCGGTGAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCATCATGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|26|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "32", "ARO_accession": "3002146", "ARO_name": "DHA-15", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92287, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35915", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGYMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCTATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3512|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4581", "ARO_accession": "3006469", "ARO_name": "DHA-28", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.9661, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MTKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKNRADLLNFYQQWQPSWQPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRTGNADLEMAMYLAQTRYYKTVAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGACAAAATCATTATCTGCAACACTGATTTCCGCCCTGCTGGCGTTTTCCGCCCCGGGGTTTTCCGCCGCTGACAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCTGTAAAGGGCAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGACGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACGCTGCTGGATCTGGCCACCTATACCGCAGGCGGGCTGCCGTTACAGGTGCCGGACGCGGTGAAAAACCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCATGGCAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCAGCGGGGATGCCGTATGAGCAGTTGCTGACTGCGCGGATCCTGGCACCGCTGGGATTATCTCACACCTTTATTACCGTGCCGGAAAGCGCGCAAAGCCAGTATGCATACGGTTATAAAAACAAAAAGCCGGTTCGCGTGTCACCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCTTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGACCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGTCGCGATTAATCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|2680|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-284", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3449", "ARO_accession": "3001739", "ARO_name": "OXA-284", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.9814, "max_identities": 21, "bit_score": 25.7942, "cvterm_id": "42810", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAR", "sequence_from_broadstreet": "MKTLIFLPLLNCLSLTACTLPVSSSPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTGATTTTTCTGCCTTTACTTAATTGCTTGAGCCTGACGGCGTGTACCTTACCCGTTTCATCTTCCCCATCTCATATCACTTCGACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCTCTGGCGTTTTAGTGATTCAGCGTGGTCAACAGATACAGGTCTATGGCAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGTAAGAAACGCAGTTTTTCAGCCTGGGAAAAAGATATGACTCTCGGTGAAGCCATGCAAGCGTCTGCTGTACCCGTCTATCAGGAACTGGCGCGTCGTATTGGCCTTGAACTGATGCAACAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAACAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTTTCTGCGTTGGCCCGAGAGCAACTGGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTATTTTTACAGGAGCGGAAAGCTTATCGACTATATGTCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCACTCAATATGCAGATGCAAAATGGTATAGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|1740|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1883", "ARO_accession": "3002141", "ARO_name": "DHA-10", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.00971, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSIS", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  + ", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVK", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLATYTAGGLPLQVPDEVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCTGCCCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCTGTCTCTGTAAAGGGTAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGACGCTGAATGACCCGGCGGAAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAAGGGATCACGCTGCTGGATCTGGCCACCTACACCGCAGGCGGGCTGCCGTTACAGGTACCGGATGAGGTGAAAAGCCGTGCGGATCTGCTGCATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCAGCGGGGATGCCGTATGAGCAGTTGCTGACCGCGCGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACCGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCAGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACTGCCGCGATTAATCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGCGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3861, "hit_start": 576, "hit_end": 729, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 23.53}, "gnl|BL_ORD_ID|1646|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1793", "ARO_accession": "3002145", "ARO_name": "DHA-14", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.00971, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGCACTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1558|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1695", "ARO_accession": "3002138", "ARO_name": "DHA-5", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.00971, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGRPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGACATTCCCGGGATGGCGGTTGCCGTCTCTGTAAAGGGCAGGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGCACTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGCATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGTTACTATAAAACCGCCGCGATTAATCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|569|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "622", "ARO_accession": "3002136", "ARO_name": "DHA-7", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.00971, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36884", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGSGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTCCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3509|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4578", "ARO_accession": "3006466", "ARO_name": "DHA-25", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.0537, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35915", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSDSKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGACTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1645|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1792", "ARO_accession": "3002151", "ARO_name": "DHA-20", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.0537, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36934", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCCCTGCTGGCATTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCTGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCCGTGGCGAAAAAAGAGATGACGCTGAATGACCCGGCAGAAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACACTGTTGGATCTGGCCACCTACACCGCAGGCGGGCTGCCGTTACAGGTACCGGATGCGGTGAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCAGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGCGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACCGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1300|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1418", "ARO_accession": "3002135", "ARO_name": "DHA-6", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.0537, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35914", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSTSKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCACCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|284|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "315", "ARO_accession": "3002133", "ARO_name": "DHA-2", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.09808, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35915", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSIS", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  + ", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVK", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMMLNDPAEKYQPELALPQWKGITLLDLATYTTGGLPLQVPDAVKNRAELLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCTGTAAAGGGCAAGCCCTATTATTTCAATTATGGTTTTGCCGATGTTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTGGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGATGTTGAATGACCCGGCAGAAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACACTGCTGGATCTGGCCACCTACACCACAGGCGGGCTGCCGTTACAGGTGCCGGATGCGGTGAAAAACCGTGCGGAACTGCTGCACTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCAGCGGGGATGCCGTATGAGCAGTTGCTGACCGCGCGGATCCTGGCACCGCTGGGATTATCTCACACCTTTATTACCGTGCCGGAAAGCGCGCAAAGCCAGTATGCGTACGGCTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAGTCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAGATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCACTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCGCTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3861, "hit_start": 576, "hit_end": 729, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 23.53}, "gnl|BL_ORD_ID|2593|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-277", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "510", "model_id": "3443", "ARO_accession": "3001733", "ARO_name": "OXA-277", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.16048, "max_identities": 18, "bit_score": 25.7942, "cvterm_id": "42806", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T +", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKITPK", "sequence_from_broadstreet": "MKILILWPLLSCLSLTACSFAVSNSPSQITSTQSIQATAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYVPASTFKMFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKITPKQEVEFASALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVVFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEA", "dna_sequence_from_broadstreet": "ATGAAAATTCTTATTTTGTGGCCTTTACTCAGTTGCTTGAGCCTGACAGCTTGTAGCTTCGCTGTTTCAAATTCGCCCTCTCAAATCACTTCAACTCAATCTATTCAAGCTACTGCAAAGTTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGTCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATGTTCCTGCTTCAACCTTTAAAATGTTTAATGCTCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATTTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGTATTCAATTTGGTAATCAGCAGATTGGTCATCAGGTCGACAACTTCTGGTTAGTCGGACCTTTGAAAATCACCCCGAAACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCGGGTTCAGCAGCAAGTTAAAACCATGTTACTGTTACAGGAGCGACAAGCTTATCGGCTTTATGCTAAATCCGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATTGAAACACCTCAGGACGAAATCGTGGTATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCTGAATTAGGGCTTTATCCGAAAGCTGAAGCGTAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.87}, "gnl|BL_ORD_ID|2031|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "MSI-OXA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2234", "ARO_accession": "3003719", "ARO_name": "MSI-OXA", "ARO_category": {"41406": {"category_aro_accession": "3004242", "category_aro_cvterm_id": "41406", "category_aro_name": "MSI-OXA family beta-lactamase", "category_aro_description": "Members of the MSI-OXA family are class D beta-lactamases that encompass hybrids of MSI-1 and putative OXA homologues.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.17889, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "40282", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGD", "match": "R++  P Y+E+A+++G      +     +   +T  V D FW D", "sequence_from_db": "RISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLD", "sequence_from_broadstreet": "MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL", "dna_sequence_from_broadstreet": "ATGAGTCACACGTTCATCATCGACCGACTTGGAGCATCCATGATCAAGCAAATTCTCGCAGCACTGTTGTTGATCAGCCCGCTGCTGGCGCAGGCCGCCGAATGGAAGGAAAGCGCGCAGGTGGCGCGCCTGTTCAAGCAGGAAGGCGTGAGCGGCACCTTCGTCGTCTACGACGTGGCCGCCGACAGCTACACGGTGCATGACCGCCAGCGCGCCAACACGCGCTTCATTCCGGCGTCGACCTTCAAGATCCCGAACACGCTGATCGCGCTGGCGCATGGCGCGGTGGCCAACGTCGACGAAGTGGTGCCGTATGGCGGCAAGCCGGTAGCGCGGCCCGAGTGGGCGCGCGACATGGGGCTGCGCGAGGCGATCCGGATCTCGAACGTGCCGGTGTACCAGGAAGTGGCGCGGCGCGTGGGCCTGGACCGGATGCGCTCGGAGCTGGTCCGGATGAAGTACGGGAACATGCAGACCGGGACCGTGGTGGACCGGTTCTGGCTCGATGGGCCTTTGAAGATCAGCGCGGTGGAGCAGACCGAATTTTTGACCAAGCTGGCGCAGGGTACGCTGCCGTTCACCAACGTGGCGATGGCGGCGGTGCGCGAGATCAGCCGTCAGGATGGAGCGCCCGAGCTGTATGCCAAGACCGGGTGGGGCAGTCGGCCGGGCGAGGCCGATATCGGGTGGTGGGTCGGTTGGCTGAAGAAGGATGGCAAGCTGTATGCATTTGCGCTGAATATGGATCTTCCCGATGGTGCGCAGGACAAGCGGGTGTCGCTGGCGAAGGCGGCGTTGCGGGAACTGGGCCTGCTGTAG", "partial": "0", "query_start": 4222, "query_end": 4353, "hit_start": 375, "hit_end": 507, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 27.27}, "gnl|BL_ORD_ID|766|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "829", "ARO_accession": "3002148", "ARO_name": "DHA-17", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.188, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAVVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGTGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3507|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4576", "ARO_accession": "3002154", "ARO_name": "DHA-23", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.23355, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "35915", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSSSKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCTCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1518|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1649", "ARO_accession": "3002152", "ARO_name": "DHA-21", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.23355, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCTGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCTGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCCGTGGCGAAAAAAGAGATGACGTTGAATGACCCGGCAGAAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACACTGCTGGATCTGGCTACCTACACCGCAGGCGGGCTGCCGTTACAGGTGCCGGATGCGGTGAAAAGCCGTGCGGATCTGCTGCATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACGGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|3700|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "MOR-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4770", "ARO_accession": "3006953", "ARO_name": "MOR-2", "ARO_category": {"43885": {"category_aro_accession": "3005425", "category_aro_cvterm_id": "43885", "category_aro_name": "MOR beta-lactamase", "category_aro_description": "MOR beta-lactamases are class C beta-lactamases found in Morganella morganii.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.4198, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGACAAAATCTGTATCTGCAACACTGATTTCCGCCCTGCTGGCATTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTACGGTTTTGCCGATGTTCAGGCAAAACAGCCTGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCCGTGGCGAAAAAAGAGATGACGCTGAATGACCCGGCAGAAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACGCTGCTGGATCTGGCCACCTACACCGCAGGCGGGCTGCCGTTACAGGTACCGGATGCGGTGAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCCAACGCAGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGCGCGCAAAGCCAGTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1545|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1679", "ARO_accession": "3001671", "ARO_name": "OXA-49", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.4271, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35507", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIGFGNAEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4044|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-809", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5114", "ARO_accession": "3006009", "ARO_name": "OXA-809", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.46805, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTYYVFASLFLSGCTVQHNLINDAQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTACTATGTGTTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAACTTAATAAATGACGCTCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTATCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATTGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATACTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4050|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-816", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5120", "ARO_accession": "3006015", "ARO_name": "OXA-816", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.51656, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "37046", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGTGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTATCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAAGAACTTGCAAGACGTATTGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATACTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2867|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-812", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "560", "model_id": "3885", "ARO_accession": "3005160", "ARO_name": "OXA-812", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.51656, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSEIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTGAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGTGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTATCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAAGAACTTGCAAGACGTATTGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATACTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|2734|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-285", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3450", "ARO_accession": "3001740", "ARO_name": "OXA-285", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.6368, "max_identities": 21, "bit_score": 25.7942, "cvterm_id": "42811", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A+ IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAR", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACTSPVSSFPSQITSTQSTQAIAQLFDQAQSSGVLVIQRGQKVQVYGNDLSRAGTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAREQLAFDPQVQQQVKAMLLLQERQAYRLYAKSGWGMDVQPQVGWLTGWVETPQAEIVSFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTACCTTTACTGAGTTGCTTGGGCCTGACAGCGTGTACCTCACCTGTTTCATCTTTCCCTTCTCAGATCACTTCAACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGTTCTGGCGTTTTAGTGATTCAGCGTGGTCAAAAAGTACAGGTCTATGGCAATGATTTAAGCCGTGCAGGTACCGAATATGTTCCAGCCTCTACTTTCAAAATGCTCAATGCCCTGATTGGTCTACAACATGGTAAAGCCACAACCAATGAGATTTTTAAATGGGATGGCAAGAAACGCAGTTTTGCAGCCTGGGAAAAAGACATGACGCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCATATTGGTTTGGAATTAATGCAGCAGGAAGTACAACGCATCCAATTTGGTAATCAGCAGATTGGTCAGCAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCTCTAGCCCGAGAGCAACTAGCCTTTGATCCTCAAGTCCAGCAGCAAGTTAAAGCCATGTTACTTTTACAGGAACGGCAAGCTTATCGCCTATATGCCAAATCCGGTTGGGGCATGGATGTACAACCTCAAGTCGGCTGGCTTACCGGCTGGGTTGAAACACCGCAAGCCGAGATCGTGTCATTTTCACTGAATATGCAGATGCAAAATGGTATGGATCCGGCGATCCGCCTTGAAATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|2569|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-276", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "520", "model_id": "3442", "ARO_accession": "3001732", "ARO_name": "OXA-276", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.6368, "max_identities": 18, "bit_score": 25.7942, "cvterm_id": "42805", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T +", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPK", "sequence_from_broadstreet": "MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPKQEVEFASALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTTATTTTGTGGCCTTTACTCAGTTACTTGAGCCTGACAGCCTGTAGCTTCCCTGTTTCAAATTCGCCCTCTCAAATCACTTCAACTCAATCTATTCAAGCTATTGCAAAGTTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGTCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATGTTCCTGCTTCAACCTTTAAAATATTTAATGCTCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATTTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTACAACGTATTCAATTTGGTAATCAGCAGATTGGTCATCAGGTCGACAACTTCTGGTTAGTCGGACCTTTGAAAGTCACCCCGAAACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCGGGTTCAGCAGCAAGTTAAAACCATGTTACTGTTACAGGAGCGACAAGCTTATCGGCTTTATGCTAAATCCGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGTTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGACTTTATCCAAAAGCTGAAGGGTGA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.87}, "gnl|BL_ORD_ID|558|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-328", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "611", "ARO_accession": "3001516", "ARO_name": "OXA-328", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.76563, "max_identities": 22, "bit_score": 25.7942, "cvterm_id": "39094", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G A  A+A+       P Y+E+AQ+IG DL+ +     G+ +      V D FW  G L +T +", "sequence_from_db": "DMTLGNAMKASAI-------PVYQELAQRIGLDLMSKEVKRIGFGNANIGSKV-DNFWLVGPLKITPQ", "sequence_from_broadstreet": "MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGNAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGTATAAAAAAGCCCTTATCGTTGCAACAAGCCTCCTATTTTTATCCGCCTGTTCTTCCAATACAGTAACACAACATCAAATACACTCTATCTCTGCCAATAAAAATTCAGAAGAAATTAAATCACTGTTTGATCAAGCACAGACCACGGGAGTCTTGGTAATTAAGCGAGGGAAAACAGAAGAAATTTATGGCAATGATCTTAAAAGAGCATCAACCGCCTATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTAATTGGACTTGAACATCATAAGGCAACTACAACTGAAGTATTTAAATGGGATGGGCAAAAACGTTTATTTCCTGATTGGGAAAAGGACATGACACTGGGTAATGCCATGAAAGCTTCTGCAATTCCAGTTTACCAAGAATTAGCCCAACGAATTGGACTTGACCTTATGTCTAAAGAGGTAAAAAGAATTGGTTTCGGTAATGCTAACATTGGTTCAAAAGTAGATAATTTTTGGCTTGTTGGCCCTCTAAAAATTACGCCTCAACAAGAAACCCAATTTGCTTATCAATTAGCCCATAAAACGCTTCCATTTAGCAAAAATGTACAAGAACAAGTTCAATCAATGGTGTTCATAGAGGAAAAAAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTTGAACCACAAGTTGGTTGGTTAACAGGCTGGGTCGTTCAACCACAAGGAGAAATTGTCGCATTCTCACTTAATTTAGAAATGAAAAAAGGAACTCCTAGCTCTATTCGCAAAGAAATTGCTTATAAAGGCTTAGAACAACTGGGTATCTTATAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 345, "hit_end": 525, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 32.35}, "gnl|BL_ORD_ID|1479|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-362", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1618", "ARO_accession": "3001549", "ARO_name": "OXA-362", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.94342, "max_identities": 21, "bit_score": 25.7942, "cvterm_id": "36948", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT-AEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T  + V ++  +AR", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVRRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAR", "sequence_from_broadstreet": "MKILILLPLLSCLGLTACTSPVSSFPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQKVQVYGNDLSRAGTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVRRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVSALAREQLAFDPQVQQQVKAMLLLQERKAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTGATTTTGCTACCTTTACTGAGTTGCTTGGGCCTGACAGCGTGTACCTCACCTGTTTCATCTTTCCCTTCTCATATCACTTCGACTCAATCGACTCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGTTCTGGCGTTTTAGTGATTCAGCGTGGTCAAAAAGTACAGGTCTATGGCAATGATTTAAGCCGTGCAGGTACCGAATATGTTCCAGCCTCTACTTTCAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGCAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCGAAGCCATGCAAGCTTCTGCTGTACCCGTGTATCAGGAACTGGCACGTCGCATTGGCCTTGAACTGATGCAACAGGAAGTGAGACGTATTCAATTCGGCAATCAGCAGATTGGGCAGCAGGTTGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAGGTCGAATTTGTCTCGGCTCTAGCCCGAGAGCAGCTTGCCTTTGATCCACAAGTCCAGCAGCAAGTCAAAGCCATGTTACTTTTACAGGAGCGGAAAGCTTATCGACTATATGCCAAATCTGGTTGGGGCATGGATGTGGAACCACAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATGGATCCGGCAATCCGCCTTGAAATTTTACAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 339, "hit_end": 552, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.92}, "gnl|BL_ORD_ID|2297|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-103", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3407", "ARO_accession": "3001707", "ARO_name": "OXA-103", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.07939, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "42784", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATGCTGAAATTGGACAGCAGGTTGACAATTTCTGGTTGATAGGCCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAGTAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4049|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-815", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5119", "ARO_accession": "3006014", "ARO_name": "OXA-815", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.35384, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATTTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATGCTGAAATTGGACAGCAGGTTGACAATTTCTGGTTGATAGGCCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAATAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTAAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4570|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "RSD2-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5640", "ARO_accession": "3006983", "ARO_name": "RSD2-2", "ARO_category": {"43901": {"category_aro_accession": "3005441", "category_aro_cvterm_id": "43901", "category_aro_name": "RSD2 beta-lactamase", "category_aro_description": "RSD2 beta-lactamases are class D beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.44556, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "36791", "query": "LTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTA-EYVMWL", "match": "++  P Y+E+A++IG    ++     ++  E   +  D FW  G L ++A E V++L", "sequence_from_db": "MSNVPIYQELARRIGLTRMQKYLKDLHYGNESVGEHVDRFWLDGPLQISAVEQVLFL", "sequence_from_broadstreet": "MQTNLIYAMEENAQIKTLFEAADVNATFILYDLQKDTIVGYDKVRSEKRYLPASTFKIANSLIGLATGAVKTVDEPIPYNGPSNPFIAAWKEDMGLKKAIAMSNVPIYQELARRIGLTRMQKYLKDLHYGNESVGEHVDRFWLDGPLQISAVEQVLFLKGLVQETLPFSKNIQKDVKSILLIEKTNAYRLYGKTGLQNAHEKGIGWFVGWIEKSEGTYIFAFNMDMTDMSDAPKRINLSKTCLTILGLLNSE", "dna_sequence_from_broadstreet": "ATGCAAACGAACCTGATTTACGCAATGGAAGAGAATGCTCAGATTAAAACACTCTTTGAAGCAGCAGATGTTAATGCCACCTTTATTCTTTATGACCTGCAAAAAGACACCATAGTTGGATATGATAAGGTAAGGTCGGAAAAAAGGTATCTCCCTGCATCGACTTTCAAAATTGCTAATTCTCTCATTGGCTTGGCAACAGGTGCCGTTAAAACGGTAGATGAACCAATACCTTACAATGGCCCCAGCAATCCGTTTATAGCGGCATGGAAGGAAGATATGGGCTTGAAAAAAGCCATTGCTATGTCCAATGTGCCTATTTATCAGGAGTTGGCCCGAAGAATTGGATTAACGAGGATGCAAAAGTATTTAAAAGATCTTCATTATGGCAATGAATCGGTGGGAGAACATGTAGATCGTTTTTGGCTGGATGGACCACTTCAAATCAGTGCTGTGGAACAAGTGCTGTTTCTAAAAGGGCTAGTCCAGGAAACGCTCCCTTTTTCAAAAAACATCCAAAAAGATGTCAAGAGTATTCTCCTAATTGAAAAAACCAATGCTTATAGACTGTATGGAAAAACAGGCTTGCAAAATGCTCACGAAAAAGGCATAGGATGGTTTGTAGGATGGATTGAAAAGTCAGAAGGAACATACATTTTTGCATTCAATATGGACATGACTGATATGTCTGATGCCCCAAAGCGTATAAATCTGAGCAAAACTTGTTTAACAATTTTGGGGCTTCTCAATAGCGAATAA", "partial": "0", "query_start": 4225, "query_end": 4386, "hit_start": 303, "hit_end": 474, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.07}, "gnl|BL_ORD_ID|4160|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-946", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5230", "ARO_accession": "3006125", "ARO_name": "OXA-946", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.49191, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "39094", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +         D FW  G L +T", "sequence_from_db": "KLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKIT", "sequence_from_broadstreet": "MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKDGHNIDTYGNDLTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQKQVQDMLLIKEVEGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIKMKPNMPGSVRNEIALKSLKRLGII", "dna_sequence_from_broadstreet": "GTGAGAACACGTTTATTTCCTTTATTAAGTATATCTATTTCAATTTTTTTAAGTGCGTGCTCCTCTCCATTTATCGAACCTAAAGACATCCTGCCTATTTCTACTACTGATCAAACTCAACAAGCGATTGGCTCTTATTTTGATGAAGCTCAGACACAGGGTGTTATTGTCATTAAGGATGGGCACAATATTGATACTTATGGTAATGATTTAACCCGAGCCAATACATTGTATGTACCTGCATCAACTTTTAAGATGTTAAATGCTTTAATTGGTTTGGAAAACAATAAAGCTACAGTCGATGAAGTTTTTAAATGGGATGGGAAAAAGCGTTCATATTCTATATGGGAAAAAGATATGAATTTGGGTGAAGCCATGAAGTTATCAGCGGTTCCTGTATATCAAGAACTCGCAAAACGGATAGGCGTAGATCTAATGCAAAAAGAAGTAAAAAGAGTCAAATTTGGTAATTCAAATATTGGGACAAAAGTTGATGACTTTTGGTTGGTAGGCCCATTAAAGATTACTCCTATTCAAGAAGTTGAGTTTGCTGACAAACTTGCCCATCAAGAGCTACCATTCAAACAGCAAGTACAAAAACAAGTCCAAGATATGCTGTTAATAAAGGAAGTAGAGGGTAACAAAATTTATGCAAAGAGCGGGTGGGGAATGAATGTCACCCCTCAAGTAGGCTGGTTAACAGGTTGGGTGGAACAACCTAACGGGAAAAAAATAGCTTTTTCATTGAACATTAAGATGAAACCAAACATGCCTGGTTCAGTCCGTAATGAAATAGCTCTTAAATCATTAAAACGCTTAGGTATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 378, "hit_end": 528, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.0}, "gnl|BL_ORD_ID|3510|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4579", "ARO_accession": "3006467", "ARO_name": "DHA-26", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.62672, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "35915", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGAAAAAATCGTTATCTGCAACACTGATTTCCGCTCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCGGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCATTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTCGCCCAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGTGTGACCAACGAGGTCGCATTGCAGCCGCATCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGCGCAACAACTGGTTTCGGCGCCTATGTCGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCTGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|4051|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-817", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5121", "ARO_accession": "3006016", "ARO_name": "OXA-817", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.69955, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATTTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCACTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATGCTGAAATTGGACAGCAGGTTGACAATTTCTGGTTGATAGGCCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAATAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|506|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-133", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "555", "ARO_accession": "3001702", "ARO_name": "OXA-133", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.81892, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "39672", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +   E     D FW  G L +T", "sequence_from_db": "KLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVT", "sequence_from_broadstreet": "MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTTTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATTTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCACTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATGCTGAAATTGGACAGCAGGTTGACAATTTCTGGTTGATAGGCCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAATAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 369, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 30.0}, "gnl|BL_ORD_ID|3922|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-679", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4992", "ARO_accession": "3005887", "ARO_name": "OXA-679", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.84497, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "39094", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +         D FW  G L +T", "sequence_from_db": "KLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKIT", "sequence_from_broadstreet": "MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKDGHNIDTYGNDLTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQKQVQDMLLIKEVEGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSLKRLGII", "dna_sequence_from_broadstreet": "GTGAGAACACGTTTATTTCCTTTATTAAGTATATCTATTTCAATTTTTTTAAGTGCGTGCTCCTCTCCATTTATCGAACCTAAAGACATCCTGCCTATTTCTACTACTGATCAAACTCAACAAGCGATTGGCTCCTATTTTGATGAAGCTCAGACACAGGGTGTTATTGTCATTAAGGATGGGCACAATATTGATACTTATGGTAATGATTTAACCCGAGCCAATACATTGTATGTACCTGCATCAACTTTTAAGATGTTAAATGCTTTAATTGGTTTGGAAAACAATAAAGCTACAGTCGATGAAGTTTTTAAATGGGATGGGAAAAAGCGTTCATATTCTATATGGGAAAAAGATATGAATTTGGGTGAAGCCATGAAGTTATCAGCGGTTCCTGTATATCAAGAACTCGCAAAACGGATAGGCGTAGATCTAATGCAAAAAGAAGTAAAAAGAGTCAAATTTGGTAATTCAAATATTGGGACAAAAGTTGATGACTTTTGGTTGGTAGGCCCATTAAAGATTACTCCTATTCAAGAAGTTGAGTTTGCTGACAAACTTGCCCATCAAGAGCTACCATTCAAACAGCAAGTACAAAAACAAGTCCAAGATATGCTGTTAATAAAGGAAGTAGAGGGTAACAAAATTTATGCAAAGAGCGGGTGGGGAATGAATGTCACCCCTCAAGTAGGCTGGTTAACAGGTTGGGTGGAACAACCTAACGGGAAAAAAATAGCTTTTTCATTGAACATTGAGATGAAACCAAACATGCCTGGTTCAGTCCGTAATGAAATAGCTCTTAAATCATTAAAACGCTTAGGTATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 378, "hit_end": 528, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.0}, "gnl|BL_ORD_ID|2684|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "DHA-9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3581", "ARO_accession": "3002140", "ARO_name": "DHA-9", "ARO_category": {"36207": {"category_aro_accession": "3000068", "category_aro_cvterm_id": "36207", "category_aro_name": "DHA beta-lactamase", "category_aro_description": "DHA beta-lactamases are plasmid-mediated AmpC \u03b2-lactamases that confer resistance to cephamycins and oxyimino-cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.10665, "max_identities": 12, "bit_score": 25.409, "cvterm_id": "36917", "query": "IGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSI", "match": "+ A +L   GLS   ++  E+ Q+    G+++  P     G+ D+ S  +", "sequence_from_db": "LTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESYGV", "sequence_from_broadstreet": "MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE", "dna_sequence_from_broadstreet": "ATGACAAAATCTGTATCTGCAACACTGATTTCTGCCCTGCTGGCGTTTTCCGCCCCGGGGTTTTCTGCCGCTGATAATGTCGCAGCGGTGGTGGACAGCACCATTAAACCGCTGATGGCACAGCAGGATATTCCCGGGATGGCGGTTGCCGTCTCCGTAAAGGGTAAGCCCTATTATTTCAATTATGGTTTTGCCGATATTCAGGCAAAACAGCCGGTCACTGAAAATACACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAAAGAGATGGCGCTGAATGATCCGGCGGCAAAATACCAGCCGGAGCTGGCTCTGCCGCAGTGGAAGGGGATCACATTGCTGGATCTGGCTACCTATACCGCAGGCGGACTGCCGTTACAGGTGCCGGATGCGGTAAAAAGCCGTGCGGATCTGCTGAATTTCTATCAGCAGTGGCAGCCGTCCCGGAAACCGGGCGATATGCGTCTGTATGCAAACAGCAGTATCGGCCTGTTTGGTGCTCTGACCGCAAACGCGGCGGGGATGCCGTATGAGCAGTTGCTGACTGCACGGATCCTGGCACCGCTGGGGTTATCTCACACCTTTATTACTGTGCCGGAAAGTGCGCAAAGCCATTATGCGTACGGTTATAAAAACAAAAAACCGGTCCGCGTGTCGCCGGGACAGCTTGATGCGGAATCTTACGGCGTGAAATCCGCCTCAAAAGATATGCTGCGCTGGGCGGAAATGAATATGGAGCCGTCACGGGCCGGTAATGCGGATCTGGAAATGGCAATGTATCTTGCACAGACCCGCTACTATAAAACCGCCGCGATTAACCAGGGGCTGGGCTGGGAAATGTATGACTGGCCGCAGCAGAAAGATATGATCATTAACGGCGTGACCAACGAGGTCGCATTGCAGCCGCACCCGGTAACAGACAACCAGGTTCAGCCGTATAACCGTGCTTCCTGGGTGCATAAAACGGGGGCAACAACTGGTTTCGGCGCCTATGTGGCCTTTATTCCGGAAAAACAGGTGGCGATTGTGATTCTGGCGAATAAAAACTACCCGAATACCGAAAGAGTCAAAGCCGCACAGGCTATTTTGAGTGCACTGGAATAA", "partial": "0", "query_start": 3709, "query_end": 3858, "hit_start": 576, "hit_end": 726, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 24.0}, "gnl|BL_ORD_ID|4162|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-948", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5232", "ARO_accession": "3006127", "ARO_name": "OXA-948", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.47653, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "36787", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +         D FW  G L +T", "sequence_from_db": "KLSAVPVYQELAKRIGLDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKIT", "sequence_from_broadstreet": "MRTRLFPLLSISISIFLSACSSPFIAPKDILPISAIKLSQQTIGTYFDEAQTQGVIVIKDGQNIDSYGNDLTRANTQYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSMWEKDMNLGEAMKLSAVPVYQELAKRIGLDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQKQVQDMLLIDEVDGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSLKHLGII", "dna_sequence_from_broadstreet": "GTGCGAACACGTTTATTTCCTTTATTAAGTATATCTATTTCAATTTTTTTAAGTGCATGTTCCTCTCCATTTATCGCACCTAAAGACATCTTACCTATTTCTGCTATTAAGCTAAGTCAACAAACGATTGGCACATACTTTGATGAAGCTCAGACTCAAGGCGTTATTGTTATTAAAGACGGTCAAAATATTGATAGTTATGGTAATGATTTAACCAGAGCCAATACACAATATGTACCTGCATCAACTTTTAAGATGTTAAATGCTTTAATTGGTTTGGAAAACAATAAAGCTACAGTCGATGAAGTTTTTAAGTGGGATGGGAAAAAACGTTCATATTCTATGTGGGAAAAAGATATGAATTTGGGTGAAGCCATGAAGTTATCAGCGGTTCCTGTATATCAAGAACTTGCAAAACGGATAGGCTTGGATCTGATGCAAAAAGAAGTAAAAAGAGTCAAATTTGGTAATTCAAATATTGGGACAAAAGTTGATGATTTCTGGTTGGTAGGTCCATTAAAGATTACTCCAATTCAAGAAGTAGAGTTTGCTGACAAACTTGCTCATCAAGAACTACCATTCAAACAGCAAGTCCAAAAACAAGTTCAAGATATGCTGTTAATAGATGAAGTAGATGGCAACAAGATTTATGCTAAGAGTGGTTGGGGAATGAATGTTACCCCTCAGGTAGGTTGGTTAACAGGTTGGGTGGAACAACCTAACGGGAAAAAAATAGCTTTTTCATTGAACATTGAGATGAAACCAAACATGCCTGGTTCAGTCCGTAATGAAATAGCTCTTAAATCATTAAAACACTTAGGTATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 378, "hit_end": 528, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.0}, "gnl|BL_ORD_ID|3827|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-568", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4897", "ARO_accession": "3005792", "ARO_name": "OXA-568", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.5428, "max_identities": 21, "bit_score": 25.409, "cvterm_id": "35506", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAEYVMWLDLIAR", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T +     D +AR", "sequence_from_db": "DMTLGEAMQASAV-------PVYQELARRIGLELMQQEVRRIKFGNQKIGQQVDNFWLVGPLKITPKQEA--DFVAR", "sequence_from_broadstreet": "MKTIMLLVLCSSLMLMACTSPTTSLSTPSQHVQTQQAQVIAELFNQAQTQGVLVIQHGAKVQSYGNDLSRADTEYVPASTFKMLNALIGLQHHKANIEEVFKWDGKKRSFPAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVRRIKFGNQKIGQQVDNFWLVGPLKITPKQEADFVARLAQQQLAFDPLVQQQVKQMLLLQQRQGYRLYAKSGWGMDLEPQVGWLTGWIETPDAEIVAFSLNMQMYNSTNPAIRLEILQQALAELGLYPKA", "dna_sequence_from_broadstreet": "ATGAAAACAATAATGCTTCTGGTGCTGTGCAGCAGCCTTATGCTGATGGCTTGTACCTCACCTACGACATCTTTATCTACACCATCACAGCATGTCCAGACCCAACAGGCACAAGTAATCGCGGAATTATTTAATCAAGCTCAGACTCAAGGGGTTTTAGTCATTCAGCATGGCGCTAAGGTACAAAGCTATGGCAATGACTTAAGCCGTGCAGATACCGAATATGTGCCCGCCTCCACTTTTAAAATGCTGAATGCCTTGATTGGATTACAACATCACAAAGCCAACATAGAGGAAGTGTTTAAATGGGATGGCAAGAAACGTAGCTTTCCGGCCTGGGAAAAGGACATGACCTTGGGCGAAGCTATGCAGGCCTCTGCTGTACCTGTCTATCAGGAGCTGGCACGCCGTATTGGTCTGGAGCTCATGCAACAGGAAGTGCGACGGATCAAATTTGGTAATCAAAAGATTGGGCAACAAGTCGATAACTTCTGGTTAGTGGGCCCCTTAAAAATCACTCCTAAACAGGAGGCCGATTTTGTCGCTCGCCTGGCTCAACAGCAATTGGCTTTTGATCCTCTGGTTCAGCAACAAGTGAAACAGATGTTACTCTTGCAACAAAGACAGGGTTATCGTCTCTATGCCAAATCTGGCTGGGGAATGGATCTTGAACCACAAGTCGGCTGGTTGACAGGCTGGATTGAAACTCCAGACGCTGAAATCGTGGCATTCTCACTGAATATGCAGATGTATAATTCGACGAATCCGGCAATTCGCCTAGAAATTTTACAACAGGCGCTGGCTGAATTAGGGCTTTATCCAAAAGCATAG", "partial": "0", "query_start": 4177, "query_end": 4401, "hit_start": 345, "hit_end": 549, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 27.27}, "gnl|BL_ORD_ID|4016|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-777", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5086", "ARO_accession": "3005981", "ARO_name": "OXA-777", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.85354, "max_identities": 22, "bit_score": 25.409, "cvterm_id": "36787", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G A  A+A+       P YRE+A++IG DL+ +     G+ + +    V D FW  G L +T +", "sequence_from_db": "DMTLGDAMKASAI-------PVYRELARRIGLDLMSKEVKRIGFGNADIGSKV-DNFWLVGPLKITPQ", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVEQHQIQSISTNKNSKKIKSLFDQAQTEGVLVIKHGQTEEVYGNDLKRASTEYVPASTFKMVNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYRELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKITPQQEVQFAYKLAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWFTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTATCGGCATGTTCTTTTAATACGGTAGAACAGCATCAAATACAGTCAATTTCTACCAATAAAAACTCAAAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACATGGGCAAACAGAGGAAGTCTATGGCAATGATCTTAAAAGAGCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGGTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACGCCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACATTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCGGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATAATTTTTGGCTTGTTGGCCCACTTAAAATTACACCTCAACAAGAAGTACAGTTTGCTTATAAATTAGCCCACAAAACTCTTCCCTTTAGCAAAAATGTACAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTTACAGGCTGGGTAGTTCAACCACAAGGAGAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 345, "hit_end": 525, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 32.35}, "gnl|BL_ORD_ID|1080|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-360", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1169", "ARO_accession": "3001547", "ARO_name": "OXA-360", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.09454, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "39096", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T +", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPK", "sequence_from_broadstreet": "MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQVYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFASALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAATTCTTATTTTGTTGCCTTTACTCAGTTGCTTGAGCCTGACAGCCTGTAGCTTCGCTGTTTCAAATTCGCCCTCTCAAATCACTTCAACTCAATCTATTCAAGCTATTGTAAAGTTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGTCCACATCTACAAGTCTATGGCAATGAGTTGAGTCGTGCACATACCGAATATGTTCCTGCTTCAACCTTTAAAATGCTTAATGCTCTGATTGGCCTGCAACATGGTAAAGCTACGACCAATGAAATTTTTAAATGGGATCGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCGGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAATTAATGCAACAGGAAGTGCAACGCATCCAATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTGGTCGGACCTTTGAAAGTTACTCCAAAACAGGAAGTCAAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCGGTTTCAGCAGCAAGTTAAAACCATGTTACTGTTACAGGAGCGACAAGCTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATTGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGCCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCCAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4177, "query_end": 4371, "hit_start": 339, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 26.87}, "gnl|BL_ORD_ID|4161|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-947", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5231", "ARO_accession": "3006126", "ARO_name": "OXA-947", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.2285, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "42801", "query": "RLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "+L+  P Y+E+A++IG  L +++     +         D FW  G L +T", "sequence_from_db": "KLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGPKVDDFWLVGPLKIT", "sequence_from_broadstreet": "MRTRLFPLSISISIFLSACSSPFIGPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKDDQDIDTYGNDLTRANTQYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGPKVDDFWLVGPLKITPIQEVEFANKLAHQELPFKQQVQKQVQDMLLIDEVDGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSLKKLGII", "dna_sequence_from_broadstreet": "GTGCGAACACGTCTATTTCCTTTAAGTATATCTATTTCAATTTTTTTAAGTGCATGCTCCTCTCCATTTATCGGACCTAAAGACATCCTGCCTATTTCTACTACTGATCAAACTCAACAAGCGATTGGCTCCTATTTTGATGAAGCTCAGACTCAGGGAGTTATTGTTATTAAGGATGATCAAGATATTGATACTTATGGTAATGATTTAACCCGAGCCAATACACAATATGTACCTGCGTCAACTTTTAAGATGTTAAATGCTTTAATTGGTTTGGAAAACAATAAAGCTACAGTCGATGAAGTTTTTAAATGGGATGGGAAAAAGCGTTCATATTCTATATGGGAAAAAGATATGAATTTGGGTGAAGCCATGAAGTTATCAGCGGTTCCTGTATATCAAGAACTCGCAAAACGGATAGGCGTAGATCTAATGCAAAAAGAAGTAAAAAGAGTCAAATTTGGTAATTCAAATATTGGACCAAAAGTTGATGATTTTTGGTTGGTAGGTCCTTTAAAGATTACTCCTATTCAAGAAGTAGAGTTTGCTAACAAACTTGCTCATCAAGAGCTACCATTCAAACAGCAAGTTCAAAAACAAGTTCAAGATATGCTATTAATAGATGAAGTAGATGGCAACAAGATTTATGCTAAGAGTGGTTGGGGAATGAATGTTACCCCTCAGGTAGGTTGGTTAACAGGTTGGGTAGAACAACCTAACGGGAAAAAAATAGCTTTTTCATTGAACATTGAGATGAAACCGAACATGCCCGGTTCGGTCCGTAATGAAATAGCTCTTAAATCATTAAAAAAATTAGGTATTATTTAA", "partial": "0", "query_start": 4222, "query_end": 4365, "hit_start": 375, "hit_end": 525, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.0}, "gnl|BL_ORD_ID|3801|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-537", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4871", "ARO_accession": "3005766", "ARO_name": "OXA-537", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.68657, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "39096", "query": "PRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "P Y+E+A++IG  L +++     +  ++     D FW  G L +T E", "sequence_from_db": "PVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPE", "sequence_from_broadstreet": "MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYIPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDLTLAEAMQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFASALAQEQLAFDPQVQQQVKAMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACCTGACCCTAGCCGAGGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAATCACCCCGGAACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGCTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCGAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4237, "query_end": 4371, "hit_start": 378, "hit_end": 519, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 29.79}, "gnl|BL_ORD_ID|139|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-236", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "160", "ARO_accession": "3001677", "ARO_name": "OXA-236", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.76356, "max_identities": 18, "bit_score": 25.0238, "cvterm_id": "35507", "query": "DSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMT", "match": "D + G+A  A+A+       P Y+E+A++IG  L +++     +  ++     D FW  G L +T", "sequence_from_db": "DMTLGQAMQASAV-------PVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKIT", "sequence_from_broadstreet": "MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPVQEVEFASALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG", "dna_sequence_from_broadstreet": "ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATACTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAATCACCCCGGTACAAGAAGTCGAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGATTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGCGCTTTATCCGAAAGCTGAAGGGTAA", "partial": "0", "query_start": 4177, "query_end": 4365, "hit_start": 339, "hit_end": 513, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 27.69}, "gnl|BL_ORD_ID|4569|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "RSD2-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5639", "ARO_accession": "3006982", "ARO_name": "RSD2-1", "ARO_category": {"43901": {"category_aro_accession": "3005441", "category_aro_cvterm_id": "43901", "category_aro_name": "RSD2 beta-lactamase", "category_aro_description": "RSD2 beta-lactamases are class D beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.41903, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36791", "query": "LTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFW--GDLDMTA-EYVMWL", "match": "++  P Y+E+A++IG    ++     ++  E   +  D FW  G L ++A E V++L", "sequence_from_db": "MSNVPIYQELARRIGLTRMQKYLKDLHYGNESVGEHVDRFWLDGPLQISAVEQVLFL", "sequence_from_broadstreet": "MQTNLIYAMEENAQIKTLFEAADVNATFILYDLQKDTIVGYDKVRSEKRYLPASTFKIANSLIGLATGAVKTEDEPIPYNGPSNPFIAAWKEDMGLKKAIAMSNVPIYQELARRIGLTRMQKYLKDLHYGNESVGEHVDRFWLDGPLQISAVEQVLFLKGLVQETLPFSKNIQKDVKSILLIEKTNAYRLYGKTGYGKTGWQNAPEKGIGWFVGWIEKSEGTYIFAFNMDMTDMSDAPKRINLSKTCLTILGLLNSE", "dna_sequence_from_broadstreet": "ATGCAAACGAACCTGATTTACGCAATGGAAGAGAATGCTCAGATTAAAACGCTCTTTGAAGCAGCAGATGTTAATGCCACCTTTATTCTTTATGACCTGCAAAAAGACACCATAGTTGGATATGATAAGGTAAGGTCGGAAAAAAGGTATCTCCCTGCATCGACTTTCAAAATTGCTAATTCTCTCATTGGCTTGGCAACAGGTGCCGTTAAAACGGAAGATGAACCAATACCTTACAATGGCCCCAGCAATCCGTTTATAGCGGCATGGAAGGAAGATATGGGCTTGAAAAAAGCTATTGCTATGTCCAATGTGCCTATTTATCAGGAGTTGGCCCGAAGAATTGGATTAACGAGGATGCAAAAGTATTTAAAAGATCTTCATTATGGCAATGAATCGGTGGGAGAACATGTAGATCGTTTTTGGCTGGATGGACCACTTCAAATCAGTGCTGTGGAACAAGTGCTGTTTCTAAAAGGGCTAGTCCAGGAAACGCTCCCTTTTTCAAAAAACATCCAAAAAGATGTCAAGAGTATTCTCCTAATTGAAAAAACCAATGCTTATAGACTGTATGGAAAAACAGGCTATGGAAAAACAGGCTGGCAAAATGCTCCCGAAAAAGGCATAGGATGGTTTGTAGGATGGATTGAAAAGTCAGAAGGAACATACATTTTTGCATTCAATATGGACATGACTGATATGTCTGATGCCCCAAAGCGTATAAATCTGAGCAAAACTTGTTTAACAATTTTGGGGCTTCTCAATAGCGAATAA", "partial": "0", "query_start": 4225, "query_end": 4386, "hit_start": 303, "hit_end": 474, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 28.07}, "gnl|BL_ORD_ID|2591|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "OXA-274", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2912", "ARO_accession": "3001730", "ARO_name": "OXA-274", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.71388, "max_identities": 17, "bit_score": 25.0238, "cvterm_id": "41741", "query": "PRYREIAQQIG-DLLCERQTPYGYWSEEETDDVADLFW--GDLDMTAE", "match": "P Y+E+A++IG DL+ +     G+ + +    V D FW  G L +T E", "sequence_from_db": "PVYQELARRIGLDLMSQEVKRVGFGNTQIGQQV-DNFWLVGPLKITPE", "sequence_from_broadstreet": "MSNNLFKFKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTYDGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKDMTLAQAMQASAVPVYQELARRIGLDLMSQEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQEAKFAYQLAKKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWIEQPNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR", "dna_sequence_from_broadstreet": "ATGAGTAATAACCTATTTAAATTTAAAATAAAAAGCAGTGTATTGATCATTCTGAGTAGTGTGGCATTTTCAGGTTGTGTTTCTAATGCCAATTTGCATGATCCAGCTTCATCACAAAGAACAAGTGAAATTCCGTTGTTGTTTAATTATGCGCAAACTCAAGCCGTCTTTGTGACTTATGATGGAACTCAATTTAAACGCTATGGGAATGATTTAAATAGAGCCAAGACTGCGTATATTCCGGCCTCTACTTTTAAAATGTTGAATGCCTTAATTGGTTTGCAACATGCGAAAGCGACAAATACAGAAGTATTTAAGTGGAATGGTGAAAAAAGATCTTTTCCTGCTTGGGAAAAAGATATGACCTTGGCACAAGCAATGCAGGCTTCCGCCGTACCTGTATATCAGGAGTTGGCACGACGTATTGGTTTGGATTTGATGAGTCAAGAAGTCAAACGTGTTGGTTTTGGTAATACACAAATTGGTCAACAGGTGGATAATTTCTGGTTGGTTGGTCCATTGAAAATCACCCCAGAGCAAGAAGCTAAATTTGCTTATCAATTGGCAAAGAAAACATTGCCTTTTGATGATGCTGTACAACAGCAAGTCAAAGATATGCTTTATGTCGAAAGACGTGGTGATTCCAAGCTCTATGCCAAAAGTGGCTGGGGAATGGATGTTGAGCCACAAGTGGGTTGGTATACAGGATGGATAGAACAGCCGAATGGTCAGATCACTGCTTTTGCTTTAAATATGCACATGCAGACAGGGGATGATCCTGCTGAACGTAAGCAACTGACATTAAGTATCTTAGATAAATTAGGCTTATTCTTTTATTTGAGATAA", "partial": "0", "query_start": 4237, "query_end": 4371, "hit_start": 396, "hit_end": 537, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 35.42}, "gnl|BL_ORD_ID|2202|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3424, "orf_end": 4449, "orf_from": "BGC0000692.1|Apramycin_4 ", "model_name": "lin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3361", "ARO_accession": "3004651", "ARO_name": "lin", "ARO_category": {"36360": {"category_aro_accession": "3000221", "category_aro_cvterm_id": "36360", "category_aro_name": "lincosamide nucleotidyltransferase (LNU)", "category_aro_description": "Resistance to the lincosamide antibiotic by ATP-dependent modification of the 3' and/or 4'-hydroxyl groups of the methylthiolincosamide sugar.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.81019, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "42702", "query": "KAGVAAAML-YRLTGKPRY-REIAQQIGDLLCERQTPYGYWSEE", "match": "KAG   A++    +GK  + +EI Q+  +LLC  Q    Y+ +E", "sequence_from_db": "KAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQE", "sequence_from_broadstreet": "MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS", "dna_sequence_from_broadstreet": "ATGTCTACAATCGAAATAAATCAATTAAAAATAGAAGTAGCAGATAGAGTTTTAGTAGAAATTCCTCATCTGCTAGTTAGTAAAAAAGCAAGAATCGGCATCATCGGTCAAAATGGTCTAGGAAAAACAACACTAATGGAAGTGATTGCTGGCGCTAAAGAAGCGACATCTGGCACGGTGACTACACAAGGAAAACTTGCTTACATCAAACAACTTTCCACGGATACAAGTACGAAAAGCGGTGGTGAAAAAACAAGAAAAGCTACTCAACACGCGATGCGCCAAAATCCAAGTGTTCTCCTAGCAGACGAACCAACAAGCAATCTTGATGTCGAAAGCGTCAAACATTTAGAACGTCAGTGGAGCGATTTCCACGGTGCGCTCATAATTATCTCGCATGACCGCGCTTTTTTAGATGCACTTTGTACAGAAATATGGGAAATCAAAAACCAAAAAATTCACGTGTACAAAGGAAACTACCACGCGTATTTAGAACAAAAACAACAACAAGAAAACCAAGCAGAACTTGCATACAAAGAATTTAAAAACAAAAAGAAACAATTGCAAGCATCTCAAACACATCACGAAATCGAAGCAGGTCGTATCGTTAAACCCGGGAAACGCTTAAACAACAAAGAAGCCAGCGCATTTAAAGCTGGAAAAGGAACACAACAAAAGAAACAACATAGTACAATCAAAGCTTTAGAAAAACGAATTGAACGGCTTGGTAATGTCGAAAAACCACATACAACTAAACCAATCAAAATTATCACCCCAGACAATCGCGTTATAAAAAAAGGCAACACGATACTAAGTGCCAAAGAAACAGCTTACGAAATTGCCGGACGAAAACTATTTGAAACAAAAGCTTTTTCTATTAAAGCAGGGGATAAAGTGGCGCTGATCGGTGAAAATGCAAGTGGGAAAACTACATTTTTAAAAGAAATAATCCAAGAAAATCCTAATCTCTTATGTAATCCCCAAGCGAAAATTGCTTATTTCGACCAAGAATTGAATGGATTAAACCAAACGAAATCCCTATTAGAAAACATCTCGGAAATTAGCGTTCAAACCAAGCAAGTAAACAGAGAAGTACTAGGTAGTATGCATTTTAAAGAAAGCGATTTGCATAAGGAAGTGCGCATGCTCTCTGGCGGGGAACGAGTGAAGTTGCTGCTCAGTATGCTCCTTCTTAGTGACGCCAATTTCTTGATTCTTGATGAACCAACCAACTATTTGGATATCTACGCAATGGAAGCGCTGGAAACGTTAATCAAACAATTTGCGGGGACGGTACTCTTCGTTTCTCATGATAGAACTTTTGTTAATCATGTGGCAGAACAGTTACTTGTTATCGAAAATAATGAAATGAATTTCCACCGGATGACTTTTGCAGAATATGAAGAAAGTAAAGCACCAAGCCGGATTACAGAAGAAGATAAGTTGATTTTAGAAATGCGTATGTCAGAAATTGCGGCAAAACTCATGCAACCCAATTTAAAGCCCACAGAAAAAGCCATACTCGAACAAGATTATCAAGAAATTATCACAAAAAGACAGCAATTTAGTTAA", "partial": "0", "query_start": 4192, "query_end": 4317, "hit_start": 879, "hit_end": 1011, "orf_dna_sequence": "TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA", "orf_prot_sequence": "MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR", "perc_identity": 34.09}}, "BGC0000692.1|Apramycin_5 # 4471 # 5055 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715": {"gnl|BL_ORD_ID|1681|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 4471, "orf_end": 5055, "orf_from": "BGC0000692.1|Apramycin_5 ", "model_name": "bacA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1820", "ARO_accession": "3002986", "ARO_name": "bacA", "ARO_category": {"39982": {"category_aro_accession": "3003398", "category_aro_cvterm_id": "39982", "category_aro_name": "undecaprenyl pyrophosphate related proteins", "category_aro_description": "Undecaprenyl phosphate is a universal lipid carrier of glycan biosynthetic intermediates for carbohydrate polymers that are exported to the bacterial cell envelope. Antibiotics that targets this compound or proteins associated with the production of this compound leads to cell death.", "category_aro_class_name": "AMR Gene Family"}, "35959": {"category_aro_accession": "0000041", "category_aro_cvterm_id": "35959", "category_aro_name": "bacitracin", "category_aro_description": "Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Bacitracin interferes with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule which carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane.", "category_aro_class_name": "Antibiotic"}, "36973": {"category_aro_accession": "3000629", "category_aro_cvterm_id": "36973", "category_aro_name": "bacitracin A", "category_aro_description": "Bacitracin A is the primary component of bacitracin. It contains many uncommon amino acids and interferes with bacterial cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "36974": {"category_aro_accession": "3000630", "category_aro_cvterm_id": "36974", "category_aro_name": "bacitracin B", "category_aro_description": "Bacitracin B is a component of bacitracin, an antibiotic mixture that interferes with bacterial cell wall synthesis. It differs from Bacitracin A with a valine instead of an isoleucine in its peptide.", "category_aro_class_name": "Antibiotic"}, "36975": {"category_aro_accession": "3000631", "category_aro_cvterm_id": "36975", "category_aro_name": "bacitracin F", "category_aro_description": "Bacitracin F is a component of bacitracin, an antibiotic mixture that interferes with bacterial cell wall synthesis. It is formed when the thiazoline ring of bacitracin A is oxidatively deaminated.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.830533, "max_identities": 12, "bit_score": 27.335, "cvterm_id": "36849", "query": "NPLDRPYGLLV-------RRCRNPREPRMPG", "match": "NP++  Y L+V         C  P+EPR PG", "sequence_from_db": "NPINVMYALVVGGLLLIAAECLKPKEPRAPG", "sequence_from_broadstreet": "MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF", "dna_sequence_from_broadstreet": "ATGAGCGATATGCACTCGCTGCTGATAGCGGCAATATTGGGTGTGGTCGAAGGATTGACAGAATTTCTGCCGGTATCCAGCACGGGCCATATGATTATTGTCGGTCACTTGTTGGGGTTTGAGGGCGACACGGCGAAAACCTTTGAAGTTGTGATCCAGTTAGGATCAATTCTGGCGGTAGTAGTGATGTTCTGGCGGCGTCTGTTTGGCCTGATTGGCATCCACTTTGGCCGCCCGTTGCAGCACGAAGGTGAAAGCAAAGGTCGTTTAACGCTGATCCACATTTTGCTGGGGATGATTCCGGCGGTGGTATTGGGGCTGTTGTTCCACGACACGATTAAGTCATTGTTTAACCCGATAAATGTGATGTATGCGCTGGTCGTTGGCGGTTTGTTGCTGATTGCCGCCGAATGCCTGAAGCCGAAAGAGCCGCGTGCGCCGGGTCTTGATGATATGACCTATCGTCAGGCATTTATGATTGGCTGTTTCCAGTGTCTGGCGCTGTGGCCGGGTTTCTCCCGTTCCGGGGCGACCATTTCAGGTGGGATGCTGATGGGGGTGAGCCGTTACGCTGCTTCCGAGTTTTCGTTCCTGCTGGCGGTGCCGATGATGATGGGCGCAACGGCGCTCGATCTCTACAAAAGCTGGGGCTTCCTGACAAGCGGCGATATCCCGATGTTTGCCGTTGGGTTTATCACCGCTTTTGTGGTGGCGCTGATAGCGATTAAAACCTTCCTGCAATTGATTAAGCGCATTTCGTTTATCCCGTTCGCCATTTATCGCTTTATTGTGGCGGCTGCGGTGTATGTCGTGTTCTTTTAA", "partial": "0", "query_start": 4801, "query_end": 4872, "hit_start": 351, "hit_end": 444, "orf_dna_sequence": "ATGGATGGGCGATTCTGGAAGAAACCCGCTCGGGTCTCGCGCCGACCGCCGCCGCGGCCGGAGAGGGGCGGGAGCCGCGACGACCGCGGGACCGACGTGCCGGCAATGGCGCACCCGATCGGCGTGGACATCCCGGGAAGCGGGGTCCGGACGATTCCGCGAGCGGGAACCGCGAACCGGGACCGCGTTTCGCCGGGAGCCGAAGAATCAGGTCGGCGGGACGGGTGCGCGCATGACGGCGAATCCGGCCGACGAGCTTCCGGAGCGAACGACATCGACCACGGGCGTCGGGTGGACCACGGCGCGCCGCTCGGGGCCGGCCGACGGGACAACCCACTGGACAGGCCGTACGGCCTGCTGGTTCGGCGATGCCGGAACCCGCGCGAGCCGCGGATGCCCGGGAAACCGGGCGGCGTTTCGGGACGGGACGCCGTCCACGCGACCGTTCGTGACCAAGAGGTGGCCGCCCCCTCCCAGCTTCCCGCCACGTGCGACCGGGAAATCGGCATGGATCGTCAACAGCCTGTTCGGGTGCCGAGGATCGCACGCGTTCACGACGCGTCGAAATACGCCGAACGAGGGTAA", "orf_prot_sequence": "MDGRFWKKPARVSRRPPPRPERGGSRDDRGTDVPAMAHPIGVDIPGSGVRTIPRAGTANRDRVSPGAEESGRRDGCAHDGESGRRASGANDIDHGRRVDHGAPLGAGRRDNPLDRPYGLLVRRCRNPREPRMPGKPGGVSGRDAVHATVRDQEVAAPSQLPATCDREIGMDRQQPVRVPRIARVHDASKYAERG", "perc_identity": 38.71}, "gnl|BL_ORD_ID|409|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 4471, "orf_end": 5055, "orf_from": "BGC0000692.1|Apramycin_5 ", "model_name": "mtrE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "910", "model_id": "453", "ARO_accession": "3000812", "ARO_name": "mtrE", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35971": {"category_aro_accession": "0000054", "category_aro_cvterm_id": "35971", "category_aro_name": "penicillin", "category_aro_description": "Penicillin (sometimes abbreviated PCN) is a beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms. It works by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.88834, "max_identities": 16, "bit_score": 25.7942, "cvterm_id": "36806", "query": "GRRVDHGAPLGAGRRDNPLDRPYGLLVRRCRNPREPRMPGKPGGVSGRDAVHATV", "match": "G  V     +G G     LD     L  R R+  E  + G    V+ RDA H ++", "sequence_from_db": "GGNVSSSYNVGLGAASYELD-----LFGRVRSSSEAALQGYFASVANRDAAHLSL", "sequence_from_broadstreet": "MNTTLKTTLTSVAAAFALSACTMIPQYEQPKVEVAETFQNDTSVSSIRAVDLGWHDYFADPRLQKLIDIALERNTSLRTAVLNSEIYRKQYMIERNNLLPTLAANANGSRQGSLSGGNVSSSYNVGLGAASYELDLFGRVRSSSEAALQGYFASVANRDAAHLSLIATVAKAYFNERYAEEAMSLAQRVLKTREETYNAVRIAVQGRRDFRRRPAPAEALIESAKADYAHAARSREQARNALATLINRPIPEDLPAGLPLDKQFFVEKLPAGLSSEVLLDRPDIRAAEHALKQANANIGAARAAFFPSIRLTGSVGTGSVELGGLFKSGTGVWAFAPSITLPIFTWGTNKANLDVAKLRQQAQIVAYESAVQSAFQDVANALAAREQLDKAYDALSKQSRASKEALRLVGLRYKHGVSGALDLLDAERSSYSAEGAALSAQLTRAENLADLYKALGGGLKRDTQTGK", "dna_sequence_from_broadstreet": "ATGAATACTACATTGAAAACTACCTTGACCTCTGTTGCAGCAGCCTTTGCATTGTCTGCCTGCACCATGATTCCTCAATACGAGCAGCCCAAAGTCGAAGTTGCGGAAACCTTCCAAAACGACACATCGGTTTCTTCCATCCGCGCGGTTGATTTGGGTTGGCATGACTATTTTGCCGACCCGCGCCTGCAAAAGCTGATCGACATCGCACTCGAGCGCAATACCAGTTTGCGTACAGCCGTATTGAACAGCGAAATCTACCGCAAACAATACATGATCGAGCGCAACAACCTCCTGCCCACGCTTGCCGCCAATGCGAACGGCTCGCGCCAAGGCAGCTTGAGCGGCGGCAATGTCAGCAGCAGCTACAATGTCGGACTGGGTGCGGCATCTTACGAACTCGATCTGTTCGGGCGCGTGCGCAGCAGCAGCGAAGCAGCACTGCAAGGCTATTTTGCCAGCGTTGCCAACCGCGATGCGGCACATTTGAGTCTGATTGCCACCGTTGCCAAAGCCTATTTCAACGAGCGTTATGCCGAAGAAGCGATGTCTTTGGCGCAGCGTGTCTTGAAAACGCGCGAGGAAACCTACAATGCTGTCCGAATTGCGGTACAAGGCAGGCGTGATTTCCGCCGTCGCCCTGCGCCAGCAGAAGCCTTGATTGAATCTGCCAAAGCCGATTATGCCCATGCCGCGCGCAGCCGCGAACAGGCGCGCAATGCCTTGGCAACCTTGATTAACCGTCCGATACCCGAAGACCTGCCCGCCGGTTTGCCGTTGGACAAGCAGTTTTTTGTTGAAAAACTGCCTGCCGGTTTGAGTTCCGAAGTATTGCTCGACCGTCCCGACATCCGCGCCGCCGAACACGCGCTCAAACAGGCAAACGCCAATATCGGTGCGGCGCGCGCCGCCTTTTTCCCGTCCATCCGCCTGACCGGAAGCGTCGGTACGGGTTCTGTCGAATTGGGCGGGCTGTTCAAAAGCGGCACGGGCGTTTGGGCGTTCGCGCCGTCTATTACCCTGCCGATTTTTACTTGGGGAACGAACAAGGCGAACCTTGATGTGGCAAAACTGCGCCAACAGGCACAAATTGTTGCCTATGAATCCGCCGTCCAATCCGCCTTTCAAGACGTGGCAAACGCATTGGCGGCGCGCGAGCAGCTGGATAAAGCCTATGACGCTTTAAGCAAACAAAGCCGCGCCTCTAAAGAAGCGTTGCGCTTGGTCGGACTGCGTTACAAACACGGCGTATCCGGCGCGCTCGATTTGCTCGATGCGGAACGCAGCAGCTATTCGGCGGAAGGTGCGGCTTTGTCGGCACAACTGACCCGCGCCGAAAACCTTGCCGATTTGTACAAGGCGCTCGGCGGCGGATTGAAACGGGATACCCAAACCGGCAAATAA", "partial": "0", "query_start": 4753, "query_end": 4917, "hit_start": 345, "hit_end": 495, "orf_dna_sequence": "ATGGATGGGCGATTCTGGAAGAAACCCGCTCGGGTCTCGCGCCGACCGCCGCCGCGGCCGGAGAGGGGCGGGAGCCGCGACGACCGCGGGACCGACGTGCCGGCAATGGCGCACCCGATCGGCGTGGACATCCCGGGAAGCGGGGTCCGGACGATTCCGCGAGCGGGAACCGCGAACCGGGACCGCGTTTCGCCGGGAGCCGAAGAATCAGGTCGGCGGGACGGGTGCGCGCATGACGGCGAATCCGGCCGACGAGCTTCCGGAGCGAACGACATCGACCACGGGCGTCGGGTGGACCACGGCGCGCCGCTCGGGGCCGGCCGACGGGACAACCCACTGGACAGGCCGTACGGCCTGCTGGTTCGGCGATGCCGGAACCCGCGCGAGCCGCGGATGCCCGGGAAACCGGGCGGCGTTTCGGGACGGGACGCCGTCCACGCGACCGTTCGTGACCAAGAGGTGGCCGCCCCCTCCCAGCTTCCCGCCACGTGCGACCGGGAAATCGGCATGGATCGTCAACAGCCTGTTCGGGTGCCGAGGATCGCACGCGTTCACGACGCGTCGAAATACGCCGAACGAGGGTAA", "orf_prot_sequence": "MDGRFWKKPARVSRRPPPRPERGGSRDDRGTDVPAMAHPIGVDIPGSGVRTIPRAGTANRDRVSPGAEESGRRDGCAHDGESGRRASGANDIDHGRRVDHGAPLGAGRRDNPLDRPYGLLVRRCRNPREPRMPGKPGGVSGRDAVHATVRDQEVAAPSQLPATCDREIGMDRQQPVRVPRIARVHDASKYAERG", "perc_identity": 29.09}}, "BGC0000692.1|Apramycin_7 # 5261 # 6337 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.794": {"gnl|BL_ORD_ID|4734|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5261, "orf_end": 6337, "orf_from": "BGC0000692.1|Apramycin_7 ", "model_name": "vanS gene in vanL cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "744", "ARO_accession": "3002938", "ARO_name": "vanS gene in vanL cluster", "ARO_category": {"36210": {"category_aro_accession": "3000071", "category_aro_cvterm_id": "36210", "category_aro_name": "vanS", "category_aro_description": "VanS is similar to histidine protein kinases like EnvZ and acts as a response regulator by activating VanR. VanS is required for high level transcription of other van glycopeptide resistance genes.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.74987, "max_identities": 16, "bit_score": 28.8758, "cvterm_id": "35918", "query": "AVRALLESPERRTALAGAAWELVDGAGRGR---VVDALAARLADRRP", "match": "A + LLE PE+R  L+   +EL +   + R     D  AA+ A++R ", "sequence_from_db": "ATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRK", "sequence_from_broadstreet": "MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRLFNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAKYTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLSWNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYTIPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYLPYID", "dna_sequence_from_broadstreet": "TTGAAAAGTAAGGCGGAAACTACAACTATAAAACAGATACTAATAAAATATTTAGTAACTATAGGTTTATCGATGCTTGCCTATTTAGTATTTCTTCTAACAATACTTATTATAATGAGAAATTTTGTATGGGACGGCACGGAGCCTATCTATCGTGTCTTGCACTTTTTTTATCGTCTTTTTAATTTTGAAGGGATATTGATTATCGGTGTGATACTTATCCTATTCGTTGTTACATTGTTTTTTGTTATGAAGATAATTGGCTATTTAAAACAAATCATCGAGGCGACGAAACAATTGCTTGAAAAACCAGAACAGCGTGTTAAGCTATCAAGTGGCCTGTTCGAATTACAAGAAGAAATGAACCAACTACGTGAAAAAAATAATGCTGACAATCGCGCAGCTAAAGAAGCGGAAAAGAGAAAAAACGATTTGATTGTTTATTTAGCTCATGATTTACGTACGCCATTAACTAGCGTAATTGGGTATTTAACGCTGTTAAAAGAAGAACCGGAAATATCGGTTCAAACTAGAGCTAAGTATACGAACATCGCTTTGAGTAAAGCTTTTCGCCTTGAAGAATTATTGAGTGAATTTTTTGATGTGACGAGATTTAATTTGACTAACTTAACAATAAATGAAGAACTAGTAGATTTAAGTGTGATGTTAGAGCAAATCAGCTACGAATTTTTACCTATTTTGGAAGAAAAAAAACTTTCTTGGAATCTACACGTCGAGAGTAATATAAAATCTCTTTTAGATCCAGGAAAAATGGAACGTGTTTTTGATAACTTGATGCGAAATGCTATTAATTATAGCTTTGAAGATACAATAATTGATTTAAGTTTAGAAAAAAAAGAATCTCAAGCTATTTTTAAAATTACAAATAGGACCTATACAATCCCAAAAGAAAAATTAGAAAAAATATTCGAACCGTTTTACCGAATGGACACATCTAGAAGTAGCAGTACAGGTGGAACTGGGCTTGGTCTACCGATTGTAAGGGAAATTATTGAAGCTTCCAAAGGAACTATAAACGTTAGTAGTAGCAATAATGAAATGACTTTTATAATCTATTTACCATACATAGATTAA", "partial": "0", "query_start": 6194, "query_end": 6325, "hit_start": 285, "hit_end": 426, "orf_dna_sequence": "ATGAGAATTGACGACGTCACGCGCCCCGGCCTCGCCGGCGGTGTCGTCGCGCTGCGGGCCGACGCCTCCGCGGAGTGGGGGGTGGGGCACGTCGTCCGCTGCCTCGCCCTCGCCGAGGAGGTCCTGGCCAGGGGCGGCCGGCCGGTGCTCGTCGCCGACCTCGGCGACGTGGCCTGGCTGGCGGAGGAGGTCCGGGCGCGCGGGCTCGCGGTGCGCCCTCCGGCGAGCGACCCGGCGGGGTTCGCCGACCAGCTCCACGCGCTCGGCGCGCGCGCCACGGTGATCGACTCCTACCGGCTCGGCCCCGAGCACTACACGGCGGCGCGCGCGGTCGCGCCGGTCGTCGCGCTCTACGACCGCCACTCCGGGCCGGTCCCCGGCGACGTGCTGGTCGACCAGGTCTTCGGCGCGGAACAGGACCCGCCGCCACCGGACGCCGACCAGGCGACGGTGCTGCGCGGACCTCGGTACGCGCTCATCCGGGACCTCGTCCGGCGTCACCGGCCAGCCACCCGACCCGCGGCCATGCCCCTCGCCGGGCGGGCGCCCCGGGTGCTGCTGGTGCTGGGCGGCACCGACGCCCGCGGCGCGACCGGGGCCCTCACCGAGATCCTGCTGGCGTCCTGCCCGTCGCTCGACCTCACCGTGGTCGGCGGCGGCCTCGACGGCCCCGCGCCGGCCACCGGCGCCGGCCAGCGCCTGTCGGTCCACCGACCGTCGGCCGAGCTGCCCCGGCTGATGGCCGAGGCCGACCTGGTGATCAGCGCGGCCGGCACCACGTTGGCGGAGCTCTGCTGCGTGGGCGCGGCGGCCGCCGCCGTGTGGGTGGTGGACAACCAGCTTCCCGTCTACCGCAGCGCGCTCGCCGCCGGCTGCGTGCACGGACTGGGCTCGCTCGCGGAGGTGCTGGCCGACCCCGGGCGCGCCGGCGCGGCCGTCCGCGCGCTGCTGGAGTCGCCGGAGCGCCGGACCGCGCTGGCCGGCGCGGCGTGGGAGCTGGTGGACGGCGCGGGCCGCGGCCGGGTGGTCGACGCTCTGGCGGCCCGGCTCGCCGACCGCCGGCCCGCCACCCGCTGA", "orf_prot_sequence": "MRIDDVTRPGLAGGVVALRADASAEWGVGHVVRCLALAEEVLARGGRPVLVADLGDVAWLAEEVRARGLAVRPPASDPAGFADQLHALGARATVIDSYRLGPEHYTAARAVAPVVALYDRHSGPVPGDVLVDQVFGAEQDPPPPDADQATVLRGPRYALIRDLVRRHRPATRPAAMPLAGRAPRVLLVLGGTDARGATGALTEILLASCPSLDLTVVGGGLDGPAPATGAGQRLSVHRPSAELPRLMAEADLVISAAGTTLAELCCVGAAAAAVWVVDNQLPVYRSALAAGCVHGLGSLAEVLADPGRAGAAVRALLESPERRTALAGAAWELVDGAGRGRVVDALAARLADRRPATR", "perc_identity": 34.04}}, "BGC0000692.1|Apramycin_8 # 6425 # 7213 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.754": {"gnl|BL_ORD_ID|850|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6425, "orf_end": 7213, "orf_from": "BGC0000692.1|Apramycin_8 ", "model_name": "AAC(3)-IIb", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "925", "ARO_accession": "3002534", "ARO_name": "AAC(3)-IIb", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46127": {"category_aro_accession": "3007377", "category_aro_cvterm_id": "46127", "category_aro_name": "6'-N-ethylnetilmicin", "category_aro_description": "6'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46128": {"category_aro_accession": "3007378", "category_aro_cvterm_id": "46128", "category_aro_name": "2'-N-ethylnetilmicin", "category_aro_description": "2'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.13094, "max_identities": 12, "bit_score": 25.409, "cvterm_id": "36783", "query": "RWEPSVALYDDSAEPFGLLRRFFAEVPD", "match": "RW P       +   FGLL RF  E PD", "sequence_from_db": "RWPPFDLATSGTYPGFGLLNRFLLEAPD", "sequence_from_broadstreet": "MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYASWDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASMVAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPNKRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGIVGRAPSYLFEAQDIVSFGVTYLEQHFGAP", "dna_sequence_from_broadstreet": "ATGAACACGATCGAATCGATCACGGCGGACCTGCACGGACTGGGCGTCCGGCCCGGCGACCTGATCATGGTCCATGCATCGCTGAAAGCCGTCGGCCCGGTCGAGGGAGGTGCGGCCTCGGTGGTGTCGGCCCTTCGCGCCGCGGTCGGGTCCGCAGGGACCCTGATGGGTTATGCCTCATGGGACCGCTCGCCCTATGAGGAGACGCTGAACGGCGCGCGGATGGACGAAGAACTGCGCCGCCGGTGGCCACCCTTCGATCTGGCCACATCCGGTACCTATCCCGGCTTCGGCCTGCTCAACCGGTTTCTGCTTGAGGCGCCCGACGCACGGCGCAGCGCGCATCCCGACGCCTCCATGGTCGCGGTCGGCCCCCTTGCCGCCACGCTGACAGAGCCGCACCGGCTTGGGCAGGCGCTGGGCGAAGGCTCGCCGCTGGAGCGCTTCGTCGGGCATGGCGGAAAGGTCCTGCTTCTGGGAGCGCCGCTCGACTCCGTCACCGTGCTGCATTACGCCGAGGCCATCGCCCCCATCCCGAACAAACGCCGCGTGACCTATGAAATGCCGATGCTCGGCCCGGATGGCAGGGTCCGATGGGAGCTGGCCGAGGATTTCGACAGCAACGGCATTCTCGATTGCTTCGCGGTCGATGGGAAGCCGGATGCCGTCGAGACGATCGCCAAGGCTTATGTCGAACTGGGCCGGCATCGGGAAGGCATCGTCGGTCGCGCACCCTCCTATCTGTTTGAAGCGCAGGATATCGTCTCGTTCGGCGTCACCTATCTCGAACAGCATTTCGGCGCGCCCTGA", "partial": "0", "query_start": 6950, "query_end": 7033, "hit_start": 243, "hit_end": 327, "orf_dna_sequence": "GTGCCCAGGATCGACGAGTCCCGCCTGCGTGATCTCCTCGCCGCCGCCGCCGGGGTGGCGCCGGCCGAGCTGGACGGCTGGCCCGGCCGGGCCGGCTGGCTGGACCGGGCGGCCGCGATGCTCACCGACTACGTGGCCGGCGTGCCGCTCGGGTACGTGCTCGGGGAGATCCACTACCTGGGCAGGGCGTTCCGCAGCGACCGCCGCGCCCTGGCCGTCCGCCGGTACAGCGAGCCGCTGGTGCGGCGGATCGTCGACGACTTCGCCGGCGAGCCGGTGCGCGCGGTGGAGATCGGCTGCGGGGCCGCCGCCGCCATCTGCACCCTCGCCAAGGAGCTGACCGGCGAGTTCGTCGGGACCGACGTCGTACCGGAGGCGCTGGAGCTGGCCGAGGAGAACGCGACCCGGCACCGGGCCCCGGTCCGGTTCGTCGTGAGCGACCTGTTCGACGCGCTCGACGGCCGGTTCGACGTGATCTACGCGAACCTGCCCCGCCACCACCCGAGCACGCCCATGCCGGAGGCCCGGTGGGAGCCCTCCGTCGCGCTGTACGACGACAGCGCCGAGCCGTTCGGGCTGCTCCGGCGGTTCTTCGCCGAGGTGCCGGACCGGCTGACCGAGCGGGGCCGGCTGTACCTGGAGATCCCGCTGGACCCCGCGATCGCGGACCTGCTGCCGGGTGAGCCGGTGGTAGACGGCGACGGGGACGACTTCGCCCGGGTGATCACCGCGGCCGACGCCCGCCGGCTCCCGGCGCTGGTCGACCGGCTCACCTGGCCCGAGGGGTGA", "orf_prot_sequence": "MPRIDESRLRDLLAAAAGVAPAELDGWPGRAGWLDRAAAMLTDYVAGVPLGYVLGEIHYLGRAFRSDRRALAVRRYSEPLVRRIVDDFAGEPVRAVEIGCGAAAAICTLAKELTGEFVGTDVVPEALELAEENATRHRAPVRFVVSDLFDALDGRFDVIYANLPRHHPSTPMPEARWEPSVALYDDSAEPFGLLRRFFAEVPDRLTERGRLYLEIPLDPAIADLLPGEPVVDGDGDDFARVITAADARRLPALVDRLTWPEG", "perc_identity": 42.86}, "gnl|BL_ORD_ID|4773|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6425, "orf_end": 7213, "orf_from": "BGC0000692.1|Apramycin_8 ", "model_name": "lsaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3847", "ARO_accession": "3005121", "ARO_name": "lsaD", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.20099, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "43338", "query": "DDFAGEPVRAV-----------EIGCGAAAAICTLAKELTGEFVGTDVVPEALELAE", "match": "+DF  EPV              E G G ++ +  L  E TG +VGT  +   L ++E", "sequence_from_db": "EDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISE", "sequence_from_broadstreet": "MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV", "dna_sequence_from_broadstreet": "ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA", "partial": "0", "query_start": 6680, "query_end": 6817, "hit_start": 960, "hit_end": 1131, "orf_dna_sequence": "GTGCCCAGGATCGACGAGTCCCGCCTGCGTGATCTCCTCGCCGCCGCCGCCGGGGTGGCGCCGGCCGAGCTGGACGGCTGGCCCGGCCGGGCCGGCTGGCTGGACCGGGCGGCCGCGATGCTCACCGACTACGTGGCCGGCGTGCCGCTCGGGTACGTGCTCGGGGAGATCCACTACCTGGGCAGGGCGTTCCGCAGCGACCGCCGCGCCCTGGCCGTCCGCCGGTACAGCGAGCCGCTGGTGCGGCGGATCGTCGACGACTTCGCCGGCGAGCCGGTGCGCGCGGTGGAGATCGGCTGCGGGGCCGCCGCCGCCATCTGCACCCTCGCCAAGGAGCTGACCGGCGAGTTCGTCGGGACCGACGTCGTACCGGAGGCGCTGGAGCTGGCCGAGGAGAACGCGACCCGGCACCGGGCCCCGGTCCGGTTCGTCGTGAGCGACCTGTTCGACGCGCTCGACGGCCGGTTCGACGTGATCTACGCGAACCTGCCCCGCCACCACCCGAGCACGCCCATGCCGGAGGCCCGGTGGGAGCCCTCCGTCGCGCTGTACGACGACAGCGCCGAGCCGTTCGGGCTGCTCCGGCGGTTCTTCGCCGAGGTGCCGGACCGGCTGACCGAGCGGGGCCGGCTGTACCTGGAGATCCCGCTGGACCCCGCGATCGCGGACCTGCTGCCGGGTGAGCCGGTGGTAGACGGCGACGGGGACGACTTCGCCCGGGTGATCACCGCGGCCGACGCCCGCCGGCTCCCGGCGCTGGTCGACCGGCTCACCTGGCCCGAGGGGTGA", "orf_prot_sequence": "MPRIDESRLRDLLAAAAGVAPAELDGWPGRAGWLDRAAAMLTDYVAGVPLGYVLGEIHYLGRAFRSDRRALAVRRYSEPLVRRIVDDFAGEPVRAVEIGCGAAAAICTLAKELTGEFVGTDVVPEALELAEENATRHRAPVRFVVSDLFDALDGRFDVIYANLPRHHPSTPMPEARWEPSVALYDDSAEPFGLLRRFFAEVPDRLTERGRLYLEIPLDPAIADLLPGEPVVDGDGDDFARVITAADARRLPALVDRLTWPEG", "perc_identity": 29.82}}, "BGC0000692.1|Apramycin_9 # 7322 # 8035 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.762": {"gnl|BL_ORD_ID|97|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7322, "orf_end": 8035, "orf_from": "BGC0000692.1|Apramycin_9 ", "model_name": "dfrA13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "114", "ARO_accession": "3003012", "ARO_name": "dfrA13", "ARO_category": {"37617": {"category_aro_accession": "3001218", "category_aro_cvterm_id": "37617", "category_aro_name": "trimethoprim resistant dihydrofolate reductase dfr", "category_aro_description": "Alternative dihydropteroate synthase dfr present on plasmids produces alternate proteins that are less sensitive to trimethoprim from inhibiting its role in folate synthesis, thus conferring trimethoprim resistance.", "category_aro_class_name": "AMR Gene Family"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.42355, "max_identities": 10, "bit_score": 25.7942, "cvterm_id": "35914", "query": "GVAAPGCPTVSTLAELVP", "match": "G +APGC  VSTL+ + P", "sequence_from_db": "GYSAPGCAVVSTLSHVSP", "sequence_from_broadstreet": "MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPLPNRHTVVLSRQAGYSAPGCAVVSTLSHVSPSTAEHGKELYVARGAEVYALALPHANGVFLSEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG", "dna_sequence_from_broadstreet": "ATGAACCCGGAATCGGTCCGCATTTATCTGGTCGCTGCCATGGGTGCCAATCGGGTTATTGGCAATGGTCCCGATATCCCCTGGAAAATCCCAGGTGAGCAGAAGATTTTTCGCAGGCTCACCGAGAGCAAAGTGGTCGTTATGGGCCGCAAGACATTTGAGTCCATAGGCAAGCCCTTACCAAACCGCCACACAGTGGTGCTCTCGCGCCAAGCTGGTTATAGCGCTCCTGGTTGTGCAGTTGTTTCAACGCTGTCACACGTATCGCCATCGACAGCCGAACACGGCAAAGAACTCTACGTAGCGCGCGGAGCCGAGGTATATGCGCTGGCGCTACCGCATGCCAACGGCGTCTTTCTATCTGAGGTACATCAAACCTTTGAGGGTGACGCCTTCTTCCCAGTGCTTAACGCAGCAGAATTCGAGGTTGTCTCATCCGAAACCATTCAAGGCACAATCACGTACACGCACTCCGTCTATGCGCGTCGTAACGGCTAA", "partial": "0", "query_start": 7949, "query_end": 8002, "hit_start": 216, "hit_end": 270, "orf_dna_sequence": "GTGCGCGACACCGAGAACGCGGCGCTGGTCGTCCTCGACATCGACGGCACGCTGCTGGACACGCCCCACCTGCCGGCATGGCGCCGGGGCCTGGCCAGGGTGCTGCGCGACCACGCGCCGGAGCGCTCCGCCGAGATCACGGTGGAGCGGTACCACCGGCACATCGCGGGCCGGCCGAGGCAGGTCGGGGCCAGGGCCGCGCTGGAGCTCGCCGGGCTGGCGCCCCCGCCGGCGCTGGTCGACGAGCTGGCCGCGGTCAAGCAGCAGGTGTTCCTGGAGCAGGCCGAGGAGACCGTCCTGTTCCCCGACGCCGGGGACTTCCTCGACGCGGCGGCGCTGGCGGGCACGCCGCTGGCGTTCTGCACGGCCTCCCGCAACGCCGGCGAGCTGCTGGCCAAGCGCCTTCCCCGACTCGACGGCGGCGACTGGCTGCTCGACCGGCTGCACCACAGCCTCGGCCCGCACGGCCACTACGGCGACGTCCCCCGGCCGGAGGCGCTGCGTCGCGTGGCGGCGGCGTGGGGCGCCGCGCCCGACGGCTGCGTGCTGGTGGACGACGCCCTGTCCGGCGTTCTCGCCGGACAACAGGTCGGGATGACCGCGGTCCTGGTCGACCGGTTCGGGCTGGGCGTCGCCGCGCCCGGCTGCCCCACCGTGAGCACGTTGGCCGAACTGGTCCCGGTGTCGACCGGTGTGCGGTTTCCGGCCGAGTAG", "orf_prot_sequence": "MRDTENAALVVLDIDGTLLDTPHLPAWRRGLARVLRDHAPERSAEITVERYHRHIAGRPRQVGARAALELAGLAPPPALVDELAAVKQQVFLEQAEETVLFPDAGDFLDAAALAGTPLAFCTASRNAGELLAKRLPRLDGGDWLLDRLHHSLGPHGHYGDVPRPEALRRVAAAWGAAPDGCVLVDDALSGVLAGQQVGMTAVLVDRFGLGVAAPGCPTVSTLAELVPVSTGVRFPAE", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1123|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7322, "orf_end": 8035, "orf_from": "BGC0000692.1|Apramycin_9 ", "model_name": "Erm(30)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1224", "ARO_accession": "3001265", "ARO_name": "Erm(30)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "37625": {"category_aro_accession": "3001226", "category_aro_cvterm_id": "37625", "category_aro_name": "narbomycin", "category_aro_description": "Produced by Streptomyces narbonensis.", "category_aro_class_name": "Antibiotic"}, "37631": {"category_aro_accession": "3001232", "category_aro_cvterm_id": "37631", "category_aro_name": "methymycin", "category_aro_description": "Produced by Streptomyces venezuelae ATCC 15439.", "category_aro_class_name": "Antibiotic"}, "37632": {"category_aro_accession": "3001233", "category_aro_cvterm_id": "37632", "category_aro_name": "pikromycin", "category_aro_description": "Produced by Streptomyces venezuelae ATCC 15439.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.28236, "max_identities": 10, "bit_score": 24.6386, "cvterm_id": "36873", "query": "RGLARVLRDHAPERSAEITVERY", "match": "RGLA +LR H P+R+     +R+", "sequence_from_db": "RGLAEILRRHIPKRTYRSLADRH", "sequence_from_broadstreet": "MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR", "dna_sequence_from_broadstreet": "ATGGCAATGCGCGACTCCATACCGAGGCGAGCGGACCGCGACACCCTTCGCCGCGAATTAGGCCAGAACTTCCTTCAGGACGACAGAGCCGTGCGCAATCTCGTCACGCATGTCGAGGGGGACGGTAGGAACGTTCTCGAAATCGGCCCCGGAAAGGGCGCGATAACCGAGGAGTTGGTGCGCTCCTTCGACACCGTGACGGTCGTGGAGATGGACCCGCACTGGGCCGCGCATGTGCGGCGGAAATTCGAAGGGGAGAGGGTCACCGTATTCCAGGGTGATTTCCTCGACTTCCGCATTCCGCGCGATATCGACACCGTCGTCGGAAACGTTCCCTTCGGCATCACGACCCAGATTCTCCGGAGTCTCCTGGAATCGACGAACTGGCAGTCGGCGGCCCTGATAGTGCAGTGGGAGGTCGCCCGCAAACGCGCCGGTCGCAGCGGCGGATCGCTCCTCACGACCTCCTGGGCCCCCTGGTACGAGTTCGCGGTCCACGACCGCGTCCGCGCCTCGTCGTTCCGTCCGATGCCCCGCGTCGACGGCGGCGTCCTGACGATCAGGCGACGCCCCCAGCCCCTGCTGCCCGAGAGCGCGAGCCGCGCCTTCCAGAACTTCGCCGAAGCCGTCTTCACCGGCCCCGGACGGGGCCTCGCGGAGATCCTCCGGCGCCACATCCCCAAGCGGACCTACCGTTCCCTCGCCGACCGCCACGGAATTCCGGACGGCGGACTGCCGAAGGACCTCACGCTCACCCAATGGATCGCCCTTTTCCAGGCCTCCCAGCCGAGTTACGCGCCGGGGGCGCCCGGCACGCGCATGCCGGGCCAGGGCGGTGGCGCCGGCGGCAGGGACTATGACTCGGAGACGAGCAGGGCCGCCGTGCCCGGGAGCCGCAGATACGGCCCCACGCGCGGCGGCGAACCCTGCGCACCCCGCGCACAGGTCCGGCAGACCAAGGGCCGCCAGGGCGCGCGAGGCTCGTCGTACGGACGCCGCACGGGCCGTTAG", "partial": "0", "query_start": 7406, "query_end": 7474, "hit_start": 645, "hit_end": 714, "orf_dna_sequence": "GTGCGCGACACCGAGAACGCGGCGCTGGTCGTCCTCGACATCGACGGCACGCTGCTGGACACGCCCCACCTGCCGGCATGGCGCCGGGGCCTGGCCAGGGTGCTGCGCGACCACGCGCCGGAGCGCTCCGCCGAGATCACGGTGGAGCGGTACCACCGGCACATCGCGGGCCGGCCGAGGCAGGTCGGGGCCAGGGCCGCGCTGGAGCTCGCCGGGCTGGCGCCCCCGCCGGCGCTGGTCGACGAGCTGGCCGCGGTCAAGCAGCAGGTGTTCCTGGAGCAGGCCGAGGAGACCGTCCTGTTCCCCGACGCCGGGGACTTCCTCGACGCGGCGGCGCTGGCGGGCACGCCGCTGGCGTTCTGCACGGCCTCCCGCAACGCCGGCGAGCTGCTGGCCAAGCGCCTTCCCCGACTCGACGGCGGCGACTGGCTGCTCGACCGGCTGCACCACAGCCTCGGCCCGCACGGCCACTACGGCGACGTCCCCCGGCCGGAGGCGCTGCGTCGCGTGGCGGCGGCGTGGGGCGCCGCGCCCGACGGCTGCGTGCTGGTGGACGACGCCCTGTCCGGCGTTCTCGCCGGACAACAGGTCGGGATGACCGCGGTCCTGGTCGACCGGTTCGGGCTGGGCGTCGCCGCGCCCGGCTGCCCCACCGTGAGCACGTTGGCCGAACTGGTCCCGGTGTCGACCGGTGTGCGGTTTCCGGCCGAGTAG", "orf_prot_sequence": "MRDTENAALVVLDIDGTLLDTPHLPAWRRGLARVLRDHAPERSAEITVERYHRHIAGRPRQVGARAALELAGLAPPPALVDELAAVKQQVFLEQAEETVLFPDAGDFLDAAALAGTPLAFCTASRNAGELLAKRLPRLDGGDWLLDRLHHSLGPHGHYGDVPRPEALRRVAAAWGAAPDGCVLVDDALSGVLAGQQVGMTAVLVDRFGLGVAAPGCPTVSTLAELVPVSTGVRFPAE", "perc_identity": 43.48}}, "BGC0000692.1|Apramycin_10 # 8039 # 8503 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.710": {"gnl|BL_ORD_ID|2724|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "tet(53)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3290", "ARO_accession": "3004589", "ARO_name": "tet(53)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.40805, "max_identities": 12, "bit_score": 27.7202, "cvterm_id": "36791", "query": "ITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAAR", "match": "+ LGVC G F IL+  ++ H T+     ++ L+S+ + +", "sequence_from_db": "VNLGVCFGVFSILNYLNLSH-TEVQCEANQKLISIWSHK", "sequence_from_broadstreet": "MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAATAAAATTCTCGTGATCGGAGCTGGTATTGCCGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCTGTCCTCATTGAAAAATTTGCCAATATACGAAAAGAAGGGCAGGCACTGGATTTTCGAGGCGTTGCGATCGACATCGTTAAAGGAATGAATATTTATGAGAAAATGTGCAATATGCACAAGCAGTTGGAGGTCGGGCGGTATGTGGACACAGAAGGCAATACCCTGCATGAAGAAAGAGGTGAAAGATTTTGCTTTAGACAAGGTGAAGACGTTGAAATTGCCCGCGGTGATTTCGCCGAAATACTGACGGGTGCCATTGAAGGTATTCCCTGTCATTTTAATCAAGTAATTGACAGCATTAAACAGAGTGACGATGATGTAAAAGTCCAGTTCAACGATGGCAGAGTCGAGCATTATGACTTGGTTATTGGTGCTGATGGCATATACTCGACAACGAGAGGTATGGTTTTTGATAAAGACGAATATAAATTAGTTAACCTTGGTGTGTGCTTTGGCGTATTTAGCATTCTGAATTATCTCAATTTGAGCCACACCGAAGTGCAGTGTGAGGCCAATCAAAAGCTGATATCTATCTGGAGCCACAAAAATCCCAAGATGGCTGAAGTTGCGTTTGTGTTCCGTACGCAGAATGTCTTGAATAACATTCGCAATAAAAACGAGCAGCAGCAACTCCTGCGTGATGCTTTTCAAGATTTTGGCTGGGAAGCATCAAAAATACTTGAGCTGATGACAGGTAGTGATGATTTTTATTTTGATTCAGCCACACAGGTAAAAATGAAATCGTGGACGAAAGGGCGGGTTGCTTTATTGGGTGATGCTGGTTACTCTGCATCTCCACTATCTGGTCAGGGTAATTATCTGGCACTGGTTGGCGCTTATATTTTTGCCGGAGAACTAAAAAAAGCAGATGGCAATTATACTCGTGCATTTAGTCGTTATAATGAATTATTACATCCACTCGTTGAAGCCTGTCACAAGTTGGGGGTCTTAGTTAGCGAATCGTTCCTCGTCCCAGATGAAGTCTCCAAAGAAGTTGCAGAAGAACGATCAAATAAGATTCTGCAAGAGGTGAAAATCGTATCGAATATGATTTCGTTGCCAGAGTATGAATGA", "partial": "0", "query_start": 8084, "query_end": 8200, "hit_start": 522, "hit_end": 636, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 30.77}, "gnl|BL_ORD_ID|2932|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "SHV-220", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "577", "model_id": "3946", "ARO_accession": "3005224", "ARO_name": "SHV-220", "ARO_category": {"36024": {"category_aro_accession": "3000015", "category_aro_cvterm_id": "36024", "category_aro_name": "SHV beta-lactamase", "category_aro_description": "SHV-1 shares 68 percent of its amino acids with TEM-1 and has a similar overall structure. The SHV-1 beta-lactamase is most commonly found in K. pneumoniae and is responsible for up to 20% of the plasmid-mediated ampicillin resistance in this species. ESBLs in this family also have amino acid changes around the active site, most commonly at positions 238 or 238 and 240. More than 60 SHV varieties are known.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.19599, "max_identities": 12, "bit_score": 25.409, "cvterm_id": "35915", "query": "RLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYF", "match": "RL+V +  +++ +++  DD  A PLIR++ P  +F", "sequence_from_db": "RLSVRSQRQLLQWMV--DDGVAGPLIRSVLPAGWF", "sequence_from_broadstreet": "MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSPRLSVRSQRQLLQWMVDDGVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTAGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTGAGCAAATTAAACTAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCAGCGGCCGCACGCTGACCGCCTGGCGCGCCGATGAACGCTTTCCCATGATGAGCACCTTTAAAGTAGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACACCTTGCCGACGGCATGACGGTCGGCGAACTCTGCGCCGCCGCCATTACCATGAGCGATAACAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTGACTGCCTTTTTGCGCCAGATCGGCGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTGAATGAGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTGACCAGCCCGCGTCTGAGCGTCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATGGGGTCGCCGGACCGTTGATCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAGACCGGAGCTGGCGAGCGGGGTGCGCGCGGCATTGTCGCCCTGCTTGGCCCGAATAACAAAGCAGAGCGCATTGTGGTGATATATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8246, "query_end": 8350, "hit_start": 579, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 34.29}, "gnl|BL_ORD_ID|1189|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-B-12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1296", "ARO_accession": "3002445", "ARO_name": "OKP-B-12", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.34351, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "TALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAG", "dna_sequence_from_broadstreet": "ACCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTTGAGCAGATTAAAATCAGCGAAGGTCAGCTGGCGGGCCGGGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCATGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCTGTGCTGGCCCGGGTGGATGCCGGCGACGAACAGCTGGATCGGCGGATCCACTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGATAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTCGGCGGCCCCGCGGGATTGACCACTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCGGCCAGCATGGCCACCACCCTGCGCAAGTTGCTAACCACCCCCTCTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGCCCGTTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGTGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGGACGGCAAAGCGGAGCGTATCGTGGTGATCTATCTGCGGGATACCGCTGCGACCATGGCCGAACGTAACCAGCAGATCGCCGGG", "partial": "1", "query_start": 8297, "query_end": 8350, "hit_start": 588, "hit_end": 642, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|896|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-B-18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "970", "ARO_accession": "3002451", "ARO_name": "OKP-B-18", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.45775, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTTGAGCAGATTAAAATCAGCGAAGGTCAGCTGGCGGGCCGGGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGCGACGAACAGCTGGATCGGCGGATCCACTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGATCGTCGGCGGCCCTGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGTCTTGACCGCTGGGAAACGGAACTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCGGCCAGCATGGCCACCACCCTGCGCAAGCTGCTAACCACCCCCTCTCTGAGCGCCCGCTCGCAGCAGCAGCTGCTGCAGTGGATGGTTGACGACCAGGTGGCCGGCCCGTTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGTGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGGACGGCAAAGCGGAGCGTATCGTGGTGATCTATCTGCGGGATACCGCAGCGACCATGGCCGAACGTAACCAGCAGATCGCCGGGATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|3714|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-B-21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "4784", "ARO_accession": "3006143", "ARO_name": "OKP-B-21", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.50809, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "43789", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNEQIAGIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCACTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTTGAGCAGATTAAAATCAGCGAAGGTCAGCTGGCGGGCCGGGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCTGTGCTGGCCCGGGTGGATGCCGGCGACGAACAGCTGGATCGGCGGATCCACTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTCGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCGGCCAGCATGGCCACCACCCTGCGCAAGTTGCTAACCACCCCCTCTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGCCCGTTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGTGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGGACGGCAAAGCGGAGCGTATCGTGGTGATCTATCTGCGGGATACCGCGGCGACCATGGCCGAACGTAACGAGCAGATCGCCGGGATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1896|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "2059", "ARO_accession": "3002418", "ARO_name": "OKP-A-1", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66189, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLVSGRTLAAWRANERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIAEKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPASMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGTCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAATGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCTGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGAAAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGTCCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|536|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "588", "ARO_accession": "3002424", "ARO_name": "OKP-A-7", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66189, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRCVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYPQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPAAMAERNQQIAKIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTGTGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTCGAACAAATTACACTCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCGAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACGGCTGGATCGGCGGATCCGCTACCCCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGATAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGGCCATGGCCGAGCGTAACCAGCAGATCGCCAAAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|199|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "219", "ARO_accession": "3002429", "ARO_name": "OKP-A-12", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.71411, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGCATTCGCCAGCCCTCAGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCACTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGTGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGCCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAACGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1620|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1767", "ARO_accession": "3002433", "ARO_name": "OKP-A-16", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.7668, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLVAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGTGGCATTCGCCAGCCCTCAGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGTGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGACTTGACCGCTGGGAAACGGAGCTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|848|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "921", "ARO_accession": "3002428", "ARO_name": "OKP-A-11", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.81998, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGCATTCGCCAGCCCTCCGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|784|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "848", "ARO_accession": "3002419", "ARO_name": "OKP-A-2", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.87364, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLFSLIAALPLAVFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGTGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1325|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1447", "ARO_accession": "3002427", "ARO_name": "OKP-A-10", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.98246, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRCVRLCLIPLIAALPLAVFASPPPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVMIYLRDTPATMAERNQQIAKIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTGTGTTCGCCTGTGCCTTATCCCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACTCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCGAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGATCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGATGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAAAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|928|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1007", "ARO_accession": "3002425", "ARO_name": "OKP-A-8", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.98246, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGCATTCGCCAGCCCTCCGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1630|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1778", "ARO_accession": "3002422", "ARO_name": "OKP-A-5", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.09328, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTCGAACAAATTACACTCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACGGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|3712|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "4782", "ARO_accession": "3006141", "ARO_name": "OKP-A-17", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.14946, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "43789", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLFSLIAALPLAVFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGCCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTCCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1760|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1908", "ARO_accession": "3002423", "ARO_name": "OKP-A-6", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.14946, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKRVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGCATTCGCCAGCCCTCAGCCGCTCGAGCAAGTTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCACGGGTGGATGCCGGAGACGAACGGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGCGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAAAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|861|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "936", "ARO_accession": "3002430", "ARO_name": "OKP-A-13", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.20615, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATATTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTTTGCGCCAGATCGGTGACAACGTCACCCGCCTCGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGTGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|546|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "599", "ARO_accession": "3002420", "ARO_name": "OKP-A-3", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.20615, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCGAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAAAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1077|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "1165", "ARO_accession": "3002421", "ARO_name": "OKP-A-4", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.26336, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCACTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGTGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|393|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "435", "ARO_accession": "3002426", "ARO_name": "OKP-A-9", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.26336, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKALLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCGAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGCGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACGCGCTGAGCGACCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTGGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAAAATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|130|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "151", "ARO_accession": "3002432", "ARO_name": "OKP-A-15", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.35255, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATGTTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTTTGCGCCAGATCGGTGACAACGTCACCCGCCTCGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCGCCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGTGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATGGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 609, "hit_end": 663, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|858|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "OKP-A-14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "933", "ARO_accession": "3002431", "ARO_name": "OKP-A-14", "ARO_category": {"38817": {"category_aro_accession": "3002417", "category_aro_cvterm_id": "38817", "category_aro_name": "OKP beta-lactamase", "category_aro_description": "OKP beta-lactamases are chromosomal class A beta-lactamase that confer resistance to penicillins and early cephalosporins in Klebsiella pneumoniae. OKP beta-lactamases can be subdivided into two groups: OKP-A and OKP-B which diverge by about 4.2%.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.49752, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "35915", "query": "DDDTAVPLIRALRPDYYF", "match": "DD  A PLIRA+ P  +F", "sequence_from_db": "DDQVAGPLIRAVLPAGWF", "sequence_from_broadstreet": "MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATIAERNQQIARIGAALIEHWQR", "dna_sequence_from_broadstreet": "ATGCGTTATATTCGCCTGTGCCTTTTCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCCGCCGCTTGAGCAAATTACACGCAGCGAAAGTCAGCTGGCGGGCCGCGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGAGACGAACAGCTGGATCGGCGGATCCGCTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTTGGCGGCCCCGCGGGATTGACCGCTTTTTTGCGCCAGATCGGTGACAACGTCACCCGCCTCGACCGCTGGGAAACGGAGCTCAATGAAGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCAGCCAGCATGGCCACCACCCTGCGCAAGCTGCTAACCAGCCACACTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCAGGTAGCCGGTCCGCTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGCGAGCGGGGCTCACGTGGCATTGTCGCCCTGCTCGGCCCGAACGGCAAAGCGGAGCGCATCGTGGTGATCTATCTGCGGGATACGCCGGCGACCATAGCCGAGCGTAACCAGCAGATCGCCAGAATAGGCGCGGCGCTGATCGAGCACTGGCAACGCTAA", "partial": "0", "query_start": 8297, "query_end": 8350, "hit_start": 624, "hit_end": 678, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 55.56}, "gnl|BL_ORD_ID|1985|hsp_num:0": {"type_match": "Loose", "snp": {"original": "G", "change": "D", "position": 316}, "query_snp": {"original": "G", "change": "D", "position": 7}, "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 700, "model_id": "2147", "ARO_accession": "3003370", "ARO_name": "Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa", "ARO_category": {"37711": {"category_aro_accession": "3001312", "category_aro_cvterm_id": "37711", "category_aro_name": "elfamycin resistant EF-Tu", "category_aro_description": "Sequence variants of elongation factor Tu that confer resistance to elfamycin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "37641": {"category_aro_accession": "3001242", "category_aro_cvterm_id": "37641", "category_aro_name": "enacyloxin IIa", "category_aro_description": "Enacyloxin IIa is structurally distinct but acts in a similar mechanism to kirromycin-like elfamycins. It prohibits the transfer of the amino acid at the A site to the elongating peptide chain. It is most likely that the mechanism of action is that EF-Tu*GDP is locked in the EF-Tu*GTP form, and EF-Tu*GDP*aa-tRNA is immobilized on the ribosome. It is an open question whether enacyloxin IIa actually belongs to the kirromycin-like group of elfamycins due to their high similarity.", "category_aro_class_name": "Antibiotic"}, "37618": {"category_aro_accession": "3001219", "category_aro_cvterm_id": "37618", "category_aro_name": "elfamycin antibiotic", "category_aro_description": "Elfamycins are molecules that inhibit bacterial elongation factor Tu (EF-Tu), a key protein which brings aminoacyl-tRNA (aa-tRNA) to the ribosome during protein synthesis. Elfamycins defined by their target (EF-Tu), rather than a conserved chemical backbone. Elfamycins follow two mechanisms to disrupt protein synthesis: 1. kirromycins and enacyloxin fix EF-Tu in the GTP bound conformation and lock EF-Tu onto the ribosome, and 2. pulvomycin and GE2270 cover the binding site of aa-tRNA disallowing EF-Tu from being charged with aa-tRNA. All elfamycins cause increased the affinity of EF-Tu for GTP.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.34111, "bit_score": 24.6386, "max_identities": 13, "cvterm_id": "36849", "query": "YVLLNDDDTA-VPLIRALRPDYYFKGADY-ANMRDPRVVEEV", "match": "Y+L  D+     P  +  RP +YF+  D    +  P  VE V", "sequence_from_db": "YILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMV", "sequence_from_broadstreet": "MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG", "dna_sequence_from_broadstreet": "GTGTCTAAAGAAAAATTTGAACGTACAAAACCGCACGTTAACGTTGGTACTATCGGCCACGTTGACCACGGTAAAACTACTCTGACCGCTGCAATCACCACCGTACTGGCTAAAACCTACGGCGGTGCTGCTCGTGCATTCGACCAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATACGACACCCCGACCCGTCACTACGCACACGTAGACTGCCCGGGGCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGACGGCGCGATCCTGGTAGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTTCGTGAACTTCTGTCTCAGTACGACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCCTGGAACTGGCTGGCTTCCTGGATTCTTATATTCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTTGTTGCTAAAGTTCTGGGCTAA", "partial": "0", "query_start": 8282, "query_end": 8401, "hit_start": 927, "hit_end": 1053, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 30.95}, "gnl|BL_ORD_ID|1969|hsp_num:0": {"type_match": "Loose", "snp": {"original": "G", "change": "D", "position": 317}, "query_snp": {"original": "G", "change": "D", "position": 8}, "orf_strand": "-", "orf_start": 8039, "orf_end": 8503, "orf_from": "BGC0000692.1|Apramycin_10 ", "model_name": "Escherichia coli EF-Tu mutants conferring resistance to kirromycin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 700, "model_id": "2137", "ARO_accession": "3003368", "ARO_name": "Escherichia coli EF-Tu mutants conferring resistance to kirromycin", "ARO_category": {"37711": {"category_aro_accession": "3001312", "category_aro_cvterm_id": "37711", "category_aro_name": "elfamycin resistant EF-Tu", "category_aro_description": "Sequence variants of elongation factor Tu that confer resistance to elfamycin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "37633": {"category_aro_accession": "3001234", "category_aro_cvterm_id": "37633", "category_aro_name": "kirromycin", "category_aro_description": "Kirromycin, also known as mocimycin, is the representative molecule of its own class of elfamycins which is composed of more than 10 analogs. Kirromycin binds to the domain 1,2 interface of elongation factor Tu. This interaction maintains the EF-Tu*GTP conformation even after GTP is hydrolyzed to GDP. EF-Tu*GDP normally releases aa-tRNA and then exits the ribosome; however, kirromycin*EF-Tu*GDP*aa-tRNA forms a strong complex and remains bound to the ribosome, prohibits translocation of the peptide chain and translation is halted.", "category_aro_class_name": "Antibiotic"}, "37618": {"category_aro_accession": "3001219", "category_aro_cvterm_id": "37618", "category_aro_name": "elfamycin antibiotic", "category_aro_description": "Elfamycins are molecules that inhibit bacterial elongation factor Tu (EF-Tu), a key protein which brings aminoacyl-tRNA (aa-tRNA) to the ribosome during protein synthesis. Elfamycins defined by their target (EF-Tu), rather than a conserved chemical backbone. Elfamycins follow two mechanisms to disrupt protein synthesis: 1. kirromycins and enacyloxin fix EF-Tu in the GTP bound conformation and lock EF-Tu onto the ribosome, and 2. pulvomycin and GE2270 cover the binding site of aa-tRNA disallowing EF-Tu from being charged with aa-tRNA. All elfamycins cause increased the affinity of EF-Tu for GTP.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.34111, "bit_score": 24.6386, "max_identities": 13, "cvterm_id": "35914", "query": "YVLLNDDDTA-VPLIRALRPDYYFKGADY-ANMRDPRVVEEV", "match": "Y+L  D+     P  +  RP +YF+  D    +  P  VE V", "sequence_from_db": "YILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMV", "sequence_from_broadstreet": "MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG", "dna_sequence_from_broadstreet": "GTGTCTAAAGAAAAATTTGAACGTACAAAACCGCACGTTAACGTTGGTACTATCGGCCACGTTGACCACGGTAAAACTACTCTGACCGCTGCAATCACCACCGTACTGGCTAAAACCTACGGCGGTGCTGCTCGTGCATTCGACCAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATACGACACCCCGACCCGTCACTACGCACACGTAGACTGCCCGGGGCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGACGGCGCGATCCTGGTAGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTTCGTGAACTTCTGTCTCAGTACGACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCCTGGAACTGGCTGGCTTCCTGGATTCTTATATTCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTTGTTGCTAAAGTTCTGGGCTAA", "partial": "0", "query_start": 8282, "query_end": 8401, "hit_start": 927, "hit_end": 1053, "orf_dna_sequence": "ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG", "orf_prot_sequence": "MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR", "perc_identity": 30.95}}, "BGC0000692.1|Apramycin_11 # 8588 # 9997 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.774": {"gnl|BL_ORD_ID|2781|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8588, "orf_end": 9997, "orf_from": "BGC0000692.1|Apramycin_11 ", "model_name": "LpsB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3793", "ARO_accession": "3005051", "ARO_name": "LpsB", "ARO_category": {"43251": {"category_aro_accession": "3005050", "category_aro_cvterm_id": "43251", "category_aro_name": "Intrinsic peptide antibiotic resistant Lps", "category_aro_description": "LpsB is involved in lipopolysaccharide synthesis. It provides intrinsic resistance to colistin and other peptide antibiotics such as polymyxins.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "37037": {"category_aro_accession": "3000693", "category_aro_cvterm_id": "37037", "category_aro_name": "defensin", "category_aro_description": "Defensins are natural cationic peptides that have antibiotic properties. It is part of the innate immune system of plants and animals.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36383": {"category_aro_accession": "3000244", "category_aro_cvterm_id": "36383", "category_aro_name": "reduced permeability to antibiotic", "category_aro_description": "Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.23745e-09, "max_identities": 38, "bit_score": 55.4546, "cvterm_id": "35507", "query": "GRVAHEKGWAHFVELAARLAADPPAEPVVFLVVGDGPQRPRMEE---RVAAAGLSDRFVFTGFLPNHEVPLTMSGIDVLVMPSVHEELGGSAIEAMVLGVPVVAYGVGGLRDTVGTVAPELLVPPQDVPALVRAVR", "match": "GR+   KG    +EL  +L +  P    V +   D  ++  + E    + + GL+D+  F G   +    L  S I VL + +  E  G +A+EA+ +G PV+ +  GG+ + +  V P+ LV  ++  AL+  V+", "sequence_from_db": "GRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDI-VLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVK", "sequence_from_broadstreet": "MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK", "dna_sequence_from_broadstreet": "ATGAAAGTGATGCAACTTCTCCCAGAACTCAATAGCGGTGGCGTAGAACGCGGCACACTGGAAATTGCACGTGCACTGGTTGCACAAGGTCATCAGTCTCTAGTTGTGTCTAATGGCGGGCGTTTGGTCTCACAACTTGAAGCTGAAGGTTCCACACACTTAACACTGCCGATTCATAAAAAATCATTGTCGAGCTTGTGGCAAATCCGTCCATTACGTCAGCTTATTGAAGAACACCAACCAGACATTGTACATGTGCGCTCTCGCGTACCTGCATGGCTAACCCACTTCGCTTTAAGAAAAATACCAGCGAATAAACGCCCTCACCTCATTAGCACGGTACATGGTTTCTATTCAGTTAATCGTTATAGTGCGATCATGACTCAGGCAGAAAAAGTGATCGCTGTTTCTGACAGCGTAGTTAAATACATCACAGGCCATTATAAAAACTGTCCACCACAAGATATTATCCGGATTTATCGAGGAATTGACCCTGCCGCTTTTCCGCATAACTATCAACCTTCAGCACAGTGGTTTAACCAAGTCTTTAACGACTTTCCCGAACTTGAAAATAAATTTTTACTTTGCCTACCTGGCCGTATTACTCGTTTAAAAGGACATGAAAGTTTAATTGAACTGATGCAGCAACTTCATTCGCAATATCCTCAACTGCATGCTGTTGTTGTAGGTGGGGCTGATGTAAAAAAACAAGCCTATTTAAGTGAGTTGCAAAACACCATTCAAAGCAAAGGACTTGCAGATAAAATTACATTTGTAGGACATCGCTCAGATATACGCGAATGGCTCGCTTTTAGCGATATAGTGCTCTCTCTATCCAATCAAGCAGAAACATTCGGTAGAACAGCATTAGAAGCGCTCTCTGTCGGTACGCCGGTCATTGGCTGGAACCGTGGAGGTGTTGCCGAGATTTTATCTCATGTGTACCCGCAGGGTCTTGTTGAAGCAGAAAATGAAAAAGCTTTATTAGAAATAGTAAAGCATCATATTGAACAACCTCAAACAGTCGCTCCTGTGACAATGTTTAGTTTAAAAGATATGTGTGACCAAACCCTTGAGCTATATCAAAGTGTATTGAAATAA", "partial": "0", "query_start": 9305, "query_end": 9703, "hit_start": 594, "hit_end": 999, "orf_dna_sequence": "ATGCGGTTGCGCGTGCTGCGGCTCACCCCGTTCTTCCACCACGACTGCGTGGACCGGTGGCCGGCGGAGTTCGACGCCGTCGGCGGGATGCAGGTGCAGATCCTCCGGCTGTCGCGGCAACTGGCGCGGCGCGGCGTGCGGCAGGAGGTGCTCACGGTCGGGTTCCCCGGCCTGCCCCGGGTCCGGGAGGACTCGCCGGGGCTGGTCGTCCGGATCACCAGGGCCCCGATGCCCCGGCTGCGGTCGGAGCTGACCGGGTTGGTCGGCCTGAACCTGGCGTGGTTCCTCGGCGCGATGGCCGAGTGCGCGCGCCGGCGGCGGAGCCGGCGGCCGGACCTCATCCAGGTGCACGCCGACGGCCAGCTCTGGGCGCTGCTGGCCGGGCCGATCGCCTCGGCCCTGCTGCGGCGGCCCTACAGCCTGGTGCTGCACTGCTCGCGGCTGGGCGTCTACCAGCCGATGTCCCGGTACGACCAGTGGCAGCACCGGTTCGTCGCCGCGGTCGAGCGGTGGGCGCTGCGGCGGGCGGACGGGGTGTGCGCCCTGACCGCACGCACGGCCGACGTCGTCCGGGCGGCGCTGCGCCCGCACGCCGTGCGCGTCGACGTGGTGCCCGACTCGGTGGACCCGGAACCCCCGGTGGACGCGGGGGTTCCGGTGGCTGAGCGGCTGCGCGCCGCCGGGCTGCCCGCCGACGCGAAGGTGGTCGGCTACGTCGGCCGGGTGGCGCACGAGAAGGGCTGGGCCCACTTCGTCGAGCTGGCCGCCCGGCTGGCCGCCGACCCGCCGGCGGAGCCCGTCGTGTTCCTCGTCGTCGGCGACGGGCCGCAGCGCCCGAGGATGGAGGAGCGGGTGGCCGCGGCCGGGCTCTCCGACCGGTTCGTGTTCACCGGGTTCCTGCCCAACCACGAGGTTCCGCTGACGATGAGCGGGATCGACGTCCTGGTGATGCCGTCGGTCCACGAGGAGCTGGGCGGCAGCGCGATCGAGGCGATGGTGCTGGGGGTCCCGGTGGTGGCCTACGGGGTCGGCGGGCTCCGGGACACCGTCGGCACGGTCGCGCCCGAGCTGCTGGTTCCGCCGCAGGACGTGCCGGCGCTGGTCCGCGCGGTCCGCGACGTACTCGCGCGGGGCGCGGAGCACCGGGCGCGGGTGCGCGCGGGCCGGCCGTGGCTGGAGGAGAACTTCGGCGACGGCGTCGGCGTCGACCGCACCGTGGCGCACTACCGGCGCGTCCTGGCCGGCCGAGGTGGTGGCGGCGACCTCGGCCCCGGCGTCCCGGGCCCCGGTGTCCCCAACCCCGGCGCCCTCAACCCGGGCGTCCCCGGACCCGGCGGCGCGGCCCCGGCGGACCCGCCCGACGGAGGCGCGTCCGCCGCCGGGCAGCGGCCGCCCGGCTCCGGTCCCTGA", "orf_prot_sequence": "MRLRVLRLTPFFHHDCVDRWPAEFDAVGGMQVQILRLSRQLARRGVRQEVLTVGFPGLPRVREDSPGLVVRITRAPMPRLRSELTGLVGLNLAWFLGAMAECARRRRSRRPDLIQVHADGQLWALLAGPIASALLRRPYSLVLHCSRLGVYQPMSRYDQWQHRFVAAVERWALRRADGVCALTARTADVVRAALRPHAVRVDVVPDSVDPEPPVDAGVPVAERLRAAGLPADAKVVGYVGRVAHEKGWAHFVELAARLAADPPAEPVVFLVVGDGPQRPRMEERVAAAGLSDRFVFTGFLPNHEVPLTMSGIDVLVMPSVHEELGGSAIEAMVLGVPVVAYGVGGLRDTVGTVAPELLVPPQDVPALVRAVRDVLARGAEHRARVRAGRPWLEENFGDGVGVDRTVAHYRRVLAGRGGGGDLGPGVPGPGVPNPGALNPGVPGPGGAAPADPPDGGASAAGQRPPGSGP", "perc_identity": 27.94}, "gnl|BL_ORD_ID|1117|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8588, "orf_end": 9997, "orf_from": "BGC0000692.1|Apramycin_11 ", "model_name": "FosC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "1215", "ARO_accession": "3000380", "ARO_name": "FosC", "ARO_category": {"41409": {"category_aro_accession": "3004245", "category_aro_cvterm_id": "41409", "category_aro_name": "fosC phosphotransferase family", "category_aro_description": "The fosC family of phosphotransferases phosphorylate fosfomycin to confer resistance and have been found in various bacterial isolates.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.849468, "max_identities": 19, "bit_score": 28.4906, "cvterm_id": "37078", "query": "DAVGGMQVQILRLSRQLARRGVRQEVLTVGFPGLPRVREDSPGL", "match": "D  GGM+ + ++  RQLAR GV  EVL+  F    RV     GL", "sequence_from_db": "DLTGGMRNKFMQ-QRQLARLGVVSEVLS--FECFDRVHLSLCGL", "sequence_from_broadstreet": "MMTSIMFSMLSDITRIFVEQGLRVYPFQSSALLGVDEEGRVTLHARQLATAMASGYMPLLTGDLLLRGEQEAQVFSSDNIAPLLAADFEVRRVLYYSDVAGVYDQGNALVPWVGNANAACMEACVGASSMTDLTGGMRNKFMQQRQLARLGVVSEVLSFECFDRVHLSLCGLRQFGTVFLSE", "dna_sequence_from_broadstreet": "ATGATGACATCGATCATGTTTTCGATGTTGTCGGACATCACGCGGATTTTTGTCGAGCAGGGGCTACGGGTCTATCCCTTTCAAAGCAGTGCCTTGCTGGGCGTCGATGAAGAGGGGCGTGTCACGCTTCATGCGCGCCAGCTGGCAACGGCCATGGCATCGGGTTACATGCCCTTGCTCACTGGGGATCTGCTGCTGCGCGGCGAGCAGGAGGCGCAGGTCTTTTCAAGTGACAATATCGCCCCGTTGCTCGCTGCGGACTTCGAAGTGCGTCGGGTCTTGTATTACTCCGATGTGGCCGGTGTCTACGACCAGGGCAATGCCTTGGTCCCTTGGGTTGGCAATGCCAACGCCGCGTGCATGGAGGCTTGTGTGGGGGCGTCGTCGATGACGGACCTGACCGGTGGCATGCGCAACAAGTTCATGCAGCAGCGCCAGTTGGCACGCCTGGGCGTGGTTTCGGAGGTCTTGTCATTCGAGTGCTTCGACAGGGTGCATCTGTCGTTGTGCGGGTTGCGTCAATTTGGAACCGTGTTCTTGAGCGAGTGA", "partial": "0", "query_start": 8660, "query_end": 8791, "hit_start": 393, "hit_end": 516, "orf_dna_sequence": "ATGCGGTTGCGCGTGCTGCGGCTCACCCCGTTCTTCCACCACGACTGCGTGGACCGGTGGCCGGCGGAGTTCGACGCCGTCGGCGGGATGCAGGTGCAGATCCTCCGGCTGTCGCGGCAACTGGCGCGGCGCGGCGTGCGGCAGGAGGTGCTCACGGTCGGGTTCCCCGGCCTGCCCCGGGTCCGGGAGGACTCGCCGGGGCTGGTCGTCCGGATCACCAGGGCCCCGATGCCCCGGCTGCGGTCGGAGCTGACCGGGTTGGTCGGCCTGAACCTGGCGTGGTTCCTCGGCGCGATGGCCGAGTGCGCGCGCCGGCGGCGGAGCCGGCGGCCGGACCTCATCCAGGTGCACGCCGACGGCCAGCTCTGGGCGCTGCTGGCCGGGCCGATCGCCTCGGCCCTGCTGCGGCGGCCCTACAGCCTGGTGCTGCACTGCTCGCGGCTGGGCGTCTACCAGCCGATGTCCCGGTACGACCAGTGGCAGCACCGGTTCGTCGCCGCGGTCGAGCGGTGGGCGCTGCGGCGGGCGGACGGGGTGTGCGCCCTGACCGCACGCACGGCCGACGTCGTCCGGGCGGCGCTGCGCCCGCACGCCGTGCGCGTCGACGTGGTGCCCGACTCGGTGGACCCGGAACCCCCGGTGGACGCGGGGGTTCCGGTGGCTGAGCGGCTGCGCGCCGCCGGGCTGCCCGCCGACGCGAAGGTGGTCGGCTACGTCGGCCGGGTGGCGCACGAGAAGGGCTGGGCCCACTTCGTCGAGCTGGCCGCCCGGCTGGCCGCCGACCCGCCGGCGGAGCCCGTCGTGTTCCTCGTCGTCGGCGACGGGCCGCAGCGCCCGAGGATGGAGGAGCGGGTGGCCGCGGCCGGGCTCTCCGACCGGTTCGTGTTCACCGGGTTCCTGCCCAACCACGAGGTTCCGCTGACGATGAGCGGGATCGACGTCCTGGTGATGCCGTCGGTCCACGAGGAGCTGGGCGGCAGCGCGATCGAGGCGATGGTGCTGGGGGTCCCGGTGGTGGCCTACGGGGTCGGCGGGCTCCGGGACACCGTCGGCACGGTCGCGCCCGAGCTGCTGGTTCCGCCGCAGGACGTGCCGGCGCTGGTCCGCGCGGTCCGCGACGTACTCGCGCGGGGCGCGGAGCACCGGGCGCGGGTGCGCGCGGGCCGGCCGTGGCTGGAGGAGAACTTCGGCGACGGCGTCGGCGTCGACCGCACCGTGGCGCACTACCGGCGCGTCCTGGCCGGCCGAGGTGGTGGCGGCGACCTCGGCCCCGGCGTCCCGGGCCCCGGTGTCCCCAACCCCGGCGCCCTCAACCCGGGCGTCCCCGGACCCGGCGGCGCGGCCCCGGCGGACCCGCCCGACGGAGGCGCGTCCGCCGCCGGGCAGCGGCCGCCCGGCTCCGGTCCCTGA", "orf_prot_sequence": "MRLRVLRLTPFFHHDCVDRWPAEFDAVGGMQVQILRLSRQLARRGVRQEVLTVGFPGLPRVREDSPGLVVRITRAPMPRLRSELTGLVGLNLAWFLGAMAECARRRRSRRPDLIQVHADGQLWALLAGPIASALLRRPYSLVLHCSRLGVYQPMSRYDQWQHRFVAAVERWALRRADGVCALTARTADVVRAALRPHAVRVDVVPDSVDPEPPVDAGVPVAERLRAAGLPADAKVVGYVGRVAHEKGWAHFVELAARLAADPPAEPVVFLVVGDGPQRPRMEERVAAAGLSDRFVFTGFLPNHEVPLTMSGIDVLVMPSVHEELGGSAIEAMVLGVPVVAYGVGGLRDTVGTVAPELLVPPQDVPALVRAVRDVLARGAEHRARVRAGRPWLEENFGDGVGVDRTVAHYRRVLAGRGGGGDLGPGVPGPGVPNPGALNPGVPGPGGAAPADPPDGGASAAGQRPPGSGP", "perc_identity": 43.18}}, "BGC0000692.1|Apramycin_12 # 10001 # 11140 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722": {"gnl|BL_ORD_ID|2350|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 10001, "orf_end": 11140, "orf_from": "BGC0000692.1|Apramycin_12 ", "model_name": "basS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "249", "ARO_accession": "3003583", "ARO_name": "basS", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.20848, "max_identities": 22, "bit_score": 26.5646, "cvterm_id": "36752", "query": "VGLGMLAE---AEIARRLGLAGEDLIELHRDLISRMGIDLAFPAHV----------SPADVQLRLRYDNK", "match": "V L  LAE   +E+AR+  +  +  + LH++ +  MGIDL   A V          +PA  Q+ +R +N+", "sequence_from_db": "VNLATLAEDVLSELARQ-AIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENR", "sequence_from_broadstreet": "MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI", "dna_sequence_from_broadstreet": "ATGTCCCGTGCCGCCGTCCCCTCCGTCCGCCGGCGCCTGCTGGTCAACCTGCTGGTCGGCTTCGTGCTGTGCTGGCTGAGCGTGGCGGCGCTGACCTACCACCTCTCGCTGAAGCAGGTGAACCGCCTGTTCGACGACGACATGGTGGACTTCGGCGAAGCCGCCCTGCGCCTGCTCGACCTTGCCACCGAAGACCAGGCCGGCGAGGACGGCTCCATCACCGAGATCATCGAACGCAGCCGCGAAGCGATCCAGGGTCTGCCCCTGCTGCGCCGCGAAAGCGCCCTCGGCTACGCCCTGTGGCGCGACGGCCAGCCGCTGCTGTCGAGCCTCAACCTGCCGCCGGAGATCACGGCCCAGGGCCCCGGCTTCAGCACCGTGGAAGCCCAGGGCACCCACTGGCGGGTGCTCCAGCTGAACATCGACGGCTTCCAGATCTGGATCAGCGAAAACCTGATCTACCGCCAGCACACCATGAACCTGCTGCTGTTCTACTCGCTGTTCCCACTGCTGCTGGCGCTGCCGTTGCTCGGCGGCCTGGTCTGGTTCGGCGTTGCCCGCGGCCTGGCGCCGCTACGCGAAGTGCAGGCCGAGGTCCAGCAGCGCTCCGCGCGACACCTGCAGCCGATCGCGGTGGAAGCGGTGCCGCTGGAGATCCGCGGCCTCATCGACGAACTCAACCTCCTGCTGGAGCGTCTGCGCACCGCCCTCGAGGCCGAACGCCGACTGACCAGCGACGCCGCCCATGAAATCCGCACGCCACTGGCCAGCCTGCGCACCCATGCCCAGGTCGCGCTGCGTTCGGAAGACCCCAAGGCCCACGCCCGCGGCCTGCTGCAAGTCAGTCGCAGCGTCGAGCGGATCAGCACCTTGATGGAGCAGATCCTGCTCCTCGCCCGCCTCGACGGCGACGCCCTGCTGGAGCAATTCCACCCGGTCAACCTCGCCACCCTGGCCGAAGACGTACTCTCCGAACTGGCGCGCCAGGCCATCGACAAGGACATCGAGCTGTCGTTGCACCAGGAGACCGTGCACGTGATGGGCATCGACCTGTGGCTGAAGGCGATGGTCGGCAACCTGGTGGGCAACGCCCTGCGCTACACACCGGCCGGGGGCCAGGTCGAGATCCGCGTCGAGAATCGCGCCCAGCACGCCGTGCTGCGGGTGCGCGACAACGGCCCCGGGGTCGCCCTGGAAGAGCAGCAGGCGATCTTCACCCGCTTCTACCGCAGCCCCGCCACCAGCAGCGGCGAGGGCAGCGGCCTGGGCCTGCCGATCGTCAAGCGCATCGTCGAACTGCACTTCGGCAGTATCGGCCTGGGCAAGGGACTGGAGGGCAAAGGGCTGGAAGTGCAGGTGTTCCTGCCGAAGACCCAGCCGGACGCGACGCGGCCGCCGGCCAGAGGTCCGGACAGCGGGCGGTCACATATCTGA", "partial": "0", "query_start": 10778, "query_end": 10948, "hit_start": 936, "hit_end": 1143, "orf_dna_sequence": "ATGGGAGACGTCCGTTTCCCCTACCGGCTGGGCACGGCGTGCGTCGACCAGATCGTCGACCGGCTGGCCGAGCTGGAGGCCAGCCGGTACCTGGTGGTCGCCGACCCCACCGTCGCCGGCCTCTACGGCACCGACCTGGTGGAGCGCGTCCGCCGCACGGCCGGCCCCGCCGAGCTGCTCGTGCACGAGGGCGGTGAGGAGAACAAGGGGCTGGGCACCCTCGCGGAGCTGGTCGAGACCGCGTTGCGGCTGGGCGCCGACCGCCGCAGCATCGTCGTCGCGCTCGGCGGCGGGATCACCGGCAACATCGCCGGCCTCATGGCCGCGCTGATGTTCCGCGGCATCCGGCTGGTGCACGTGCCCACGACGATCGTCGCGATGCTGGACTCGGTCCTGTCGCTCAAGCAGGCGGTCAACAGCTCGGTCGGCAAGAACCTGGTCGGCACGTTCTACCAGCCGGTGGAGGTGCTCGCCGACACCGCTTTCCTGCGGACGCTGAGCACCAGGGACATCCGGTCGGGCCTGTGCGAGGTGGTCAAGAACGCCCTCGCGATCCGGCCGAGCATGATCGACCGGCTGGCCGCGCACCTGCCGCTGGACCAGCGCTACGACGACGACGTGATGCGCTGGATCATCGACGAGAGCATCGCGGCCAAGGCGCAGGTCACCGAGGCCGACGTCCACGAGCGGAAACAGGGCCTGGTCCTGGAGTACGGGCACACCGTGGGGCACGCCCTCGAACACGCCGCCAAGGGCGAGGTCTCGCACGGCGCCGCCGTGGGGCTGGGCATGCTCGCCGAGGCCGAGATCGCCCGCCGGCTCGGGCTGGCCGGCGAGGACCTCATCGAGCTGCACCGGGACCTCATCTCCCGGATGGGGATCGACCTGGCGTTCCCGGCCCACGTCAGCCCGGCCGACGTCCAGCTCCGCCTGCGCTACGACAACAAGCGCGGCTACCTCAGCGGAGCCGGCGACGACGGGTACGTGATGGTGCTGCTCAAGGCGCCGGGCGTCCCGCTCCAGTCGGAGGGCCTGCCGCTCACCGTCGCCGACCGGGCGGTCGTGGACGCGGTGGTCTCCGAGTTCGCCCACCCCGCGTCGGCGGCGGCGATCGGCCGTCGCACGCGGCCCGAGGGATAG", "orf_prot_sequence": "MGDVRFPYRLGTACVDQIVDRLAELEASRYLVVADPTVAGLYGTDLVERVRRTAGPAELLVHEGGEENKGLGTLAELVETALRLGADRRSIVVALGGGITGNIAGLMAALMFRGIRLVHVPTTIVAMLDSVLSLKQAVNSSVGKNLVGTFYQPVEVLADTAFLRTLSTRDIRSGLCEVVKNALAIRPSMIDRLAAHLPLDQRYDDDVMRWIIDESIAAKAQVTEADVHERKQGLVLEYGHTVGHALEHAAKGEVSHGAAVGLGMLAEAEIARRLGLAGEDLIELHRDLISRMGIDLAFPAHVSPADVQLRLRYDNKRGYLSGAGDDGYVMVLLKAPGVPLQSEGLPLTVADRAVVDAVVSEFAHPASAAAIGRRTRPEG", "perc_identity": 31.43}, "gnl|BL_ORD_ID|412|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 10001, "orf_end": 11140, "orf_from": "BGC0000692.1|Apramycin_12 ", "model_name": "adeR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "480", "model_id": "456", "ARO_accession": "3000553", "ARO_name": "adeR", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.28143, "max_identities": 13, "bit_score": 25.409, "cvterm_id": "35507", "query": "PTTIVAMLDSVLSLKQAVNSSVGKNLVGTFYQPVEVLADT", "match": "P  +VA + +VL   Q  N +  KN     Y+ +E+  DT", "sequence_from_db": "PNEVVARVQAVLRRTQFANKATNKN---KLYKNIEIDTDT", "sequence_from_broadstreet": "MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA", "dna_sequence_from_broadstreet": "ATGTTTGATCATTCTTTTTCTTTTGATTGCCAAGATAAAGTTATTCTTGTGGTAGAAGATGACTACGATATTGGCGACATTATTGAAAATTATTTAAAACGTGAAGGCATGAGTGTTATTCGGGCCATGAATGGAAAGCAAGCGATTGAATTGCACGCTAGCCAACCCATCGATTTAATCTTACTTGATATTAAATTACCCGAATTAAACGGTTGGGAAGTATTAAATAAAATACGCCAAAAAGCTCAGACTCCCGTGATCATGTTGACGGCGCTAGATCAAGATATTGATAAAGTTATGGCATTACGCATAGGTGCAGATGACTTTGTGGTGAAGCCTTTTAACCCAAATGAAGTCGTCGCTAGAGTTCAGGCAGTCCTAAGACGTACTCAGTTTGCAAACAAAGCAACTAATAAAAATAAACTCTATAAAAATATTGAAATTGATACCGACACTCATAGCGTTTATATACACTCTGAGAATAAGAAGATCTTGCTTAATCTGACGCTGACTGAATATAAAATTATTTCATTCATGATTGATCAGCCTCATAAAGTTTTTACGCGCGGAGAGCTTATGAATCACTGCATGAATGATAGCGATGCACTAGAGCGAACCGTAGATAGCCATGTGAGTAAGCTGAGAAAAAAACTAGAAGAACAAGGCATATTTCAAATGTTAATTAATGTGCGTGGCGTGGGATATAGACTAGATAATCCCCTAGCTGTAAAAGATGATGCCTAA", "partial": "0", "query_start": 10361, "query_end": 10480, "hit_start": 345, "hit_end": 456, "orf_dna_sequence": "ATGGGAGACGTCCGTTTCCCCTACCGGCTGGGCACGGCGTGCGTCGACCAGATCGTCGACCGGCTGGCCGAGCTGGAGGCCAGCCGGTACCTGGTGGTCGCCGACCCCACCGTCGCCGGCCTCTACGGCACCGACCTGGTGGAGCGCGTCCGCCGCACGGCCGGCCCCGCCGAGCTGCTCGTGCACGAGGGCGGTGAGGAGAACAAGGGGCTGGGCACCCTCGCGGAGCTGGTCGAGACCGCGTTGCGGCTGGGCGCCGACCGCCGCAGCATCGTCGTCGCGCTCGGCGGCGGGATCACCGGCAACATCGCCGGCCTCATGGCCGCGCTGATGTTCCGCGGCATCCGGCTGGTGCACGTGCCCACGACGATCGTCGCGATGCTGGACTCGGTCCTGTCGCTCAAGCAGGCGGTCAACAGCTCGGTCGGCAAGAACCTGGTCGGCACGTTCTACCAGCCGGTGGAGGTGCTCGCCGACACCGCTTTCCTGCGGACGCTGAGCACCAGGGACATCCGGTCGGGCCTGTGCGAGGTGGTCAAGAACGCCCTCGCGATCCGGCCGAGCATGATCGACCGGCTGGCCGCGCACCTGCCGCTGGACCAGCGCTACGACGACGACGTGATGCGCTGGATCATCGACGAGAGCATCGCGGCCAAGGCGCAGGTCACCGAGGCCGACGTCCACGAGCGGAAACAGGGCCTGGTCCTGGAGTACGGGCACACCGTGGGGCACGCCCTCGAACACGCCGCCAAGGGCGAGGTCTCGCACGGCGCCGCCGTGGGGCTGGGCATGCTCGCCGAGGCCGAGATCGCCCGCCGGCTCGGGCTGGCCGGCGAGGACCTCATCGAGCTGCACCGGGACCTCATCTCCCGGATGGGGATCGACCTGGCGTTCCCGGCCCACGTCAGCCCGGCCGACGTCCAGCTCCGCCTGCGCTACGACAACAAGCGCGGCTACCTCAGCGGAGCCGGCGACGACGGGTACGTGATGGTGCTGCTCAAGGCGCCGGGCGTCCCGCTCCAGTCGGAGGGCCTGCCGCTCACCGTCGCCGACCGGGCGGTCGTGGACGCGGTGGTCTCCGAGTTCGCCCACCCCGCGTCGGCGGCGGCGATCGGCCGTCGCACGCGGCCCGAGGGATAG", "orf_prot_sequence": "MGDVRFPYRLGTACVDQIVDRLAELEASRYLVVADPTVAGLYGTDLVERVRRTAGPAELLVHEGGEENKGLGTLAELVETALRLGADRRSIVVALGGGITGNIAGLMAALMFRGIRLVHVPTTIVAMLDSVLSLKQAVNSSVGKNLVGTFYQPVEVLADTAFLRTLSTRDIRSGLCEVVKNALAIRPSMIDRLAAHLPLDQRYDDDVMRWIIDESIAAKAQVTEADVHERKQGLVLEYGHTVGHALEHAAKGEVSHGAAVGLGMLAEAEIARRLGLAGEDLIELHRDLISRMGIDLAFPAHVSPADVQLRLRYDNKRGYLSGAGDDGYVMVLLKAPGVPLQSEGLPLTVADRAVVDAVVSEFAHPASAAAIGRRTRPEG", "perc_identity": 32.5}}, "BGC0000692.1|Apramycin_14 # 12575 # 13507 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.735": {"gnl|BL_ORD_ID|4807|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 12575, "orf_end": 13507, "orf_from": "BGC0000692.1|Apramycin_14 ", "model_name": "Streptomyces rimosus otr(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "275", "model_id": "1273", "ARO_accession": "3002891", "ARO_name": "Streptomyces rimosus otr(A)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.04636, "max_identities": 57, "bit_score": 27.335, "cvterm_id": "36773", "query": "PDALDLKAACQVEPLAVALHAVANAGIGEGDKVAVLG-------AGGIGLLLMQAAALRGATVTTV--SEPVTERRERARELGARTVT---------SAAPGE-LAALVESRPELVP------DVVLEASGYPV---AVQEAIEVVR-----PGGRIGLVGYRVEETGVMAPHHATVKALSI", "match": "PD +  +   ++ P AVAL AVA+AG      +A LG       A  +G LL   A    A +T     E V   +E A EL A+T           SA  GE L  LV    EL+P      D  L A+ + V   A  EA+  +R      G R  +  +RV+ TG +  H   + AL +", "sequence_from_db": "PDGVLREIRDRLTPAAVALSAVADAGTPRARAIA-LGPDTDPDFAVRVGELL---ADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRV", "sequence_from_broadstreet": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV", "dna_sequence_from_broadstreet": "ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCCCCGCCGCGCAACTTCTTCGCGCCGCCCAGCCTGGAGACCGTGATCAGGCCGGAGCGCCCGGAGGAAGCGGGACGGCTGCACGCCGCGCTGCGCATGCTGGACGAGCAGGACCCCTCGATCGACCTGCGGCAGGACGAGGAGAACGCGGCCGGCGCGGTGGTCCGCCTCTACGGGGAGGTGCAGAAGGAGATCCTCGGCAGCACGCTCGCGGAGTCCTTCGGCGTACGGGTGCGCTTCGACCCGACCCGTACGGTCTGCATCGAAAAGCCCGTGGGGACCGGCGAGGCGCTGATCGAGCTGGACACGCGGACGCACAACTACTTCTGGGGCGCACCGTGGGTCTGCGCGTCGGACCGGCCGAGCCCGGCGCGGGCGATCACGTTCCGTTTGGCGGTGGAACTGGGCTCGCTCCCCCTGGCCTTCCACAAGGCCATCGAGGAGACGGTGCACACCACCCTGCGGCACGGTCTGTACGGCTGGCAGGTCACCGACTGCGCCGTCACCCTGACCCGTACCGGCGTTCGCAGTCCGGTCAGCGCGGCCGACGACTTCCGCAAGGCCAACGCGCGCTTGGTCCTGATGGACGCGCTCGGCAGGGCCGGTACGGAGGTGCACGAGCCGGTCAGCTCCTTCGAACTGGAGGTGCCCGCCGCCCGGCTCAGCCCGGTACTTGCGAAACTCGCGGAACTGGGCGCGACGCCCGGTGTGCCCACGGCCGAGGGGGACGTCTTCCGCCTGGAGGGCACGATGCCGACCAGCCTCGTGCACGACTTCAACCAGCGGGTTCCCGGACTGACCCAGGGCGAGGGCGTGTTCCTGGCCGAGCACCGGGGCTACCGGCCCGCCGTCGGACAGCCGCCCGTGCGGCCGCGGCCCGAGGGGCCCAACCCGCTCAACCGCGACGAGTACATCCTGCACGTGCTCAAGCGCGTGTGA", "partial": "0", "query_start": 12881, "query_end": 13327, "hit_start": 408, "hit_end": 942, "orf_dna_sequence": "GTGAAGATCGCCTACAACTCGCTGTGCGGCAGCGACCTGTCGCTGTACCGCGGGGTGTGGCACGGGTTCACCTACCCCGTCGTGCCGGGCCACGAGTGGAGCGGCACCGTCGTGGAGGTCAACGGGGCCGACGAGAGCCTGCGCGGCGCGAAGGTGACCGGCGACCTCACCGTCTCCTGCAGCCGGTGCGCCCCGTGCGAGCGCGGCACCCCGGTGCTCTGCGACAACCTCCAGGAGCTCGGGTTCAACCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCCGTGCACAACGTGTACCGGCTGCCGGACGCGCTGGACCTGAAGGCGGCCTGCCAGGTCGAGCCGCTCGCGGTGGCCCTGCACGCGGTCGCCAACGCGGGGATCGGGGAGGGCGACAAGGTCGCGGTGCTGGGCGCGGGCGGCATCGGGCTGCTGCTGATGCAGGCCGCCGCGCTGCGCGGCGCGACGGTCACGACCGTCTCCGAGCCGGTGACCGAGCGGAGGGAGCGGGCGCGGGAGCTCGGCGCGCGGACCGTGACCTCGGCGGCGCCGGGTGAGTTGGCGGCGCTGGTGGAGAGCCGCCCGGAGCTGGTGCCGGACGTCGTGCTGGAGGCGTCGGGCTACCCCGTCGCGGTCCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGGCTCGTCGGCTACCGGGTCGAGGAGACCGGCGTGATGGCCCCGCACCACGCCACCGTCAAGGCGCTGTCGATCAGGGGCTCGCTCGGCCCCGGCGGCCGGTTCGCCGAGGCGATCGAGGTGCTGGCCTCGGGCGCGATCAACACCGACGCGCTGCTGAGCCACGAGTTCGGCCTCGACGACTACGCGGACGCCCTGGACCTCGCGCTGCGGCGCACGAACGGCAACACGCGCTCGTACTTCAACCTCGGCTGA", "orf_prot_sequence": "MKIAYNSLCGSDLSLYRGVWHGFTYPVVPGHEWSGTVVEVNGADESLRGAKVTGDLTVSCSRCAPCERGTPVLCDNLQELGFNRDGACAEYMTIPVHNVYRLPDALDLKAACQVEPLAVALHAVANAGIGEGDKVAVLGAGGIGLLLMQAAALRGATVTTVSEPVTERRERARELGARTVTSAAPGELAALVESRPELVPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYRVEETGVMAPHHATVKALSIRGSLGPGGRFAEAIEVLASGAINTDALLSHEFGLDDYADALDLALRRTNGNTRSYFNLG", "perc_identity": 31.32}, "gnl|BL_ORD_ID|3576|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 12575, "orf_end": 13507, "orf_from": "BGC0000692.1|Apramycin_14 ", "model_name": "GOB-32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4645", "ARO_accession": "3005681", "ARO_name": "GOB-32", "ARO_category": {"41376": {"category_aro_accession": "3004212", "category_aro_cvterm_id": "41376", "category_aro_name": "GOB beta-lactamase", "category_aro_description": "The GOB family of beta-lactamases have been discovered in the Elizabethkingia meningoseptica and are classified as subclass B3 beta-lactamase. They confer resistance to cephalosporins, penicillins, and carbapenems.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.2649, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "35506", "query": "PVLCDNLQELGFN", "match": "P++ DN+Q+LGFN", "sequence_from_db": "PIIKDNIQKLGFN", "sequence_from_broadstreet": "MRNFATLFFLSVCLSLNLNAQIVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKDNIQKLGFNYKDIKILLLTQAHYDHTGALEDFKTETGAKFYADKADADVLRTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK", "dna_sequence_from_broadstreet": "ATGAGAAATTTTGCTACACTGTTTTTTCTGTCAGTTTGTTTGAGTTTGAATTTGAATGCTCAGATAGTAAAAGAACCTGAGAATATGCCTAAAGAATGGAATCAGGCTTATGAACCATTCAGAATTGCAGGTAACCTGTATTACGTAGGAACTTATGATTTGGCTTCTTACCTTATTGTGACGGACAAAGGCAATATTCTCATTAATACAGGAACGGCAGAATCGCTTCCAATAATAAAAGACAATATTCAAAAGCTGGGGTTTAATTATAAAGACATTAAGATCTTGCTGCTTACCCAGGCTCATTATGACCATACAGGTGCGTTAGAGGATTTTAAAACAGAAACCGGTGCAAAATTCTATGCAGATAAAGCAGATGCTGATGTCCTGAGAACAGGGGGTAAGTCCGATTATGAATTGGGAAAATATGGTGTGACATTTAAACCTATTACTCCGGATAGAACGTTAAAAGATCAGGATAAAATAACACTGGGAAATACAACCCTGACTTTGCTTCATCACCCGGGACATACAAAAGGTTCCTGCAGTTTTATTTTTGAAACAAAAGATGAGAAGAGAAAGTATAGAGTTCTGATAGCTAATATGCCCTCTATTATTGTTGATAAGAAATTTTCTGAAGTTACAGCATATCCGAATATTCAGTCCGATTATGCTTATACCTTTGGTGCAATGAAAAAGCTTGATTTTGACCTTTGGGTGGCATCGCATGCAAGTCAGTTCGATCTGCATGAAAAACGTAAAGAAGGAGATCCGTACAATCCACAATTGTTTATGGATAAGCAAAGCTATTTCCAAAACCTTAATGATTTGGAGAAAAGCTATCTCGACAAAATAAAAAAAGATTCACAAGATAAATAA", "partial": "0", "query_start": 12785, "query_end": 12823, "hit_start": 228, "hit_end": 267, "orf_dna_sequence": "GTGAAGATCGCCTACAACTCGCTGTGCGGCAGCGACCTGTCGCTGTACCGCGGGGTGTGGCACGGGTTCACCTACCCCGTCGTGCCGGGCCACGAGTGGAGCGGCACCGTCGTGGAGGTCAACGGGGCCGACGAGAGCCTGCGCGGCGCGAAGGTGACCGGCGACCTCACCGTCTCCTGCAGCCGGTGCGCCCCGTGCGAGCGCGGCACCCCGGTGCTCTGCGACAACCTCCAGGAGCTCGGGTTCAACCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCCGTGCACAACGTGTACCGGCTGCCGGACGCGCTGGACCTGAAGGCGGCCTGCCAGGTCGAGCCGCTCGCGGTGGCCCTGCACGCGGTCGCCAACGCGGGGATCGGGGAGGGCGACAAGGTCGCGGTGCTGGGCGCGGGCGGCATCGGGCTGCTGCTGATGCAGGCCGCCGCGCTGCGCGGCGCGACGGTCACGACCGTCTCCGAGCCGGTGACCGAGCGGAGGGAGCGGGCGCGGGAGCTCGGCGCGCGGACCGTGACCTCGGCGGCGCCGGGTGAGTTGGCGGCGCTGGTGGAGAGCCGCCCGGAGCTGGTGCCGGACGTCGTGCTGGAGGCGTCGGGCTACCCCGTCGCGGTCCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGGCTCGTCGGCTACCGGGTCGAGGAGACCGGCGTGATGGCCCCGCACCACGCCACCGTCAAGGCGCTGTCGATCAGGGGCTCGCTCGGCCCCGGCGGCCGGTTCGCCGAGGCGATCGAGGTGCTGGCCTCGGGCGCGATCAACACCGACGCGCTGCTGAGCCACGAGTTCGGCCTCGACGACTACGCGGACGCCCTGGACCTCGCGCTGCGGCGCACGAACGGCAACACGCGCTCGTACTTCAACCTCGGCTGA", "orf_prot_sequence": "MKIAYNSLCGSDLSLYRGVWHGFTYPVVPGHEWSGTVVEVNGADESLRGAKVTGDLTVSCSRCAPCERGTPVLCDNLQELGFNRDGACAEYMTIPVHNVYRLPDALDLKAACQVEPLAVALHAVANAGIGEGDKVAVLGAGGIGLLLMQAAALRGATVTTVSEPVTERRERARELGARTVTSAAPGELAALVESRPELVPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYRVEETGVMAPHHATVKALSIRGSLGPGGRFAEAIEVLASGAINTDALLSHEFGLDDYADALDLALRRTNGNTRSYFNLG", "perc_identity": 61.54}, "gnl|BL_ORD_ID|4834|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 12575, "orf_end": 13507, "orf_from": "BGC0000692.1|Apramycin_14 ", "model_name": "Nocardia farcinica rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5821", "ARO_accession": "3007210", "ARO_name": "Nocardia farcinica rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.47557, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "41346", "query": "VAVLGAGGIGLLLMQAAALRGA-TVTTVSEPVTERRERARELGARTV", "match": "V + G G  GL+L     L G  TV    EP   +  R+R L AR++", "sequence_from_db": "VIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSI", "sequence_from_broadstreet": "MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT", "dna_sequence_from_broadstreet": "GTGATCGATGTGATCATCGCGGGTGGCGGACCGACCGGCTTGATGCTGGCCGGCGAACTGCGCCTGCACGGTGTGCGCACGGTGGTACTGGAGAAGGAGCCCACCCCGAACCAGCACTCCCGCAGTCGGGGCCTGCACGCGCGCAGCATCGAGGTGATGGACCAGCGCGGGCTGCTGGAGCGGTTCCTCGCGCACGGCGAGCAGTTCCGGGTCGGCGGGTTCTTCGCCGGGCTGGCCGCCGAATGGCCCGCCGACCTGGACACCGCGCACTCCTACGTGCTCGCGATTCCCCAGGTCGTCACCGAGCGCCTGCTCACCGAGCACGCCACCGAACTCGGCGCCGAGATCCGCCGCGGCTGCGAAGTGGCCGGGTTGGATCAGGACGCGGACGGGGTGACCGCCGAGCTGGCCGACGGCACGCGGTTGCGCGCCCGGTACCTGGTCGGCTGCGACGGCGGACGCTCGACCGTGCGCCGTCTGCTCGGGGTCGACTTCCCCGGCGAACCCACCCGGGTCGAGACGTTGCTGGCCGACGTGCGGATCGACGTGCCGGTCGAGACACTGACCGCGGTGGTCGCCGAGGTGCGCAAGACCCAACTGCGATTCGGGGCCGTCCCGGCCGGCGACGGGTTCTTCCGGCTGATCGTGCCCGCGCAGGGCCTGTCCGCGGACCGCGCCGCACCCACCCTCGACGAGCTGAAGCGATGCCTGCACGCGACGGCGGGCACCGATTTCGGCGTGCACTCCCCGCGCTGGCTGTCCCGCTTCGGCGACGCCACCCGGCTCGCCGAGCGCTACCGCACCGGGCGGGTGCTGCTGGCGGGCGACGCCGCCCACATCCATCCGCCGACCGGCGGCCAGGGCCTCAATCTGGGCATCCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGCGATCGGCGGCTGGGCGCCGCCGGACCTGCTGGACAGCTACCACGACGAACGCCATCCGGTCGCCGCCGAGGTGCTGGACAACACCCGCGCCCAGATGACGCTGCTCTCCCTCGACCCCGGCCCGCGCGCGGTGCGCAGACTGATGGCGGAGCTGGTCGAATTCCCCGACGTGAACCGGCACCTGATCGAGAAGATCACCGCGATCGCCGTCCGCTACGACCTCGGCGACGGCCACGACCTGGTCGGTCGACGGCTGCGCGACATCCCGCTCACCGAAGGCCGCCTCTACGAGCGGATGCGCGGCGGCCGCGGGCTGCTGCTCGACCGGACCGGGCGGCTGTCGGTATCGGGCTGGTCCGACCGCGTCGACCACCTCGCCGACCCGGGCGCGGCGCTCGACGTCCCGGCGGCGCTGCTGCGCCCGGACGGGCACGTCGCGTGGGTGGGCGAGGACCAGGACGATCTGCTCGCCCACCTGCCCCGCTGGTTCGGCGCCGCCACCTGA", "partial": "0", "query_start": 12977, "query_end": 13114, "hit_start": 9, "hit_end": 150, "orf_dna_sequence": "GTGAAGATCGCCTACAACTCGCTGTGCGGCAGCGACCTGTCGCTGTACCGCGGGGTGTGGCACGGGTTCACCTACCCCGTCGTGCCGGGCCACGAGTGGAGCGGCACCGTCGTGGAGGTCAACGGGGCCGACGAGAGCCTGCGCGGCGCGAAGGTGACCGGCGACCTCACCGTCTCCTGCAGCCGGTGCGCCCCGTGCGAGCGCGGCACCCCGGTGCTCTGCGACAACCTCCAGGAGCTCGGGTTCAACCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCCGTGCACAACGTGTACCGGCTGCCGGACGCGCTGGACCTGAAGGCGGCCTGCCAGGTCGAGCCGCTCGCGGTGGCCCTGCACGCGGTCGCCAACGCGGGGATCGGGGAGGGCGACAAGGTCGCGGTGCTGGGCGCGGGCGGCATCGGGCTGCTGCTGATGCAGGCCGCCGCGCTGCGCGGCGCGACGGTCACGACCGTCTCCGAGCCGGTGACCGAGCGGAGGGAGCGGGCGCGGGAGCTCGGCGCGCGGACCGTGACCTCGGCGGCGCCGGGTGAGTTGGCGGCGCTGGTGGAGAGCCGCCCGGAGCTGGTGCCGGACGTCGTGCTGGAGGCGTCGGGCTACCCCGTCGCGGTCCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGGCTCGTCGGCTACCGGGTCGAGGAGACCGGCGTGATGGCCCCGCACCACGCCACCGTCAAGGCGCTGTCGATCAGGGGCTCGCTCGGCCCCGGCGGCCGGTTCGCCGAGGCGATCGAGGTGCTGGCCTCGGGCGCGATCAACACCGACGCGCTGCTGAGCCACGAGTTCGGCCTCGACGACTACGCGGACGCCCTGGACCTCGCGCTGCGGCGCACGAACGGCAACACGCGCTCGTACTTCAACCTCGGCTGA", "orf_prot_sequence": "MKIAYNSLCGSDLSLYRGVWHGFTYPVVPGHEWSGTVVEVNGADESLRGAKVTGDLTVSCSRCAPCERGTPVLCDNLQELGFNRDGACAEYMTIPVHNVYRLPDALDLKAACQVEPLAVALHAVANAGIGEGDKVAVLGAGGIGLLLMQAAALRGATVTTVSEPVTERRERARELGARTVTSAAPGELAALVESRPELVPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYRVEETGVMAPHHATVKALSIRGSLGPGGRFAEAIEVLASGAINTDALLSHEFGLDDYADALDLALRRTNGNTRSYFNLG", "perc_identity": 36.17}}, "BGC0000692.1|Apramycin_15 # 13696 # 14460 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731": {"gnl|BL_ORD_ID|2214|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 13696, "orf_end": 14460, "orf_from": "BGC0000692.1|Apramycin_15 ", "model_name": "aphA15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3374", "ARO_accession": "3004675", "ARO_name": "aphA15", "ARO_category": {"36265": {"category_aro_accession": "3000126", "category_aro_cvterm_id": "36265", "category_aro_name": "APH(3')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 3'-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin and neomycin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35958": {"category_aro_accession": "0000040", "category_aro_cvterm_id": "35958", "category_aro_name": "streptomycin", "category_aro_description": "Streptomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Streptomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.54454, "max_identities": 19, "bit_score": 25.7942, "cvterm_id": "36752", "query": "SDDDCGFDPELHL-----------------DMDHA--GALETSVYGALF", "match": "S DDC FD  LHL                 D DHA  G L   VY  LF", "sequence_from_db": "SPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLF", "sequence_from_broadstreet": "MTVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEILQEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARALRDLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPGAEQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFFIEYGEPNPNIAKIEYYRILDEFF", "dna_sequence_from_broadstreet": "ATGACAGTCGCCCTCGACGAAGTATCTGAACTAAAGAATTTGCTTTCACCCTTGTTGGATGAATGCACTTTTGAAGAAGTTGAGTATGGTCAGTCAGATGCTCGAGTGATTCGAGTTCTATTTCCTGATCGCAATACCGCGTATCTAAAGTACGCCTCCGGATCTTCTGCTCAAGAAATTCTTCAAGAGCATCAGCGCACTAGATGGCTCAGAACACGAGCTCTCGTACCGGAAGTGATCTCATATGTCTCGACTTCAACTGTCACCATCCTGTTGACAAAAGCATTGATTGGCCACAATGCCGCTGACGCCGCAGATGCAGATCCAGTTATTGTTGTTGCAGAGATGGCACGAGCGTTACGCGACCTCCATTCGATCTCGCCTGACGATTGCCCATTCGACGAAAGGCTCCACCTGCGACTGAAGCTGGCTTCGGGCCGTTTGGAAGCCGGGTTAGTTGATGAGGAGGACTTTGATCACGCAAGGCAAGGCATGCTGGCGCGGGATGTTTACGAGCAACTTTTTATACAAATGCCTGGAGCGGAGCAGCTGGTAGTCACACATGGCGACGCCTGTCCCGAGAACTTCATCTTCCAAGGTAATGCCTTCGTCGGCTTCATAGACTGCGGTCGGGTCGGGCTTGCCGATAAGTATCAAGACCTGGCGCTTGCATCGAGAAACATTGACGCGGTATTTGGACCAGAACTCACTAACCAGTTCTTCATCGAGTATGGAGAGCCAAATCCGAACATAGCTAAGATTGAGTACTACCGGATCTTGGATGAGTTCTTCTAA", "partial": "0", "query_start": 14116, "query_end": 14205, "hit_start": 378, "hit_end": 525, "orf_dna_sequence": "GTGCGGTACGACCGGCTGCTGCCCAGGGAGTTCGAGGCCCGGCTCGCGGCGGCTCCCGTCGCCTACGTGCCGGTCGGCTCCCTGGAGTGGCACAGCGCCCACATGCCCTACGGCGTCGACACCGACAAGGCGACCGCGATCTGCGAGCGCGCGGCGCGCCGGCACGGCGGCATCGTGCTGCCGGGCAGCCCCTGGGGCTTCATGCAGGGCAACTGGCGCGGCGCGACCCACCCCGGCCTGCGGGTCGAGACGATCTTCCAGCTCTACACCGACATCCTGCGCGGTCTGTCCACTGTGGGCTTCCGCGCGGCGGTGGTGGTGTCCGGGCACTGGACCACCAAGCAGACGATCCCCATCGCCTGCGCCCTGGAGCGGGTCAGGAACGAGACCGGGCTGCGCGGCATGGTCACCTTCGACGGCTCGGACGACGACTGCGGGTTCGACCCCGAGCTGCACCTGGACATGGACCACGCCGGCGCGTTGGAGACCTCCGTGTACGGGGCGTTGTTCCCGGAGAACGTGCACCTGGAGCGGCTGGACGAGCTGGATCTCTCCGACCTGCCCGGCAGGGAGTGCCACCTGACCCGCTCCGGCATCCAGGGCAGGGACCCGAGGGAGCACGCCGACTTCGAGCGCGGCCGCTGGCACGTCGACCAGGTTGTGGACCTGCTCGGCGCCGAGGCGCGACGCCTGCTCGCCGAGGCCGAGGCTGCGCCGGCCGAGGCGGTGCCAGGGGCCGAGTCGGCGCCCCCGGCCGGCGGTTGA", "orf_prot_sequence": "MRYDRLLPREFEARLAAAPVAYVPVGSLEWHSAHMPYGVDTDKATAICERAARRHGGIVLPGSPWGFMQGNWRGATHPGLRVETIFQLYTDILRGLSTVGFRAAVVVSGHWTTKQTIPIACALERVRNETGLRGMVTFDGSDDDCGFDPELHLDMDHAGALETSVYGALFPENVHLERLDELDLSDLPGRECHLTRSGIQGRDPREHADFERGRWHVDQVVDLLGAEARRLLAEAEAAPAEAVPGAESAPPAGG", "perc_identity": 38.78}, "gnl|BL_ORD_ID|671|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 13696, "orf_end": 14460, "orf_from": "BGC0000692.1|Apramycin_15 ", "model_name": "ErmS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "727", "ARO_accession": "3001304", "ARO_name": "ErmS", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37627": {"category_aro_accession": "3001228", "category_aro_cvterm_id": "37627", "category_aro_name": "carbomycin", "category_aro_description": "Produced by Streptomyces halstedii and Streptomyces thermotolerans.", "category_aro_class_name": "Antibiotic"}, "37629": {"category_aro_accession": "3001230", "category_aro_cvterm_id": "37629", "category_aro_name": "niddamycin", "category_aro_description": "Produced by Streptomyces caelestis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.00539, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "36838", "query": "LAAAPVAYVPVGSLEWHSAHMPYGVDTDKA", "match": "+A AP +  P  S E   AH PYG   D+A", "sequence_from_db": "MARAPRSPHPARSRETSRAHPPYGTRADRA", "sequence_from_broadstreet": "MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR", "dna_sequence_from_broadstreet": "GTGGCCCGTGCACCCCGATCGCCCCACCCTGCCCGCTCGCGGGAGACCTCCCGCGCCCACCCGCCGTACGGCACCCGTGCGGATCGCGCCCCCGGCCGTGGCCGTGACCGTGACCGCAGCCCCGACAGCCCCGGCAACACCAGCAGCCGCGACGGCGGCCGCAGCCCCGACCGCGCGCGGCGCGAGCTCTCGCAGAACTTCCTCGCCCGCCGGGCCGTCGCCGAGCGCGTCGCGCGCCTGGTCCGGCCGGCCCCCGGCGGTCTGTTGCTGGAGGTCGGCGCCGGGCGCGGCGTCCTGACCGAGGCGCTGGCCCCGTACTGCGGGCGGCTGGTCGCCCACGAGATCGACCCCCGTCTGCTGCCGGCGCTGCGCGACCGGTTCGGCGGCCCGCACCATGCCCATGTGCGGATCAGCGGCGGCGACTTCCTGGCAGCCCCCGTCCCCCGTGAGCCGTTCGCCCTCGCGGGGAACATCCCCTACTCCCGGACCGCGGGAATCGTGGACTGGGCGCTGCGGGCGCGCACGCTCACCTCGGCGACCTTCGTCACCCAGCTCGAGTACGCCCGCAAGCGGACCGGCGACTATGGACGCTGGAGCCTGCTGACGGTGCGGACCTGGCCCCGCCACGAGTGGCGGCTGCTCGGCAGGGTCTCCCGCCGGGAGTTCCGGCCGGTGCCCCGCGTGGACTCGGGCATCCTCCGGATCGAGCGGCGCGAGCGGCCCCTGCTGCCGTCCGCCGCCCTCGGCGACTACCACCGCATGGTGGAGCTGGGTTTCTCCGGCGTGGGCGGATCGCTGTACGCATCGCTGCGCCGGGCCCACCGGGCGGGGCCGCTCGACGCCGCGTTCCGTGCCGCGCGGCTGGACCGCTCCGTCGTCGTCGCGTATGTCACACCGGAGCAGTGGCTCACGGTCTTCCGCACGTTGCGGCCCGTCCGCAGCCGACCGGCCGGACGGTGA", "partial": "0", "query_start": 13738, "query_end": 13827, "hit_start": 0, "hit_end": 90, "orf_dna_sequence": "GTGCGGTACGACCGGCTGCTGCCCAGGGAGTTCGAGGCCCGGCTCGCGGCGGCTCCCGTCGCCTACGTGCCGGTCGGCTCCCTGGAGTGGCACAGCGCCCACATGCCCTACGGCGTCGACACCGACAAGGCGACCGCGATCTGCGAGCGCGCGGCGCGCCGGCACGGCGGCATCGTGCTGCCGGGCAGCCCCTGGGGCTTCATGCAGGGCAACTGGCGCGGCGCGACCCACCCCGGCCTGCGGGTCGAGACGATCTTCCAGCTCTACACCGACATCCTGCGCGGTCTGTCCACTGTGGGCTTCCGCGCGGCGGTGGTGGTGTCCGGGCACTGGACCACCAAGCAGACGATCCCCATCGCCTGCGCCCTGGAGCGGGTCAGGAACGAGACCGGGCTGCGCGGCATGGTCACCTTCGACGGCTCGGACGACGACTGCGGGTTCGACCCCGAGCTGCACCTGGACATGGACCACGCCGGCGCGTTGGAGACCTCCGTGTACGGGGCGTTGTTCCCGGAGAACGTGCACCTGGAGCGGCTGGACGAGCTGGATCTCTCCGACCTGCCCGGCAGGGAGTGCCACCTGACCCGCTCCGGCATCCAGGGCAGGGACCCGAGGGAGCACGCCGACTTCGAGCGCGGCCGCTGGCACGTCGACCAGGTTGTGGACCTGCTCGGCGCCGAGGCGCGACGCCTGCTCGCCGAGGCCGAGGCTGCGCCGGCCGAGGCGGTGCCAGGGGCCGAGTCGGCGCCCCCGGCCGGCGGTTGA", "orf_prot_sequence": "MRYDRLLPREFEARLAAAPVAYVPVGSLEWHSAHMPYGVDTDKATAICERAARRHGGIVLPGSPWGFMQGNWRGATHPGLRVETIFQLYTDILRGLSTVGFRAAVVVSGHWTTKQTIPIACALERVRNETGLRGMVTFDGSDDDCGFDPELHLDMDHAGALETSVYGALFPENVHLERLDELDLSDLPGRECHLTRSGIQGRDPREHADFERGRWHVDQVVDLLGAEARRLLAEAEAAPAEAVPGAESAPPAGG", "perc_identity": 43.33}}, "BGC0000692.1|Apramycin_16 # 14511 # 15470 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700": {"gnl|BL_ORD_ID|3872|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-616", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4942", "ARO_accession": "3005837", "ARO_name": "OXA-616", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.21925, "max_identities": 8, "bit_score": 26.9498, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++  ++  F+    L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYVKTGFNDSINLAWIVGFVKTKNKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFIMFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYVKTGFNDSINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATAATGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGTGGGACTTTTATAGTTTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAAAAAGCTTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGTTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAAATCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGTTAAAACAGGTTTTAATGATAGTATAAATTTAGCTTGGATTGTTGGATTTGTAAAGACTAAAAATAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAG", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|2302|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-446", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "3515", "ARO_accession": "3003602", "ARO_name": "OXA-446", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.6513, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNIDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNIDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTCTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATATTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3893|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-637", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4963", "ARO_accession": "3005858", "ARO_name": "OXA-637", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.94984, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "37052", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAACCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTCTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAACTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3871|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-615", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4941", "ARO_accession": "3005836", "ARO_name": "OXA-615", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.98923, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTCTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTCCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3870|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-614", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4940", "ARO_accession": "3005835", "ARO_name": "OXA-614", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.98923, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "37052", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAACCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTCTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTCCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3891|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-635", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4961", "ARO_accession": "3005856", "ARO_name": "OXA-635", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.00277, "max_identities": 10, "bit_score": 26.5646, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-LRHAMR-DVEHV", "match": "++++  +++++   +  F+ +  L W++G V+  ++ L  A+  D++HV", "sequence_from_db": "LLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHV", "sequence_from_broadstreet": "MKKIILFLWILNFAFGQDKILEDFFKDYNTSGIFIIFDGKNYASNDFQRAKQTFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLSSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHVKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAAAAAAATCATCTTGTTTTTATGGATTTTAAATTTTGCCTTTGGACAAGATAAAATATTAGAAGATTTTTTTAAAGATTATAATACAAGTGGGATTTTTATAATCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCAAAACAAACCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGTCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTAGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTGGATAATTCTTTGCAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAACTTCTTCTTTTTAAAGAAAATAAAATACAAAAAATTTATGCCAAAACAGGTTTTAATGATAATATAAATTTAGCTTGGATTGTTGGATTCGTAAAGACTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGCACGTTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 690, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 20.41}, "gnl|BL_ORD_ID|3894|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-638", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4964", "ARO_accession": "3005859", "ARO_name": "OXA-638", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.02958, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "37052", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3892|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-636", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4962", "ARO_accession": "3005857", "ARO_name": "OXA-636", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.16729, "max_identities": 10, "bit_score": 26.5646, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-LRHAMR-DVEHV", "match": "++++  +++++   +  F+ +  L W++G V+  ++ L  A+  D++HV", "sequence_from_db": "LLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHV", "sequence_from_broadstreet": "MKKIILFLWILNFAFGQDKILEDFFKDYNTSGIFIIFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHVKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAAAAAAATCATCTTGTTTTTATGGATTTTAAATTTTGCCTTTGGACAAGATAAAATATTAGAAGATTTTTTTAAAGATTATAATACAAGTGGGATTTTTATAATCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTAGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTGGATAATTCTTTGCAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAACTTCTTCTTTTTAAAGAAAATAAAATACAAAAAATTTATGCCAAAACAGGTTTTAATGATAATATAAATTTAGCTTGGATTGTTGGATTCGTAAAGACTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGCACGTTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 690, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 20.41}, "gnl|BL_ORD_ID|3876|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-620", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4946", "ARO_accession": "3005841", "ARO_name": "OXA-620", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.18088, "max_identities": 8, "bit_score": 26.5646, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTCCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3869|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-613", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4939", "ARO_accession": "3005834", "ARO_name": "OXA-613", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.22959, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFFQQ", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAACCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTCTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTTCCAACAATAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3875|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-619", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4945", "ARO_accession": "3005840", "ARO_name": "OXA-619", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.23786, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAATTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTCCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|2325|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-447", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "3516", "ARO_accession": "3003603", "ARO_name": "OXA-447", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.23786, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFFNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGTAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTCGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAATTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTTCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3908|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-658", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4978", "ARO_accession": "3005873", "ARO_name": "OXA-658", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.2526, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "37052", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKFSQNSLPFSKKIQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIRENY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACTTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAATTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAATTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAAATTATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3895|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-639", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4965", "ARO_accession": "3005860", "ARO_name": "OXA-639", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.46174, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGVFITFDGKHYASNDFKRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGCAATACAAGTGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3874|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-618", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4944", "ARO_accession": "3005839", "ARO_name": "OXA-618", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.5384, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFMVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQVDLLFKLSQNSLPFSKKIQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFFNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGCGGGACTTTTATGGTTTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAAAAAGCTTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGTTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGTTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAATTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTTCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3896|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-640", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4966", "ARO_accession": "3005861", "ARO_name": "OXA-640", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.99073, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGVFITFDGKHYASNDFKRAKQAFSPASTFKIFNALIALDNDVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTGCAATACAAGTGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGATGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAGGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCCAAAAAAAGTCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTGCTAGAAAAATATCTAGCAATCATAACAAATTAA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3880|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-624", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4950", "ARO_accession": "3005845", "ARO_name": "OXA-624", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.15128, "max_identities": 8, "bit_score": 26.1794, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKIKNKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKCSQVPAFKELARNIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKKIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKIKNKILSFALNVDIKDIKNIKIREELLNKYLANFFNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAAAAAGCTTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGACACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAATGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAACATAGGACTTAAAACTATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAAATCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGATTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTTCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3878|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-622", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4948", "ARO_accession": "3005843", "ARO_name": "OXA-622", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.3396, "max_identities": 8, "bit_score": 25.7942, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKIKNKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKCSQVPAFKELARNIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKIKNKILSFALNVDIKDIKNIKIREELLNKYLANFFNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAAATTTTATTGTATTTATATTGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTAAAAGAGCTAAAAAAGCTTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGACACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAATGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAACATAGGACTTAAAACTATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAAATCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGATTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTTCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3877|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-621", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4947", "ARO_accession": "3005842", "ARO_name": "OXA-621", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.4173, "max_identities": 8, "bit_score": 25.7942, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDR-----LRHAMRDVEHV", "match": "++++  D++++   +  F+ +  L W++G V+  ++     L   ++D++++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNI", "sequence_from_broadstreet": "MRDFIVFIWFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPVFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY", "dna_sequence_from_broadstreet": "ATGAGAGATTTTATTGTATTTATATGGTTTTTGAATATAGCCATTGGAGAGGATAAAATACTTGGTAATTTTTTTAAAGATTATAATACAAGTGGGACTTTTATAGTCTTTGATGGAAAAAATTATGCAAGTAATGATTTTCAAAGAGCTAAACAAGCCTTTTCTCCTGCTTCAACTTTTAAAATTTTTAATGCTTTAATTGCACTTGATAATGGTGTAGTTAGAGATACAAAGGAAATTTTTTATCATTATAAGGGCGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCTATAAAACGCTCTCAAGTACCTGTTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCTTATGGAAATGCAAAAATTTCAAAAATCGATACTTTTTGGCTAGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTACTTTTTAAACTTTCGCAAAATTCTTTACCTTTTTCTAAAAAAAATCAAGAAGAAGTTAAAGAAATTATTCTTTTTAAGGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATCAATTTAGCTTGGATTGTTGGATTTGTAAAGACTGAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGGGAAGAATTATTAAATAAGTATTTAGCTAATTTTTCCAACAATAATAGGATTAAAAGCTTTTACTGA", "partial": "0", "query_start": 14586, "query_end": 14726, "hit_start": 543, "hit_end": 699, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 15.38}, "gnl|BL_ORD_ID|3889|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "OXA-633", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4959", "ARO_accession": "3005854", "ARO_name": "OXA-633", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.51194, "max_identities": 6, "bit_score": 25.7942, "cvterm_id": "36772", "query": "VVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRL", "match": "++++  D++++   +  F+ +  L W++G V+  +++", "sequence_from_db": "IILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTKNKI", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGATCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATAAATTTAGCTTGGATTGTTGGATTCGTAAAGACTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 14586, "query_end": 14696, "hit_start": 543, "hit_end": 654, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 16.22}, "gnl|BL_ORD_ID|1100|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "ErmH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1193", "ARO_accession": "3002823", "ARO_name": "ErmH", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37627": {"category_aro_accession": "3001228", "category_aro_cvterm_id": "37627", "category_aro_name": "carbomycin", "category_aro_description": "Produced by Streptomyces halstedii and Streptomyces thermotolerans.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.05433, "max_identities": 19, "bit_score": 25.409, "cvterm_id": "36843", "query": "ITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGD", "match": "+  G G++ R   R       C  VV Y  D      LREA   D R+E V GD", "sequence_from_db": "VGAGNGAITRELARL------CRRVVAYEIDRHFADRLREATAEDPRIEVVAGD", "sequence_from_broadstreet": "MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR", "dna_sequence_from_broadstreet": "ATGGCTGCGCTCCTGAAGCGCATACTTAGGAGACGCATGGCTGAAAAGAGGTCAGGACGCGGGCGCATGGCCGCAGCGCGTACAACCGGAGCTCAGTCGCGTAAAACGGCACAGCGGTCGGGCCGGAGTGAGGCTGACCGTAGAAGAAGAGTCCACGGGCAGAATTTCCTCGTCGACCGGGAAACAGTACAACGGTTTGTGCGTTTCGCCGATCCGGACCCCGGGGAGGTCGTTCTCGAGGTCGGTGCCGGTAATGGTGCGATCACGCGCGAGCTGGCGCGATTATGCCGACGAGTGGTGGCGTATGAGATCGACCGGCACTTCGCGGACCGATTACGTGAGGCGACCGCCGAGGATCCGCGGATCGAGGTCGTCGCCGGCGACTTCCTGAAGACCTCGCAGCCCAAGGTCCCGTTCTCCGTGGTCGGCAACATCCCGTTCGGCAACACCGCGGACATAGTGGACTGGTGCCTGAACGCGCGGCGGCTGCGTACGACCACCCTGGTCACCCAGCTCGAATACGCCCGCAAGCGCACCGGCGGCTATCGGCGCTGGTCACGGCTCACCGTGGCCACCTGGCCCGAGGTGGAGTGGCGGATGGGCGAGCGGATCAGCCGCCGCTGGTTCCGGCCCGTCCCCGCCGTCGACTCCGCGGTACTGCGACTGGAACGGCGACCGGTGCCGCTGATCCCACCCGGTCTGATGCACGACTTCCGGGACCTGGTGGAGACCGGGTTCACGGGAAAGGGCGGTTCGCTGGACGCCTCGCTGCGCCGGCGCTTCCCGGCCCGGCGGGTGGCCGCCGGGTTCCGCAGGGCCCGCCTGGAGCAGGGCGTGGTCGTCGCCTACGTCACCCCGGGCCAATGGATCACACTCTTCGAGGAACTCCACGGGCGCTGA", "partial": "0", "query_start": 14514, "query_end": 14675, "hit_start": 240, "hit_end": 384, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 35.19}, "gnl|BL_ORD_ID|1427|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 14511, "orf_end": 15470, "orf_from": "BGC0000692.1|Apramycin_16 ", "model_name": "norA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1554", "ARO_accession": "3000391", "ARO_name": "norA", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.90936, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "36868", "query": "LCADKLFVAASEYAGRRGTRFGVVRYGNVLG--SRGSVIP", "match": "+C   +F A SE+    G  F ++    VLG  S G V+P", "sequence_from_db": "ICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMP", "sequence_from_broadstreet": "MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN", "dna_sequence_from_broadstreet": "ATGAAAAAACAATTATTCATTCTTTATTTTAATATATTTCTTATATTTTTAGGGATTGGATTAGTTATTCCTGTACTTCCTGTATATTTGAAGGATTTAGGATTAAAAGGTAGTGACTTAGGAATGCTAGTTGCTGCTTTTGCATTATCACAAATGATTATTTCACCATTTGGTGGGACACTAGCTGATAAATTGGGTAAAAAATTAATTATATGTATCGGTTTAGTATTCTTTGCTGTCTCTGAATTTATGTTCGCAGCCGGTCAAAGTTTTACCATTTTAATCATTTCACGTGTTTTAGGTGGCTTTAGTGCAGGCATGGTCATGCCTGGTGTAACAGGTATGATTGCAGATATTTCTCCAGGAGCTGATAAAGCTAAAAACTTTGGTTACATGTCGGCAATTATTAATTCAGGTTTTATATTAGGACCTGGATTTGGAGGCTTTTTAGCTGAAATTTCACATAGATTACCTTTCTATGTTGCTGGAACATTAGGTGTTGTTGCATTCATTATGTCAGTTTTATTAATTCATAATCCTCAAAAAGCAACTACAGATGGATTCCACCAATATCAACCTGAATTATTCACTAAAATTAATTGGAAAGTATTTATTACTCCAGTCATATTAACACTTGTATTAGCATTTGGTTTATCTGCTTTTGAAACATTATTTTCTTTATATACAGCTGACAAAGTAAATTATACTCCTAAAGATATTTCGATAGCTATTATCGGTGGAGGCGTGTTTGGCGCATTATTCCAAGTATTCTTCTTTGATAAATTTATGAAATATATGAGTGAACTTAATTTTATTGCATGGTCATTACTATATTCAGCCATTGTTCTCGTTATGTTAGTGCTTGCAAACGGTTATTGGACGATTATGATTATTAGCTTTGTTGTTTTTATAGGTTTTGATATGATTAGACCAGCTTTAACCAATTACTTCTCGAATATAGCAGGCAAACGGCAAGGTTTTGCAGGTGGATTGAATTCAACTTTTACCAGTATGGGTAACTTTATAGGTCCTCTTGTAGCTGGTGCATTATTCGATGTTAATTTAGAGTTTCCTTTATATATGGCTATTGCGGTTTCATTAAGTGGAATTATCATTATTTTTATTGAAAAAGGACTTAAGTCACGCCGTAAAGAAGCAAATTAA", "partial": "0", "query_start": 14910, "query_end": 15023, "hit_start": 210, "hit_end": 330, "orf_dna_sequence": "ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA", "orf_prot_sequence": "MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA", "perc_identity": 35.0}}, "BGC0000692.1|Apramycin_17 # 15731 # 16714 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.782": {"gnl|BL_ORD_ID|2117|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 15731, "orf_end": 16714, "orf_from": "BGC0000692.1|Apramycin_17 ", "model_name": "AAC(6')-Il", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "275", "model_id": "3334", "ARO_accession": "3004635", "ARO_name": "AAC(6')-Il", "ARO_category": {"36484": {"category_aro_accession": "3000345", "category_aro_cvterm_id": "36484", "category_aro_name": "AAC(6')", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 6'-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 6-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46128": {"category_aro_accession": "3007378", "category_aro_cvterm_id": "46128", "category_aro_name": "2'-N-ethylnetilmicin", "category_aro_description": "2'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46129": {"category_aro_accession": "3007379", "category_aro_cvterm_id": "46129", "category_aro_name": "5-episisomicin", "category_aro_description": "5-episosomicin is a semisynthetic aminoglycoside antibiotic similar to sisomicin.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.08407, "max_identities": 21, "bit_score": 25.409, "cvterm_id": "36770", "query": "RGWSVVLGCRRVGDVGPVLARA-----RGRGAPVSAVALDVTDPGSVAAAVAA", "match": " GW VV   RR G VG  L +A     RGRG    A    +T+  S +A +AA", "sequence_from_db": "EGWYVVPSARRQG-VGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAA", "sequence_from_broadstreet": "MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDGEALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL", "dna_sequence_from_broadstreet": "ATGGATAGTTCGCCGCTCGTCAGGCCTGTTGAAACTACCGATTCGGCCAGTTGGCTAAGCATGCGCTGTGAGCTGTGGCCAGATGGCACATGTCAAGAGCACCAGTCAGAGATCGCAGAATTTCTGTCCGGAAAAGTCGCCCGGCCTGCTGCTGTCCTCATTGCTGTAGCACCCGACGGAGAAGCACTAGGGTTTGCCGAGCTTTCGATCCGCCCGTATGCGGAGGAGTGCTACTCCGGCAACGTTGCGTTCTTGGAGGGTTGGTACGTTGTGCCAAGTGCGCGGCGTCAGGGCGTAGGTGTAGCTCTGGTAAAAGCCGCCGAGCATTGGGCTCGTGGTCGCGGATGCACCGAATTCGCCTCCGACACTCAACTTACCAACAGCGCAAGCACCTCGGCGCACCTGGCGGCTGGATTCACGGAGGTTGCTCAAGTACGCTGCTTCCGGAAACCGTTGTGA", "partial": "0", "query_start": 16052, "query_end": 16195, "hit_start": 255, "hit_end": 411, "orf_dna_sequence": "ATGCGGGCGCGCGTCGTTGTCCGCCGCGCGGAACCGCCGCGCCGCGGCGGCGCGTGCGGAAGAACCGCCCCGCGGGCGGGTGATCGGGATGGTGACCAGGTGCGGGAACGTGGTGAGAGCCGGCGGGGCGACCCCGACCGGTGGACCGGTCGCGGCGGCGGCCGGCGAGTGGGAACGGCGTGGCGGACCGGGGTGGCCCGGGTCCTCGCGCGCGCCGTCGACGTGGGCGGGTTCCGGGTGACGGCGGCGGGTCCCAGGCGCGTGCTGGTCACCGGCGCCAGCCGGGGCCTGGGTCTGCGTGCAGCGGAGGCGTTGGCCGACCGGGGGTGGTCGGTCGTCCTGGGCTGCCGCCGGGTCGGCGACGTCGGGCCGGTGCTCGCGAGAGCGCGTGGTCGGGGCGCGCCGGTGTCCGCCGTCGCGCTGGACGTGACGGACCCGGGCAGCGTCGCCGCCGCCGTCGCGGCGGTGGCCGAGCTCGGCGGGCCGCTGCACGCCCTGGTCAACAACGCCGGGGTGTTCCGGCACGAGGAGGAGGAGTTCCAGGACCTCCGGCCTGGGGACGCGCTCGACCTGCTGCTGACCAACGCCTGCGGCCCGCTGCTGGTGACCAGGGCGTTCCTGCCGCTGCTGCGCGCCGCCGGCGGCGCGGCCGTGGTGAACGTGACCAGCCGGGACGCCGACGAGGACACCTTCGACGGCCTGTTCACCGGCTACCGGATGGCCAAGGCCGCCCTGAACGCGATGACCAGGAACCTGGCCATCGCGCTGCGACCCGACCGGATCGTGGTCAACGCCGTCGACCCGGGGTGGATCCCCACCGACATGGGCGGACCGGAGGCACCGGACAGCCTGGACGCCGCGGTGGCGGCGGTGGCCGGCGCCGTCGAGCTGGCTGGCGGCGACCGGACCGGCCGCCTCCTGCGCGCCCAGCGCCCGCCCGGGTCCCCGGGGCGCCGCCGGGCTGACGGGGCGACGCGGCGCTGA", "orf_prot_sequence": "MRARVVVRRAEPPRRGGACGRTAPRAGDRDGDQVRERGESRRGDPDRWTGRGGGRRVGTAWRTGVARVLARAVDVGGFRVTAAGPRRVLVTGASRGLGLRAAEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNACGPLLVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVAAVAGAVELAGGDRTGRLLRAQRPPGSPGRRRADGATRR", "perc_identity": 39.62}, "gnl|BL_ORD_ID|3091|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 15731, "orf_end": 16714, "orf_from": "BGC0000692.1|Apramycin_17 ", "model_name": "AAK-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "4122", "ARO_accession": "3006863", "ARO_name": "AAK-1", "ARO_category": {"43847": {"category_aro_accession": "3005387", "category_aro_cvterm_id": "43847", "category_aro_name": "AAK beta-lactamase", "category_aro_description": "AAK beta-lactamases are a group of class A beta-lactamases found in Klebsiella pneumoniae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.1782, "max_identities": 24, "bit_score": 25.409, "cvterm_id": "35915", "query": "DVGPVLARARGRGAPV---SAVALDVTDPGSVAAAVAAVAELGGP------LHALVNNAGVFRHEEEEFQDLRPGDALD", "match": "D  PV  +    G PV    A A+ ++D    +AA   +A +GGP      L  + +N       E E     PGDA D", "sequence_from_db": "DYSPVSEKHLADGMPVGELCAAAITISD---TSAANLLLATVGGPAGFTAFLRQIGDNVTRLHRWETELHAALPGDARD", "sequence_from_broadstreet": "MRYIRLCIISLFATLPLAVHASPQPLQQITLRESQLSGRVGTIEMDLASGRTLTAWRADQRFPIMRTFTVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMPVGELCAAAITISDTSAANLLLATVGGPAGFTAFLRQIGDNVTRLHRWETELHAALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLLRSVLPAGWFIADKTGAGERGARGIVALLGPNHKAERIVVIYLRDTPASMAERNQQIAGIGAALLEHWQQ", "dna_sequence_from_broadstreet": "ATGCGTTATATTCGCCTGTGTATTATCTCCCTGTTCGCCACCCTGCCGCTGGCGGTACACGCCAGCCCGCAGCCGCTTCAGCAAATTACACTACGCGAAAGCCAGCTGTCGGGCCGCGTCGGCACGATCGAAATGGATCTGGCCAGCGGCCGCACGCTCACCGCCTGGCGCGCCGATCAACGCTTTCCCATCATGCGCACCTTTACAGTCGTGCTCTGCGGCGCAGTGCTGGCGCGGGTGGATGCCGGTGACGAACAGCTGGAGCGAAAGATCCACTATCGCCAGCAGGATCTGGTGGACTACTCGCCGGTCAGCGAAAAACACCTTGCCGACGGCATGCCGGTCGGCGAACTCTGCGCCGCCGCCATTACCATCAGCGATACCAGCGCCGCCAATCTGCTGCTGGCCACCGTCGGCGGCCCCGCAGGATTCACTGCCTTTTTGCGCCAGATCGGCGACAACGTCACCCGCCTTCACCGCTGGGAAACGGAACTGCATGCGGCGCTTCCCGGCGACGCCCGCGACACCACTACCCCGGCCAGCATGGCCGCGACCCTGCGCAAGCTGCTCACCAGCCAGCGTCTCAGCGCCCGTTCGCAACGGCAGCTGCTGCAGTGGATGGTGGACGATCGGGTCGCCGGACCGTTGCTCCGCTCCGTGCTGCCGGCGGGCTGGTTTATCGCCGACAAGACCGGAGCTGGCGAGCGGGGTGCGCGCGGCATTGTCGCCCTGCTTGGCCCGAATCACAAAGCAGAGCGCATTGTGGTCATTTATCTGCGGGATACGCCGGCGAGCATGGCCGAGCGAAATCAGCAAATCGCCGGGATCGGCGCGGCGCTGCTCGAGCACTGGCAACAATGA", "partial": "0", "query_start": 16091, "query_end": 16300, "hit_start": 297, "hit_end": 525, "orf_dna_sequence": "ATGCGGGCGCGCGTCGTTGTCCGCCGCGCGGAACCGCCGCGCCGCGGCGGCGCGTGCGGAAGAACCGCCCCGCGGGCGGGTGATCGGGATGGTGACCAGGTGCGGGAACGTGGTGAGAGCCGGCGGGGCGACCCCGACCGGTGGACCGGTCGCGGCGGCGGCCGGCGAGTGGGAACGGCGTGGCGGACCGGGGTGGCCCGGGTCCTCGCGCGCGCCGTCGACGTGGGCGGGTTCCGGGTGACGGCGGCGGGTCCCAGGCGCGTGCTGGTCACCGGCGCCAGCCGGGGCCTGGGTCTGCGTGCAGCGGAGGCGTTGGCCGACCGGGGGTGGTCGGTCGTCCTGGGCTGCCGCCGGGTCGGCGACGTCGGGCCGGTGCTCGCGAGAGCGCGTGGTCGGGGCGCGCCGGTGTCCGCCGTCGCGCTGGACGTGACGGACCCGGGCAGCGTCGCCGCCGCCGTCGCGGCGGTGGCCGAGCTCGGCGGGCCGCTGCACGCCCTGGTCAACAACGCCGGGGTGTTCCGGCACGAGGAGGAGGAGTTCCAGGACCTCCGGCCTGGGGACGCGCTCGACCTGCTGCTGACCAACGCCTGCGGCCCGCTGCTGGTGACCAGGGCGTTCCTGCCGCTGCTGCGCGCCGCCGGCGGCGCGGCCGTGGTGAACGTGACCAGCCGGGACGCCGACGAGGACACCTTCGACGGCCTGTTCACCGGCTACCGGATGGCCAAGGCCGCCCTGAACGCGATGACCAGGAACCTGGCCATCGCGCTGCGACCCGACCGGATCGTGGTCAACGCCGTCGACCCGGGGTGGATCCCCACCGACATGGGCGGACCGGAGGCACCGGACAGCCTGGACGCCGCGGTGGCGGCGGTGGCCGGCGCCGTCGAGCTGGCTGGCGGCGACCGGACCGGCCGCCTCCTGCGCGCCCAGCGCCCGCCCGGGTCCCCGGGGCGCCGCCGGGCTGACGGGGCGACGCGGCGCTGA", "orf_prot_sequence": "MRARVVVRRAEPPRRGGACGRTAPRAGDRDGDQVRERGESRRGDPDRWTGRGGGRRVGTAWRTGVARVLARAVDVGGFRVTAAGPRRVLVTGASRGLGLRAAEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNACGPLLVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVAAVAGAVELAGGDRTGRLLRAQRPPGSPGRRRADGATRR", "perc_identity": 30.38}, "gnl|BL_ORD_ID|969|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 15731, "orf_end": 16714, "orf_from": "BGC0000692.1|Apramycin_17 ", "model_name": "APH(9)-Ib", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "1059", "ARO_accession": "3002663", "ARO_name": "APH(9)-Ib", "ARO_category": {"36292": {"category_aro_accession": "3000153", "category_aro_cvterm_id": "36292", "category_aro_name": "APH(9)", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 9-hydroxyl group of the respective antibiotic. These enzymes are characterized by enzymatic antibiotic inactivation, specifically of spectinomycin, by the ATP-dependent phosphorylation of the 9-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35957": {"category_aro_accession": "0000039", "category_aro_cvterm_id": "35957", "category_aro_name": "spectinomycin", "category_aro_description": "Spectinomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Spectinomycin works by binding to the bacterial 30S ribosomal subunit inhibiting translation.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.00582, "max_identities": 10, "bit_score": 25.0238, "cvterm_id": "39531", "query": "RVGDVGPVLARARGRGAPV", "match": "R+ + G ++AR RGRGAP+", "sequence_from_db": "RMAEFGELVARVRGRGAPL", "sequence_from_broadstreet": "MEDLPENLDQESLFQGLREFGISTTSASYAPLGFGDYHWHITGDDGQRWFATVSDLEHKEHCGHGAPAALRGLRRAMDTAVHLREQGGLPFVVAPRTTSDGASLVPLDSRYALTVFPHVSARPGEFGQKLTERERDQVLVLLAELHGQAPPKCTPTTDMVPTGLDGVHTALAEPSGTWTGGPFSEPARELLAEHEATLRGRMAEFGELVARVRGRGAPLVVTHGEPHPGNLILGEDGYVLVDWDTVGLAIPERDLSLISDDPAALARYTELTGHTPDPAALALYRLRWSLLDVAEFVEWFRGEHQRTSDTEAAWQSFAETLDHLNSEVPS", "dna_sequence_from_broadstreet": "ATGGAAGATCTTCCTGAGAACCTGGACCAGGAAAGCCTATTTCAGGGACTACGAGAATTCGGTATCTCCACGACCAGTGCGTCGTACGCGCCGCTCGGCTTCGGCGACTATCACTGGCACATCACCGGTGACGACGGGCAGCGGTGGTTCGCCACCGTCTCCGACCTCGAACACAAGGAGCACTGCGGGCACGGTGCCCCGGCGGCACTGCGAGGTCTGCGGAGAGCCATGGACACCGCGGTGCACTTGCGTGAGCAGGGCGGCCTGCCGTTCGTGGTGGCACCCCGGACCACGAGTGACGGCGCTTCACTGGTCCCGCTGGACTCGCGGTACGCGTTGACCGTATTTCCCCATGTCTCGGCCCGACCCGGGGAGTTCGGCCAGAAGCTGACGGAGCGGGAGCGGGACCAGGTGCTGGTGCTGCTCGCAGAATTGCACGGCCAGGCACCGCCGAAGTGCACCCCGACCACCGACATGGTGCCGACCGGACTGGATGGCGTGCACACCGCGCTGGCCGAGCCGTCCGGAACCTGGACGGGCGGGCCGTTCTCCGAGCCGGCCCGCGAGTTGCTGGCCGAGCACGAGGCGACGCTCCGCGGGCGGATGGCGGAGTTCGGCGAACTGGTGGCGCGGGTACGGGGCCGCGGCGCCCCGCTGGTCGTCACACACGGCGAGCCGCACCCGGGGAACCTGATCCTTGGTGAGGACGGCTATGTGCTGGTGGACTGGGACACGGTGGGCCTCGCGATACCCGAACGGGACCTCTCCCTGATCTCGGACGACCCGGCAGCTCTCGCCCGCTACACCGAACTGACCGGGCACACGCCCGACCCGGCCGCGCTGGCGCTCTACCGGCTGCGGTGGAGCCTGCTGGACGTCGCCGAGTTCGTCGAGTGGTTCCGCGGGGAACACCAGCGCACCTCCGACACCGAAGCCGCTTGGCAGAGCTTCGCCGAGACTCTCGACCATCTGAACTCCGAAGTACCGAGCTGA", "partial": "0", "query_start": 16082, "query_end": 16138, "hit_start": 600, "hit_end": 657, "orf_dna_sequence": "ATGCGGGCGCGCGTCGTTGTCCGCCGCGCGGAACCGCCGCGCCGCGGCGGCGCGTGCGGAAGAACCGCCCCGCGGGCGGGTGATCGGGATGGTGACCAGGTGCGGGAACGTGGTGAGAGCCGGCGGGGCGACCCCGACCGGTGGACCGGTCGCGGCGGCGGCCGGCGAGTGGGAACGGCGTGGCGGACCGGGGTGGCCCGGGTCCTCGCGCGCGCCGTCGACGTGGGCGGGTTCCGGGTGACGGCGGCGGGTCCCAGGCGCGTGCTGGTCACCGGCGCCAGCCGGGGCCTGGGTCTGCGTGCAGCGGAGGCGTTGGCCGACCGGGGGTGGTCGGTCGTCCTGGGCTGCCGCCGGGTCGGCGACGTCGGGCCGGTGCTCGCGAGAGCGCGTGGTCGGGGCGCGCCGGTGTCCGCCGTCGCGCTGGACGTGACGGACCCGGGCAGCGTCGCCGCCGCCGTCGCGGCGGTGGCCGAGCTCGGCGGGCCGCTGCACGCCCTGGTCAACAACGCCGGGGTGTTCCGGCACGAGGAGGAGGAGTTCCAGGACCTCCGGCCTGGGGACGCGCTCGACCTGCTGCTGACCAACGCCTGCGGCCCGCTGCTGGTGACCAGGGCGTTCCTGCCGCTGCTGCGCGCCGCCGGCGGCGCGGCCGTGGTGAACGTGACCAGCCGGGACGCCGACGAGGACACCTTCGACGGCCTGTTCACCGGCTACCGGATGGCCAAGGCCGCCCTGAACGCGATGACCAGGAACCTGGCCATCGCGCTGCGACCCGACCGGATCGTGGTCAACGCCGTCGACCCGGGGTGGATCCCCACCGACATGGGCGGACCGGAGGCACCGGACAGCCTGGACGCCGCGGTGGCGGCGGTGGCCGGCGCCGTCGAGCTGGCTGGCGGCGACCGGACCGGCCGCCTCCTGCGCGCCCAGCGCCCGCCCGGGTCCCCGGGGCGCCGCCGGGCTGACGGGGCGACGCGGCGCTGA", "orf_prot_sequence": "MRARVVVRRAEPPRRGGACGRTAPRAGDRDGDQVRERGESRRGDPDRWTGRGGGRRVGTAWRTGVARVLARAVDVGGFRVTAAGPRRVLVTGASRGLGLRAAEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNACGPLLVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVAAVAGAVELAGGDRTGRLLRAQRPPGSPGRRRADGATRR", "perc_identity": 52.63}, "gnl|BL_ORD_ID|4712|hsp_num:0": {"type_match": "Loose", "snp": {"original": "M", "change": "T", "position": 159}, "query_snp": {"original": "M", "change": "T", "position": 139}, "orf_strand": "-", "orf_start": 15731, "orf_end": 16714, "orf_from": "BGC0000692.1|Apramycin_17 ", "model_name": "Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 450, "model_id": "2666", "ARO_accession": "3004045", "ARO_name": "Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan", "ARO_category": {"41434": {"category_aro_accession": "3004270", "category_aro_cvterm_id": "41434", "category_aro_name": "antibiotic resistant fabI", "category_aro_description": "fabI is a enoyl-acyl carrier reductase used in lipid metabolism and fatty acid biosynthesis. The bacterial biocide Triclosan blocks the final reduction step in fatty acid elongation, inhibiting biosynthesis. Point mutations in fabI can confer resistance to Triclosan and Isoniazid.", "category_aro_class_name": "AMR Gene Family"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.26966, "bit_score": 27.7202, "max_identities": 47, "cvterm_id": "36849", "query": "RRVLVTGASRGLGLRA--AEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNA-------CGPLLVTRAFLPLLRAA-----GGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPT", "match": "+R+LVTG +  L +    A+A+   G  +    +     G V   A   G+ +  +  DV +  S+    A + ++       V++ G             PGD LD    NA           + + +F+ + +A       G+A++ ++   A+    +    G  +AKA+L A  R +A A+ P+ + VNA+  G I T", "sequence_from_db": "KRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDI-VLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIG-----------FAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMG--LAKASLEANVRYMANAMGPEGVRVNAISAGPIRT", "sequence_from_broadstreet": "MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK", "dna_sequence_from_broadstreet": "ATGGGTTTTCTTTCCGGTAAGCGCATTCTGGTAACCGGTGTTGCCAGCAAACTATCCATCGCCTACGGTATCGCTCAGGCGATGCACCGCGAAGGAGCTGAACTGGCATTCACCTACCAGAACGACAAACTGAAAGGCCGCGTAGAAGAATTTGCCGCTCAATTGGGTTCTGACATCGTTCTGCAGTGCGATGTTGCAGAAGATGCCAGCATCGACACCATGTTCGCTGAACTGGGGAAAGTTTGGCCGAAATTTGACGGTTTCGTACACTCTATTGGTTTTGCACCTGGCGATCAGCTGGATGGTGACTATGTTAACGCCGTTACCCGTGAAGGCTTCAAAATTGCCCACGACATCAGCTCCTACAGCTTCGTTGCAATGGCAAAAGCTTGCCGCTCCATGCTGAATCCGGGTTCTGCCCTGCTGACCCTTTCCTACCTTGGCGCTGAGCGCGCTATCCCGAACTACAACGTTATGGGTCTGGCAAAAGCGTCTCTGGAAGCGAACGTGCGCTATATGGCGAACGCGATGGGTCCGGAAGGTGTGCGTGTTAACGCCATCTCTGCTGGTCCGATCCGTACTCTGGCGGCCTCCGGTATCAAAGACTTCCGCAAAATGCTGGCTCATTGCGAAGCCGTTACCCCGATTCGCCGTACCGTTACTATTGAAGATGTGGGTAACTCTGCGGCATTCCTGTGCTCCGATCTCTCTGCCGGTATCTCCGGTGAAGTGGTCCACGTTGACGGCGGTTTCAGCATTGCTGCAATGAACGAACTCGAACTGAAATAA", "partial": "0", "query_start": 15986, "query_end": 16549, "hit_start": 18, "hit_end": 582, "orf_dna_sequence": "ATGCGGGCGCGCGTCGTTGTCCGCCGCGCGGAACCGCCGCGCCGCGGCGGCGCGTGCGGAAGAACCGCCCCGCGGGCGGGTGATCGGGATGGTGACCAGGTGCGGGAACGTGGTGAGAGCCGGCGGGGCGACCCCGACCGGTGGACCGGTCGCGGCGGCGGCCGGCGAGTGGGAACGGCGTGGCGGACCGGGGTGGCCCGGGTCCTCGCGCGCGCCGTCGACGTGGGCGGGTTCCGGGTGACGGCGGCGGGTCCCAGGCGCGTGCTGGTCACCGGCGCCAGCCGGGGCCTGGGTCTGCGTGCAGCGGAGGCGTTGGCCGACCGGGGGTGGTCGGTCGTCCTGGGCTGCCGCCGGGTCGGCGACGTCGGGCCGGTGCTCGCGAGAGCGCGTGGTCGGGGCGCGCCGGTGTCCGCCGTCGCGCTGGACGTGACGGACCCGGGCAGCGTCGCCGCCGCCGTCGCGGCGGTGGCCGAGCTCGGCGGGCCGCTGCACGCCCTGGTCAACAACGCCGGGGTGTTCCGGCACGAGGAGGAGGAGTTCCAGGACCTCCGGCCTGGGGACGCGCTCGACCTGCTGCTGACCAACGCCTGCGGCCCGCTGCTGGTGACCAGGGCGTTCCTGCCGCTGCTGCGCGCCGCCGGCGGCGCGGCCGTGGTGAACGTGACCAGCCGGGACGCCGACGAGGACACCTTCGACGGCCTGTTCACCGGCTACCGGATGGCCAAGGCCGCCCTGAACGCGATGACCAGGAACCTGGCCATCGCGCTGCGACCCGACCGGATCGTGGTCAACGCCGTCGACCCGGGGTGGATCCCCACCGACATGGGCGGACCGGAGGCACCGGACAGCCTGGACGCCGCGGTGGCGGCGGTGGCCGGCGCCGTCGAGCTGGCTGGCGGCGACCGGACCGGCCGCCTCCTGCGCGCCCAGCGCCCGCCCGGGTCCCCGGGGCGCCGCCGGGCTGACGGGGCGACGCGGCGCTGA", "orf_prot_sequence": "MRARVVVRRAEPPRRGGACGRTAPRAGDRDGDQVRERGESRRGDPDRWTGRGGGRRVGTAWRTGVARVLARAVDVGGFRVTAAGPRRVLVTGASRGLGLRAAEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNACGPLLVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVAAVAGAVELAGGDRTGRLLRAQRPPGSPGRRRADGATRR", "perc_identity": 23.27}}, "BGC0000692.1|Apramycin_19 # 17684 # 19195 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.720": {"gnl|BL_ORD_ID|4833|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 17684, "orf_end": 19195, "orf_from": "BGC0000692.1|Apramycin_19 ", "model_name": "Streptomyces venezuelae rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5820", "ARO_accession": "3007209", "ARO_name": "Streptomyces venezuelae rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.640256, "max_identities": 15, "bit_score": 29.6462, "cvterm_id": "36873", "query": "VFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQ", "match": "+FDV VVG G +G + A  L   G+ VLV+E+", "sequence_from_db": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEK", "sequence_from_broadstreet": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG", "dna_sequence_from_broadstreet": "ATGTTTGACGTGATCGTTGTCGGTGGCGGTCCGACCGGCTTGATGCTGGCCGGCGAACTGCGGCTGCACGGCGTGCGCGTACTCGTGCTGGAGAAGGAGACGGAGCCGACGCGGCAGTCCCGCGCGCAGGGGCTGCACGTCCGCAGCATCGAGGTGATGGCCCAGCGCGGGCTCCTGGAGCGCTTCCTCGAACGCGGGCACACGGTCGCGGTCGGCGGCTTCTTCGCCGGTCTGGCGACCTCGTGGCCCGAGCGGCTGGACACCGCGCACTCGTACGTCCTCGCCGTCCCGCAGGTGATCACCGAGCAGCTGCTGGCCGAGCACGCCACCGCACTCGGAGCCGAGATCCGACGCGGCCGGGCACTGGTCGGTCTCCGCCAGGACGAGGACGGCGTGACGGTCGACCTGGCCGACGGCGAACAGCTGCGCGCACGGTACGTCGTCGGCTGCGACGGCGGCCGCAGCACGGTGCGCAAGCTGCTCGGCGTGGCGTTCCCCGGCGAGCCGTCCAGGGTCGAGACCCTGCTCGGCGAGATGGAGATGACCGCCTCCCAGGAGGAGTTGACCTCCGTCATGACCGAGGTCCGCAAGACCCAGCAGCGATTCGGCGCGATGCCCCTGGGGGACGGGGTCTTCCGCGTCGTCGTCCCCGCCGAGGGCGTCGCCGAGGACCGGACGGCCTCCCCGACCCTCGACGAGTTCAAGCAGCAGCTGCGGGCCCACGCCGGGACGGACTTCGGCGTGCACTCGCCCCGGTGGCTCTCCCGCTTCGGCGACGCCACCCGACAGGCCGAGCGCTACCGGGTCGACCGGGTGTTCCTCGCTGGCGACGCGGCGCACATCCACCCGCCGACCGGCGGGCAGGGCCTCAACCTCGGCATCCAGGACGCGTTCAACCTCGGCTGGAAGCTGGCCGCCGAGGTCGACGGCTGGGCGCCGGAGGGACTCCTCGACACGTACCACGCCGAGCGGCACCCGGTGGCCACCGAGGTCCTGGACAACACCCGCGCGCAGATCCAGCTGATGTCGACGGAGCCGGGGCCGCAGGCGGTCCGCCGGCTCATGGCGGAACTCGTGGAGTTCGAGAACGTCAACCGGTACCTGATCGAGAAGATCACGGCGATCTCGGTCCGTTACGACGTCGGCGAGGGCCACGAGCTGCTCGGCCGCCGGATGCGGGACCTCGCGCTCAAGCACGGCCGGCTCTACGAGCGGATGCACGAGGGCCGTGGACTGCTGCTCGACCAGACCGGCCGGCTCTCGGTCGCCGGGTGGGAGGACCGGGTCGACCACGTCGTCGAGGTCAGCGAGGAACTGGACGTGCCCGCGGTGCTGCTGCGTCCCGACGGCCACGTCGTGTGGGCGGGCGAGGACCAGCAGGAGCTGCTCACCCGGATGCCCGCGTGGTTCGGCGCCGCCACGGCCGGCTGA", "partial": "0", "query_start": 17720, "query_end": 17815, "hit_start": 0, "hit_end": 96, "orf_dna_sequence": "GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA", "orf_prot_sequence": "MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS", "perc_identity": 46.88}, "gnl|BL_ORD_ID|1640|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 17684, "orf_end": 19195, "orf_from": "BGC0000692.1|Apramycin_19 ", "model_name": "mexY", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1800", "model_id": "1786", "ARO_accession": "3003033", "ARO_name": "mexY", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36998": {"category_aro_accession": "3000654", "category_aro_cvterm_id": "36998", "category_aro_name": "arbekacin", "category_aro_description": "A synthetic derivative (1-N-(4-amino-2-hydroxybutyryl) of dibekacin used in Japan. It is active against methicillin-resistant Staph. aureus and shows synergy with ampicillin when treating gentamicin and vancomycin resistant enterocci.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37007": {"category_aro_accession": "3000663", "category_aro_cvterm_id": "37007", "category_aro_name": "ofloxacin", "category_aro_description": "Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.91204, "max_identities": 18, "bit_score": 29.261, "cvterm_id": "36804", "query": "GRVRHVSTKYELGSAHLHGTLRSGR-DPRSSVTDPLGRL", "match": "GR+   + + E+G+A   G +R GR DPR + TDPL RL", "sequence_from_db": "GRLHVRNEQGEMGAA---GDVRQGRLDPRPAATDPLQRL", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA", "dna_sequence_from_broadstreet": "ATGGCTCGTTTCTTCATTGACCGGCCGGTCTTCGCCTGGGTGATCTCCCTGCTGATCGTGCTCGCCGGGGTCCTGGCGATCCGCTTCCTGCCGGTCGCCCAGTACCCGGACATCGCGCCGCCGGTGGTCAACGTCAGCGCCACGTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCGGTGACCGCGATCATCGAGCGCGAGATGAACGGCGCGCCCGGCCTGCTCTACACCAAGGCCACCAGCAGCACCGGCCAGGCCTCGCTGACCCTGACCTTCCGCCAGGGCGTGAACGCGAACCTCGCCGCGGTGGAAGTGCAGAACCGCCTGAAGATCGTCGAGTCGCGCCTGCCCGAATCGGTGCGGCGCGACGGCATCTACGTGGAGAAGGCGGCGGACAGCATCCAGCTGATCGTTACCCTTACCTCCTCCAGCGGCCGCTACGACGCCATGGAGCTGGGCGAGATCGCCTCGTCCAACGTGTTGCAGGCGCTGCGCCGGGTGGAGGGCGTGGGCAAGGTCGAGACCTGGGGCGCCGAGTACGCCATGCGCATCTGGCCCGACCCGGCCAAGCTGACCTCGATGAACCTCAGCGCCAGCGACCTGGTCAACGCCGTGCGCCGGCACAACGCCCGCCTCACCGTGGGCGACATCGGCAACCTCGGGGTCCCCGACTCGGCGCCGATCAGCGCCACGGTGAAGGTCGACGACACCCTGGTGACGCCCGAGCAGTTCGGCGAAATTCCGCTGGCGCATCCGCGCGACGGCGGCGCGATCCGCCTGCGCGACGTGGCCCGCGTCGAGTTCGGCCAGAGCGAGTACGGCTTCGTCTCGCGGGTCAACCAAATGACCGCCACCGGCCTGGCGGTGAAGATGGCGCCCGGCTCCAACGCGGTGGCCACCGCCAAGCGCATCCGCGCCACCCTCGACGAGCTGTCGCGCTACTTCCCGGAGGGCGTGAGCTACAACATCCCCTATGACACCTCGGCGTTCGTCGAGATCTCGATCAGGAAGGTGGTCAGCACCCTGCTCGAGGCGATGCTGCTGGTGTTCGCCGTGATGTACCTGTTCATGCAGAACTTCCGCGCCACCCTGATCCCGACACTGGTGGTGCCGGTGGCCCTGCTGGGCACCTTCACGGTGATGCTCGGCCTGGGCTTCTCGATCAACGTGCTGACCATGTTCGGCATGGTCCTGGCGATCGGCATCCTGGTGGACGACGCGATCATCGTGGTGGAGAACGTCGAGCGGCTGATGGCCGAGGAAGGCCTGTCGCCGCACGACGCCACGGTCAAGGCGATGCGCCAGATCAGCGGGGCCATCGTCGGCATCACCGTAGTGCTGGTCTCGGTGTTCGTGCCGATGGCGTTCTTCAGCGGCGCGGTGGGCAACATCTACCGCCAGTTCGCGGTGACCCTGGCGGTCTCCATCGGCTTCTCGGCGTTCCTCGCGCTGTCGCTGACCCCGGCCCTGTGCGCCACCCTGCTGCGCCCGATCGACGCCGACCACCACGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCCTGCGCCTGACCGGACGCTACCGCAACGCGGTGGCCGGCATCCTCGCCCGGCCGATCCGCTGGATGCTGGTCTACACCCTGGTCATCGGCGTGGTCGCCCTGCTCTTCGTGCGCCTGCCGCAGGCGTTCCTGCCGGAAGAGGACCAGGGCGACTTCATGATCATGGTGATGCAGCCCGAAGGCACGCCGATGGCGGAGACCATGGCCAACGTCGGCGACGTCGAGCGCTACCTGGCGGAGCACGAACCGGTGGCCTACGCCTATGCGGTCGGCGGCTTCAGCCTGTACGGCGACGGCACCAGCTCGGCGATGATCTTCGCCACCCTGAAGGACTGGTCGGAACGCCGGGAGGCCAGCCAGCACGTCGGCGCCATCGTCGAGCGCATCAACCAGCGCTTCGCCGGCCTGCCCAACCGTACGGTGTATGCGATGAACTCGCCGCCGCTGCCGGACCTGGGTTCCACCAGCGGCTTCGACTTCCGCCTGCAGGACCGTGGCGGGGTTGGCTACGAGGCCCTGGTCAAGGCCCGCGACCAGTTGCTGGCGCGCGCCGCCGAGGACCCGCGCCTGGCCAACGTGATGTTCGCCGGCCAGGGCGAGGCGCCGCAGATCCGCCTGGACATCGACCGGCGCAAGGCGGAGACCCTTGGCGTGAGCATGGACGAGATCAACACCACCCTGGCGGTGATGTTCGGCTCGGACTACATCGGCGACTTCATGCACGGCAGCCAGGTGCGCAAGGTGGTGGTCCAGGCCGACCGGCGCAAGCGCCTGGGCATCGACGACATCGGCCGGCTTCACGTGCGCAACGAGCAGGGCGAGATGGGTGCCGCTGGCGACGTTCGCCAAGGCCGCCTGGACCCTCGGCCCGCCGCAACTGACCCGCTACAACGGCTATCCCTCGTTCAACCTCGAGGGCCAGGCCGCGCCGGGCTACAGCAGCGCGAAGCCATGCAGGCGATGGAGCAATTGATGCAGGGAACTGCCCGAGGCATTCGCCCACGAGTGGTCCGGCCAGTCCTTCGAAGAACGCCTGTTGCCGGCGCCCAGGCGCCGGCGCTGTTCGCCCTCTCGGTGTTGATCGTGTTCCTCGCCCTGGCCGCCCTCTACGAAAGCTGGTCGATCCCGCTGGCGGTGATCCTGGTGGTGCCGCTGGGCGTACTCGGCGCACTGCTCGGGGTGAGCCTGCGCGGTCTGCCCAACGACATCTACTTCAAGGTCGGCCTGATCACCATCATCGGCCTCTCGGCGAAGAACGCCATCCTCATCATCGAGGTGGCCAAGGACCATTACCAGGAAGGCATGAGCCTGCTGCAGGCGACCCTGGAGGCCGCGCGCCTGCGCCTGCGACCGATCGTCATGACCTCGCTGGCGTTCGGTTTCGGCGTGGTCCCGCTGGCGCTCTCCAGCGGCGCCGGTATCCGCGCCCAGGTCGCCATCGGCACCGGGGTGCTCGGCGGGATCGTCACCGCCACGGTACTCGCGGTGTTCCTGGTACCGCTGTTCTTCCTGGTGGTCGGGCGCCTGTTCCGGTTGCGCAAGGCGCCGCGCACCGGCAACTCGCCCCAGATCCCCACGGAGCAAGCCTGA", "partial": "0", "query_start": 18965, "query_end": 19078, "hit_start": 2340, "hit_end": 2448, "orf_dna_sequence": "GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA", "orf_prot_sequence": "MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS", "perc_identity": 46.15}, "gnl|BL_ORD_ID|2051|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 17684, "orf_end": 19195, "orf_from": "BGC0000692.1|Apramycin_19 ", "model_name": "salA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2265", "ARO_accession": "3003749", "ARO_name": "salA", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.22992, "max_identities": 11, "bit_score": 26.9498, "cvterm_id": "36794", "query": "GLTRQDLDPYYDW-IEDQLAVAGPSGATV", "match": " +  QDL PYYDW + D +  + P  A +", "sequence_from_db": "AMMEQDLTPYYDWTVMDYIIESYPEIAKI", "sequence_from_broadstreet": "MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAAGCATTAGAAGTTGAACATAAAGTATTAATACCCGAGTTGACTTTTTCAATAGAGGACCATGAACATTTAGCAATCGTTGGTGTTAATGGTGTTGGAAAATCAACATTATTAAAAGTCATTCATCAAGATCAATCAGTTGATTCAGCGATGATGGAACAAGATTTAACACCTTATTATGATTGGACTGTTATGGATTATATAATTGAATCATATCCTGAAATCGCAAAGATTAGATTGCAACTTAATCATACAGATATGATTAATAAATATATTGAATTAGATGGATACATTATAGAAGGTGAAATCGTAACAGAAGCAAAAAAGCTCGGAATAAAAGAGGAACAACTAGAACAGAAAATTTCTACTTTAAGTGGTGGAGAACAAACAAAAGTATCATTTTTAAAAGTGAAAATGTCTAAAGCATCATTACTATTAATCGATGAACCAACAAACCACATGGATTTAGAAATGAAGGAATGGTTGACGAAAGCTTTTAAACAAGAACAACGTGCTATATTATTTGTATCTCATGACCGAACATTTTTAAATGAAACGCCAGATGCTATATTAGAATTGAGTCTTGATGGGGCTAAGAAGTATATCGGTAAATACGATAAATACAAACAACAAAAAGATATAGAGCATGAAACATTAAAGCTACAGTATGAAAAACAACAAAAAGAACAAGCGGCCATTGAAGAAACGATTAAAAAATATAAAGCATGGTATCAAAAAGCAGAACAAAGTGCTTCTGTGAGAAGCCCATATCAACAAAAACAATTAAGTAAGTTAGCGAAACGGTTTAAATCAAAAGAACAACAATTAAATCGTAAACTTGATCAAGAGCATATCCCAAATCCACATAAAAAAGAGAAAACTTTCTCAATACAACATCATAATTTTAAATCACATTATTTAGTTCAATTTAATCATGTTTCGTTTGCTTATGATAACCGGAAAATATTCGATGATGTATCATTCTATATTAAGCGAAATCAAAATGTTATTGTTGAAGGCAGAAATGGTACAGGTAAATCAACTTTAATCAAATTGATACTCGGTGAACTCGAGCCAACTAAAGGTGATATAACTGTTCATCCAGAATTAGAAATTGGATATTTCTCTCAAGATTTTGAGAATTTAAATATGCATCATACTGTCTTAGATGAAATATTAGAAATTCCTGAAATGAAAGAAGCAGATGCAAGAACCATATTAGCAAGCTTTTATTTTGATAAAGATAGGATAAATGATGTTGTTGAAACACTATCGATGGGTGAAAAATGTAGGTTACAATTTGTAAAATTATATTTTTCAAATCCTCATATTATGATATTAGATGAGCCAACAAACTATTTCGATATTGGCATGCAAGAAAATATCATTCAATTAATACAATCATTTCAAGGTTCGGTCCTTATTGTATCTCATGATAATTATTTTAAATCACAAATTAAAGATCAGACTTGGACTATAAAAAATCATCAAATGACGCATGAAAATGTTCAAGTCAAAGATCCTATTAATACAGAATCTATGAAACATCATTTAAAAGAATTAGAACAATATACAGATGAAAGAAATCGTGAAACAGAGTTCTAG", "partial": "0", "query_start": 18038, "query_end": 18121, "hit_start": 168, "hit_end": 255, "orf_dna_sequence": "GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA", "orf_prot_sequence": "MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS", "perc_identity": 37.93}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 17684, "orf_end": 19195, "orf_from": "BGC0000692.1|Apramycin_19 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.36039, "max_identities": 13, "bit_score": 26.5646, "cvterm_id": "46173", "query": "RCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRAR", "match": "RCD N + L  +R    V    G ++     ++D RD+   R R", "sequence_from_db": "RCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCR", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 18350, "query_end": 18481, "hit_start": 87, "hit_end": 219, "orf_dna_sequence": "GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA", "orf_prot_sequence": "MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS", "perc_identity": 29.55}, "gnl|BL_ORD_ID|2720|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 17684, "orf_end": 19195, "orf_from": "BGC0000692.1|Apramycin_19 ", "model_name": "tet(48)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "3284", "ARO_accession": "3004581", "ARO_name": "tet(48)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.06462, "max_identities": 12, "bit_score": 26.5646, "cvterm_id": "36791", "query": "VCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGG", "match": "V VVG+G +G    + L   G S  ++E+ + +  GG", "sequence_from_db": "VLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGG", "sequence_from_broadstreet": "MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK", "dna_sequence_from_broadstreet": "ATGACATTCCTATTTAAGGAATTTAAAGGTGTGTTTAAAATGAAAAAAGTACTAGTGGTTGGTGCAGGGGTTGCTGGATTGGCAGTTTGTTATTGGCTAAAGGAGTTTGGGTTTTCGCCTACATTAATTGAAAAAAGTAATGCTTTAAGGAAGGGTGGTTATGGAGTAGATATCTTTGGTATTGCTGTTGATATTGCTAAAAAAATGAGCGTTTATGAAAAAATATGTGCTATGCGCACCCAGTTAGAACACGGGTTTTATGTGAATGCTGATGGTCATACATTAGTTGAAGAACAAGGGGAAAAATTTGGTTTCAGGCAGGGTGAGGAAGTCGAAATTCTCCGAGAAGATTTAATTGAAATCTTAAAGCAAGCTATTAAAGATATTCCATGCCATTTTAATCAACGTATAAAGCGGATTAAGCAGGATGGTAAACATGTTGAAGTTACTTTTAAGGATAATAAGACTGAAAATTATGATTTAGTTATTGGCGCTGACGGGGTACATTCAACCACTAGAGCTTTTACTTTTGATAAAGAAGAGTATGATCTAATTGATTTTGGATGTTATTCTGCAATATTTAGCCTCCCAAATTATTTAAAATTGAGGCAAAGCGAAATAGCTTTTGATGCGAACCAAAAATTCATTTCTGTCAGTAGCGATAAAAACCCTACTATAGCTCTTGCATCCCTTATGTTCCATTCTAATCGTGGAGACAACATTCGCAATGAGAAGGACCAGAAAAGTTTTTTTAAAGATGCTTTTATTGATCTTGGATGGGAGACAAATAATCTACTTCAGTACATGGAAGAAAGTAATGATTTCTATTTCGATGTTGCTACTCAGATTAAAATGAAATCATGGACAAAAGGAAGAATTGCGTTGGTGGGTGATTCAGGTTATTGTTCAACCGCATTGTCTGGGCAAGGCACCACTACAGCACTTGTTGGAGCTTATATTTTGGCAGGAGAATTAAAAGCTGCAAATGGAAACCATATAACTGCTTTTGAACGCTATAATATGTTGCTACATCCATTTGTTGAAGCTAATCAAGAACTAGGAGCATGGATTAATGAAACGTTTCTTTTAGAAGACGCAGTATCTAAAGAAGCAGTAGAAGCAAGAACAGACAATATCATAAAGAAAATCAGCGCCATCTCGAATGTAATTAAATTACCTGAGTATTCAGCCTATAAATAA", "partial": "0", "query_start": 17729, "query_end": 17839, "hit_start": 48, "hit_end": 159, "orf_dna_sequence": "GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA", "orf_prot_sequence": "MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS", "perc_identity": 32.43}}, "BGC0000692.1|Apramycin_20 # 19265 # 20626 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.706": {"gnl|BL_ORD_ID|166|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19265, "orf_end": 20626, "orf_from": "BGC0000692.1|Apramycin_20 ", "model_name": "adeS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "183", "ARO_accession": "3000549", "ARO_name": "adeS", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.13077, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35507", "query": "ELGLAHTEFNLSV--ITPYPGTELHQIAVDKGWIDGS---QDNFTSHNAV", "match": "+L +A T  NLSV   +   G  ++  A++KGWI  S   Q+++TS + V", "sequence_from_db": "QLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFV", "sequence_from_broadstreet": "MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG", "dna_sequence_from_broadstreet": "ATGAAAAGTAAGTTAGGAATTAGTAAGCAACTTTTTATTGCCTTAACTATTGTGAATTTAAGCGTTACGCTATTTTCTATAGTATTGGGTTATATCATTTATAACTATGCGATTGAAAAAGGCTGGATTAGCTTAAGCTCATTTCAACAAGAAGATTGGACCAGTTTTCATTTTGTAGACTGGATCTGGTTAGCCACTGTTATCTTCTGTGGCTGTATTATTTCATTAGTGATTGGCATGCGCCTCGCAAAGCGTTTTATTGTGCCAATTAACTTCTTAGTCGAAGCAGCAAAAAAAATTAGTCACGGCGACCTCTCTGCTAGAGCTTACGATAATAGAATTCACTCCGCCGAAATGTCGGAGCTTTTATATAATTTTAATGATATGGCTCAAAAGCTAGAGGTTTCCGTCAAAAATGCGCAGGTTTGGAATGCAGCTATCGCACATGAGTTAAGAACGCCTATAACGATATTACAAGGTCGTTTACAGGGAATTATTGATGGCGTTTTTAAACCTGATGAAGTCCTATTTAAAAGCCTTTTAAATCAAGTTGAAGGTTTATCTCACTTAGTCGAAGACTTACGGACTTTAAGCTTAGTAGAGAACCAGCAACTCCGGTTAAATTATGAATTGTTTGACTTGAAGGCGGTAGTTGAAAAAGTTCTTAAAGCATTTGAAGATCGTTTGGATCAAGCTAAGCTAGTACCAGAACTTGACCTAACGTCCACTCCTGTATATTGCGACCGCCGTCGTATTGAGCAAGTTTTAATTGCTTTAATTGATAATGCGATTCGCTATTCAAATGCAGGCAAACTTAAAATCTCTTCAGAAGTGGTTGCAGACAACTGGATATTAAAAATTGAGGATGAAGGCCCCGGCATTGCAACCGAGTTTCGGGACGATTTATTTAAGCCTTTCTTTAGATTAGAAGAATCAAGGAATAAAGAATTTGGCGGCACAGGTTTAGGTCTTGCTGTTGTACATGCAATTATTGTGGCACTGAAAGGCACTATTAAATATAGCAATCAAGGCTCGAAAAGTGTTTTCACCATAAAAATTTCTATGGGTCATGAAGAGATGGGGTAA", "partial": "0", "query_start": 20348, "query_end": 20482, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "ATGCGGCTCGGCAAGTTACTGCTGGTGAGTCCGAAGACCTCCTTCGGACGTGATCTGCAACGGACCTACGCCGGAGGGCTCGGCACCGTCTGCAAGGACGAGGACTTCCTGCTGCCCCCGCTCGACCTGATGCGGCTGGCCGGCGTCCTGCGGGAGGACGCCGACGAGATCGCGATCGCGGACGAGGAGGTCACCGGCGTCGTCGCCGCCTCCCCCGGCAGCACGGTGATCTGCCACGTCTCCCTGCCCAGCCTGCTGGAGGACGCCGAGCGCATGGCGACCTTCCGGGAGCAGGGCGCGCGCTGCTACGCCTACACGAGCATCCGCAGCCCCGTGCAGTGGCGGGAGCTGTTCGAGCGGGCCGGCTGCGTCGGCATCCTGCTGCCCGAGTCGATCTCGTTCGCCCGCGCCGCGCTCGCCGGCGACGCCACCGTCCCCGGCCTGGTCACCCCGGAGAACCTGCTGGAGCCGCGGCACCACCAGCCGCGGTTCGGCGACCTGGCGGCCGAGCCGCTGCCCGCGCGGGACCTCGTCGACCACACGCCCTACATGTTCCCGCCGATCTCCCTCAACGGGATCACGAGCATCAACGGCAGCTTCGGCTGCCCCTACCCGTGCCGCTTCTACTGCCCGTACCCGCTCAGCGAGGGCCGCAAGATCCGCACCTACCCGGTGGAGCGGATCGTCGCCGAGTTCCGCCAGTGCGCCGAGCTGGGCATCACCGCCGCGGTCTTCCGCGACCCGGTGTTCTCCTTCCACCGCGACCGCACGATCGAGATGTGCCGGGCGATCGAGGCCGCCGGCACCGGGGTGCCGTGGTGGTGCGAGACCCGCATCGACCGGCTCGACGAGGAGGTCGTCGCCGCGCTCGTGGCCGCCGGCTGCGTCGGCGTCGAGGTGGGCGTGGAGAGCGGCGACCCGGAGATGCAGGCGACGGCCGTGCGCAAGCGGCTCGACCTGGACACCGTCCGCCGGTTCCACGCGGTGGCCAGGAAGGCCGGGCTGAAGCTGGTCTTCCTGTTCCTGATCGGCCTGCCCAGGGAGACCAGGATGTCGATCCGGCGCACGTTCGACTTCATCCTCGAACTCGGACTGGCGCACACCGAGTTCAACCTCAGCGTGATCACGCCGTACCCGGGAACCGAGCTGCACCAGATCGCCGTGGACAAGGGCTGGATCGACGGCTCGCAGGACAACTTCACCAGCCACAACGCGGTCATGCACACGGACCAGCTCACGATCGGGGACCTGGAGCAGGCCAGCCGGTTCGTCGACGAGCTGCACGGGGTGTGCAAGGCGGGGCCCGCGGAGCGGGCCGAGTTCCAGGCCAGGCTGCACGCCTGGTCGACCAGCGACGCCTGA", "orf_prot_sequence": "MRLGKLLLVSPKTSFGRDLQRTYAGGLGTVCKDEDFLLPPLDLMRLAGVLREDADEIAIADEEVTGVVAASPGSTVICHVSLPSLLEDAERMATFREQGARCYAYTSIRSPVQWRELFERAGCVGILLPESISFARAALAGDATVPGLVTPENLLEPRHHQPRFGDLAAEPLPARDLVDHTPYMFPPISLNGITSINGSFGCPYPCRFYCPYPLSEGRKIRTYPVERIVAEFRQCAELGITAAVFRDPVFSFHRDRTIEMCRAIEAAGTGVPWWCETRIDRLDEEVVAALVAAGCVGVEVGVESGDPEMQATAVRKRLDLDTVRRFHAVARKAGLKLVFLFLIGLPRETRMSIRRTFDFILELGLAHTEFNLSVITPYPGTELHQIAVDKGWIDGSQDNFTSHNAVMHTDQLTIGDLEQASRFVDELHGVCKAGPAERAEFQARLHAWSTSDA", "perc_identity": 36.0}}, "BGC0000692.1|Apramycin_21 # 20651 # 22051 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.737": {"gnl|BL_ORD_ID|652|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 20651, "orf_end": 22051, "orf_from": "BGC0000692.1|Apramycin_21 ", "model_name": "AIM-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "707", "ARO_accession": "3000853", "ARO_name": "AIM-1", "ARO_category": {"41380": {"category_aro_accession": "3004216", "category_aro_cvterm_id": "41380", "category_aro_name": "AIM beta-lactamase", "category_aro_description": "A subclass B3 family of beta-lactamases that confer resistance to a range of beta-lactam antibiotics including penams, cephamycins, and cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.87821, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "36752", "query": "GMTATLITNEGGHMTVNYATGLPGELQEHTGTQVRIAGYGPQ", "match": "G++A L+T++ GH+ V+ AT   G         +R  G+ P+", "sequence_from_db": "GISALLVTSDAGHILVDAATPQAG---PQILANIRALGFRPE", "sequence_from_broadstreet": "MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP", "dna_sequence_from_broadstreet": "ATGAAACGTCGCTTCACCCTGCTGGGCAGCGTAGTCGCCCTCGCCCTCTCATCCACAGCCCTCGCCTCCGATGCGCCCGCCTCCAGGGGCTGCGCCGACGATGCCGGCTGGAACGATCCGGCAATGCCCCTGAAGGTGTACGGAAACACCTGGTACGTTGGCACCTGCGGCATCAGTGCGCTGCTGGTCACTTCCGACGCGGGCCATATCCTGGTCGATGCCGCCACGCCGCAGGCGGGCCCACAGATCCTGGCCAACATCCGCGCACTCGGTTTCAGGCCGGAGGACGTGCGCGCCATCGTGTTCTCGCACGAGCATTTCGACCATGCCGGCAGCCTCGCCGAACTGCAGAAGGCCACGGGTGCACCGGTGTACGCGCGCGCGCCCGCGATCGACACGCTGAAGCGCGGCCTGCCGGACCGCACCGACCCGCAATTCGAGGTGGCCGAACCCGTTGCGCCGGTCGCCAACATCGTCACCCTGGCCGACGACGGCGTGGTGAGCGTCGGCCCGCTGGCCCTGACGGCGGTCGCCTCGCCTGGCCACACCCCGGGTGGCACCAGTTGGACCTGGCGCTCCTGCGAAGGCGACGACTGTCGCCAGATGGTCTACGCCGACAGCCTGACGGCGATCTCGGACGACGTCTTCCGCTACAGCGACGACGCCGCGCATCCCGGCTACCTGGCGGCATTCCGCAACACCCTCGCACGGGTCGCAGCGCTCGACTGCGACATCCTGGTCACCCCGCACCCCTCGGCCAGCGGCCTGTGGAACCGGATCGGCCCGAGGGCCGCCGCACCGCTGATGGACACCACCGCCTGCCGCCGCTACGCGCAGGGCGCGAGGCAGCGGCTGGAGAAGCGCCTGGCCGAGGAAGCCGCCACCTCCCCCTCCAGCGGCGCGCGGCCTTGA", "partial": "0", "query_start": 21851, "query_end": 21976, "hit_start": 168, "hit_end": 285, "orf_dna_sequence": "ATGTCGCCGCACCCGCAGAAGCGAAGATCCCGCACCAGCGCGCTCCTCGCGGTCGCCGCCCTCGCGGCGGCGCTCTCCCCGACGATCCCCGCCGTGGCCGACGACACCGCCGAGGGCTTCGCCCTGGCCCCCAACGCGGACCGGACGCACCACGTCCGGAGCGCGGTCAGGGGCGGCAAGGCCCGCAACGTCCTGCTGTTCGTCGGCGACGGCATGGGCGACTCCGAGATCACCCTGGCCCGCAACTACGAGCTGGGGGCCGCCGGCCGGCTGAACCTGGACCGGCTGCCCCTGACCGGCGCCTACACCACCTACTCGGTCGCCAAGGGCGACCCGGGGCGCGTCGAGTACGTCACCGACTCGGCGGCGGCGGCCACGGGCTACGCCATCGGGGCCAAGACCTACAACGGCGCCGTGGGCGTCGACGCGCACGGCAGGGAGCGGCCGACGATCCTGGAGCTGGCCAAGCGCCGGGGCTACCGCACCGGCAACGTCACCACCGCCGAGCTCCAGGACGCCACCCCCGCCGCCCTCTCGGCGCACGTGCTCGACCGCACCTGCCGAGGCCCGCAGGACATGAAGGAGTGCGCGCCGAACGACAAGCGGAACGGCGGCGCGGGCTCGATCGCCGAGCAGCAGGTCGCGCTGCGGGCCGACGTGCTCATGGGCGGTGGCGGCAAGTACTTCGACCAGCAGGTCGCCGCCGGCCAGTTCGCCGGGCGGACCGTGCGCCAGCAGGCGGTCGACTCCGGCTTCCAGGTGATCACCTCGGCCGACCAGATGCGGGCCCTCGACCGGGAGCGGCCCGTACTCGGCGTGTTCGCCGCCGAGGGTCTGGACAGCACCTGGACCGGCCCGCCGGCCAAGGCGGGCGGGACGCCGCCGAGCCGGTGCGCGGAGAACCCCGCCCGCCGGAAGGACCAGCCGACGCTGGCCGACATGACCCGTGCCTCGATCGACCTGCTCGAACGCCGATCCCGCGGCCACGACAGGGGGTTCTTCCTCCAGGTCGAGGGCGCGCAGATCGACTGGGGCGCGCACGACGGCCTGCCCTGCGAGCAGATCGGCGAGACCGTCCAGTTCGACCGGGCGGTGGCCGTCGGCATGGAGTTCGCGCGGCGGCGCCCGGACACGCTGGTCATCGTCACCGCCGACCACGCGCAGACCACCCAGATCATCCCCAACGGCCAGAAGAGCCCCGGCATGACCGCCACCCTCATCACCAACGAGGGCGGCCACATGACGGTCAACTACGCCACCGGGCTGCCCGGCGAGCTCCAGGAGCACACCGGGACCCAGGTGCGGATCGCCGGGTACGGGCCCCAGGCCGCCAACGTCGTCGGCGTCACCGACCAGACCGACCTGTTCCGCACCCTGTCCAGGGCGATGGGAGTCCGCTGA", "orf_prot_sequence": "MSPHPQKRRSRTSALLAVAALAAALSPTIPAVADDTAEGFALAPNADRTHHVRSAVRGGKARNVLLFVGDGMGDSEITLARNYELGAAGRLNLDRLPLTGAYTTYSVAKGDPGRVEYVTDSAAAATGYAIGAKTYNGAVGVDAHGRERPTILELAKRRGYRTGNVTTAELQDATPAALSAHVLDRTCRGPQDMKECAPNDKRNGGAGSIAEQQVALRADVLMGGGGKYFDQQVAAGQFAGRTVRQQAVDSGFQVITSADQMRALDRERPVLGVFAAEGLDSTWTGPPAKAGGTPPSRCAENPARRKDQPTLADMTRASIDLLERRSRGHDRGFFLQVEGAQIDWGAHDGLPCEQIGETVQFDRAVAVGMEFARRRPDTLVIVTADHAQTTQIIPNGQKSPGMTATLITNEGGHMTVNYATGLPGELQEHTGTQVRIAGYGPQAANVVGVTDQTDLFRTLSRAMGVR", "perc_identity": 30.95}}, "BGC0000692.1|Apramycin_22 # 22165 # 23289 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=3bp;gc_cont=0.742": {"gnl|BL_ORD_ID|4906|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "FosA8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "100", "model_id": "5899", "ARO_accession": "3007371", "ARO_name": "FosA8", "ARO_category": {"36272": {"category_aro_accession": "3000133", "category_aro_cvterm_id": "36272", "category_aro_name": "fosfomycin thiol transferase", "category_aro_description": "Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.122497, "max_identities": 19, "bit_score": 30.4166, "cvterm_id": "35914", "query": "LAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGV", "match": "L   YDE        +PP+  D  H  + +SV  EH DA+   L DAGV", "sequence_from_db": "LCLSYDETRT----FIPPQNSDYTH--YAFSVEPEHFDAVAQKLKDAGV", "sequence_from_broadstreet": "MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA", "dna_sequence_from_broadstreet": "ATGCTTAACGCCCTTAACCATCTGACCCTTGCTGTCAGCAACTTGCCTGCCAGCATCACTTTCTGGCGCGATCTTCTTGGCCTGCGCCTGCACGCCGAATGGCACACCGGAGCTTACCTTACCTGTGGCGATCTCTGGCTCTGCCTGTCTTATGACGAGACGCGGACATTCATCCCACCACAGAACAGCGATTACACCCACTACGCCTTTTCTGTTGAACCGGAACACTTTGACGCCGTCGCGCAAAAGCTCAAAGACGCTGGCGTAACGGTCTGGAAAGAGAACAAAAGCGAAGGGGCGTCGTTCTATTTTCTCGACCCGGACGGGCACAAACTGGAACTGCATGTGGGCGATCTGGCCGCGCGTCTGGCGGCGTGTCGGGAGAAGCCTTACGCGGGAATGGTTTTTACGTCAGATGAAGCGTAA", "partial": "0", "query_start": 22936, "query_end": 23082, "hit_start": 138, "hit_end": 267, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 38.78}, "gnl|BL_ORD_ID|4618|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "VHH-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5689", "ARO_accession": "3007003", "ARO_name": "VHH-1", "ARO_category": {"43915": {"category_aro_accession": "3005455", "category_aro_cvterm_id": "43915", "category_aro_name": "VHH beta-lactamase", "category_aro_description": "VHH beta-lactamases are class A beta-lactamases found in Vibrio harveyi.", "category_aro_class_name": "AMR Gene Family"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.517343, "max_identities": 24, "bit_score": 29.261, "cvterm_id": "36785", "query": "MMSSHVSFAHV----DTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVG", "match": "MMS+  + A      D +N  L       ++ER    + +    +DR+  +  R+     A  + S   A  +  R++G PRG T      TF+ ++G", "sequence_from_db": "MMSTFKTLACATMLSDMDNEKLDKNATAKVEER---NMVVWSPVMDRMASQTTRIEHACEAAMLMSDNTAANIVLRSIGGPRGVT------TFLRSIG", "sequence_from_broadstreet": "MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPMMSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAMLMSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI", "dna_sequence_from_broadstreet": "ATGAAAAAGCTATTTCTGCTACTTGGATTGTTAGCCTGTTCGAGTGCAACGTACGCCGCAAACTTAATGAAAACATCTCCGCGATTGAAGAAGCATATTTCGGGTCGAATCGGTGTGTCTGTCTGGGATACTCAAACCGATGAACATTGGGACTATAGAGGCGACGAGCGCTTCCCGATGATGAGCACATTCAAAACGCTTGCATGTGCAACGATGCTTAGTGACATGGATAATGAAAAGCTCGATAAAAACGCCACTGCCAAAGTAGAAGAGCGCAATATGGTGGTTTGGTCACCAGTAATGGATCGTATGGCAAGTCAAACAACGCGTATTGAACATGCTTGTGAAGCCGCAATGCTGATGAGCGACAATACCGCAGCCAACATTGTTTTGCGTAGCATTGGGGGTCCACGCGGTGTCACTACGTTCTTGCGTTCTATCGGTGATAAAGCAACGCGCCTTGACCGTTTTGAACCAAGACTGAACGAGGCGAACCCGGGCGACAAGCGAGACACCACAACACCTAATGCCATGGTAAATACGCTGCATACGTTGTTAGAAGGTGATGCGCTATCCTACGAATCACGCATTCAATTAAAAATCTGGATGCAGGATAACAAAGTCTCTGATTCTTTGATGCGCTCTGTGTTACCAAAGGGTTGGTCGATTGCCGATCGTTCTGGCGCAGGTGGCTTTGGATCACGCGGTATCACAGCAATGATCTGGAAAGAGAATCATAAACCGGTCTACATCAGCATTTACATTACTGAAACCGATTTATCCTTGCAGGCGCGCGATCAGGTTATCGCTCAAGTGAGCCAGTTAATACTGGATGAGTACAATACTATTTAG", "partial": "0", "query_start": 22165, "query_end": 22446, "hit_start": 177, "hit_end": 444, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 24.49}, "gnl|BL_ORD_ID|2051|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "salA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2265", "ARO_accession": "3003749", "ARO_name": "salA", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.32781, "max_identities": 15, "bit_score": 27.335, "cvterm_id": "36794", "query": "GINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVR", "match": "G + LL  +  D++VD A +E+ +TP     V  ++     EIA +R", "sequence_from_db": "GKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIR", "sequence_from_broadstreet": "MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAAGCATTAGAAGTTGAACATAAAGTATTAATACCCGAGTTGACTTTTTCAATAGAGGACCATGAACATTTAGCAATCGTTGGTGTTAATGGTGTTGGAAAATCAACATTATTAAAAGTCATTCATCAAGATCAATCAGTTGATTCAGCGATGATGGAACAAGATTTAACACCTTATTATGATTGGACTGTTATGGATTATATAATTGAATCATATCCTGAAATCGCAAAGATTAGATTGCAACTTAATCATACAGATATGATTAATAAATATATTGAATTAGATGGATACATTATAGAAGGTGAAATCGTAACAGAAGCAAAAAAGCTCGGAATAAAAGAGGAACAACTAGAACAGAAAATTTCTACTTTAAGTGGTGGAGAACAAACAAAAGTATCATTTTTAAAAGTGAAAATGTCTAAAGCATCATTACTATTAATCGATGAACCAACAAACCACATGGATTTAGAAATGAAGGAATGGTTGACGAAAGCTTTTAAACAAGAACAACGTGCTATATTATTTGTATCTCATGACCGAACATTTTTAAATGAAACGCCAGATGCTATATTAGAATTGAGTCTTGATGGGGCTAAGAAGTATATCGGTAAATACGATAAATACAAACAACAAAAAGATATAGAGCATGAAACATTAAAGCTACAGTATGAAAAACAACAAAAAGAACAAGCGGCCATTGAAGAAACGATTAAAAAATATAAAGCATGGTATCAAAAAGCAGAACAAAGTGCTTCTGTGAGAAGCCCATATCAACAAAAACAATTAAGTAAGTTAGCGAAACGGTTTAAATCAAAAGAACAACAATTAAATCGTAAACTTGATCAAGAGCATATCCCAAATCCACATAAAAAAGAGAAAACTTTCTCAATACAACATCATAATTTTAAATCACATTATTTAGTTCAATTTAATCATGTTTCGTTTGCTTATGATAACCGGAAAATATTCGATGATGTATCATTCTATATTAAGCGAAATCAAAATGTTATTGTTGAAGGCAGAAATGGTACAGGTAAATCAACTTTAATCAAATTGATACTCGGTGAACTCGAGCCAACTAAAGGTGATATAACTGTTCATCCAGAATTAGAAATTGGATATTTCTCTCAAGATTTTGAGAATTTAAATATGCATCATACTGTCTTAGATGAAATATTAGAAATTCCTGAAATGAAAGAAGCAGATGCAAGAACCATATTAGCAAGCTTTTATTTTGATAAAGATAGGATAAATGATGTTGTTGAAACACTATCGATGGGTGAAAAATGTAGGTTACAATTTGTAAAATTATATTTTTCAAATCCTCATATTATGATATTAGATGAGCCAACAAACTATTTCGATATTGGCATGCAAGAAAATATCATTCAATTAATACAATCATTTCAAGGTTCGGTCCTTATTGTATCTCATGATAATTATTTTAAATCACAAATTAAAGATCAGACTTGGACTATAAAAAATCATCAAATGACGCATGAAAATGTTCAAGTCAAAGATCCTATTAATACAGAATCTATGAAACATCATTTAAAAGAATTAGAACAATATACAGATGAAAGAAATCGTGAAACAGAGTTCTAG", "partial": "0", "query_start": 22462, "query_end": 22602, "hit_start": 117, "hit_end": 258, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 31.91}, "gnl|BL_ORD_ID|3149|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-113", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4187", "ARO_accession": "3006291", "ARO_name": "ADC-113", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.26112, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "35507", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGT", "match": "D E   LVD+ F P+L++    G+ +G  + ++       L  V+   AVNS T", "sequence_from_db": "DQEIKKLVDQNFKPLLEKYDVSGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSST", "sequence_from_broadstreet": "MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVSGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTGTCTACTTTTATCCCCGCTTTTTATTTTTAGTACCTCAATTTATGCGGGCAATACACCAAAAGACCAAGAAATTAAAAAACTGGTAGATCAAAACTTTAAACCGTTATTAGAAAAATATGATGTGTCAGGTATGGCTGTGGGTGTTATTCAAAATAATAAAAAGTATGAAATGTATTATGGTCTTCAATCTGTTCAAGATAAAAAAGCCGTAAATAGCAGTACTATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACCGCGACAGCAGGTGGATATGCAAAAAATAAAGGAAAAATCTCTTTTGACGATACGCCTGGTAAGTATTGGAAAGAACTAAAAAATACACCGATTGACCAAGTTAACTTACTTCAACTCGCGACGTATACAAGTGGTAACCTTGCCTTGCAATTTCCAGATGAAGTAAAAACAGATCAGCAAGTTTTAACATTTTTTAAAGACTGGAAACCTAAAAACTCAATCGGTGAATATCGACAATATTCAAACCCAAGCATTGGTTTATTTGGAAAAGTTGTAGCTTTGTCTATGAATAAACCTTTCGACCAAGTCTTAGAAAAAACAATTTTTCCGGCCCTTGGCTTAAAACATAGCTATGTAAATGTACCTAAGACCCAGATGCAAAACTATGCTTTTGGCTATAACCAAGAAAATCAGCCGATTCGAGTTAACCCCGGCCCACTCGATGCCCCAGCATATGGCGTCAAATCGACACTACCCGACATGTTGAGTTTTATTCATGCCAACCTAAATCCACAAAAATATCCAGCAGATATTCAACGGGCAATTAATGAAACACATCAGGGTCGCTATCAAGTAAATACCATGTATCAGGCACTCGGTTGGGAAGAGTTTTCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAGGAACCTTCAGTTAAGATGTACCATAAAACTGGCTCAACTAACGGTTTCGGAACATATGTGGTGTTTATTCCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGTATTCCAAATGAAGAGCGCATTAAGGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22356, "hit_start": 84, "hit_end": 246, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 31.48}, "gnl|BL_ORD_ID|3163|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-130", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4201", "ARO_accession": "3006305", "ARO_name": "ADC-130", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.49554, "max_identities": 25, "bit_score": 26.1794, "cvterm_id": "37046", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGA", "match": "D E   LVD+ F P+L++    G+ +G  + ++       L  V+   AVNS       T   LG        +V+  F AT GA", "sequence_from_db": "DQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSN------TIFELG--------SVSKLFTATAGA", "sequence_from_broadstreet": "MRFKKISYLLLPSLFIFNTSIYAGNSSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQCAINETHQGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTACTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCGGGCAATAGTTCTAAAGACCAAGAAATTAAACAATTGGTAGATCAAAATTTTAAACCCTTATTAGAAAAATATAATGTGCCGGGCATGGCGGTAGGTGTTATTCAAAACAATAAAAAATATGAAACGTATTATGGTCTACAATCCGTTCAAGATAAAAAAGCTGTAAATAGCAATACCATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACTGCGACGGCAGGTGCTTATGCAAAAAATACAGGAAAAATTTCTTTTGATGATACGCCGGGCAAATACTGGAAAGAGTTAAAAAACACCCCAATTGATCAGGTCAATTTACTTCAACTTGCCACCTATACAAGTGGTAACCTCGCCTTGCAATTCCCAGATGAAGTACAAACAGATCAACAGGTTTTAACTTTTTTTAAAGATTGGAAACCTAAAAACCCAATCGGTGAATATAGACAATATTCAAACCCAAGTATCGGTCTATTTGGGGAAATAGTTGGTTTATCAATGAAGCAGCCTTTTAGTCAGGTCTTGGAAAAAACGATTTTTCCGGACCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAGATGCAAAACTATGCATTTGGTTATAACCAAGAAAATCAGCCAATTCGAGTTAACCCTGGCCCACTCGATGCCCCAGCATACGGCGTCAAATCGACCCTACCCGACATGCTGAGCTTTATTCATGCCAACCTGAATCCACAGAAATATCCGGCAAATATTCAATGTGCAATTAATGAGACACATCAAGGTCGCTATCAAGTAAATAGCATGTATCAGGCACTCGGTTGGGAAGAGTTTGCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTCATGAAACCTAATAAAGTGACTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCACAAAACTGGTTCAACAAATGGTTTCGGAACCTATGCCGTATTTATACCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGCATTCCAAATGAAGAACGCATTAAAGCAGCTTATGCTGTGCTAAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22449, "hit_start": 84, "hit_end": 297, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 29.41}, "gnl|BL_ORD_ID|3164|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-131", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4202", "ARO_accession": "3006306", "ARO_name": "ADC-131", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.54366, "max_identities": 25, "bit_score": 26.1794, "cvterm_id": "36949", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGA", "match": "D E   LVD+ F P+L++    G+ +G  + ++       L  V+   AVNS       T   LG        +V+  F AT GA", "sequence_from_db": "DQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSN------TIFELG--------SVSKLFTATAGA", "sequence_from_broadstreet": "MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGVIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKDNIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTACTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCGGGCAATACTTCTAAAGACCAAGAAATTAAACAATTGGTAGATCAAAATTTTAAGCCCTTATTAGAAAAATATAATGTGCCGGGTATGGCGGTAGGTGTTATTCAAAACAATAAAAAATATGAAACGTATTATGGTCTACAATCCGTTCAAGATAAAAAAGCTGTAAATAGCAATACCATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACTGCGACGGCAGGTGCTTATGCAAAAAATACAGGGAAAATTTCTTTTGATGATACGCCGGGCAAATACTGGAAAGAGTTAAAAAACACCCCAATTGATCAGGTCAATTTACTTCAACTTGCCACCTATACAAGTGGTAACCTCGCTTTGCAATTCCCAGATGAAGTACAAACAGATCAACAGGTTTTAACTTTTTTTAAAGATTGGAAACCTAAAAACCCAATCGGTGAATATAGACAATATTCAAACCCAAGTATTGGCCTATTTGGGGTAATAGTTGGTTTATCAATGAAGCAGCCTTTTAGTCAGGTCTTGGAAAAAACGATTTTTCCGGACCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAGATGCAAAACTATGCATTTGGTTATAACCAAGAAAATCAGCCAATTCGAGTTAACCCTGGCCCACTCGATGCCCCAGCATACGGCGTCAAATCGACCCTACCCGACATGCTGAGCTTTATTCATGCCAACCTGAACCCACAGAAATATCCGGCAAATATTCAACGTGCAATTAATGAGACACATCAAGGTCGCTATCAAGTAAATAGCATGTATCAGGCACTCGGTTGGGAAGAGTTTGCTTATCCAGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCACAAAACTGGTTCAACAAATGGTTTCGGAACCTATGTCGTATTTATTCCTAAAGACAATATTGGTTTAGTCATGTTAACCAATAAACGCATTCCAAATGAAGAACGCATTAAGGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22449, "hit_start": 84, "hit_end": 297, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 29.41}, "gnl|BL_ORD_ID|3237|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-239", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4304", "ARO_accession": "3006408", "ARO_name": "ADC-239", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.04867, "max_identities": 25, "bit_score": 25.7942, "cvterm_id": "40550", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGA", "match": "D E   LVD+ F P+L++    G+ +G  + ++       L  V+   AVNS       T   LG        +V+  F AT GA", "sequence_from_db": "DQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSN------TIFELG--------SVSKLFTATAGA", "sequence_from_broadstreet": "MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTACTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCGGGCAATACTTCTAAAGACCAAGAAATTAAACAATTGGTAGATCAAAATTTTAAACCCTTATTAGAAAAATATAATGTGCCGGGTATGGCGGTAGGTGTTATTCAAAACAATAAAAAATATGAAACGTATTATGGTCTACAATCCGTTCAAGATAAAAAAGCTGTAAATAGCAATACCATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACTGCGACGGCAGGTGCTTATGCAAAAAATACAGGAAAAATCTCTTTTGATGATACGCCGGGCAAATACTGGAAAGAGTTAAAAAACACCCCAATTGATCAGGTCAATTTACTTCAACTTGCCACCTATACAAGTGGTAACCTCGCTTTGCAATTCCCAGATGAAGTACAAACAGATCAACAGGTTTTAACTTTTTTTAAAGATTGGAAACCTAAAAACCCTATCGGTGAATATAGACAATATTCAAACCCAAGTATTGGCCTATTTGGGGAAATAGTTGGTTTATCAATGAAGCAGCCTTTTAGTCAGGTCTTGGAAAAAACGATTTTTCCGGACCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAGATGCAAAACTATGCATTTGGCTATAACCAAGAAAATCAGCCAATTCGAGTTAACCCTGGCCCACTCGATGCCCCAGCATACGGCGTCAAATCGACCCTACCCGACATGCTGAGCTTTATTCATGCCAACCTGAACCCACAGAAATATCCGGCAAATATTCAACGTGCAATTAATGAGACACATCAAGGTCGCTATCAAGTAAATAGCATGTATCAGGCACTCGGTTGGGAAGAGTTTGCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCACAAAACTGGTTCAACAAATGGTTTCGGAACCTATGCCGTATTTATACCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGCATTCCAAATGAAGAACGCATTAAGGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22449, "hit_start": 84, "hit_end": 297, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 29.41}, "gnl|BL_ORD_ID|3254|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-255", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4321", "ARO_accession": "3006425", "ARO_name": "ADC-255", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.39152, "max_identities": 24, "bit_score": 25.7942, "cvterm_id": "36949", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGA", "match": "D E   L+D+ F P+L++    G+ +G  + ++       L  V+   AVNS       T   LG        +V+  F AT GA", "sequence_from_db": "DQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSN------TIFELG--------SVSKLFTATAGA", "sequence_from_broadstreet": "MQFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCAATTTAAAAAAATTTCTTACTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCGGGCAATACTTCTAAAGACCAAGAAATTAAACAATTGATAGATCAAAATTTTAAACCCTTATTAGAAAAATATAATGTGCCGGGTATGGCGGTAGGTGTTATTCAAAACAATAAAAAATATGAAACGTATTATGGCCTACAATCCGTTCAAGATAAAAAAGCTGTAAATAGCAATACCATTTTTGAGCTAGGTTCTGTCAGTAAGTTATTTACTGCGACGGCAGGTGCTTATGCAAAAAATACAGGAAAAATCTCTTTTGATGATACGCCGGGCAAATACTGGAAAGAGTTAAAAAACACCCCAATTGATCAGGTCAATTTACTTCAACTTGCCACCTATACAAGTGGTAACCTCGCCTTGCAATTCCCAGATGAAGTACAAACAGATCAACAGGTTTTAACTTTTTTTAAAGATTGGAAACCTAAAAACCCAATCGGTGAATATAGACAATATTCAAACCCAAGTATTGGCCTATTTGGGGAAATAGTTGGTTTATCAATGAAGCAGCCTTTTAGTCAGGTCTTGGAAAAAACGATTTTTCCGGACCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAGATGCAAAACTATGCATTTGGCTATAACCAAGAAAATCAGCCAATTCGAGTTAACCCTGGCCCACTCGATGCCCCAGCATACGGCGTCAAATCGACCCTACCCGACATGCTGAGCTTTATTCATGCCAACCTGAACCCACAAAAATATCCGGCTGATATTCAACGGGCAATTAATGAGACACATCAAGGTCGCTATCAAGTAAATAGCATGTATCAGGCACTCGGTTGGGAAGAGTTTGCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTCATGAAACCTAATAAAGTGACTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCACAAAACTGGTTCAACCAATGGTTTCGGAACCTATGTCGTCTTTATTCCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGCATTCCAAATGAAGAACGCATTAAGGCAGCTTATGCTGTGCTAAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22449, "hit_start": 84, "hit_end": 297, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 28.24}, "gnl|BL_ORD_ID|3253|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-254", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4320", "ARO_accession": "3006424", "ARO_name": "ADC-254", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.65378, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "35507", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGT", "match": "D E   LVD+ F P+L++    G+ +G  + ++       L  V+   AVNS T", "sequence_from_db": "DQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSST", "sequence_from_broadstreet": "MRFKKISCLLLPSLFIFNTSIYAGTISKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATTGTYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPGEVQTDQQVLTFFKDWQSKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLNFIHANLNPQKYPADIQSAINETHQGFYQVGTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVSAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTGCTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCAGGCACTATCTCTAAAGATCAAGAAATTAAACAATTAGTAGATCAAAACTTTAAACCCTTATTAGAAAAATATAATGTGCCGGGTATGGCGGTAGGCGTTATTCAAAATAATAAAAAGTATGAAACGTATTATGGTCTACAATCCGTTCAAGATAAAAAAGCCGTAAATAGCAGTACCATTTTTGAGCTAGGTTCCGTTAGTAAATTATTTACCGCGACAACAGGTACTTATGCAAAAAATAAAGGAAAAATCTCTTTTGACGATACGCCTGGTAAATATTGGAAAGAACTAAAAAACACGCCAATTGACCAAGTTAACTTACTTCAACTCGCGACGTATACAAGTGGCAACCTCGCTTTACAATTTCCAGGTGAAGTACAAACAGATCAACAAGTTTTAACTTTTTTCAAAGACTGGCAATCTAAAAATCCAATTGGTGAATACAGACAATATTCAAATCCAAGTATTGGCCTATTTGGAAAGGTTGTAGCTTTGTCTATGAATAAACCTTTCGACCAAGTCTTAGAAAAAACAATTTTTCCGGCCCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAAATGCAAAACTATGCATTTGGCTATAACCAAGAAAATCAGCCGATTCGAGTTACCCCTGGCCCACTCGATGCTCCAGCATACGGTGTTAAATCAACTCTACCGGATATGCTTAATTTTATTCATGCCAACCTAAACCCACAGAAATATCCGGCAGATATTCAAAGCGCAATTAATGAAACACATCAAGGTTTCTATCAAGTAGGTACCATGTATCAGGCACTTGGTTGGGAAGAGTTTTCTTATCCTGCAACCTTACAAACTTTATTAGACAGTAATTCAGAACAAATTGTGATGAAACCTAATAAAGTGAGTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCATAAAACAGGTTCTACCAACGGTTTTGGAACGTATGTCGTATTTATTCCTAAAGAAAATATTGGCTTAGTCATGTTAACCAATAAACGCATTCCAAACGAAGAACGTATTAAGGCGGCTTATGCTGTGTTGAATGCGATAAAAAAATAA", "partial": "0", "query_start": 22198, "query_end": 22356, "hit_start": 84, "hit_end": 246, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 31.48}, "gnl|BL_ORD_ID|3180|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "ADC-148", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4218", "ARO_accession": "3006322", "ARO_name": "ADC-148", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.2065, "max_identities": 24, "bit_score": 25.409, "cvterm_id": "36949", "query": "DTENAALVDE-FLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGA", "match": "D E   L+D+ F P+L++    G+ +G  + ++       L  V+   AVNS       T   LG        +V+  F AT GA", "sequence_from_db": "DQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSN------TIFELG--------SVSKLFTATAGA", "sequence_from_broadstreet": "MQFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFNDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCAATTTAAAAAAATTTCTTACTTACTTTTACCTTCTCTTTTTATTTTTAATACCTCAATTTATGCGGGCAATACTTCTAAAGACCAAGAAATTAAACAATTGATAGATCAAAATTTTAAACCCTTATTAGAAAAATATAATGTGCCGGGTATGGCGGTAGGTGTTATTCAAAACAATAAAAAATATGAAACGTATTATGGTCTACAATCCGTTCAAGATAAAAAAGCTGTAAATAGCAATACCATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACTGCGACGGCAGGTGCTTATGCAAAAAATACAGGAAAAATCTCTTTTAATGATACGCCGGGCAAATACTGGAAAGAGTTAAAAAACACCCCAATTGATCAGGTCAATTTACTTCAACTTGCCACCTATACAAGTGGTAACCTCGCTTTGCAATTCCCAGATGAAGTACAAACAGATCAACAGGTTTTAACTTTTTTTAAAGATTGGAAACCTAAAAACCCAATCGGTGAATATAGACAATATTCAAACCCAAGTATTGGCCTATTTGGGGAAATAGTTGGTTTATCAATGAAGCAGCCTTTTAGTCAGGTCTTGGAAAAAACGATTTTTCCGGACCTTGGCTTAAAACATAGCTATGTCAATGTGCCTAAAACTCAGATGCAAAACTATGCATTTGGCTATAACCAAGAAAATCAGCCAATTCGAGTTAACCCTGGCCCACTCGATGCCCCAGCATACGGCGTCAAATCGACCCTACCCGACATGCTGAGCTTTATTCATGCCAACCTGAACCCACAGAAATATCCGGCAAATATTCAACGTGCAATTAATGAGACACATCAAGGTCGCTATCAAGTAAATAGCATGTATCAGGCACTCGGTTGGGAAGAGTTTGCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAAGAACCTTCAGTTAAGATGTACCACAAAACTGGTTCAACAAATGGTTTCGGAACCTATGCCGTATTTATACCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGCATTCCAAATGAAGAACGCATTAAAGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA", "partial": "0", "query_start": 22198, "query_end": 22449, "hit_start": 84, "hit_end": 297, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 28.24}, "gnl|BL_ORD_ID|2786|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22165, "orf_end": 23289, "orf_from": "BGC0000692.1|Apramycin_22 ", "model_name": "AAC(3)-IVb", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3801", "ARO_accession": "3005061", "ARO_name": "AAC(3)-IVb", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.23713, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "43264", "query": "AELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRR", "match": "AEL     +G+    TV+R G+ +R+D L+      + D ++ W + +", "sequence_from_db": "AELMAGVPYGVPHHCTVLRDGKPARIDYLENDHCCQRFDLVDGWLKEK", "sequence_from_broadstreet": "MVTQLRALGVPPGAVLLVHASFRSIRPVQGGPQGLIEALREAAGPAGTLVMPSWGDDDDAPFDPAATPAAADLGAVADAFWRLPDVVRSHHPFAFAAAGPQAHRITADPLPLPPHIPASPVGRVHELDGQVLLLGVGHDANTTIHLAELMAGVPYGVPHHCTVLRDGKPARIDYLENDHCCQRFDLVDGWLKEKGLQREGPVGNAGARLMRARDIVDVVRQQLARDPLVFLHPPQVGCEECDAARRSVSTK", "dna_sequence_from_broadstreet": "TTGGTGACCCAGTTGCGCGCGCTCGGCGTGCCACCCGGCGCCGTGCTGCTGGTCCACGCGTCGTTCCGCTCGATCAGGCCCGTGCAAGGGGGCCCACAAGGATTGATCGAGGCGCTGCGGGAAGCGGCCGGCCCTGCCGGCACGCTGGTGATGCCGTCGTGGGGCGATGACGATGACGCGCCCTTCGACCCGGCCGCCACGCCGGCAGCGGCGGACCTTGGCGCGGTCGCCGATGCCTTCTGGCGACTGCCCGACGTGGTTCGCAGCCACCACCCGTTTGCCTTCGCGGCGGCGGGACCGCAGGCGCATCGAATCACCGCGGATCCCTTGCCGTTGCCGCCCCATATTCCGGCCAGCCCGGTCGGCCGCGTGCACGAGCTCGATGGACAGGTGCTGCTGCTTGGCGTGGGCCATGACGCCAACACCACGATCCATCTGGCCGAACTGATGGCCGGCGTGCCTTACGGCGTGCCGCATCACTGCACGGTGCTGCGGGACGGCAAGCCGGCTCGCATCGACTATCTCGAAAACGACCACTGCTGCCAGCGCTTCGATCTGGTGGACGGATGGCTCAAGGAAAAGGGCCTTCAGCGTGAAGGCCCAGTTGGCAATGCCGGCGCCCGCTTGATGCGGGCGCGGGACATCGTCGATGTCGTGCGGCAGCAGTTGGCTCGCGATCCGCTCGTCTTCCTGCATCCGCCTCAGGTTGGCTGCGAGGAGTGCGATGCCGCGCGGCGGTCGGTCAGCACCAAGTAG", "partial": "0", "query_start": 22786, "query_end": 22929, "hit_start": 438, "hit_end": 582, "orf_dna_sequence": "ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG", "orf_prot_sequence": "MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR", "perc_identity": 27.08}}, "BGC0000692.1|Apramycin_23 # 23342 # 24379 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697": {"gnl|BL_ORD_ID|1513|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 23342, "orf_end": 24379, "orf_from": "BGC0000692.1|Apramycin_23 ", "model_name": "arnA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "1643", "ARO_accession": "3002985", "ARO_name": "arnA", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.61077e-14, "max_identities": 76, "bit_score": 71.2478, "cvterm_id": "36804", "query": "VLITGGAGYIGSVLTRRLL-DKRVRVRVLDSRIFGDGLRDL-ADPGLENVQGDIR-DADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHP---LVPITD----YNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTVNLLTAQAVGNREIT--------------VFGGAQYRPNVHIDDLVEVYQRLVLDDSLGALNGAPINVGN", "match": "VLI G  G+IG+ L+ RLL D R  V  +D  I  D +  L ADP    V+GDI   ++     ++  DV++ L A+A    +  NP     ++FE    ++R   + G +R V+ S++ VYG+   P+ DE      + PI      Y+  K L + +++            R     G     RLD    L +A+   +R IT              V GGAQ R    +DD +E   R ++D+  G  +G  +N+GN", "sequence_from_db": "VLILGVNGFIGNHLSERLLRDGRYEVHGMD--IGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYG-KRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMG----PRLD---RLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALAR-IIDNRDGRCDGQIVNIGN", "sequence_from_broadstreet": "MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA", "dna_sequence_from_broadstreet": "ATGACCTCGAAAGCCGTCGTCTTCGCCTACCACGACATCGGTTGCACCGGTATCGAAGCCCTGCTCAATGCCGGCTACGAGATCGCCGCCGTCTTCACCCATGCCGACGACCCACGGGAAAACACCTTCTACGCCTCGGTCGCACGCCTCTGCGCCGAGCGCGGCATTCCGCTGCACGCGCCCGAGGACGTGAACCATCCGCTGTGGCTGGAGCGTATCCGCCAACTGCGCCCGGACTTCCTGTTCTCCTTCTACTACCGCCGCCTGCTCGGCGCCGAGCTGCTCGCCTGCGCCGCACGCGGCGCCTACAACCTGCACGGTTCGCTGCTGCCGCGCTACCGCGGACGCGCCCCGGCGAACTGGGTGCTGGTCAACGGCGAAACGCAGACCGGGGTGACCCTGCATCGCATGATCGAGCGCGCCGACGCCGGGCCGATCCTCGCCCAGCAGGCCGTCGCCATCGACCCCGAGGACACCGCCCTGAGCCTGCACGGCAAGCTGCGCAAGGCCGCCGGCGCCCTGCTGCGCGACAGCCTGCCGCTGCTCGCCCTCGGCGTGCTGCCGGAAGTCGAGCAGGACGAGAGCCAGGCCAGCCACTTCGGCCGGCGCACCCCGGCGGACGGCCTGCTCGACTGGCACAGGCCGGCACGGCAGTTGTACGACCTGGTGCGCGCGGTGACCCAGCCCTACCCTGGCGCCTTCTGCCAGGTCGGCGAACAGAAGCTGATCGTCTGGAGCGCCGAGGTGGTCGCCGGCAACCACGGCCGCGAGCCGGGCAGCGTACTGTCCTGCGACCCGCTGCGGATCGCCTGCGGCGAGGACTCGCTGGTGCTGCGCTTCGGCCAGCGCGGCGAGCGCGGCCTGTACCTGGCCGGCACGCAACTGGCCACCGAGCTGGGCCTGGTCGAGGGCGCGCGCCTGCGTGGCGCGGCATGCAGTCCGCAGCGCCGCACGCGGGTGCTGATCCTCGGGGTCAACGGCTTCATCGGCAACCACCTGTCCGAACGCCTGCTGCGCGACGGTCGCTACGAGGTCCACGGCATGGACATCGGCTCCGACGCCATCGAACGGCTCAAGGCCGACCCGCATTTCCACTTCGTCGAAGGCGACATCGGCATCCATTCGGAGTGGCTCGAATACCATGTGAAGAAATGCGACGTGATCCTGCCGCTGGTGGCCATCGCCACGCCCATCGAGTACACGCGCAACCCGCTGCGGGTGTTCGAACTGGACTTCGAGGAAAACCTGCGGATCGTCCGCTACTGCGTGAAATACGGCAAACGCGTGGTGTTCCCTTCCACCTCCGAGGTCTACGGCATGTGCCAGGACCCGGACTTCGACGAAGACCGCTCGAACCTGGTGGTCGGGCCGATCAACAAGCAGCGCTGGATCTACTCGGTGTCCAAGCAGTTGCTCGACCGGGTGATCTGGGCCTACGGCCAGCAGGGCCTGCGCTTCACCCTGTTCCGTCCGTTCAACTGGATGGGCCCGCGCCTGGACCGCCTGGATTCGGCGCGGATCGGCAGCTCGCGGGCGATCACCCAGCTCATCCTGCACCTGGTCGAAGGCACGCCGATCCGCCTGGTCGACGGCGGCGCGCAGAAGCGCTGCTTCACCGACGTCGACGACGGCATCGAGGCCCTCGCGCGGATCATCGACAACCGCGACGGCCGCTGCGACGGGCAGATCGTCAACATCGGCAACCCGGACAACGAGGCGAGCATCCGCCAGCTCGGCGAGGAACTGCTGCGCCAGTTCGAGGCCCACCCGCTGCGCGCGCAGTTCCCGCCCTTCGCCGGCTTCCGCGAGGTGGAGAGCCGCAGCTTCTACGGCGACGGCTACCAGGACGTGGCCCACCGCAAGCCGAGCATCGACAACGCCCGGCGCCTGCTCGACTGGCAGCCCACCATCGAACTGCGCGAGACCATCGGCAAGACCCTCGACTTCTTCCTCCACGAAGCGCTCCGCGAGCGCGAGGCACAGGCGTGA", "partial": "0", "query_start": 23369, "query_end": 24076, "hit_start": 957, "hit_end": 1704, "orf_dna_sequence": "ATGAACAAGCACGCCGGTCCCGGCCTCGTCCTGATCACGGGCGGCGCCGGCTACATCGGCTCGGTCCTCACCCGGCGGCTGCTGGACAAGCGGGTCCGGGTGCGGGTGCTCGACTCGCGGATCTTCGGCGACGGCCTGCGGGACCTCGCCGACCCCGGCCTGGAGAACGTCCAGGGCGACATCCGCGACGCCGACCTGTTCCGGACGGCACTGCGGGACGTCGACGTCGTCGTCCACCTCGCGGCCGTGGCCAACGACCCCAGCTTCGACCTGAACCCCGAGCTGGGCCGCTCGGTGAACTTCGAGTGCCTCGACCACGTCATGCGGCTCTCGAAGGAGGCCGGCGTCCGCCGCTTCGTCTACGCCTCCTCGGCCAGCGTCTACGGGATCAGCGACTCCCCCGAGGTCGACGAGTCCCACCCGCTGGTGCCGATCACCGACTACAACCGGTACAAGGCACTGGGCGAGGAAATCCTCTTCCCCCTCACCGACACCTCGTTCGAGACCGTCGCGCTCCGCGCGGCGACCGTGTGCGGCGTGTCCACCCGCCAGCGCCTCGACCTCACGGTCAACCTGCTGACCGCCCAGGCCGTGGGCAACCGCGAGATCACCGTCTTCGGCGGCGCCCAGTACCGCCCCAACGTCCACATCGACGACCTGGTCGAGGTCTACCAACGACTGGTCCTGGACGACTCGCTGGGCGCCCTCAACGGCGCCCCCATCAACGTCGGCAACGAGAACCTCCCGGTCGCCGACATCGCGAAGGTCATCGCCACCAGGGTCACCGCCAAACTCGGCGCCGAGGTCACCACCACGACCACCCCCACCGACGACCGCCGCTCCTACCGCCTGACCTCCCGCCGCCTCCACCAGCTCCTGGGCATCACCCCCACCCGCACCGTCGCCGACGCCAGCGACGACGTCACCGACGCCATCCTCGACGGCCGCCTCCCCAACCCCCTCACGGAAGCCCGTTACTACAACGTCCGCTGGATGAAAGACCCCCGCAGCCAGGACCTCCTCACCTACACCCCCTGA", "orf_prot_sequence": "MNKHAGPGLVLITGGAGYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQGDIRDADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHPLVPITDYNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTVNLLTAQAVGNREITVFGGAQYRPNVHIDDLVEVYQRLVLDDSLGALNGAPINVGNENLPVADIAKVIATRVTAKLGAEVTTTTTPTDDRRSYRLTSRRLHQLLGITPTRTVADASDDVTDAILDGRLPNPLTEARYYNVRWMKDPRSQDLLTYTP", "perc_identity": 29.23}, "gnl|BL_ORD_ID|3706|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 23342, "orf_end": 24379, "orf_from": "BGC0000692.1|Apramycin_23 ", "model_name": "MYO-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4776", "ARO_accession": "3006954", "ARO_name": "MYO-1", "ARO_category": {"43886": {"category_aro_accession": "3005426", "category_aro_cvterm_id": "43886", "category_aro_name": "MYO beta-lactamase", "category_aro_description": "MYO beta-lactamases are class B1 beta-lactamases found in Myroides odoratimimus.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.91561, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "39072", "query": "LPVADIAKVIATRVTAKLGAEVTTTTTPTDDRRSYRL----TSRRLHQLLGITPTRTVADASDDVTD", "match": "L   D  KV    +      +V    TPTDD+ S  L    T+    +++G+ PT    D    +T+", "sequence_from_db": "LNTDDFGKVACNGMLVLNENKVVVFDTPTDDKSSLELINFVTNTLKSEIIGLIPTHFHDDCIGGITE", "sequence_from_broadstreet": "MKILLAFFLLSSLTFISCKESSSNHNQANQENKKEIINKPLTDSLIVYQTENLIINKLSNHIYEHISFLNTDDFGKVACNGMLVLNENKVVVFDTPTDDKSSLELINFVTNTLKSEIIGLIPTHFHDDCIGGITEFENHNIQTYVSKETIELLKDNGQEFSNPTKDFDNSLTLDIGNKKVYAEYFGEGHTKDNVVGYFPEDNAVFGGCLIKEIDASKGYLGDANIKEWSTTVEKVKLKYPNAKIVIPGHGKWGGIELFDYTIKLFE", "dna_sequence_from_broadstreet": "ATGAAAATATTATTAGCATTCTTTCTTCTTTCAAGTTTGACTTTTATTTCTTGCAAAGAATCATCCTCTAACCACAATCAGGCAAATCAAGAAAACAAGAAGGAAATAATCAATAAACCTTTAACCGACAGCTTGATAGTCTATCAAACCGAAAATCTGATAATTAACAAACTCTCAAATCACATTTATGAACATATTTCCTTTTTAAATACGGACGATTTTGGAAAAGTTGCCTGCAATGGAATGTTAGTTTTAAATGAGAATAAAGTAGTTGTTTTTGATACACCAACAGACGACAAAAGTTCGTTAGAGTTAATAAATTTTGTAACGAATACATTAAAAAGTGAAATTATAGGGCTAATTCCAACTCATTTTCACGATGATTGTATTGGTGGAATAACGGAATTTGAAAACCATAATATTCAAACCTATGTCTCTAAAGAAACTATAGAATTATTAAAAGATAACGGTCAAGAATTCTCTAATCCAACTAAAGATTTTGACAATAGTCTCACATTAGATATCGGAAACAAGAAAGTTTATGCGGAATATTTTGGAGAAGGGCACACTAAAGATAATGTTGTGGGCTATTTCCCAGAAGATAACGCAGTATTCGGTGGATGCTTGATAAAGGAAATTGACGCGAGTAAAGGATATTTAGGAGATGCAAATATTAAAGAATGGTCAACAACAGTAGAAAAAGTAAAACTCAAATATCCCAATGCTAAAATTGTAATACCAGGACACGGAAAATGGGGTGGAATTGAATTATTTGACTACACAATAAAACTATTTGAATAG", "partial": "0", "query_start": 24083, "query_end": 24271, "hit_start": 204, "hit_end": 405, "orf_dna_sequence": "ATGAACAAGCACGCCGGTCCCGGCCTCGTCCTGATCACGGGCGGCGCCGGCTACATCGGCTCGGTCCTCACCCGGCGGCTGCTGGACAAGCGGGTCCGGGTGCGGGTGCTCGACTCGCGGATCTTCGGCGACGGCCTGCGGGACCTCGCCGACCCCGGCCTGGAGAACGTCCAGGGCGACATCCGCGACGCCGACCTGTTCCGGACGGCACTGCGGGACGTCGACGTCGTCGTCCACCTCGCGGCCGTGGCCAACGACCCCAGCTTCGACCTGAACCCCGAGCTGGGCCGCTCGGTGAACTTCGAGTGCCTCGACCACGTCATGCGGCTCTCGAAGGAGGCCGGCGTCCGCCGCTTCGTCTACGCCTCCTCGGCCAGCGTCTACGGGATCAGCGACTCCCCCGAGGTCGACGAGTCCCACCCGCTGGTGCCGATCACCGACTACAACCGGTACAAGGCACTGGGCGAGGAAATCCTCTTCCCCCTCACCGACACCTCGTTCGAGACCGTCGCGCTCCGCGCGGCGACCGTGTGCGGCGTGTCCACCCGCCAGCGCCTCGACCTCACGGTCAACCTGCTGACCGCCCAGGCCGTGGGCAACCGCGAGATCACCGTCTTCGGCGGCGCCCAGTACCGCCCCAACGTCCACATCGACGACCTGGTCGAGGTCTACCAACGACTGGTCCTGGACGACTCGCTGGGCGCCCTCAACGGCGCCCCCATCAACGTCGGCAACGAGAACCTCCCGGTCGCCGACATCGCGAAGGTCATCGCCACCAGGGTCACCGCCAAACTCGGCGCCGAGGTCACCACCACGACCACCCCCACCGACGACCGCCGCTCCTACCGCCTGACCTCCCGCCGCCTCCACCAGCTCCTGGGCATCACCCCCACCCGCACCGTCGCCGACGCCAGCGACGACGTCACCGACGCCATCCTCGACGGCCGCCTCCCCAACCCCCTCACGGAAGCCCGTTACTACAACGTCCGCTGGATGAAAGACCCCCGCAGCCAGGACCTCCTCACCTACACCCCCTGA", "orf_prot_sequence": "MNKHAGPGLVLITGGAGYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQGDIRDADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHPLVPITDYNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTVNLLTAQAVGNREITVFGGAQYRPNVHIDDLVEVYQRLVLDDSLGALNGAPINVGNENLPVADIAKVIATRVTAKLGAEVTTTTTPTDDRRSYRLTSRRLHQLLGITPTRTVADASDDVTDAILDGRLPNPLTEARYYNVRWMKDPRSQDLLTYTP", "perc_identity": 26.87}, "gnl|BL_ORD_ID|742|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 23342, "orf_end": 24379, "orf_from": "BGC0000692.1|Apramycin_23 ", "model_name": "mecC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1250", "model_id": "810", "ARO_accession": "3001209", "ARO_name": "mecC", "ARO_category": {"37589": {"category_aro_accession": "3001208", "category_aro_cvterm_id": "37589", "category_aro_name": "methicillin resistant PBP2", "category_aro_description": "In methicillin sensitive S. aureus (MSSA), beta-lactams bind to native penicillin-binding proteins (PBPs) and disrupt synthesis of the cell membrane's peptidoglycan layer. In methicillin resistant S. aureus (MRSA), foreign PBP2a acquired by lateral gene transfer is able to perform peptidoglycan synthesis in the presence of beta-lactams.", "category_aro_class_name": "AMR Gene Family"}, "35934": {"category_aro_accession": "0000015", "category_aro_cvterm_id": "35934", "category_aro_name": "methicillin", "category_aro_description": "Derived from penicillin to combat penicillin-resistance, methicillin is insensitive to beta-lactamases (also known as penicillinases) secreted by many penicillin-resistant bacteria. Methicillin is bactericidal, and acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.08788, "max_identities": 14, "bit_score": 25.7942, "cvterm_id": "42590", "query": "GYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQG", "match": "GY+G + +  L  K+ R    ++ I   GL  L D  L+N  G", "sequence_from_db": "GYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDG", "sequence_from_broadstreet": "MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ", "dna_sequence_from_broadstreet": "ATGAAAAAAATTTATATTAGTGTGCTAGTTCTTTTACTAATTATGATTATAATAACTTGGTTATTCAAAGATGACGATATTGAGAAAACAATTAGTTCTATTGAAAAAGGAAACTATAACGAAGTATATAAAAATAGTTCAGAAAAATCTAAACTGGCATATGGAGAAGAAGAAATTGTAGATAGGAATAAAAAAATTTACAAAGATTTAAGTGTCAATAACTTAAAAATTACTAATCATGAAATTAAAAAAACTGGAAAAGATAAAAAGCAAGTTGATGTTAAATATAACATATATACAAAATATGGAACTATACGACGTAATACACAATTAAACTTTATTTATGAAGATAAGCATTGGAAATTAGATTGGAGACCAGACGTAATAGTACCTGGTTTGAAAAATGGACAGAAAATTAATATAGAAACATTAAAATCAGAGCGAGGCAAAATAAAAGATAGAAATGGTATAGAATTAGCTAAAACTGGAAATACATATGAAATCGGTATTGTCCCTAACAAAACACCCAAAGAAAAATATGATGATATTGCTCGTGACTTACAAATTGATACAAAAGCTATAACCAATAAAGTTAATCAAAAATGGGTTCAGCCAGATTCATTTGTACCAATTAAAAAGATAAATAAACAAGATGAATATATAGACAAATTAATTAAATCATACAATTTACAAATAAACACTATAAAAAGCCGTGTTTATCCATTGAACGAAGCAACAGTACACCTTTTAGGTTATGTGGGTCCAATTAATTCTGACGAGTTAAAAAGTAAGCAATTTAGAAACTATAGCAAAAATACTGTTATTGGAAAAAAAGGCTTAGAACGCCTCTATGATAAACAATTGCAAAACACTGATGGTTTTAAGGTATCCATTGCAAATACTTATGACAATAAACCTTTAGACACATTATTGGAGAAAAAGGCTGAAAACGGAAAAGATCTTCATTTAACTATAGATGCTAGAGTACAAGAAAGTATTTATAAACATATGAAAAATGACGATGGATCTGGTACAGCATTACAACCAAAAACTGGAGAAATTTTAGCTTTGGTAAGTACCCCATCGTACGATGTTTATCCATTCATGAATGGATTAAGCAATAATGACTACCGTAAATTAACTAACAATAAAAAAGAGCCTTTGCTCAACAAATTTCAAATCACTACATCACCAGGTTCAACCCAAAAAATATTAACATCTATTATAGCCTTAAAAGAAAATAAACTAGACAAAAATACTAATTTTGATATTTATGGTAAGGGTTGGCAAAAAGATGCATCATGGGGGAATTATAATATCACAAGATTTAAAGTAGTAGACGGCAATATCGATTTAAAGCAAGCAATAGAATCATCAGACAACATATTTTTTGCCCGCATTGCATTAGCATTAGGAGCCAAAAAATTTGAGCAAGGTATGCAAGATTTGGGAATCGGTGAAAATATCCCGAGTGATTATCCCTTTTATAAAGCACAAATCTCAAATAGTAATTTAAAAAATGAAATATTATTAGCAGATTCAGGATATGGCCAAGGCGAGATACTAGTAAACCCTATACAAATTTTATCAATATACAGTGCTTTAGAAAATAACGGAAATATACAAAATCCTCATGTTTTACGTAAAACAAAATCTCAAATATGGAAAAAAGATATTATACCTAAAAAAGACATAGATATATTAACTAATGGTATGGAACGTGTAGTTAATAAAACACATAGGGATGATATATACAAAAATTATGCCCGAATTATTGGTAAATCTGGCACAGCAGAATTAAAAATGAATCAAGGGGAAACTGGAAGACAAATAGGTTGGTTTGTTTCATATAATAAAAATAATCCTAATATGTTAATGGCGATTAATGTTAAAGACGTTCAAAATAAAGGGATGGCCAGCTATAATGCTACTATATCTGGAAAAGTTTATGATGATTTGTATGATAATGGAAAAACTCAATTTGATATAGATCAGTAA", "partial": "0", "query_start": 23390, "query_end": 23518, "hit_start": 750, "hit_end": 879, "orf_dna_sequence": "ATGAACAAGCACGCCGGTCCCGGCCTCGTCCTGATCACGGGCGGCGCCGGCTACATCGGCTCGGTCCTCACCCGGCGGCTGCTGGACAAGCGGGTCCGGGTGCGGGTGCTCGACTCGCGGATCTTCGGCGACGGCCTGCGGGACCTCGCCGACCCCGGCCTGGAGAACGTCCAGGGCGACATCCGCGACGCCGACCTGTTCCGGACGGCACTGCGGGACGTCGACGTCGTCGTCCACCTCGCGGCCGTGGCCAACGACCCCAGCTTCGACCTGAACCCCGAGCTGGGCCGCTCGGTGAACTTCGAGTGCCTCGACCACGTCATGCGGCTCTCGAAGGAGGCCGGCGTCCGCCGCTTCGTCTACGCCTCCTCGGCCAGCGTCTACGGGATCAGCGACTCCCCCGAGGTCGACGAGTCCCACCCGCTGGTGCCGATCACCGACTACAACCGGTACAAGGCACTGGGCGAGGAAATCCTCTTCCCCCTCACCGACACCTCGTTCGAGACCGTCGCGCTCCGCGCGGCGACCGTGTGCGGCGTGTCCACCCGCCAGCGCCTCGACCTCACGGTCAACCTGCTGACCGCCCAGGCCGTGGGCAACCGCGAGATCACCGTCTTCGGCGGCGCCCAGTACCGCCCCAACGTCCACATCGACGACCTGGTCGAGGTCTACCAACGACTGGTCCTGGACGACTCGCTGGGCGCCCTCAACGGCGCCCCCATCAACGTCGGCAACGAGAACCTCCCGGTCGCCGACATCGCGAAGGTCATCGCCACCAGGGTCACCGCCAAACTCGGCGCCGAGGTCACCACCACGACCACCCCCACCGACGACCGCCGCTCCTACCGCCTGACCTCCCGCCGCCTCCACCAGCTCCTGGGCATCACCCCCACCCGCACCGTCGCCGACGCCAGCGACGACGTCACCGACGCCATCCTCGACGGCCGCCTCCCCAACCCCCTCACGGAAGCCCGTTACTACAACGTCCGCTGGATGAAAGACCCCCGCAGCCAGGACCTCCTCACCTACACCCCCTGA", "orf_prot_sequence": "MNKHAGPGLVLITGGAGYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQGDIRDADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHPLVPITDYNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTVNLLTAQAVGNREITVFGGAQYRPNVHIDDLVEVYQRLVLDDSLGALNGAPINVGNENLPVADIAKVIATRVTAKLGAEVTTTTTPTDDRRSYRLTSRRLHQLLGITPTRTVADASDDVTDAILDGRLPNPLTEARYYNVRWMKDPRSQDLLTYTP", "perc_identity": 32.56}}, "BGC0000692.1|Apramycin_26 # 26677 # 27489 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.701": {"gnl|BL_ORD_ID|1027|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "FOX-8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1123", "ARO_accession": "3002161", "ARO_name": "FOX-8", "ARO_category": {"36206": {"category_aro_accession": "3000067", "category_aro_cvterm_id": "36206", "category_aro_name": "FOX beta-lactamase", "category_aro_description": "FOX beta-lactamases are plasmid-encoded AmpC-type beta-lactamase which conferred resistance to broad-spectrum cephalosporins and cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.57812, "max_identities": 19, "bit_score": 28.4906, "cvterm_id": "35914", "query": "EGGKGYTQDQLVKLGQAVGISG----GDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTP", "match": "E   GY  D LVK   A+  +G    G+    +    Y+  + +Q+  AGN+PA+  ++     F  P", "sequence_from_db": "EANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSLQANPVTRFAVP", "sequence_from_broadstreet": "MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSLQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE", "dna_sequence_from_broadstreet": "ATGCAACAACGACGTGCGTTCGCGCTACTGACGCTGGGTAGCCTGCTGCTAGCCCCTTGTACTTATGCCAGCGGGGAGGCCCCGCTGACCGCCACTGTGGACGGCATTATCCAGCCGATGCTCAAGGAGTATCGGATCCCGGGGATAGCGGTCGCCGTACTGAAAGATGGCAAGGCCCACTATTTCAACTATGGGGTTGCCAACCGCGAGAGTGGCCAGCGCGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAGACCCTGACCGCGACCCTCGGTGCCTATGCTGCGGTCAAGGGGGGCTTTGTGCTGGATGACAAGGTGAGCCAGCACGCCCCCTGGCTCAAAGGTTCCGCCTTGGATGGTGTGACCATGGCCGAGCTTGCCACCTACAGTGCGGGTGGTTTGCCGCTGCAGTTCCCCGATAAGGTGGATTCGAATGACAAGATGCAAACTTACTATCGGAGCTGGTCACCGGTTTATCCGGCAGGGACTCATCGCCAGTATTCCAACCCCAGCATAGGCCTGTTTGGTCACCTGGCCGCAAATAGTCTGGGCCAGCCATTTGAGCAACTGATGAGCCAGACCCTGCTGCCCAAGCTGGGTTTGCACCACACCTATATCCAGGTGCCGGAGTCGGCCATGGCGAACTATGCCTACGGCTATTCGAAGGAAGATAAGCCCATCCGGGTCACTCCGGGCGTGCTGGCGGCCGAGGCTTACGGGATCAAGACCGGCTCGGCGGATCTGCTGAAGTTTGCCGAGGCAAACATGGGGTATCAGGGAGATGCCCTGGTAAAAAGCGCAATCGCGCTGACCCACACCGGTTTCTACTCGGTGGGGGAAATGACCCAGGGGCTGGGCTGGGAGAGTTACGACTATCCCGTCACCGAGCAGGTGCTGCTGGCGGGCAACTCCCCGGCGGTGAGCCTCCAGGCCAATCCGGTTACGCGCTTTGCGGTGCCCAAAGCGATGGGCGAGCAGCGGCTCTATAACAAGACGGGCTCGACTGGCGGCTTTGGCGCCTATGTGGCGTTCGTGCCCGCCAGAGGGATCGCCATCGTCATGCTGGCCAATCGCAACTATCCCATCGAGGCCAGGGTGAAGGCGGCTCACGCCATCCTGAGTCAGTTGGCCGAGTGA", "partial": "0", "query_start": 27214, "query_end": 27405, "hit_start": 768, "hit_end": 972, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 27.94}, "gnl|BL_ORD_ID|3538|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "FOX-17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4607", "ARO_accession": "3006475", "ARO_name": "FOX-17", "ARO_category": {"36206": {"category_aro_accession": "3000067", "category_aro_cvterm_id": "36206", "category_aro_name": "FOX beta-lactamase", "category_aro_description": "FOX beta-lactamases are plasmid-encoded AmpC-type beta-lactamase which conferred resistance to broad-spectrum cephalosporins and cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.59365, "max_identities": 19, "bit_score": 28.4906, "cvterm_id": "36946", "query": "EGGKGYTQDQLVKLGQAVGISG----GDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTP", "match": "E   GY  D LVK   A+  +G    G+    +    Y+  + +Q+  AGN+PA+  ++     F  P", "sequence_from_db": "EANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVP", "sequence_from_broadstreet": "MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTSSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE", "dna_sequence_from_broadstreet": "ATGCAACAACGACGTGCGTTCGCGCTACTGACGCTGGGTAGCCTGCTGCTAGCCCCTTGTACTTATGCCAGCGGGGAGGCCCCGCTGACCGCCACTGTGGACGGCATTATCCAGCCGATGCTCAAGGAGTATCGGATCCCGGGGATAGCGGTCGCCGTACTGAAAGATGGCAAGGCCCACTATTTCAACTATGGGGTTGCCAACCGCGAGAGTGGCCAGCGCGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAGACCCTGACCGCGACCCTCGGTGCCTATGCTGCGGTCAAGGGGGGCTTTGTGCTGGATGACAAGGTGAGCCAGCACGCCCCCTGGCTCAAAGGTTCCGCCTTGGATGGTGTGACCATGGCCGAGCTTGCCACCTACAGTGCGGGTGGTTTGCCGCTGCAGTTCCCCGATAAGGTGGATTCGAATGACAAGATGCAAACTTACTATCGGAGCTGGTCACCGGTTTATCCGGCAGGGACTCATCGCCAGTATTCCAACCCCAGCATAGGCCTGTTTGGTCACCTGGCCGCAAATAGTCTGGGCCAGCCATTTGAGCAACTGATGAGCCAGACCCTGCTGCCCAAGCTGGGTTTGCACCACACCTATATCCAGGTGCCGGAGTCGGCCATGGCGAACTATGCCTACGGCTATTCGAAGGAAGATAAGCCCATCCGGGTCACTCCGGGCGTGCTGGCGGCCGAGGCTTACGGGATCAAGACCAGCTCGGCGGATCTGCTGAAGTTTGCCGAGGCAAACATGGGGTATCAGGGAGATGCCCTGGTAAAAAGCGCAATCGCGCTGACCCACACCGGTTTCTACTCGGTGGGGGAAATGACCCAGGGGCTGGGCTGGGAGAGTTACGACTATCCCGTCACCGAGCAGGTGCTGCTGGCGGGCAACTCCCCGGCGGTGAGCTTCCAGGCCAATCCGGTTACGCGCTTTGCGGTGCCCAAAGCGATGGGCGAGCAGCGGCTCTATAACAAGACGGGCTCGACTGGCGGCTTTGGCGCCTATGTGGCGTTCGTGCCCGCCAGAGGGATCGCCATCGTCATGCTGGCCAATCGCAACTATCCCATCGAGGCCAGGGTGAAGGCGGCTCACGCCATCCTGAGTCAGTTGGCCGAGTGA", "partial": "0", "query_start": 27214, "query_end": 27405, "hit_start": 768, "hit_end": 972, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 27.94}, "gnl|BL_ORD_ID|71|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "FOX-3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "81", "ARO_accession": "3002157", "ARO_name": "FOX-3", "ARO_category": {"36206": {"category_aro_accession": "3000067", "category_aro_cvterm_id": "36206", "category_aro_name": "FOX beta-lactamase", "category_aro_description": "FOX beta-lactamases are plasmid-encoded AmpC-type beta-lactamase which conferred resistance to broad-spectrum cephalosporins and cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.654241, "max_identities": 19, "bit_score": 28.4906, "cvterm_id": "36788", "query": "EGGKGYTQDQLVKLGQAVGISG----GDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTP", "match": "E   GY  D LVK   A+  +G    G+    +    Y+  + +Q+  AGN+PA+  ++     F  P", "sequence_from_db": "EANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVP", "sequence_from_broadstreet": "MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE", "dna_sequence_from_broadstreet": "ATGCAACAACGACGTGCGTTCGCGCTACTGACGCTGGGTAGCCTGCTGCTAGCCCCTTGTACTTATGCCAGCGGGGAGGCCCCGCTGACCGCCACTGTGGACGGCATTATCCAGCCGATGCTCAAGGAGTATCGGATCCCGGGGATAGCGGTCGCCGTACTGAAAGATGGCAAGGCCCACTATTTCAACTATGGGGTTGCCAACCGCGAGAGTGGCCAGCGCGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAGACCCTGACCGCGACCCTCGGTGCCTATGCTGCGGTCAAGGGGGGCTTTGTGCTGGATGACAAGGTGAGCCAGCACGCCCCCTGGCTCAAAGGTTCCGCCTTGGATGGTGTGACCATGGCCGAGCTTGCCACCTACAGTGCGGGTGGTTTGCCGCTGCAGTTCCCCGATAAGGTGGATTCGAATGACAAGATGCAAACTTACTATCGGAGCTGGTCACCGGTTTATCCGGCAGGGACTCATCGCCAGTATTCCAACCCCAGCATAGGCCTGTTTGGTCACCTGGCCGCAAATAGTCTGGGCCAGCCATTTGAGCAACTGATGAGCCAGACCCTGCTGCCCAAGCTGGGTTTGCACCACACCTATATCCAGGTGCCGGAGTCGGCCATGGCGAACTATGCCTACGGCTATTCGAAGGAAGATAAGCCCATCCGGGTCACTCCGGGCGTGCTGGCGGCCGAGGCTTACGGGATCAAGACCGGCTCGGCGGATCTGCTGAAGTTTGCCGAGGCAAACATGGGGTATCAGGGAGATGCCCTGGTAAAAAGCGCAATCGCGCTGACCCACACCGGTTTCTACTCGGTGGGGGAAATGACCCAGGGGCTGGGCTGGGAGAGTTACGACTATCCCGTCACCGAGCAGGTGCTGCTGGCGGGCAACTCCCCGGCGGTGAGCTTCCAGGCCAATCCGGTTACGCGCTTTGCGGTGCCCAAAGCGATGGGCGAGCAGCGGCTCTATAACAAGACGGGCTCGACTGGCGGCTTTGGCGCCTATGTGGCGTTCGTGCCCGCCAGAGGGATCGCCATCGTCATGCTGGCCAATCGCAACTATCCCATCGAGGCCAGGGTGAAGGCGGCTCACGCCATCCTGAGTCAGTTGGCCGAGTGA", "partial": "0", "query_start": 27214, "query_end": 27405, "hit_start": 768, "hit_end": 972, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 27.94}, "gnl|BL_ORD_ID|900|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "lmrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "974", "ARO_accession": "3002881", "ARO_name": "lmrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37630": {"category_aro_accession": "3001231", "category_aro_cvterm_id": "37630", "category_aro_name": "celesticetin", "category_aro_description": "Produced by Streptomyces caelestis, which also produces the macrolide niddamycin.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.27299, "max_identities": 14, "bit_score": 26.9498, "cvterm_id": "36862", "query": "VGGAERTARKRKQTTQAARAVAAARGGNDRRN", "match": "V GAE+  R+ K+  QAA+  A  R  N +RN", "sequence_from_db": "VRGAEQELRRHKREAQAAQERAQRRASNAKRN", "sequence_from_broadstreet": "MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK", "dna_sequence_from_broadstreet": "ATGGCTGACGCGAGTATTGTCTGCACCAATCTCTCCTTCTCCTGGCCCGACGAGACGCCGGTCTTCGACGGGTTGTCCTTTGCCCTCGGCGCCGGCCGTTGCGGCCTCGTGGGCCCCAATGGCGCGGGAAAGTCCACACTGTTGCGGCTCGCCGTAGGGGAACTCACCCCTACCGCAGGCTCGATCACCGCGCAGGGACATGTCGGGTACCTGCCGCAGTCCCTGCCGCTGATCGACGGCACCGTCGACGAGGCCCTGGAGATCGCCTCCATCCGGGCGGCTCTGCATGCCATCGAGTCAGGTGACGTGGACGAGGCGCACTTCACCACTGTGGGCGATCACTGGGACATCGAGGAACGCACCACGATCGTCCTGGACCGTCTGGGTCTCGGCGACGTGTCCCTTGACCGCCCGCTTCGCTCCCTCAGCGGCGGCCAGGTCCTCGCCATCGGCCTGGCCGCGCAGCTCCTGAAGCGACCCGACGTGCTGATCCTCGACGAACCCACCAACAACCTTGACCTGGCCGCCCGGCAGCGGCTCTACCAGGTCGTCGAAGAGTGGAAGGGGGCCCTCCTCGTCGTCAGCCACGACCGGGAGCTCCTGGACCGCGTAGACACCATCGCCGAGCTGCAGGCATCCGAACTCCGCCTCTACGGTGGCAACTTCACCGCCTACACGGAAGCCGTCGAGCTGGAACAGGAGAACGTGCAGCGCGCGGTGCGCGGGGCGGAGCAGGAGTTGCGCCGCCACAAGCGCGAGGCGCAGGCGGCCCAGGAGCGGGCCCAGCGCCGGGCCAGCAACGCCAAGCGCAACAAGGCTTCGTCGGGGGTGCCCCGTATCCACGCGGGCGCCCTTCAGCGACAGGCTCAGGAATCGGCGGGCCGCGCCGCCTCGGTGCACCAGGACCGGGTGTCCCAGGCCAAGGCCAAGCTGGACGAGGCCAGTCAGGGGATGCGTGAGGAAGCGCGCCTGGCGATCACCCTTCCGCAGACCTCGGTCCCGGCCGGACGCACCGTGTTGACGTGCCATGAGGCCAATGTCCGGTACGGGGAACGGACGTTGTTCACCGGCTCGGGCGTCGACCTCGGGATCCGCGGGCCGGAGCGGATCGCGCTGCTCGGGCCCAACGGCTCGGGCAAGTCAACGCTGTTGAAGCTGATCGCCGGCGAGCTCGAACCCTCCTCGGGGACGGTCACGGCGCCGACGGACCGGGTGTCCTATCTCTCGCAGCGCCTCGATCTGCTCGACTTGGACGCCAGCGTCCTGGACAACCTGCGCCGTTTCGCCCCGCATCTGCAGGACGGCGAAGTCCGCTACCGCCTGGCGCAGTTCCTCTTCCGCGGCGACCGAGTTCATCGCACCGCCGGATGGCTCTCCGGCGGTGAGCGGCTGCGCGCGACCCTGGCGTGTGTCCTGTCCACGGACCCTGCCCCTCAGCTGCTCCTGCTGGACGAGCCGACGAACAACCTCGACCTCAACAGTGCCGCCCAGCTGGAGAACGCGCTCAACGCCTTCCAGGGCGCCTTCGTAGTCGTCAGCCACGACCAGGCGTTCCTGCGCGCCATCGGTGTCTCGCGCTGGCTGCGCCTGGCGGACGGAACCCTGGAGGAGATCGCGGAGGCGGACGACGCGTGGCCTCATCGGGATAAGTGA", "partial": "0", "query_start": 26686, "query_end": 26781, "hit_start": 717, "hit_end": 813, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3193|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "ADC-178", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4246", "ARO_accession": "3006350", "ARO_name": "ADC-178", "ARO_category": {"43920": {"category_aro_accession": "3005460", "category_aro_cvterm_id": "43920", "category_aro_name": "ADC beta-lactamases pending classification for carbapenemase activity", "category_aro_description": "ADC beta-lactamases with undetermined carbapenemase activity.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.88353, "max_identities": 19, "bit_score": 26.5646, "cvterm_id": "35507", "query": "QYPTKVEDDGTVLA--GNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSN", "match": "Q+P +V+ D  VL    +   K ++  Y  +  P+ G FEK+    + K       K  +  L L   Y N", "sequence_from_db": "QFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFEKVVALSMNKPFDQVLEKTIFPALGLKHSYVN", "sequence_from_broadstreet": "MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFEKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK", "dna_sequence_from_broadstreet": "ATGCGATTTAAAAAAATTTCTTGTCTACTTTTATCCCCGCTTTTTATTTTTAGTACCTCAATTTATGCGGGCAATACACCAAAAGACCAAGAAATTAAAAAACTGGTAGATCAAAACTTTAAACCGTTATTAGAAAAATATGATGTGCCAGGTATGGCTGTGGGTGTTATTCAAAATAATAAAAAGTATGAAATGTATTATGGTCTTCAATCTGTTCAAGATAAAAAAGCCGTAAATAGCAGTACTATTTTTGAGCTAGGTTCTGTCAGTAAATTATTTACCGCGACAGCAGGTGGATATGCAAAAAATAAAGGAAAAATCTCTTTTGACGATACGCCTGGTAAGTATTGGAAAGAACTAAAAAATACACCGATTGACCAAGTTAACTTACTTCAACTCGCGACGTATACAAGTGGTAACCTTGCCTTGCAATTTCCAGATGAAGTAAAAACAGATCAGCAAGTTTTAACATTTTTTAAAGACTGGAAACCTAAAAACTCAATCGGTGAATATCGACAATATTCAAACCCAAGCATTGGTTTATTTGAAAAAGTTGTAGCTTTGTCTATGAATAAACCTTTCGACCAAGTCTTAGAAAAAACAATTTTTCCGGCCCTTGGCTTAAAACATAGCTATGTAAATGTACCTAAGACCCAGATGCAAAACTATGCTTTTGGCTATAACCAAGAAAATCAGCCGATTCGAGTTAACCCCGGCCCACTCGATGCCCCAGCATATGGCGTCAAATCGACACTACCCGACATGTTGAGTTTTATTCATGCCAACCTAAATCCACAAAAATATCCAGCAGATATTCAACGGGCAATTAATGAAACACATCAGGGTCGCTATCAAGTAAATACCATGTATCAGGCACTCGGTTGGGAAGAGTTTTCTTATCCGGCAACGTTACAAACTTTATTAGACAGTAATTCAGAACAGATTGTGATGAAACCTAATAAAGTGACTGCTATTTCAAAGGAACCTTCAGTTAAGATGTACCATAAAACTGGCTCAACTAACGGTTTCGGAACATATGTGGTGTTTATTCCTAAAGAAAATATTGGTTTAGTCATGTTAACCAATAAACGTATTCCAAATGAAGAGCGCATTAAGGCAGCTTATGCTGTGCTGAATGCAATAAAGAAATAA", "partial": "0", "query_start": 26905, "query_end": 27111, "hit_start": 429, "hit_end": 642, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 26.76}, "gnl|BL_ORD_ID|3537|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "FOX-16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4606", "ARO_accession": "3006474", "ARO_name": "FOX-16", "ARO_category": {"36206": {"category_aro_accession": "3000067", "category_aro_cvterm_id": "36206", "category_aro_name": "FOX beta-lactamase", "category_aro_description": "FOX beta-lactamases are plasmid-encoded AmpC-type beta-lactamase which conferred resistance to broad-spectrum cephalosporins and cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.20115, "max_identities": 19, "bit_score": 25.409, "cvterm_id": "35915", "query": "EGGKGYTQDQLVKLGQAVGISG----GDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTP", "match": "E   GY  D  VK   A+  +G    GD    +    Y   + +Q   AGN+PA+  ++     F  P", "sequence_from_db": "EANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTEQTLLAGNSPAVSFQANPVTRFAVP", "sequence_from_broadstreet": "MQQRCAFALLTLVSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDNVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTEQTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE", "dna_sequence_from_broadstreet": "ATGCAACAAAGATGTGCGTTCGCGCTACTGACGCTGGTTAGCCTGCTGCTAGCCCCTTGTACTTATGCCAGCGGGGAGGCCCCGCTGACCGCCACTGTGGACGGCATTATCCAGCCGATGCTCAAGGAGTATCGGATCCCGGGGATGGCGGTCGCCGTACTGAAAGATGGCAAGGCCCACTATTTCAACTATGGGGTTGCCAACCGCGAGAGTGGCCAGCGCGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAGACCCTGACCGCGACCCTCGGTGCCTATGCCGCGGTCAAGGGGGGCTTTGTGCTGGATGACAATGTGAGCCAGCACGCCCCTTGGCTCAAAGGTTCCGCCTTGGATGGTGTGACCATGGCCGAGCTTGCCACCTACAGTGCGGGTGGTTTGCCGCTGCAGTTCCCCGATGAGGTAGATTCGAATGACAAGATGCGCACTTACTATCGGAGCTGGTCACCGGTTTATCCGGCGGGGACCCATCGCCAGTATTCCAACCCCAGCATAGGCCTGTTTGGTCACCTGGCCGCAAATAGTCTGGGCCAGCCATTTGAGCAACTGATGAGCCAGACCCTGCTGCCCAAGCTGGGTTTGCACCACACCTATATTCAGGTGCCGGAGTCGGCCATAGCGAACTATGCCTACGGCTATTCGAAGGAAGATAAGCCCGTCCGGGTCACTCCGGGCGTGCTGGCGGCCGAGGCTTACGGGATCAAGACCGGCTCGGCGGATCTGCTGAAGTTTGCCGAGGCAAACATGGGGTATCAGGGAGATGCCGCGGTAAAAAGCGCGATCGCGCTGACCCACACCGGTTTCTACTCGGTGGGAGACATGACTCAGGGACTGGGCTGGGAGAGTTACGCCTATCCGGTGACCGAGCAGACATTGCTGGCGGGCAATTCACCAGCGGTGAGCTTCCAGGCCAATCCGGTTACGCGCTTTGCGGTGCCCAAAGCGATGGGCGAGCAGCGGCTCTATAACAAGACGGGCTCGACTGGCGGCTTTGGCGCCTATGTGGCGTTCGTGCCCGCCAGAGGGATCGCCATCGTCATGCTGGCCAATCGCAACTATCCCATCGAGGCTAGGGTGAAGGCGGCTCACGCCATCCTGAGTCAGTTGGCCGAGTGA", "partial": "0", "query_start": 27214, "query_end": 27405, "hit_start": 768, "hit_end": 972, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 27.94}, "gnl|BL_ORD_ID|916|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 26677, "orf_end": 27489, "orf_from": "BGC0000692.1|Apramycin_26 ", "model_name": "FOX-9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "990", "ARO_accession": "3002163", "ARO_name": "FOX-9", "ARO_category": {"36206": {"category_aro_accession": "3000067", "category_aro_cvterm_id": "36206", "category_aro_name": "FOX beta-lactamase", "category_aro_description": "FOX beta-lactamases are plasmid-encoded AmpC-type beta-lactamase which conferred resistance to broad-spectrum cephalosporins and cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.979, "max_identities": 18, "bit_score": 25.0238, "cvterm_id": "35915", "query": "EGGKGYTQDQLVKLGQAVGISG----GDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTP", "match": "E   GY  D  VK   A+  +G    GD    +    Y+  + +Q+  A N+PA+  ++     F  P", "sequence_from_db": "EANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTEQVLLADNSPAVSFQANPVTRFAVP", "sequence_from_broadstreet": "MQQRRAFALLTLGSLLLAPCTYASGEAPLTVTVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPEEVDSNDKMRTYYRSWSPVYPAGTHRQYANTSIGLFGYLAANSLGQSFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEEKPIRVTPGMLAAEAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTEQVLLADNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE", "dna_sequence_from_broadstreet": "ATGCAACAACGACGTGCGTTCGCGCTACTGACGCTGGGTAGCCTGCTGTTAGCCCCTTGTACCTATGCCAGCGGGGAGGCCCCGCTGACCGTCACTGTGGACGGCATTATCCAGCCGATGCTCAAGGCGTATCGGATCCCGGGGATGGCGGTCGCCGTACTGAAAGATGGCAAGGCCCACTATTTCAACTATGGGGTTGCCAACCGCGAGAGTGGTCAGCGCGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAAACCCTGACCGCGACCCTTGGCGCTTATGCAGCGGTCAAGGGAGGCTTTGAGCTGGATGACAAGGTGAGCCAGCACGCCCCCTGGCTGAAAGGTTCCGCCTTTGATGGGGTGACCATGGCCGAGCTTGCCACCTACAGTGCGGGTGGTTTGCCGCTGCAGTTCCCCGAAGAGGTGGATTCGAATGACAAGATGCGCACTTACTATCGGAGTTGGTCACCGGTTTATCCGGCGGGGACCCACCGTCAGTACGCCAATACCAGTATCGGTCTGTTCGGCTATCTGGCTGCCAACTCCCTGGGCCAGTCATTTGAGCAACTGATGAGCCAGACCCTGCTGCCCAAGCTGGGTTTGCACCACACCTATATCCAGGTGCCGGAGTCGGCCATGGCGAACTATGCCTACGGCTATTCGAAGGAAGAGAAGCCCATCCGGGTCACTCCGGGCATGCTGGCGGCCGAGGCTTACGGGATCAAGACCGGTTCGGCGGATCTGCTGAAGTTTGCCGAGGCAAACATGGGGTATCAGGGAGATGCCGCGGTAAAAAGCGCGATCGCGCTGACCCACACCGGTTTCTACTCGGTGGGAGACATGACTCAGGGGCTGGGCTGGGAGAGTTACGACTATCCCGTCACCGAGCAGGTGCTGCTGGCGGACAACTCACCAGCGGTGAGCTTCCAGGCCAATCCGGTTACGCGTTTTGCTGTGCCCAAAGCGATGGGCGAGCAGCGGCTCTATAACAAGACGGGCTCGACCGGCGGCTTTGGCGCCTATGTGGCGTTCGTGCCCGCCAGAGGGATAGCCATCGTCATGCTGGCCAATCGCAACTATCCCATCGAGGCCAGGGTGAAGGCGGCTCACGCCATCCTGAGTCAGTTGGCCGAGTGA", "partial": "0", "query_start": 27214, "query_end": 27405, "hit_start": 768, "hit_end": 972, "orf_dna_sequence": "ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA", "orf_prot_sequence": "MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG", "perc_identity": 26.47}}, "BGC0000692.1|Apramycin_28 # 28268 # 28969 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745": {"gnl|BL_ORD_ID|165|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 28268, "orf_end": 28969, "orf_from": "BGC0000692.1|Apramycin_28 ", "model_name": "arlS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "880", "model_id": "182", "ARO_accession": "3000839", "ARO_name": "arlS", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.45263, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "35511", "query": "MGLTRPTAERVAAE---VHANPELAVRVHVTQELGVNPDEQ", "match": "+ LT+     +++E   VH N E+  R+H  ++L  +PD Q", "sequence_from_db": "LELTKGDVNDISSEAQTVHINDEIRSRIHSLKQL--HPDYQ", "sequence_from_broadstreet": "MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF", "dna_sequence_from_broadstreet": "ATGACAAAACGTAAATTGCGCAATAACTGGATTATTGTTACCACGATGATTACGTTTGTCACGATATTTTTGTTTTGTTTAATTATTATTTTTTTCTTGAAAGATACACTGCATAATAGTGAGCTTGATGATGCAGAACGAAGCTCAAGCGATATTAATAATTTATTTCATTCTAAGCCTGTTAAAGATATATCTGCATTAGACTTGAATGCATCTTTAGGTAATTTTCAAGAGATAATTATTTATGATGAGCATAATAATAAATTATTTGAGACATCGAATGATAACACAGTGAGAGTTGAACCAGGTTATGAACACCGTTATTTTGACCGCGTAATAAAAAAACGCTATAAAGGCATTGAATATTTAATTATTAAAGAACCAATTACAACGCAAGATTTCAAAGGGTATAGCTTGTTAATTCATTCACTAGAAAATTATGATAACATCGTAAAATCATTGTATATCATTGCGCTGGCATTTGGAGTGATTGCAACAATTATAACTGCCACAATCAGTTATGTATTTTCAACACAAATTACTAAACCGCTTGTCAGTTTATCAAATAAAATGATTGAGATTCGACGAGATGGTTTTCAAAATAAATTGCAATTAAATACAAATTATGAAGAAATAGATAATTTAGCAAATACGTTTAATGAGATGATGAGCCAAATTGAAGAATCATTTAATCAACAAAGACAATTTGTTGAAGATGCGTCACATGAATTACGAACACCATTACAAATTATTCAAGGTCATTTAAATTTGATTCAGCGATGGGGAAAAAAAGACCCAGCAGTATTAGAAGAATCGTTAAATATTTCTATTGAAGAAATGAATCGTATCATAAAATTAGTCGAAGAATTACTTGAATTGACTAAAGGAGATGTAAATGACATTTCTTCTGAAGCACAGACCGTGCATATTAATGATGAAATTCGCTCGCGAATACACTCATTAAAACAATTGCATCCTGATTATCAATTTGATACGGATCTGACATCTAAAAATCTAGAAATTAAAATGAAACCTCATCAATTCGAACAATTATTTTTAATCTTTATTGATAATGCAATCAAATATGATGTGAAGAATAAGAAAATTAAAGTTAAGACAAGGTTAAAAAATAAGCAAAAAATAATTGAAATTACAGATCATGGAATTGGTATTCCAGAGGAAGATCAAGATTTCATTTTTGATCGCTTTTATCGAGTGGATAAATCTCGTTCAAGAAGTCAAGGCGGTAATGGACTCGGATTATCTATTGCTCAAAAAATCATTCAATTAAACGGAGGATCGATTAAAATTAAAAGTGAAATTAACAAAGGAACAACGTTTAAAATCATATTTTAA", "partial": "0", "query_start": 28589, "query_end": 28702, "hit_start": 870, "hit_end": 987, "orf_dna_sequence": "GTGGGCCACGGGGAAATCGGGCACATCCACTCCGACGTCTCCGGGGGCTGGCTGCGGCCGGCGGTCTTCGGCGCGATGGACGGCCTGGTCACCAACATCGCGCTGGTGGCCGGCGTCGGGGGCGGCGGGGCCGGACCCGACGTGGTCGTGCTGTCCGGGGTGGCCGGCCTGGTCGCCGGAGCCCTCTCGATGGCGATCGGCGAGTACACGTCGGTGGAGACCCAGAACGACGCGGTGCGCGCCGAGGTCGCGGTGGAACGGGCGGAACTGCGCGACAACCCCGAAGGGGAGCGGGCCGAACTGGTCGAGGCGTACGTCGCGATGGGGCTGACCCGGCCGACGGCCGAGCGCGTGGCCGCCGAGGTCCACGCGAACCCGGAGCTCGCGGTGCGGGTTCACGTCACCCAGGAGCTGGGCGTCAATCCGGACGAACAGCCCTCGCCGTGGACGGCCGCCCTCCTGTCCTTCCTCTGCTTCTCCCTCGGCGCGCTGACCCCGCTGGCGCCGTTCCTCCTCGGGTTCGCCTCGCTGCCGGCCGGCCTGCTCGTCGGCGGCGCGGGGCTGTTCGTCGCCGGCGCCCTGGTCGCGCGGTGGACGACTCGTTCGTGGTGGCGCAACGGCCTGCGGCAGCTCGCCCTCGGCGCGCTCGCGGCGGTCGCCACCTTCCTCGTCGGCTCGGTCGTCGGCGTCGTCACGACCTGA", "orf_prot_sequence": "MGHGEIGHIHSDVSGGWLRPAVFGAMDGLVTNIALVAGVGGGGAGPDVVVLSGVAGLVAGALSMAIGEYTSVETQNDAVRAEVAVERAELRDNPEGERAELVEAYVAMGLTRPTAERVAAEVHANPELAVRVHVTQELGVNPDEQPSPWTAALLSFLCFSLGALTPLAPFLLGFASLPAGLLVGGAGLFVAGALVARWTTRSWWRNGLRQLALGALAAVATFLVGSVVGVVTT", "perc_identity": 31.71}}, "BGC0000692.1|Apramycin_29 # 29198 # 29896 # 1 # ID=1_29;partial=01;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.758": {"gnl|BL_ORD_ID|4591|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 29198, "orf_end": 29896, "orf_from": "BGC0000692.1|Apramycin_29 ", "model_name": "SPR-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "575", "model_id": "5661", "ARO_accession": "3006996", "ARO_name": "SPR-1", "ARO_category": {"43908": {"category_aro_accession": "3005448", "category_aro_cvterm_id": "43908", "category_aro_name": "SPR beta-lactamase", "category_aro_description": "SPR beta-lactamases are class B beta-lactamases found in Serratia proteamaculans.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.78766, "max_identities": 17, "bit_score": 24.6386, "cvterm_id": "35506", "query": "GALVVNVTDDGAADEVRRSGATAKKVDRGVTDLNA---AKARLDQAGKAARGASW", "match": "G ++++   D +A  +R   A  + +   + DL     + ARLDQAG  AR   W", "sequence_from_db": "GLILIDAALDASAPAIR---AHIEALGFNIKDLRYILNSHARLDQAGGIARLQVW", "sequence_from_broadstreet": "MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARLQVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALMTPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQQADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM", "dna_sequence_from_broadstreet": "ATGAAAAAAAACCTTGGTTATCTGACGGCTATGACGGTTGCTCTGTGTTTCGGCGCTCAGGCGCAGCTTAATCCGGCACAGCCGTTGTCCAGTGCGCCGCCCTATTCGCTTTTTGAACAGTGGGCGCAGCCGGTCGCGCCATTTCAGATGTTCCCGCATGTTTATTACGTGGGCACCCGCAACCTATCGTCCGTGCTGCTGAGCACGCCGGAAGGACTGATTCTGATCGACGCCGCGCTGGACGCCAGCGCTCCGGCAATAAGAGCGCACATAGAGGCTTTGGGTTTTAACATCAAGGATCTGCGCTATATCCTCAATAGTCACGCGCGTCTCGATCAGGCGGGTGGCATTGCGCGTCTGCAAGTCTGGAGCGGGGCAAAAGTTGTCGCCAGCGCTGCCAATGCCCAACAGTTGGCGCTTGGCGGCAAACAGGATTTTGCTCTGGGAGATGCGCTGAGCTTCCCGCCGGTGAAGGTCGATATTATCGTCGGGGAGGGGGACAGCATTACCTTGGGCGACCTGAAATTAACGGCATTGATGACGCCAGGCCATTTGCCGGGGGCCACCTCGTGGCTGACCACGCTACATCAGGGAGGGCAAAGTTACCGACTGGTCTATGCTGATAGCCTGGCAACGCCGGACTACTATCTGATCGACAACAAAAACTACCCCAGTCTGGTGCAGGATATCCGTGGCAGTTTTGCTCGGTTGGCTCAGCAGCAGGCGGATATTTTTATCGTCAATAAGGGAACGCGCTTCGATCTGGATAATAAAATGCAACGCCTGCAGGCTGGCGATCTGGATGCGTTTGTCGATCGTCAGGGGTTGCAGCAATATGTGCAACAGTCACAACAGACATTTGAGGCGCAGTTAAAACAGCAACAAAGTAAAATGTGA", "partial": "0", "query_start": 29486, "query_end": 29641, "hit_start": 213, "hit_end": 369, "orf_dna_sequence": "ATGTCCGCACGCACCAGACTGCGGGGTCGAACACTCGGCGTCGCCGCCACCCTCGCGGCGCTGGCCGCCGTCGCGCTCACCGGCGCGGCCGGCTCCGCGGTCGCCGCGCCCGCCGAGCAGCTCTCCGGCGGCCAGCTCGCCGCCGTGGACTACCTGAGCGGCCGGGGCCTCGACCGGGCCGAGGCGGTGCGCCGGGTGCTCGCCCAGGAGGGGCAGACCCGCACCGCGACCCAGCTCGCCGACAAGCTCGGCGCGCGGGTGGCCGGCTCCTACGTCGACCAGGGATCGGGCGCCCTGGTCGTCAACGTCACCGACGACGGCGCGGCCGACGAGGTGCGCCGCTCCGGCGCGACGGCGAAGAAGGTCGACCGCGGCGTCACGGACCTCAACGCGGCCAAGGCCAGGCTCGACCAGGCCGGCAAGGCCGCGCGGGGCGCGAGCTGGTACGTCGACGTGCCGAACAACCAGGTCGTGGTCCAGGCTCCCGCCGGCGACAGCTCGGCCGGCGTGACCGACCTGCTGCGCACGGCGGAGGCGCTGGGCGGCACGGCCCGCGTGGAGCGCGTCCAGGGCAAGGCCACCACCCAGGCCACCAACCTCTACGGCGGCCAGCAGATCGAGTTCAGCGTCAACGGCAGCGGCTACGTGTGCTCGGACGGCTTCAACGCCACCGACCGCTCCGGCCGGGCCGTGATGATC", "orf_prot_sequence": "MSARTRLRGRTLGVAATLAALAAVALTGAAGSAVAAPAEQLSGGQLAAVDYLSGRGLDRAEAVRRVLAQEGQTRTATQLADKLGARVAGSYVDQGSGALVVNVTDDGAADEVRRSGATAKKVDRGVTDLNAAKARLDQAGKAARGASWYVDVPNNQVVVQAPAGDSSAGVTDLLRTAEALGGTARVERVQGKATTQATNLYGGQQIEFSVNGSGYVCSDGFNATDRSGRAVMI", "perc_identity": 30.91}}, "BGC0000692.1|Apramycin_27 # 27495 # 28037 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748": {"gnl|BL_ORD_ID|1955|hsp_num:0": {"type_match": "Loose", "snp": {"original": "S", "change": "L", "position": 303}, "query_snp": {"original": "S", "change": "L", "position": 24}, "orf_strand": "-", "orf_start": 27495, "orf_end": 28037, "orf_from": "BGC0000692.1|Apramycin_27 ", "model_name": "Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 1400, "model_id": "1176", "ARO_accession": "3003392", "ARO_name": "Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid", "ARO_category": {"40000": {"category_aro_accession": "3003416", "category_aro_cvterm_id": "40000", "category_aro_name": "isoniazid resistant katG", "category_aro_description": "Bifunctional enzyme with both catalase and broad-spectrum peroxidase activity. It is a catalase-peroxidases that catalyzes the activation of isoniazid. Mutations that arises within this protein cause changes that results in the inability for katG to activate antibiotics, conferring resistance.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.98955, "bit_score": 23.8682, "max_identities": 11, "cvterm_id": "39507", "query": "PDALAGPVAAVLPFVELGLGVLVLFGVGT", "match": "P  L GP     P  ++GLG    +G GT", "sequence_from_db": "PADLVGPEPEAAPLEQMGLGWKSSYGTGT", "sequence_from_broadstreet": "MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR", "dna_sequence_from_broadstreet": "GTGCCCGAGCAACACCCACCCATTACAGAAACCACCACCGGAGCCGCTAGCAACGGCTGTCCCGTCGTGGGTCATATGAAATACCCCGTCGAGGGCGGCGGAAACCAGGACTGGTGGCCCAACCGGCTCAATCTGAAGGTACTGCACCAAAACCCGGCCGTCGCTGACCCGATGGGTGCGGCGTTCGACTATGCCGCGGAGGTCGCGACCATCGACGTTGACGCCCTGACGCGGGACATCGAGGAAGTGATGACCACCTCGCAGCCGTGGTGGCCCGCCGACTACGGCCACTACGGGCCGCTGTTTATCCGGATGGCGTGGCACGCTGCCGGCACCTACCGCATCCACGACGGCCGCGGCGGCGCCGGGGGCGGCATGCAGCGGTTCGCGCCGCTTAACAGCTGGCCCGACAACGCCAGCTTGGACAAGGCGCGCCGGCTGCTGTGGCCGGTCAAGAAGAAGTACGGCAAGAAGCTCTCATGGGCGGACCTGATTGTTTTCGCCGGCAACTGCGCGCTGGAATCGATGGGCTTCAAGACGTTCGGGTTCGGCTTCGGCCGGGTCGACCAGTGGGAGCCCGATGAGGTCTATTGGGGCAAGGAAGCCACCTGGCTCGGCGATGAGCGTTACAGCGGTAAGCGGGATCTGGAGAACCCGCTGGCCGCGGTGCAGATGGGGCTGATCTACGTGAACCCGGAGGGGCCGAACGGCAACCCGGACCCCATGGCCGCGGCGGTCGACATTCGCGAGACGTTTCGGCGCATGGCCATGAACGACGTCGAAACAGCGGCGCTGATCGTCGGCGGTCACACTTTCGGTAAGACCCATGGCGCCGGCCCGGCCGATCTGGTCGGCCCCGAACCCGAGGCTGCTCCGCTGGAGCAGATGGGCTTGGGCTGGAAGAGCTCGTATGGCACCGGAACCGGTAAGGACGCGATCACCAGCGGCATCGAGGTCGTATGGACGAACACCCCGACGAAATGGGACAACAGTTTCCTCGAGATCCTGTACGGCTACGAGTGGGAGCTGACGAAGAGCCCTGCTGGCGCTTGGCAATACACCGCCAAGGACGGCGCCGGTGCCGGCACCATCCCGGACCCGTTCGGCGGGCCAGGGCGCTCCCCGACGATGCTGGCCACTGACCTCTCGCTGCGGGTGGATCCGATCTATGAGCGGATCACGCGTCGCTGGCTGGAACACCCCGAGGAATTGGCCGACGAGTTCGCCAAGGCCTGGTACAAGCTGATCCACCGAGACATGGGTCCCGTTGCGAGATACCTTGGGCCGCTGGTCCCCAAGCAGACCCTGCTGTGGCAGGATCCGGTCCCTGCGGTCAGCCACGACCTCGTCGGCGAAGCCGAGATTGCCAGCCTTAAGAGCCAGATCCGGGCATCGGGATTGACTGTCTCACAGCTAGTTTCGACCGCATGGGCGGCGGCGTCGTCGTTCCGTGGTAGCGACAAGCGCGGCGGCGCCAACGGTGGTCGCATCCGCCTGCAGCCACAAGTCGGGTGGGAGGTCAACGACCCCGACGGGGATCTGCGCAAGGTCATTCGCACCCTGGAAGAGATCCAGGAGTCATTCAACTCCGCGGCGCCGGGGAACATCAAAGTGTCCTTCGCCGACCTCGTCGTGCTCGGTGGCTGTGCCGCCATAGAGAAAGCAGCAAAGGCGGCTGGCCACAACATCACGGTGCCCTTCACCCCGGGCCGCACGGATGCGTCGCAGGAACAAACCGACGTGGAATCCTTTGCCGTGCTGGAGCCCAAGGCAGATGGCTTCCGAAACTACCTCGGAAAGGGCAACCCGTTGCCGGCCGAGTACATGCTGCTCGACAAGGCGAACCTGCTTACGCTCAGTGCCCCTGAGATGACGGTGCTGGTAGGTGGCCTGCGCGTCCTCGGCGCAAACTACAAGCGCTTACCGCTGGGCGTGTTCACCGAGGCCTCCGAGTCACTGACCAACGACTTCTTCGTGAACCTGCTCGACATGGGTATCACCTGGGAGCCCTCGCCAGCAGATGACGGGACCTACCAGGGCAAGGATGGCAGTGGCAAGGTGAAGTGGACCGGCAGCCGCGTGGACCTGGTCTTCGGGTCCAACTCGGAGTTGCGGGCGCTTGTCGAGGTCTATGGCGCCGATGACGCGCAGCCGAAGTTCGTGCAGGACTTCGTCGCTGCCTGGGACAAGGTGATGAACCTCGACAGGTTCGACGTGCGCTGA", "partial": "0", "query_start": 27648, "query_end": 27734, "hit_start": 837, "hit_end": 924, "orf_dna_sequence": "ATGGCTGTCGGAATGCCCGCCCGCCGGTCGGTCGGGGACCTGCTCGGCACGCTGGTCCGGTTCGGACTGGCCGCGGTCTGGCTCGTCTCCGGCGCGATCAAGGCCGCGGCCCCGGAGCGGACCTACCTGTCCGTGCAGGCGTTCCGGGTGCTGCCGGACGCCCTGGCCGGGCCGGTGGCGGCCGTGCTGCCGTTCGTCGAGCTGGGACTCGGCGTCCTGGTGCTGTTCGGCGTGGGCACGCGCGTCGTCGCGGCGTTGTCCTGCCTGGTGCTGCTCGCGTTCGTCGCCGGCATCACGCAGGCGTGGGCACGGGGGCTGAGCATCGACTGCGGGTGCTTCGGCGGCGGCGGCGACGTCGCCCCCGGCGAGACCCGCTACCCCGAGGAACTGGCCAGGGACACCGGTTTCCTGGCGCTGGCCGTCTGGCTGCTCGTCCGGCCGCGCTCGCTGCTGTCCGTCGACGGCTGGCTGGGCCTGGGCCGTCCGGCGCGCGACGGGGATGATGGTGACGACCGGGACGAACCCGTCCCGGCCGAGTCGTAG", "orf_prot_sequence": "MAVGMPARRSVGDLLGTLVRFGLAAVWLVSGAIKAAAPERTYLSVQAFRVLPDALAGPVAAVLPFVELGLGVLVLFGVGTRVVAALSCLVLLAFVAGITQAWARGLSIDCGCFGGGGDVAPGETRYPEELARDTGFLALAVWLLVRPRSLLSVDGWLGLGRPARDGDDGDDRDEPVPAES", "perc_identity": 37.93}}}